PROGRESS IN
Nucleic Acid Research and Molecular Biology Volume
73
This Page Intentionally Left Blank
PROGRESS IN
...
8 downloads
1048 Views
26MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
PROGRESS IN
Nucleic Acid Research and Molecular Biology Volume
73
This Page Intentionally Left Blank
PROGRESS IN
NucIeic Acid Research and Molecular Biology edited by
J. N. DAVIDSON
WALDO E. COHN
Department of Biochemistry The University of Glasgow Glasgow, Scotland
Biology Division Oak Ridge National Laboratory Oak Ridge, Tennessee
Volume
73
7973
ACADEMIC PRESS New York and London
COPYRIGHT 0 1973, BY ACADEMIC PRESS, INC. ALL RIGHTS RESERVED. NO PART OF THIS PUBLICATION MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM OR BY ANY MEANS, ELECTRONIC OR MECHANICAL, INCLUDING PHOTOCOPY, RECORDING, OR ANY INFORMATION STORAGE AND RETRIEVAL SYSTEM, WITHOUT PERMISSION IN WRITING FROM THE PUBLISHER.
ACADEMIC PRESS, INC.
111 Fifth Avenue,New York, New York 10003
United Kingdom Edition published by ACADEMIC PRESS, INC. (LONDON) LTD. 24/18 Oval Road, London NW1
LIEIRARY OF CONORESS CATALOO CARDNUMBER:63-15847
PRINTED IN THE UNITED STATES OF AMERICA
Contents
. . . . . . . . . . PREFACE. . . . . . . . . . . . . . . ABBREVIATIONS .4ND SYMBOLS . . . . . . . . . . SOMEARTICLESPLANNED FOR FUTURE VOLUMES . . . . . ERRATA . . . . . . . . . . . . . . . OBITUABYAAMES NORMAN DAVIDBON. . . . . . . .
.
.
ix
. .
. .
...
xi11
.
.
xvii
.
.
xix
.
.
xxi
I. Introduction . . , . . , . . . . . 11. Interaction of Formaldehyde with Bases, Nucleosides and Nucleotides 111. Interaction of Formaldehyde with Polynucleotides . . . . IV. Interaction of Formaldehyde with Nucleoproteins . . . . . V. Use of Reactions of Nucleic Acids and Nucleoproteins with Formaldehyde . . . . . . . . . . . . . . VI. Related Reactions and Their Effects (as Compared to Formaldehyde . . . . . . . . . . . . . Reactions) . VII. Conclusion . . . . . . . . . . . References . . . . . . . . . . .
1 3 15 30
LIST
OF
C~NTRIBUT~RS .
xi
Reactions of Nucleic Acids and Nucleoproteins with Formaldehyde
M. YA. FELDMAN
.
. .
.
.
.
.
.
. .
.
. .
35 40 44 44
Synthesis and Functions of the -C-C-A Terminus of Transfer RNA
MURRAY P. DEUTSCHER
.
. . .
. . .
I. Introduction . . . . . . . . . . 11. Location of the -C-C-A Terminus in the Three-Dimensional Structure of tRNA . . . . . . . . . . . . 111. Synthesis and Turnover of the -C-C-A Terminus in Vivo . . . IV. Enzymatic Synthesis of the -C-C-A Terminus in Vitro . . . . V. Role of the -C-C-A Terminus in tRNA Function . . . . . VI. Possible Control Functions of the -C-C-A Terminus of tRNA . . References . . . . . . . . . .
.
.
.
V
.
.
.
51
52 57
60 78 86 88
vi
CONTENTS
Mammalian RNA Polymerases
SAMSON T. JACOB I . Introduction . . . . . . . . . . . . . . 93 I1. Quantitative Extraction of RNA Polymerase from Mammalinn Cells 95 I11. Multiplicity. Nomenclature and Intranuclear Localixntion . . . 101 IV . Properties of RNA Polymerases . . . . . . . . . . 106 V . Subunit Structure and Molecular Weight . . . . . . . 112 VI . Regulation of RNA Polymerases . . . . . . . . . . 114 VII . Mitochondria1 RNA Polyrnerasc . . . . . . . . . . 117 VIII . Summary and Conclusions . . . . . . . . . . . 119 Notes Added in Proof . . . . . . . . . . . . 121 References . . . . . . . . . . . . . . . 121
Poly(adenosine diphosphate ribose)
TAKASHI SUGIMURA I . Introduction . . . . . . . . . I1. Chemical and Physical Properties of Poly(ADP-Rib) I11. Purification of Poly(ADP-Rib) . . . . . IV . Biosynthesis of Poly(ADP-Rib) . . . . . V . Biodegradation of Poly (ADP-Rib) . . . . VI . Natural Occurrence . . . . . . . . VII . Possible Biological Significance . . . . . VIII . Related Phenomena . . . . . . . . I X . Future Problems . . . . . . . . References . . . . . . . . . .
.
. .
.
. .
.
. .
. . . . . . . . . . . .
.
. .
. . . .
.
. .
. . . .
. . . . . . . . . . . . . . .
127 129 133 134 142 14.5 146 147 148 140
The Stereochemistry of Actinomycin Binding to D N A and Its Implications in Molecular Biology
HENRYM . SOBELL I . Introduction . . . . . . . . . . . . I1. Solution Studies of the Actinomycin-DNA Interaction . . I11. The Actinomycin-Deoxyguanosine Crystalline Complex . . IV . The ActinomycinaDNA Complex . . . . . . . V . A General Principle Governing Protein-Nucleic Acid Recognition VI . Possible Medical Implications . . . . . . . . VII . Summary . . . . . . . . . . . . . References . . . . . . . . . . . . .
. . . . .
.
. . . . . .
. . . .
153 155 158 165 178 187 158 189
vi i
CONTENTS
Resistance Factors and Their Ecological Importance to Bacteria and to M a n
M . H . RICHMOND I . Introduction . . . . . . . . I1. Resistance Factors and the Genes They Carry I11. Resistance Determinants . . . . . . IV . Other Plasmids Related to Resistance Factors V . The Mating Process . . . . . . . VI . Resistance Factor Transfer in Nature . . References . . . . . . . . .
.
.
.
.
.
.
. . . . . . . . . . . . . . . . . .
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
191 193 213 220 221 233 244
Lysogenic Induction
ERNESTBOREKAND ANN RYAN I . Introduction . . . . . . . . . . . I1. Historical . . . . . . . . . . . . I11. Dircct Methods for Inducing Lysogcns . . . . . IV. A Program Analysis of Early Phage Functions . . . V . Prophage Induction: A TwoStage Process . . . . VI . Indirect Modes of Induction . . . . . . . VII . Proposed Mechanisms for Lysogenic Induction in Bacteria VIII . Analogies in Mammalian Systems . . . . . . References . . . . . . . . . . . .
. . . . . . . . . . . .
.
.
.
. .
. .
. .
.
.
.
.
.
.
249 250 252 254 260 265 282 289 292
Recognition in Nucleic Acids and the Anticodon Families
.JACQUES NINIO I . Introduction . . . . I1. Remarks on Recognition . I11. The Wobble Hypothesis . . IV . The Missing Triplet Hypothesis V . The Experimental Evidence . VI . Discussion . . . . . References . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
301 303 312 317 327 333 335
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
339 340 341 348
. . . . . . . . . .
Translation and Transcription of the Tryptophan Operon
FUMIOIMAMOTO I . Introduction . . . . I1. Historical Background . . I11. Translation of the t r p Operon IV . Transcription of the trp Operon
...
CONTENTS
V ll l
V . Translation and Transcription of the trp Operon in Nonsensr Mutants of E. coli . . . . . . . . . . . VI . Effect of n Block in Translation on Transcription . . . . References . . . . . . . . . . . . .
. .
. . . .
377 398 402
lymphoid Cell RNA’s and Immunity
A . ARTHURG~TTLIEB I . Introduction . . . . . . . . . . . . . . I1. Historical Perspective . . . . . . . . . . . I11. Biosynthesis of RNA in Immunized Systems . . . . . . IV . Transfer of Immune Phenomena by RNA . . . . . . V . Nonspecific Stimulators of Immune Responses . . . . . VI . Macrophage RNA’s and Immunity . . . . . . . . VII . Possible Mechanisms of Action of RNA’s in the Immune Response VIII . A Hypothesis Regarding the Mechanism of Action of Antigen. . . . . . . . . Ribonucleoprotein Complexes IX. Conclusion . . . . . . . . . . . . . . Referencrs . . . . . . . . . . . . . . SUBJECTINDEX
. .
. . . . .
409 410 412 425 440 442 454
. .
.
457 459 480
. . . . . . . . . . . . . . .
467
CONTENTS OF PREVIOUS
VOLUMES
.
.
.
.
.
.
.
.
.
.
.
470
List of Contributors Numbers in parentheses refer to the pages on which the authors' contributions begin.
ERNESTBOREK(249), Department of Microbiology, University of Colorado Medical Center, Denver, Colorado MURRAY P. DEUTSCHER (51) Department of Biochemistry, University of Connecticut Health Center, Farmington, Connecticut
M. YA. FELDMAN ( l ) ,Institute of Molecular Biology, Academy of Sciences, MOSCOW, U.S.S.R. A. ARTHUR GOTTLIEB (409) Institute of Microbiology, Rutgers University, New Brunswick, New Jersey FUMIOIMAMOTO (339) Department of Microbial Genetics, The Research Institute for Microbial Diseases, Osaka University, Yamada-kami, Suita, Osaka, Japan SAMSON T. JACOB(93) Physiological Chemistry Laboratories, Department of Nutrition and Food Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts
NINIO(301), Laboratoire de Biochimie du De'veloppement, Faculte' des Sciences de Paris VII, Paris, France
JACQUES
M. H. RICHMOND ( l g l ) , Department of Bacteriology, University Bristol, Bristol, England
of
ANN RYAN(249),t Department of Microbiology, University of Colorado Medical Center, Denver, Colorado HENRYM. SOBELL(153) ,$ Department of Chemistry, The University of Rochester, Rochester, New York; and Department of Radiation Biology and Biophysics, The University of Rochester, School of Medicine and Dentistry, Rochester, New York
* Present address: Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey Medical Center, Hershey, Pennsylvania. i Deceased. $ Present address: Department of Pharmacology, Stanford University School of Medicine, Palo Alto, California. ix
X
LIST OF CONTRIBUTORS
TAHASHI SUGIMURA ( 127), Biochemistry Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, and Department of Molecular Oncology, The Institute of Medical Science, T o k y o Uwiwersity, Minato-ku, Tokyo, Japan
Preface Volume 13 of Progress in Nucleic Acid Research and Molecular Biology includes ten essays covering a wide spectrum in the nucleic acid field. We believe that our readers will find the contributions of topical interest and importance. They follow our usual pattern of attempting to present “essays in circumscribed areas” in which recent developments in particular aspects of the field of nucleic acids and molecular biology are discussed by workers provided with an opportunity for more personal expression of points of view that may be individualistic and perhaps even controversial. We have not attempted to define or restrict any author’s approach to his chosen subject, and have confined our editing to ensuring maximum clarity to the reader, whom we envisage to be a person himself active in or concerned with the general field of nucleic acids or molecular biology. Needless to say, we do not necessarily share all the opinions or concepts of all the authors and accept no responsibility for them. We seek rather to provide a forum for discussion and debate, and we welcome further suggestions from readers as to how this end may best be served. Indeed, we should like again to remind readers that we wish them to write to us with their comments. Abbreviations and symbols used for nucleic acids and their derivatives are now well established by the authority of the Combined Commission on Biochemical Nomenclature (CBN) of the International Union of Biochemistry (IUB) and the International Union of Pure and Applied Chemistry (IUPAC). Those pertinent to our subject are not usually listed a t the beginning of each chapter, but are listed on the following pages. I n this volume, in the interests of conserving space and reducing costs, we have made an innovation by simplifying the contractions for the titles of some of the most commonly cited journals. A list of these is appended to the section on abbreviations and symbols. We hope that this new usage will be acceptable to our authors and readers alike.
J. N. D. W. E. C.
xi
This Page Intentionally Left Blank
Abbreviations and Symbols All contributors to this Series are asked to use the terminology (abbreviations arid symbols) recommended by the IUPAC-IUB Commission on Biochemical Nomenclature (CBN) and approved by IUPAC and IUB, and the Editors endeavor to assure conformity. These Recommendations have been published in many journals (I) and compendia (5)in four languages and are available in reprint form from the NAS-NRC Ofice of Biochemical Nomenclature (OBN), as stated in each publication, and are therefore considered to be generally known. Those used in nucleic acid work, originally set out in section 5 of t,he above Recommendations ( 1 ) and recently revised and expanded (2-4), are given in condensed form (I-V) below for the convenience of the reader.
I. Bases, Nucleosides, Mononucleotides 1. Bases (in tables, figures, equations, or chromatograms) are symbolized by Ade, Gua, Hyp, Xan, Cyt, Thy, Oro, Ura; Pur = any purine, Pyr = any pyrimidine, Base = any base. The prefixes S-, H,, F-, Br, Me, etc., may be used for modifications of these. 2. Ribonueleosides (in tables, figures, equations, or chromatograms) are symbolized, in the same order, by Ado, Guo, Ino, Xao, Cyd, Thd, Ord, Urd (Urd), Puo, Pyd, Nuc. Modifications may be expressed as indicated in (1)above. Sugar residues may be specified by the prefixes r (optional), d ( = deoxyribo), a, x, 1, etc., to these, or by two threeletter symbols, as in Ara-Cyt (for aCyd) or dRib-Ade (for dAdo). 3. Mono-, di-, and triphosphutes of nucleosides (5‘) are designated by NMP, NDP, NTP. The N (for “nucleoside”) may be replaced by any one of the nucleoside symbols given in 11-1 below. 2’-, 3’-, and 5’- are used as prefixes when necessary. The prefix d signifies “deoxy.” [Alternatively, nucleotides may be expressed by attaching P to the symbols in (2) above. Thus: P-Ado = AMP; Ado-P = 3’-AMP.] cNMP = cyclic 3‘: 5‘-NMP.
11. Oligonucleotides and Polynucleotides 1. Ribonucleoside Residues (a) Common: A, G, I, X, C, T, 0, U, U, It, Y, N (in the order of 1-2 above). (b) Base-modified: sI or M for thioinosine = 6-mercaptopurine ribonucleoside; sU or S for thiouridine; brU or B for 5-bromouridine; hU or 1) for 5,Gdihydrouridine; i for isopentenyl; f for formyl. Other modifications are similarly indicated by appropriate lower-ease prefixes (in contrast to 1-1 above) (8, 3). (c) Sugar-modified: prefixes are d, a, x, or 1 as in 1-2 above; alternatively, by italics or boldface type (with definition) unless the entire chain is specified by an appropriate prefix. The 2’-O-methyl group is indicated by suflz m (e.g., -Am- for 2’-O-methyladenosine, but -mA- for N-methyladenosine). (d) Locants and multiplien, when necessary, are indicated by superscripts and subscripts, respectively, e.g., - 4 A - = Gdimethyladenosine; - s W - or -‘s-= 4-thiouridine; -a“= 2’-O-methyl-P-acetylcytidine. (e) When space is limited, 89 in two-dimensional arrays or in aligning homologous sequences, the prefixes may be placed over the capital letter, the suffixes over the phoaphodiester symbol. xiii
xiv
ABBREVIATIONS AND SYMBOLS
2. Phosphoric Acid Residues [left side
= 5’,
right side
= 3’
(or 2’)
I
.
(a) Terminal: p; e.g., pppN . . is a polynucleotide with a 5‘-triphosphate a t one end; Ap is adenosine 3’-phosphate; C > p is cytidine 2’:3‘-cyclic phosphate (1,6,3). (b) Internal: hyphen (for known sequence), comma (for unknown sequence); unknown sequences are enclosed in parentheses. E.g., pA-G-A-C(C2,A,U)A-U-G-C > p is a sequence with a (5’) phosphate at one end, a 2’: 3’-cyclic phosphate a t the other, and a tetranucleotide of unknown sequence in the middle. (Only codon triplets are written without some punctuation separating the residues.)
3. Polarity, or Direction of Chain The symbol for the phosphodiester group (whether hyphen or comma or parenthesis, as in 2b) representg a 3’-5’ link (i.e., a 5‘ . 3’ chain) unless otherwise indicated by appropriate numbers. “Reverse polarity” (a chain proceeding from a 3’ terminus at left to a 5’ terminus at right) may be shown by numerals or by right-to-left arrows. Polarity in any direction, as in a two-dimensionalarray, may be shown by appropriate rotation of the (capital) letters so that 5’ is a t left, 3’ a t right when the letter is viewed right-side-up.
..
4. Synthetic Polymers The complete name or the appropriate group of symbols (see 11-1 above) of the repeating unit, enclosed in parentheses if complex or a symbol, is either (a) preceded by ‘‘poly,” or (b) followed by a subscript “n” or appropriate number. No epace follows “poly” (8, 6). The conventions of 11-2b are used to specify known or unknown (random) sequence, e.g.1
polyadenylate = poly(A) or (A),,, a simple homopolymer; poly(3 adenylate, 2 cytidylate) = poly(AIC2) or (AI,CZ)., a random copolymer of A and C in 3:2 proportions; poly(deoxyadenylabdeoxythymidy1ate) = poly [d(A-T)]or poly (dA-dT)or (dA-dT), or d(A-T),, an allernuting copolymer of dA and dT; poly(adenylate, guanylate, cytidylate, uridylate) = poly(A,G,C,U) or (A,G,C,U)., a random assortment of A, G, C, and U residues, proportions unspecified. The prefix copoly or oligo may replace poly, if deaired. The subscript ‘WJ may be replaced by numerals indicating actual size.
111. Association of Polynucleotide Chains 1. Associated (e.g., H-bonded) chains, or bases within chains, are indicated by a center dot (not a hyphen or a plus sign) separating the comp2ete names or symbols, e.g. : P O ~ Y(A).poly (U1 or (A),. (U )m poly(A).2 poly(U) or (A)n+2(U)m poly(dA-dC).poly(dG-dT) or (dA-dC)..(dG-dT),; also, “the adeninethymidine base-pair” or “A-T base-pair” in text. 2. Nonasaociated chains are separated by the plus sign, e.g. : 2boly(A).poly(U)I 5 polyW.2 poly(U) poly(A) (1I-W or 2[An.Um]5 A..2U, A,, (114b). 3. Unspecified or unknown association is expressed by a comma (again meaning “unknown”) between the completely specified residues. Note: In all cases, each chain is completely specified in one or the other of the two systems described in 11-4 above.
+
+
xv
ABBREVIATIONS AND SYMBOLS
IV. Natural Nucleic Acids ribonucleic acid or ribonucleate deoxyribonucleicacid or deoxyribonucleate messenger RNA; ribosomal RNA; nuclear RNA “DNA-like” RNA; complementary RNA mitochondrial DNA transfer (or acceptor or amino acid-accepting) RNA; replaces sRNA, which is not to be used for any purpose aminoacyl-tRNA “charged” tRNA (i.e., tRNA’s carrying aminoacyl reaidues); may be abbreviated to AA-tRNA tRNA normally capable of accepting alanine, to form alanine tRNA or alanyl-tRN A tRNAA’a, etc. The same, with alanyl residue covalently attached. alanyl-tRNA or [Note: fMet = formylmethionyl; hence tRNA1M.t or alanyl-tRNAA1a tRNAP*l Isoacceptors are indicated by ‘appropriate subscripts, i.e., tRNA;”, tRNA:’&, etc. RNA DNA mRNA; rltNA; nRNA D-RNA; cRNA mtDNA tRNA
V. Miscellaneous Abbreviations Pi, PPi inorganic orthophosphate, pyrophosphate RNase, DNase ribonuclease, deoxyribonuclease Others listed in Table I1 of Reference 1 may also be used without definition. No others, with or without definition, are used unless, in the opinion of the editors, they increase the ease of reading.
Enzymes In naming enzymes, the recommendations of the IUB Commission on Enzymes, approved by IUB in 1964 (4), are followed as far as possible. At first mention, each enzyme is described either by its systematic name or by the equation for the reaction catalyzed, followed by its EC number in parentheses. Subsequent mention may use a trivial name. Enzyme names are not to be abbreviated except when the substrate has an approved abbreviation (e.g., ATPase, but not LDH, is acceptable). REFERENCES* 1. JBC 241, 527 (1966);Bchem 5, 1445 (1966);BJ 101, 1 (1966);ABB 115, 1 (1966), 129, 1 (1969);and elsewhere.t 8. EJB 15, 203 (1970);JBC 245, 5171 (1970);J M B 55, 299 (1971);and eh3ewhere.t
S. “Handbook of Biochemistry” (H. A. Sober, ed.), 2nd ed. Chemical Rubber Co., Cleveland, Ohio, 1970,Section A and pp. H130-133. 4. “Enzyme Nomenclature,” Elsevier Publ. Co., New York, 1965. [Revision under construction.] 6. “Nomenclature of Synthetic Polypeptides,” JBC 247, 323 (1972);Bwpolymem 11, 321 (1972);and e1sewhere.t
* Contractions for names of journals follow. t Reprints of all CBN Recommendations are available from the Office of Biochemical Nomenclature (W. E. Cohn, Director), Biology Division, Oak Ridge National Labors tory, Box Y, Oak Ridge, Tennessee 37830, USA.
xvi
ABBREVIATIONS AND SYMBOLS
Abbreviations of Journal Titles
Journals
Abbreviations w e d
Annu. RRv. Biochem. Arch. Biochem. Biophys. Biochem. Biophys. Res. Commun. Biochemistry Biochem. J. Biochim. Biophys. Acta Cold Spring Harbor Symp. Quant. Biol. Eur. J. Biochem. Fed. Proc. J. h e r . Chem. SOC. J. Bacteriol. J. Biol. Chem. J. Chem. SOC. J. Mol. Biol. Proc. Nat. Acad. Sci. U.S. Proc. SOC.Exp. Biol. Med.
ARB ABB BBRC Bchem BJ BBA CSHSQB EJB FP JACS J. Bact. JBC JCS JMB PNAS PSEBM
Some Articles Planned for Future Volumes DNA Modification and Restriction
W. ARBER Mechanisms in Polypeptide Chain Elongation on Ribosomes
E. BERMEKAND H. hfATTHAEI Primary Structure of Ribosomal RNA
P. FELLNER Bacterial Ribosomal Proteins
R. A. GARRETT,K. NIERHAUS, AND H. G. WITTMAN DNA Polymerases II and Ill
M. L. GEFTER RNA-Directed DNA Polymerases
M. GREENAND G. GERARD Initiation of Protein Synthesis
M. GRUNBERG-MANAGO AND F. GROS Immunogenic Polynucleotides
L. D. HAMILTON X-Ray Diffraction Studies of Nucleic Acids and Their Components
R. LANGRIDGE, E. SUBRAMANIAN, AND P. J. BOND Base Sequence Determination in DNA
K. MURRAY AND R. W. OLD Mechanism of Bacterial Transformation and Transfection
J. K. SETLOWAND N. K. NOTANI Chemistry of Alkylation and Its Relationship to Mutagenesis and Carcinogenesis
B. SINGER Structure and Function of Viral RNA
C. WEISSMAN Aliphatic Polyomines and the Regulation o f Macromolecular Biosynthetic Reaction in Eukaryotes
H. G. WILLIAMS-ASHMAN AND A. CORTI xvii
This Page Intentionally Left Blank
Errata Volume 12
Page 56. Thc structurcs for 11 and 111 should he cxchangcd with cach other.
Pages 63 arid 67. Structures of 2-mcthyladenosine and l-mcthylguanosine should appcar on pagc 67, and structures VIII and IX should appear on page 63. Page 75, Table V. Codon recognition of tRNAp’ should be as shown below.
-
xix
JAMES NORMAN DAVIDSON
James Norman Davidson 191 1-1972
Professor Norman Davidson, Gardiner Professor of Biochemistry in the University of Glasgow since 1948, died a t his home on September 11th at the age of 61. Dux of George Watson’s College in Edinburgh, he won a scholarship in medicine to the University of Edinburgh where he graduated B.Sc. with 1st Class Honours in Chemistry in 1934 and M.B. Ch.B. with Honours in 1937. Even by this time his interests had come to lie in the laboratory and in 1937 he was awarded a Carnegie Fellowship to work a t the Kaiser Wilhelm Institut fur Zellphysiologie in Berlin under the direction of Otto Warburg. On his return to Britain in 1938 he was appointed to a lectureship in Biochemistry a t the University of St. Andrews, a t University College Dundee, and in 1939 he received the degree of M.D., from Edinburgh University, for a thesis on the enzyme uricase. At the outbreak of war he became interested in the so-called “wound hormones.” This led him to learn the techniques of tissue culture and to his first investigations of the nucleic acids. In 1940 he moved to the University of Aberdeen where he continued his work on tissue culture and nucleic acids, and it was during the period 1940-1945 that he demonstrated that deoxyribonucleic acid and ribonucleic acid were normal constituents of both plant and animal cells. In 1945 he was awarded the degree of D.Sc. by Edinburgh University for work on cellular proliferation, and in the same year he joined the scientific staff of the Medical Research Council in London. After only one year he was appointed Professor of Biochemistry a t St. Thomas’ Hospital Medical School. Norman Davidson always felt very strongly about the effect on Scotland of the drain of trained personnel to the south and overseas and it is not surprising that in 1947 he accepted the offer of appointment to the Gardiner Chair of Physiological Chemistry in the University of Glasgow. Under his influence the department at Glasgow flourished and grew to an independent department of biochemistry second to none in Britain and with an international reputation for research, particularly in the fields of nucleic acids and cell culture. Work in Glasgow showed that deoxyribonucleic acid was largely confined to the cell nucleus while ribonucleic acid occurred in both the nucleus and the cytoplasm. Major contributions were also made to the demonstration of the conxxi
xxii
JAMES NORMAN DAVIDSON
stancy in the amount of deoxyribonucleic acid per avcrage cell in the somatic cells of any given species and to our present understanding of the mechanisms of biosynthesis of both deoxyribonucleic acid and ribonucleic acid in normal, malignant, and virus-infected cells. An outstanding teacher and research worker himself, Norman Davidson held very strong views on the importance of teaching and research in university departments and of the place of biochemistry in relation to medicine and science. As an administrator he had a remarkable capacity for grasping the main objectives clearly while dismissing the trivia and remaining aware of all the relevant matters of detail. He took a keen interest in other areas of science and medicine and was active in the affairs of many medical and scientific societies. In 1960 he was elected a Fellow of the Royal Society and he served two terms as President of the Royal Society of Edinburgh. He was for a time Secretary and later Chairman of the Committee of the Biochemical Society, and among other societies in which he took a particular interest were the Association of Clinical Biochemists, the European Molecular Biology Organization, the Institute of Biology, and the Nutrition Society. I n 1967 he was made a Commander of the British Empire for his services to science in the United Kingdom. I n addition to his own contributions in the field of nucleic acids, he was the author of a monograph (“The Biochemistry of the Nucleic Acids”), which has run to seven editions and is to be found on the bookshelves of all workers in this field throughout the world. With Erwin Chargaff he edited a three-volume series, “The Nucleic Acids,” which for many years served as one of the most important reference works in the field, and with Waldo Cohn he has been editor of the serial publication “Progress in Nucleic Acid Research and Molecular Biology.” His writings, however, were not restricted to the nucleic acid field and he was joint author of a textbook of physiology and biochemistry intended principally for medical students. He was at various times a guest lecturer a t many European and American universities and was well known in universities and research institutes throughout the world. His counsel and advice were widely sought by many official bodies and private individuals and he gave willingly of his time where he knew that he was able to make a useful contribution. The strain of all these activities took its toll on his health and a t the peak of his career he was beset by illness. He would not allow this, however, to prevent him from playing a full part in the affairs of his department and the university. Norman Davidson will be remembered by his friends not only for his energy, his powers of organization, his grasp of his subject, his clarity and incisiveness in the lecture theatre or in debate, but as a man who
xxiii
JAMES NORMAN DAVIDSON
was courteous, kindly, warm-hearted and generous. His death is a serious loss to the scientific community in general and more particularly to biochemistry, the field of nucleic x i d s , his university, and his department.
R. M. S. SMELLIE The U n i v e r d y Glasgow, Scotlnird
This Page Intentionally Left Blank
Reactions of Nucleic Acids and Nucleoproteins with Forma Idehyde'
I
M. YA. FELDMAN Institute of Molecular Biology, Acrtdemy of Scie)ices, iMoscoto, V.S.S.R.
I. Introduction . . . . . . . . . . . . . 11. Interaction of Formaldehyde with Bases, Nuclcosides and Nucleotides . . . . . . . . . . . . . . A. Primary Reactions : Formation of Methylol Derivatives, R--CH?OH . . . . . . . . . . . . . 13. Secondary Rciictions: Formntion of Metliylcne Dinucleotides, R-CHL-R' . . . . . . . . . . . . 111. Interaction of Formaldchydc with Polynuclrotidcs . . . . A. Synthetic Polynucleotidcs . . . . . . . . . B. Ribonucleic Acids . . . . . . . . . . C. Deoxyribonucleic Acids . . . . . . . . . . D. Effect of Secondary Structure . . . . . . . . E. Effect of Formaldehyde on thc Functional Activity of Nuclcic Acids . . . . . . . . . . . . . . IV. Interaction of Formaldcliyde with Nucleoproteins . . . . . A. Formation of Mcthylene Bridges in thc Reaction of Protein with . . . . . . . Formaldeh ydc B. Effect of Formaldehyde on Nuclcoprotcins . . . . . V. Use of Reactions of Nucleic Acids and Nucleoproteins with Formaldehydt . . . . . . . . . . . . A. Structural and Functional Studics of Nidcic Acids . . . B. Inactivation of Viruses by Formoldchydc in Vaccine Production. C. Effect of Formaldehyde on the Genetic Aplmratus of thc Cell . VI. Related Reactions and Thcir Effects (:I* Compsred to Formaldc. . . . . hyde Reactions) . . . A. Miscellanc~ousAldehydes . . . . . . . . . . B. Difunctional Alkylating Agents . . . . . . . . VII. Conclusion . . . . . . . . . . . . . . References . . . . . . . . . . . . .
.
.
. .
. . . .
.
. . . . .
1 3 3 10 15 15 16 19
m
28 30 30 33 35 35 36
38 40 40 42 44 44
1. Introduction Three main reiLsons for the chemical modification of nucleic acids can be singled out in a review of the information available on modifying agents. These agents are used for inactivations of various kinds (such as inactivation of viral RNA or of cytostatic action), for directed functional Translntcd by A. L. Pumpinnsky, Moscow. 1
2
M. YA. FELDMAN
changes of nucleic acids in vivo (mutagenesis, oncogenesis) and for the elucidation, through resulting modification, of structural and functional characteristics peculiar to synthetic or native polynucleotides. Some of these agents can be useful for one, two or all three of these purposes. One of the few agents that serves all three of them is formaldehyde. It is widely used as an inactivator of viruses to obtain vaccines ( I ) and is reported to exert a cytostatic (carcinostatic) effect (a). It is also one of the most promising mutagenic agents affecting multicellular organisms (3, 4 ) . Formaldehyde is used extensively in structural and functional studies of nucleic acids as an agent not so much for causing denaturation as for preventing renaturation, and as a fixator of nucleic acids and nucleoproteins in electron microscope and sedimentation investigations. The use of nucleic acid reactions with formaldehyde has outstripped our knowledge of their mode of action. In many cases a chemical mechanism was postulated for some biological or physical effect that could not plausibly be substantiated, and such diverse products as Schiff bases (5-7), monomethylol derivatives (RNH-CH,OH) (8,9), (R-N=CH,) mono- and dimethylol (R-N(CH,OH) *) derivatives ( l o ) , as well as methylol and methylene (RNH-CH,-NHR) compounds (11-13) were suggested., Recently some progress in the structural study of formaldehyde interaction products with nucleotides and nucleic acids has been made. Evidence has been presented that the reactions proceed according to the following scheme:
A '
0 -NH RNH, RNH-CHZOH
A '
+ CHZO F? 0 -N-CHzOH + CHzO + RNH-CHIOH + RNHZ + RNH-CHz-NHR
4-HzO
(14 (1b) (2)
Reaction ( l a ) proceeds with the participation of the -CO-NH- grouping of pyrimidine and purine heterocycles. In reaction ( l b ) , formaldehyde interacts with the exocyclic amino groups of AMP, GMP and CMP. Reaction (2) involves aminopurines only. This review is the first attempt to sum up the data available on the interaction of formaldehyde with nucleic acids and nucleoproteins with particular emphasis on the evidence for the formation of various structures and the molecular mechanisms of biological and other effects of formaldehyde. *Useful information on formaldehyde chemistry is provided by Walker in his book (14).
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
3
II. Interaction of Formaldehyde with Bases, Nucleosides and Nucleotides
A. Primary Reactions: Formation of Methylol Derivatives, R-CH OH The reactions described in this section were discovered by FraenkelConrat in 1954 ( 5 ) . They result in labile noncrystallizable compounds found only in solutions also containing starting compounds (formaldehyde and the nucleic base or its derivative). The reaction product is readily dissociated on simple dilution. However, it was later shown (15, 16) that these reactions are not the only ones to occur when formaldehyde acts on bases or nucleotides. When the reaction mixtures are allowed to stand for many days, the labile (hydroxymethyl or methylol) derivative reacts with the starting base present in the mixture [Eq. ( 2 ) ] to form a methylene bis-compound as the end product. The formation of methylene derivatives does not affect the investigation of primary (methylol) derivatives, the former appearing much later. Some methylene derivatives are precipitated quantitatively ( 1 5 ) . 1. FUNCTIONAL GROUPS
The question, what functional groups react with formaldehyde, was formerly settled by comparing different bases, nucleosides and nucleotides. The comparison was made by means of two tests involving the spectral changes of bases under the action of formaldehyde ( 5 ) and the quantitative estimation of the formaldehyde added (12). Reactions were essentially carried out in neutral buffered aqueous medium a t room temperature for 24-48 hours. I n this time, the primary reaction was almost completed whereas the products of the secondary reaction were still practically absent. The resulting data are presented in Table I. I n all cases studied, compounds containing amino groups reacted with formaldehyde with a marked change in the ultraviolet spectrum, the maximum shifting to longer wavelengths by 3-5 nm and its intensity rising by about 20%. Similar spectral changes occur when formaldehyde acts on deoxyribonucleotides containing amino groups (6). The data presented in the last column of Table I indicate the participation in the reaction not only of the exocyclic groups, but also of the NH-groups in position 9 (or 7) of purines and, possibly, in position 1 of pyrimidines (e.g., in hypoxanthine, 1,3-dimethylxanthine, 2,6,8-trichloropurine, uracil). No reaction takes place if the hydrogen atoms in these positions are replaced by methyl or ribosyl residues (inosine, 1,9-di- and 1,3,9-trimethylxanthine, uridine) .
4
M. YA. FELDMAN
TABLE IR INTERACTION OF PYRIMIDINE AND PURINE DERIVATIVES WITH FORMALDEHYDE IN NEUTRAL AQUEOUS SOLUTION AT ROOM TEMPERATURE AND RELATIVELY Low CONCENTRATION OF CHsO. PRIMARY REACTION (24-48 HOURS) Spectral changes in the presence of 1-2% CHzO (6) Increase of
Compound
emax
(%I
Formaldehyde bound (mole per Shift of XmRx to 100 moles of longer wave- purine or pyrimilength dine derivative)b (nm1 (18)
Pyrimidine derivatives
Uracil Thymine 1,3-Dirnethyluracil Uridine Uridylic acid Cytosine 2-Amino-4-ox yp yrimidine (isocytosine) 2-Aminop y rimidine Cytidylic acid
None None
-
None None -
1 3 None None
-
-
16
3
4 2 0 0
11
5 10
-
Purine derivatives
Adenine Adenosine Adenylic acid Guanylic acid Hypoxanthme 1,3-Dimethylxanthine 2,6,8-Trichloropurine Inosine 1,g-Dimethylxanthine 1,3,9-Trirnethylxanthine
23 19 22 5 -
5 5 5 5
-
-
20
10 9 13 10 9 24 0 1 0
Nucleic acida
RNA (TMV) DNA (thymus)
29 None
3 None
-
Reproduced by permission of Elsevier Publishing Co., Amsterdam. concentrations of reagents were 0.01 M. The free formaldehyde was determined (17,18) and the bonded aldehyde was calculated as the difference between the overall and free formaldehyde. 4
* The initial
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
5
It was later shown that the experiments listed in Table I failed to take into account the reaction of formaldehyde with ring NH-groups in position 3 of pyrimidines and 1 of purines, seemingly owing to the relatively low formaldehyde concentration used. At high CH,O concentrations, the absorption spectra of nucleosides with no NH,-group change slightly, thus indicating that they react with formaldehyde. The ultraviolet maxima for uridine and thymidine in 3.3M formaldehyde solution (pH 6.9) decrease by 2% and are shifted to longer wavelength by 2 nm (18). The spectra of uridylic and polyuridylic acids (18, 19) as well as that of inosine (20) reveal similar changes. These changes are believed to be caused by addition of formaldehyde to the N-3 of uridine and the N-1 of inosine. The respective N-1 and N-9 positions must be excluded as they are blocked by ribose residues. That the spectral changes cannot result from formaldehyde addition to C-5 was shown by experiments with thymidine (18), whose spectral changes with formaldehyde were similar to those for uridine, in spite of its blocked C-5 position. The reported spectral data (18-20) do not allow for possible formaldehyde interaction with hydroxyl groups of bases and ribose. The spectral analysis of pseudouridine with different formaldehyde concentrations suggested (18) that, in compounds containing two unsubstituted NH-groups in the ring (pseudouridine, uracil, thymine), both groups react. The participation of ‘
PH
FIG.1 . Titration of 0.00227 M adenine hydrochloride solution, with (B) and without (A) added formaldehyde (0.34%) at 19”C,by aqueous sodium hydroxide (21). By permission of the Chemical Society, London.
6
M. YA. FELDMAN
(9.8) is shifted upward ( 2 1 , 2 2 ) .I n the first case, the pH depression arises from the interaction of the free amino groups with formaldehyde, similar to the reaction of formaldehyde with other amines, in particular with amino acids. I n the region of the acidic dissociation constant (pKg), arising from the g-NH-group, the pH is raised by the following mechanism:
\NH
/
+F
\NHI:
/
[see (19-23)]. The pK values (ca. 4) of cytidylic ( 2 4 ) , adenylic and polyadenylic (25) acids are also lowered by formaldehyde, additional proof of the interaction of formaldehyde with the amino groups of nucleotides. A marked shift of the titration plot to higher p H is observed in the pI(, region of the NH-groups of inosine (20) and of uridylic and polyuridylic acids (19). This fact, together with spectral evidence, proved the interaction of formaldehyde and compounds containing the HN3-C40
I I
grouping in the pyrimidines or the HN1-CEOgrouping in the purines.
I I
A reaction of formaldehyde with the hydroxyl groups of uracil in the tautomeric form is excluded because the pH of solutions of compounds containing “acidic” hydroxyl groups, such as phenol, is not affected on formaldehyde addition whereas such a change is typical of compounds containing amino and imino groups ( 2 1 ) .Titration data do not indicate a participation of the N-1 of adenine in the formaldehyde reaction (22, 25), nor does spectral evidence (see Section 11, A, 2). Formaldehyde addition to the C-5 of uracil (26) (resulting in the formation of a crystalline product, 5-hydroxymethyluracil) takes place in the presence of 0.42 M KOH (73 hours a t 50°C) or 0.5 M HCl (reflux for 25 hours). To prepare 5-hydroxymethyl derivatives of uridylic and cytidylic acids, even more rigorous conditions were used (27). The results on the reaction of formaldehyde with sugars in neutral aqueous medium (14) do not unequivocally exclude the interaction of formaldehyde with the hydroxyl groups of ribose and deoxyribose to form labile semiacetals (R-0-CH,OH) . There is, however, no evidence that such an interaction does actually take place. In any case, low concentrations of CH,O (0.01 M ) do not react in a measurable amount with D-ribose and D-2-deoxyribose (12). Under ordinary conditions, if the nucleotides are not destroyed, their phosphate groups are unlikely to
7
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
react with formaldehyde [on formaldehyde reactions with phosphoric acid, see (14)1. It can thus be concluded that a t a pH close to neutral, formaldehyde reacts with the NH,- and NH-groups marked in formulas I-IV with asterisks.
Rib
Rib
(n)
(1)
NH;
0
I
Rib
(III)
Rib
(IV)
This scheme can be considered as proved for uridine ( I ) , cytidine (11) and adenosine (111) but not as conclusively for guanosine (IV). When the ribose residue is replaced by hydrogen, the glycosyl nitrogen a t position 1 of the pyrimidine bases and position 9 of the purine bases can also be attacked by CH,O. 2. SUBSTANTIATION OF THE FORMATION OF MONOMETHYLOL
DERIVATIVES The identification of the primary products of the reaction of formaldehyde with bases and nucleotides is made difficult by their lability. There exists only indirect, spectral and kinetic, proof that these products are monomethylol derivatives (>NCH,OH) . a. Spectral Evidence. Michelson and Grunberg-illanago (65) synthesized N6-hydroxyethyladenylic and poly ( No-hydroxyethyladenylic) acids and found their spectra to be similar to those of adenylic and polyadenylic acids treated with formaldehyde (1% CH,O, pH 6.8, 2.5 hours a t 37"). The similarity shows that the formaldehyde reaction with adenylic and polyadenylic acids most likely gives rise to hydroxymethyl (monomethylol, -NH-CH,OH) derivatives rather than to Schiff bases (-N=CH,) , As No-hydroxyethyladenylic and poly (Ns-hydroxyethyl-
8
M. YA. FELDMAN
adenylic) acids do not react with formaldehyde (the spectra remaining unaffected on addition of CH,O), formaldehyde is unlikely to react with adenylic and polyadenylic acids to give N6-dialkyl derivatives. Similar results were reported by Scheit (28). 2',3'-O-Isopropylidene cytidine reacted with formaldehyde (pH 7, 37°C) to give a product that could be separated chromatographically from the starting product on a thin silica gel layer. The ultraviolet spectrum of this product was found to be similar to that of isopropylidene N6-hydroxyethylcytidine. The latter compound failed to react with formaldehyde. It follows from this that formaldehyde reaction with isopropylidene cytidine leads to isopropylidene N6-hydroxymethylcytidine (V) rather than to a bis (N6hydroxymethyl) derivative. HN-C&OH
I
H,C0 x 0 CH,
The formaldehyde addition products with AMP (25) and isopropylidene adenosine (28) have spectra similar to those of No-methyladenosine (maximum shift to long wavelengths and increased absorption in the maximum as compared to adenosine in both acidic and alkali media), but different from those of N1-methyladenosine. This fact leads again to the conclusion that in the formaldehyde reaction alkylation proceeds a t the 6-amino group rather than N-1. b. Kinetic Evidence. The results from the kinetic study of the primary reaction only (at the early stage of the interaction) are in fair accord with the conception that one NH,-group reacts with one formaldehyde molecule (6, 8, 29). The same result is also always observed from the analysis of pH shifts and spectral changes due to formaldehyde interaction with ring NH-groups (18-23).In the latter case, the l-to-1 ratio points unambiguously to the formation of the structure >NCH,OH, because another derivative allowing for the same ratio, the Schiff base, cannot be produced in the reaction with NH-groups. The proof for the formation of monomethylol derivatives obtained
9
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
(SO) by the kinetic study of the overall conversion of adenosine in the primary and secondary reactions is presented in Section 11, B, 1.
3. PROPERTIES OF METHYLOL DERIVATIVES
It has been noted above that these compounds are extremely labile and dissociate into the starting components on simple dilution of the reaction mixtures. Since this dissociation takes place under chromatographic conditions, few workers (31, 28) have succeeded in observing the separation of hydroxymethyl derivatives from the starting compounds on chromatography or electrophoresis. When equimolar concentrations of reagents are used, the amount of formaldehyde bound to nucleotides and bases is much lower than would be expected from considerations of equivalency (see Table I). Spectral changes (8, 22, 19, 18) and the shift of titration plots (24,22,19) increase up to a certain limit as the formaldehyde concentration is raised. This dependence on concentration is used to estimate the equilibrium constants presented in Table 11. It will be seen that various authors have obtained almost the same results by different methods. The reaction constants for the ring NH-groups are much lower than those for the exocyclic amino TABLE I1 EQUILIBRIUM CONSTANTS (K = [RCH20H]/[RH].[CH20])OF PRIMARY FORMALDEHYDE REACTIONS WITH NUCLEOSIDES AND NUCLEOTIDES Compound reacting with CHzO
Reaction conditions
Adenosine
pH 4.8; room temp.
Adenosine
pH 7.3; room temp.
Adenylic acid 5'-AMP 5'-dAMP 5'-CMP 5'-dCMP Uridine 5'-UMP
pH 7.3; room temp.
Inosinic acid 4
pH 7.05; room temp. pH 7.05; room temp. pH 7.05; room temp. pH 7.05; room temp. pH 6.6; 23°C pH 4.7; 20°C 20°C 40°C pH 6.6; 23°C
K Method Quantitative analysis of the reaction products Quantitative analysis of the reaction products Quantitative analysis of the reaction products UV spectrophotometry UV spectrophotometry UV spectrophotometry UV spectrophotometry UV spectrophotometry UV spectrophotometry Titration Titration UV spectrophotometry
(1.mole-1)
Reference
15.8
30
12.3
a
10.9 11.4 11.3 16.6 15.5 2.5
2.6 2.42 1.35 1.7
K is calculated from data (18) listed in the last column of Table I.
(I
8 8 8 8 18 19
19 19
18
10
M. YA. FELDMAN
groups. No results for uracil (23) and guanylic acid (8) are given, for further studies have indicated that formaldehyde may add to each of these substances in two positions rather than one, as previously suggested (see Section 11, A, 1). In the reactions with the NH-groups of nucleosides and poly(U), the equilibrium is reached in less than 30 seconds (18).At room temperature and in a neutral medium, the primary reactions of CH,O with NH,-groups are close to equilibrium in 1-2 days, The adenosine reaction with formaldehyde a t pH 4.8 and 20°C attains equilibrium in 72 hours (SO). Kinetic analysis of spectrophotometric data reveals (69) that as the temperature is raised from 30" to 45°C the formaldehyde interaction with adenosine and poly(A) in a neutral medium is accelerated in both the direct and reverse reactions, the reaction rates increasing from 5 to 10 times. The values of the equilibrium constants for the primary formaldehyde reaction with bases and nucleotides fall with rising temperature as first observed in the titration of the NH,- and 9-NH-groups of adenine (22, 23) and the NH-group of uridylic acid (19).The decreased K for 5'-UMP when the temperature is raised from 20" to 40°C is exemplified in Table 11. This evidence was substantiated spectrophotometrically for mixtures of formaldehyde with AMP and CMP over a wide temperature range, from 15" to 85"C, a t p H 7.5 (32) as well as for CH,O and adenosine (30"-45") (29). Higher temperature never affects the extent of the reaction markedly, and in experiments with G M P (32) and poly (A) (29), the reaction is practically unaffected. There are insufficient results on the influence of hydrogen ion concentration to warrant any general conclusions. Lowering the pH to 2.4 to the acidic side or raising it to 10.8 to the alkaline side does not increase formaldehyde bonding to adenine, adenosine, adenylic acid, hypoxanthine, or thymine. On the contrary, even a t these pH values the amount of formaldehyde bound is lower than that in neutral solution (12). From spectrophotometric results (8), the primary CH,O reactions with nucleotides involving the NH,-group, equilibrium is attained a t the same rate over the pH range of 4 to 8, whereas at pH 10 it is sharply increased. It was shown spectrophotometrically that changing the concentration of the neutral phosphate buffer does not affect ( I I ) , or only weakly affects (8),the interaction of formaldehyde with nucleotides.
B. Secondary Reactions: Formation of Methylene Dinucleotides, R-CH,-R' Numerous stable products of the reaction of formaldehyde with purine and pyrimidine compounds have been isolated and identified, such as
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
11
5-hydroxymethyl derivatives of uracil (26), uridylic and cytidylic acids (27) (the reactions proceeding in the presence of alkali or acid with heating) , 7-hydroxymethyluric acid (condensation in the presence of KOH) (33), methylene bis (2-aminopyrimidine) ( 3 4 ) , methylene bis (6arninouracil) (12, 55) (synthesized in neutral medium with or without heating) (see reviews (36-38)) . The patent literature describes the preparation of resins through the action of formaldehyde on di-, tri- and tetraaminopyrimidines under different conditions (39-41). However, if the choice of bases is confined to those characteristic of nucleic acids and the reaction conditions are limited to those compatible with biological experiments, only those purine compounds will be of interest that react with formaldehyde to give stable condensation products, methylene derivThese compounds are dealt with in this atives of the type R-CH,-R’. section. Methylene bis-compounds are formed in the reactions of formaldehyde with adenine, adenosine and adenylic and guanylic acids (15,16). A reaction mixture containing AMP, GMP and formaldehyde gives, together with methylene bis-adenylic and methylene bis-guanylic acids, methylene adenine-guanine dinucleotide ( 1 6 ) . Pyrimidine components of nucleic acids fail to form stable condensation products with formaldehyde under similar conditions (16). 1. METHYLENE BIS-COMPOUNDS OF THE ADENINE SERIES
a. Methylene bis-Adenine ( V I ; R = H ) and Methylene bis-Adenosine ( V I ; R = Ribose Residue), These compounds are formed when adenine or adenosine and formaldehyde are kept a t room temperature and pH 4.5 for many days ( 1 5 ) . This pH is optimal. The product yield is diminished in a more acidic medium as well as in neutral and weakly alkaline media.
I
I
R
R
(VI)
The proof of the formation of methylene bis-compounds is as follows. Two moles of adenine or adenosine react with one mole of formaldehyde ( 1 5 ) . The dependence of the yield of reaction product (during time t ) upon the logarithm of the initial concentration of formaldehyde is graphically represented by a bell-shaped curve (Fig. 2) (SO). Both criteria are specific for methylene bis-compounds.
12
M. YA. FELDMAN
3.0 2.5 +
E
b 2.0 n 0
+
L
1.5
L11
I
1 " 1.0 V I
rn
0.5 0
-3
-2
-1
0
Logarithm of initial molar CH,O concentration
FIQ. 2. Influence of CH,O concentration on the formation of methylene bisadenosine (SO).pH 4.8, 20°C. Curve 1: initial adenosine concentration 0.01 M, incubation for 85 days; Curve 2: 0.015 M adenosine, 53 days.The experimentally found points are placed on the curves derived from theory, taking K N 16 l.mole-', kz 1.4 l.mole-'.day-', K being the equilibrium constant of reaction (3) and kl the rate constant of reaction (4). Reproduced by permission of Nauka, USSR.
The curves presented in Fig. 2 need special explanation. The experimental data are in good accord with theoretical plots corresponding to the reaction sequence RH R-CHIOH
+ CH20 @ R-CHIOH + R H R-CHZ-R + HzO +
(3) (4)
Raising the formaldehyde concentration gives an increased amount of methylol derivative (R--CHIOH) and, conversely, a decreased amount of adenosine (RH) in the reaction mixture. Ideally, the maximal rate of the secondary reaction is when [R-CH20H] = [RH] . With an initial adenosine concentration of 0.01-0.015 M, conversion of 50% of adenosine to its methylol derivative necessitates a formaldehyde 7 (the equilibrium constant for the primary concentration of ~ 0 . 0 M reaction being c 16). With this initial concentration of formaldehyde (0.07M), the secondary reaction runs a t the maximal rate (Fig. 2), whereas higher or lower formaldehyde concentrations lead to slower rates of methylene bis-adenosine formation.
13
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
Two important reaction characteristics should be borne in mind when constructing the ideal curve and in plotting the experimental results, 1. The primary reaction practically reaches equilibrium before the secondary reaction starts (prior to the appearance of a measurable amount of methylene bis-derivative) . With an initial adenosine concentration of 0.01-0.015 M and a formaldehyde concentration of 0.014.1 M, methylene bis-adenosine is reported (30) to appear (as a negligible precipitate) only after the solutions have been kept at room temperature (pH 4.8) for 6-8 days. This is in contrast to the primary reaction (Section 11, A, 3 ) , which reaches equilibrium in about 70 hours. On the other hand, if the methylene bis-derivative is readily formed, the reaction fails to give a bell-shaped curve for concentration dependence, as exemplified by the interaction of CH,O with 6-aminouracil (30). 2. No essential shift in equilibrium (3) is observed during reaction (4),which requires an equimolar amount of RH and R-CH,OH on the left and right sides of Eq. ( 3 ) , respectively. The superimposition of the theoretical and experimental plots (Fig. 2) is considered (30) as definitely proving the reaction to lead to methylene bis-adenosine, the monomethylol derivative being an intermediate product. Other possible reactions (see Section I) cannot give a symmetrical bell-shaped curve of concentration dependence. The ultraviolet absorption spectra of methylene bis-adenine and methylene bis-adenosine are characterized by the shift of the maximum to longer wavelengths and an increased absorption a t the maximum as compared with adenine and adenosine, respectively (Table 111). These spectral changes are typical of 6-N-alkyl substitution, being stronger for TABLE I11 ULTRAVIOLET MAXIMA OF METHYLENE BI&OMPOUNDS Compound Methylene bis-adenine Methylene bis-adenosine Methylene bis(adenosine 2’(3’)-phosphate) Methylene bis(guanosine 2’(3’)-phosphate)b
Reference
Xmax
fmnxa
Solvent
(nm)
(X10’)
0 . 0 5 M HCl 0 . 1 M NaOH 0.25 M KOH Acetate, pH 5
28 1 277 and 284 272 272
17.2 14.8 and 13.4 16.8 -
16 48
Acetate, pH 5
255
13.0
43
16 43
Absorbance at the maximum, calculated for 1 M monomer (or 0.5 M methylene bis-compound). Under the same conditions, Xmax = 252 nm and emnr = 12100 for guanosine-2‘(3’)phosphate. (1
14
M. YA. FELDMAN
methylene than 6-N-hydroxymethyl derivatives (see Section 11, A, 1 ) . The nuclear magnetic resonance spectrum of methylene bis-adenine (42) (100 Mc/sec, 10% solution of the compound in 1M NaOD) reveals three signals (singlets) due to protons bonded to carbons. Two signals common to adenine (44, 45) with a chemical shift of 8.46 and 8.27 ppm 6 are due to H-2 and H-8 (2 and 8 positions remaining thus unsubstituted). The third signal (5.51 ppm) has the same intensity as the first two (corrcsponding to two protons) and is to be accounted for by the inethylene group binding two adenine residues. The chemical shift of 5.51 ppm conforms to the position of the methylene group between two exocyclic nitrogens, HN-CH,-NH. (The methylene group bonded to two nitro-
I
I
gens involved in the heterocycles is expected to cause a chemical shift of about 7 ppm.) Methylene bis-adenine and methylene bis-adenosine share several common characteristics (15), such as insolubility in water and organic solvents, decomposition in mineral acids with liberation of formaldehyde and base, low chromatographic mobility and high melting points. b. Methylene bis-Adenylic Acid (VZ; R, Phosphoribosyl Residue). This acid may be isolated chromatographically from the mixture of AMP and CH,O ( 1 6 ) . The reaction goes to completion in 15 days (at room temperature and pH 4.8) and gives rise to a very low yield of C H , ( A P ) ~ not exceeding 6 4 % of theory. When chromatographed according to Cohn (46) on Dowex 1 in a formate system, methylene bis(adenosine 2'(3')phosphate) is separated from 2'- and 3'-AMP to give three isomers (16) with different positions of phosphate groups ( P-2'-Ado-CH2-Ado-2'-P, P-2'-Ado-CH2-Ado-3'-P, P-3'-Ado-CHz-Ado-3'-P) . Dephosphorylation of the three products results in methylene bis-adenosine. When chromatographed on DEAE-cellulose in a concentration gradient of NaCl (pH 5 ) , CH2(Ap) separates without dissociating into isomers (4s). 2. METHYLENE BIS-COMPOUNDS OF THE GUANINE SERIES These products have been less extensively studied than those of the adenine series. The low solubility of guanine and guanosine hinders the investigation of their interaction with formaldehyde. Dissolution of guanosine a t 70" (0.01 M, pH 4.8) and immediate addition of formaldehyde (0.1 M ) leads to a stable (at 36°C) solution that gives rise, in 10-15 days, to a slowly growing precipitate ( 4 7 ) .This precipitate has not yet been identified but its properties resemble those of the methylene bisderivatives of adenine and adenosine. It is insoluble in water, on paper chromatography in alcohol-acid mixtures it follows guanosine with an R, close to that of methylene bis-adenosine, and on hydrolysis in 1 M
15
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
HC1 a t 100" it gives off CH,O. It might thus be suggested that the precipitated product is methylenc bis-guanosine. The reaction product of GMP and CH,O, methylene bis-guanylic acid, is formed as slowly as is CH2(Ap)a(16).The effect of formaldehyde concentration is expressed by a symmetrical bell-shaped curve. On paper chromatography, CH, (Gp) , runs far behind GMP. Ion-exchange chromatography on Dowex 1 makes it possible to separate methylene bis(guanosine 2'(3') -phosphate) into isomers that are eluted over the same range of formic acid concentrations (approximately from 2.6 M to 4.0M ) as are C H , ( A P ) ~isomers, though the CH,(Ap), and CH,(Gp), isomers can be separated quite sharply.
3. MISCELLANEOUS DIMERS A reaction mixture containing CH,O and two nucleotides (AMP and GMP) yields a product not found in mixtures involving CH,O and only one of the two nucleotides. Thus the reaction product should have the structure P-Guo-CHa-Ado-P, which agrees with base composition (A and G in a 1-to-1 ratio) as well as by the bell-shaped curve for the concentration dependence. Other mixtures, such as UMP CMP + C H 2 0 and AMP G M P UMP CH,O have also been studied, but failed to show any additional condensation products (16, 48).
+
+
+
+
111. Interaction of Formaldehyde with Polynucleotides
A. Synthetic Polynucleotides The only results available on the interaction of biosynthetic polynucleotides with formaldehyde are concerned only with the labile primary products formed in the early stage of the reaction. On treatment of polynucleotides with [W]formaldehyde (0.1%) in neutral solutions a t room temperature for 16-20 hours followed by precipitation of polynucleotides with ethanol (11), the label is bound appreciably only in those polynucleotides containing amino groups: poly(A) and poly ( C ) , but not poly(U) and poly(1). When poly(A) (49, 29) and poly(C) (6, 50) are treated with formaldehyde, their spectra change just as do those of corresponding monomers. Poly (N6-hydroxyethyladenylic acid) does not react with formaldehyde ( 2 5 ) , nor does N6-hydroxyethyladenylic acid. The similarity in spectra indicates that the action of CH,O on polymers gives rise to the same products obtained on CH,O treatment of the corresponding monomers, that is, aminomethylol derivatives R-NH CH,OH. This
.
16
M. YA. FELDMAN
accords the decreased pk' of poly(A) in formaldehyde solutions, to 3.0 (25j.
The reactions of formaldehyde with poly(U) and UMP have many common characteristics (18, 19), such as identical spectral changes in solutions with a high formaldehyde concentration, increased pK, ready completion of the reactions that rcach equilibrium in less than 30 seconds, and similar equilibrium constants whose values are similarly lowered a t higher temperature (evidence for UMP is given in Section 11,A, 1).It is evident that formaldehyde is bound to the uracil residues in poly(U) just as it is in free uridylic acid. The resulting N3-hydroxymethyl derivatives are extremely labile, and it apparently suffices for their quantitative dissociation to remove the free formaldehyde by repeated polynucleotide precipitation. This, as well as the low initial formaldehyde concentration, seems to explain the almost complete absence of bound [14C]formaldehyde in the experiments (11) with poly(U) and poly(1).
B. Ribonucleic Acids As far back as 1901 the patent literature carried reports on the treatment of nucleic acid with formaldehyde (51). Yet it was only after Fraenkel-Conrat indicated a change in the ultraviolet absorption spectrum of TMV-RNA in the presence of formaldehyde ( 5 ) (see Table I) that biologists and biochemists directed their attention to the reaction of RNA with formaldehyde. In the same work (5)-that is, two years before it was discovered that TMV-RNA is infectious (56, 53)-he suggested that the formaldehyde inactivation of viruses is due to the action of formaldehyde on the nucleic component rather than on the protein. In 1958, Staehelin (11) suggested that the TMV-RNA reaction with formaldehyde gives rise both to labile products that dissociate on dialysis and to stable derivatives. He also suggested that by analogy with the formaldehyde interaction with proteins, this reaction can be considered as resulting in labile aminomethylol compounds and stable methylene compounds R-CH,-R'. However, Staehelin's results could be interpreted quite differently and did not necessarily point to the formation of two types of compounds (9). Yet, his suggestion about the successive formation of methylol and methylene derivatives was substantiated both by low molecular models (see Section 11, B) and by direct study of the reaction of RNA with formaldehyde (6.4,16). 1. METHYLOL DERIVATIVES
The main methods used to study the primary reaction products of RNA and formaldehyde are spectral analysis and quantitative estimation of bound [ I T ] formaldehyde. However, neither of them provides any
17
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
information about CH,O addition to cyclic nitrogen (N-3 of uracil and N-1 of guanine residues). Minute changes in the ultraviolet spectrum caused by this addition are obscured by the large spectral changes due to the reaction of exocyclic amino groups with formaldehyde. Quantitative cstiniation of the bound label requires the removal of the free [14C]forinaldehyde, which seems to be accompanied by the complete dissociation of extremely labile products of the addition of formaldehyde to NHgroups in the heterocycles. Therefore, it is only possible to discuss formaldehyde interaction with exocyclic amino groups of ribonucleic acids. The formation of aminomethylol derivatives (R-NHCH,OH) may be judged by characteristic spectral changes (see Table I ) .These spectral changes are almost completely reversible on prolonged (4 days) dialysis ( 5 5 ) . The dynamics of the formation of methylol derivatives in the formaldehyde reaction with amino groups of RNA a t room temperature and pH 4.6 is shown in Fig. 3 (curve 1 ) . To simplify the understanding of primary reactions, the equilibrium shift due to the very slow formation of methylene derivatives is not considered. The same time is required for equilibrium to be reached (about 100 hours) a t pH 7.6 (9) whereas the aminomethylol derivative of adenosine is formed in 72 hours a t p H 4.8 and 20°C (SO).
!
8
y I
100
-
200
300
3
I
4 I
400
I
I
500
600
Hours
FIG.3. Reaction of tRNA with "CH,O with time. Measurements were made by different workers (9, 56) under similar conditions. The nonfractionated yeast tRNA reacts with "CH20 in a weak acidic solution (pH 4.3-4.7) a t low ionic strength a t room temperature. Curve 1: Total number of nucleotides labeled in 0.1 M "CH,O without Mg" (tRNA concentration on nucleotides, 0.003 M) ; Curve 2: the same in the presence of Mg2+( 9 ) ; Curve 3: tRNA nucleotides participating in the formation of methylene cross-links L0.2 M "CH,O, 0.02 M (as nucleotides) tRNA1; Curve 4 : same as 3 in the presence of Mg2+( 6 6 ) . By permission of John Wiley & Sons, Inc., Nrw York, and Elsevier Publishing Co., Amsterdam.
18
M. YA. FELDMAN
Equilibrium is attained much more quickly in the primary RNA reaction with formaldehyde as the temperature is raised. Thus, a t 63" in 1 M formaldehyde (0.1 M phosphate, pH 8.5), the reaction with amino groups is nearly complete (about 85%) in 10 minutes (32). I n a 0.5% solution of CH,O (in 0.001 M phosphate buffer) the reaction is over in 10 hours a t 80°C (57). Such an acceleration of the reaction a t higher temperatures cannot be considered as due solely to the destruction of the secondary structure of RNA. In Section 11, A, 3 evidence was presented (29) on the increased rate of both the direct and reversed reactions when CHrO mixtures with adenosine or poly(A) are heated in neutral medium. Judging by the equilibrium constants, the NH,-groups of RNA react with formaldehyde just as do the amino groups of free nucleotides. According to Boedtker ( 3 2 ) , under denaturation conditions (at 63°C) the NH,-groups of RNA are responsible for the bonding of an amount of l'CH,O that corresponds to K N 11.0, i.e., to a value close to those of equilibrium constants for the formaldehyde reactions with the NH,groups of free nucleotides (see Section 11, A, 3 ) . Changes in pH over the range of 5-8 do not affect the amount of 14CH,0 bound to RNA (11). At pH 4.6, [14C]formaldehyde is bound to the amino groups of tRNA in a somewhat smaller amount than a t pH 7.6 (9), with 40% of the tRNA amino groups reacting with formaldehyde in the former case (see Fig. 3) and 48% in the latter. The difference is accounted for by a partial dissociation at pH 4.6 of the amino groups of cytidylic acid (pK,, = 4.5)'. 2. METHYLENE DERIVATIVES Methylene bis-adenylic acid, methylene bis-guanylic acid and methylene adenine-guanine dinucleotide have been isolated chromatographically (on Dowex 1, formate) from alkali hydrolyzates of formaldehyde-treated rRNA (rabbit liver) (16). Every methylene bis-nucleotide is in turn divided into isomers differing in the positions of phosphate groups whose exact location in the isomers is, however, as yet uncertain. No stable condensation products of formaldehyde with pyrimidine residues of RNA have been discovered (16). The dynamics of the formation of methylene his-derivatives in the tRNA reaction with formaldehyde is shown in Fig. 3. The same kinetic plots as in Fig. 3 are also obtained on '*CH,O action on the rRNA of rabbit liver and TMV-RNA (16, 56). In our experiments (16, 43) a t pH 3.5, from 27 to 30% of purine nucleotides of the rRNA are involved in the formation of methylene bridges; a t pH 4.8, the percentage is 12-17; a t p H 7 to 8.5, only 6-7 (15-24 days, room temperature, 0.2 M CH,O; ionic strength of buffer, 0.1). The reaction becomes faster as the formaldehyde
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
19
concentration is raised to 0.2 M (pH 4.8, room temperature, 0.02 M rRNA nucleotides) . A further increase in formaldehyde concentration does not affect the rate of formation of methylene bridges (16). The concentrations of hydrogen ion and CH,O do not affect the secondary RNA reaction with formaldehyde in the same way as they do the secondary reactions of adenosine and purine mononucleotides (see Section 11, B ) . The elucidation of this fact requires more detailed study allowing, in particular, for the role played by the macrostructure of RNA in the reaction with CH,O. At 37°C the amount of methylene cross-links formed is 2.5 times higher than a t 20” (tRNA, p H 4.8) ( 5 6 ) . Dialysis does not reduce the amount of the cross-links (16). The effect of ionic strength and Mg2+is dealt with in Section 111, D, 2.
C. Deoxyribonucleic Acids I n 1953 Zamenhof, Alexander, and Leidy (58) reported that formaldehyde a t high concentrations ( 4 M , p H 7.2, 30”) causes a sharp decrease in the transforming activity of DNA and a gradual drop of viscosity. This does not happen with 0.33M CH,O. It was suggested that formaldehyde reacts with the amino groups of nucleic acid and destroys hydrogen bonds. Later, direct proof of the interaction of DNA with formaldehyde was presented (11).I t was shown that denatured DNA was capable of adding [14C]f~rmaldehyde(for the role of the secondary structure of DNA in this reaction, see Section 111, D, 3 ) . The reaction of DNA with formaldehyde is much less well understood than are the reactions with mono- and polyribonucleotides. However, it can be expected that the bases in DNA react with C H 2 0 in principle just as do the free bases or bases in RNA. Early results (11) on the RNA-formaldehyde reaction, which gives not only labile derivatives but also derivatives remaining intact after prolonged dialysis, were also found t o be valid for denatured DNA ( 5 9 ) . The DNA reaction with 14CH20was carried out under denaturation conditions (10 minutes, 100°C). A small part of bound radioactivity was not removed even on prolonged dialysis (up to 5 days) ( 5 9 ) . According to spectral evidence, the primary formaldehyde reactions with ribo- and deoxyribonucleoside phosphates result in the same (monomethylol) derivatives (see Section 11, A). Similar changes of ultraviolet spectra are observed after formaldehyde treatment of single-stranded and denatured double-stranded bacteriophage DNA’s (60, 8). The evidence for methylene bridge formation between purines, reviewed in Sections 11, B and 111, B, 2, suggest that a t least some of the so-called “firmly bound formaldehyde” that is not detached from DNA
20
M. YA. FELDMAN
on dialysis is actually in methylene bonds. Some authors tried to determine by ultracentrifugation whether DNA chains separate on formaldehyde treatment and thermal denaturation or are prevented from doing so by the cross-links formed. Centrifuging in a density gradient (61, 62, 69) gave equivocal results. Analytical ultracentrifuging appears to indicate the formation of cross-links hindering the complete separation of chains (6% 64) *
D. Effect of Secondary Structure Numerous studies have been concerned with the effect of the secondary polynucleotide structure on the reaction of formaldehyde and with the reverse relation, that of the effect of the reaction on the structure of the polymer. The evidence available can be summed up as follows. 1. The base functional groups involved in the formation of hydrogen bonds do not react with formaldehyde, and, conversely, bound formaldehyde hinders the formation of the usual hydrogen bonds between complementary bases of nucleic acid. 2. The stacking interaction of bases does not hinder the reaction of amino groups with formaldehyde. In turn, the reaction with CH,O does not prevent base stacking. 3. Formaldehyde does not destroy the polymer chain, does not disrupt base stacking, and does not seem by itself to break hydrogen bonds. It does, however, make nucleic acid more sensitive to the action of denaturing agents, in particular to the action of heat (the “melting temperature” of DNA is lowered in the presence of formaldehyde). This may be explained by the fact that in the presence of formaldehyde denaturation is irreversible because the formaldehyde bound to the bases hinders rmaturation. The main experimental evidence presented below is principally obtained a t the first reaction stages when practically only methylol derivatives are formed. (The effect of the secondary structure on the formation of methylene bridges has been studied only for ribonucleic acids; see Section 111,D, 2.) 1. SYNTHETIC POLYNUCLEOTIDES
The stable complex of poly(U) and poly(A) (0.1M phosphate buffer, room temperature) is similar to DNA in not binding [14C]for-* maldehyde (in 0.05% solution). However, when the ionic strength is low, (0.001M phosphate), poly (A) reacts with formaldehyde as if there were no poly(U) in the solution a t all (11). Thus the DNA-like secondary structure fixed by hydrogen bonds hinders the formaldehyde reaction with bases.
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
21
The question how formaldehyde treatment affects the polynucleotide secondary structure has been discussed by Haselkorn and Doty (6). Having studied differential spectra, the authors chose a wavelength a t which changes in the intensity of absorption characterize either the extent of denaturation or only that of the reaction. At about 280 nm for poly(A,U) and 290 nm for poly(I,C), the changes in optical density are due to formaldehyde binding, whereas at about 260 and 250 nm, respectively, they are due only to denaturation. Kinetic studies during the short incubation period (up to 1.5 hours) at pH 6.8 (0.11 M phosphate) showed formaldehyde to cause denaturation of polynucleotide complexes a t a relatively high concentration (about 1 M) and somewhat elevated temperature (35”C), the rate of denaturation greatly exceeding that of the reaction and, thus, not limiting the latter. Poly (A,U) reacts with formaldehyde a t the same rate as does poly(A). Similarly, poly(1,C) reacts a t the same rate as does poly(C). However denaturation becomes markedly slower as the ionic strength is raised to 1.0. Under these conditions, it limits the reaction and lowers the formaldehyde interaction rate with amino groups. It is to be noted that what is termed by Haselkorn and Doty (6) as “denaturation” has been actually shown by further studies to be a much more complex process, apparently involving thermal denaturation and a fast formaldehyde addition to uridine and inosine residues that cannot be registered spectrophotometrically. The formaldehyde added to ring -NH-COgroups hinders renaturation and thus favors the less rapid formaldehyde reaction with exocyclic amino groups reported by the authors. Such an interpretation is in accord with experimental data on polydeoxynucleotides, poly (dA,dT) and poly (dA) apoly (dT) (65). The alternative concept of the “induction effect” (66) (see Section 111, D, 3), which completely ignores the very fast CHzO addition to the ring NH-groups, can hardly provide a better understanding of the process. The effect of formaldehyde concentration on denaturation of polynucleotides was studied with poly(1) (6). When the concentration is increased by 1% (ionic strength of about 0.9, pH 6 ) , the T, drops by about 18”. To minimize denaturation it is proposed (6) to make use of as low a CH,O concentration as possible (about 0.1 M ) , high ionic strength and low temperature (about 20°C). It has been shown by optical rotatory dispersion (50) that in neutral solution poly(C) has a highly ordered secondary structure. It is not destroyed in the presence of formaldehyde, i.e., it contains few or no hydrogen bonds, and it is completely disrupted by ethylene glycol as would be expected to be the case for structures maintained by hydro-
22
M. TA. FELDMAN
phobic interactions. It is thought (50) that poly(C) a t pH 7 has a single-stranded helical structure stabilized by intrastrand stacking of pyrimidine bases. (The pH is critical as poly(C) a t pH 4.1 has a hydrogen-bonded, double-stranded structure.) The reaction with CH,O plays an important role for two reasons. First, it helps to elucidate the nature of forces maintaining the secondary structure of poly(C) in neutral medium, and second, it shows that base stacking does not affect the formaldehyde reaction with amino groups and is not destroyed by it. Formaldehyde treatment of poly(C) was carried out by heating up to 90°C followed by slow cooling down to 20" (50), guaranteeing the irreversible destruction of hydrogen bonds (see Section 111, D, 3 ) . Yet, the Cotton effect, whose intensity can be considered as a measure of asymmetry (helicity) of poly (C) molecules, is the same whether poly(C) is treated with formaldehyde or not. It is thus seen that the secondary structure of poly(C) a t pH 7 has no relevance to hydrogen bonding and CH,O does not destroy the forces maintaining this structure. This was also proved in the same work (50) by the following facts. a. Rising temperature affects the intensity of the Cotton effects of poly (C) and formaldehyde-treated poly (C) similarly. In both cases, the changes are gradual and noncooperative as distinct from the temperature dependence for the DNA-like double-stranded structures supported by hydrogen bonds. b. On formaldehyde treatment, the absorption spectrum of poly (C) undergoes the usual changes: the intensity of the maximum rises by 14% and the maximum is shifted to longer wavelengths by 4-5 nm, showing that the reaction actually takes place. However, on heating treated and untreated poly (C) , the relative increases in optical density due to thermal denaturation were both gradual and identical. I n the experiments with formaldehyde-treated poly (C) , structures stabilized by hydrogen bonds were certainly absent before thermal denaturation started. The hyperchromic e k c t was caused in this study by the disruption of other forces maintaining the secondary structure of poly (C) in neutral medium, such as, possibly, the stacking interaction. Fasman et al. (50) proved that formaldehyde does not affect the stacking interaction. Later, Stevens and Rosenfeld ($9) showed unequivocally that single-stranded base-stacking does not affect the chemical affinity of bases for formaldehyde. Their work on poly(A) a t p H 7.5 and with 1-2% CH,O suggests that: (i) a t p H 7.5, poly(A) has few or no hydrogen bonds; (ii) the secondary structure of poly(A) can be judged by the form of the thermal denaturation plots, which resemble those of poly(C) and are apparently due to stacking interaction between adjacent bases, with formaldehyde leaving the Structure intact; and (iii) base
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
23
stacking does not hinder the interaction of bases and formaldehyde as evidenced both by an almost quantitative addition of ["C] formaldehyde without any disruption of the secondary structure and by the results of comparative kinetic studies of formaldehyde reactions with poly (A) and adenosine. The ratios of the rate constants for the direct and back reactions were practically identical for the interaction of formaldehyde with poly(A) and in the reaction with adenosine at 30", 35", 40", and 45°C. The absolute values of these constants were somewhat lower in the former than in the latter case. 2. RIBONUCLEIC ACIDS At a low ionic strength, all the amino groups of tRNA can react with formaldehyde at 25°C. The extent of the primary reaction is determined by the equilibrium a t the particular concentration of reagents chosen and is independent of the initial secondary structure (9).As the ionic strength is raised, the rate and extent of both the primary (11, 57, 66) and secondary (16) reactions fall. Mg2+ions are particularly effective in this respect (Fig. 3). RNA is generally much less stable to formaldehyde than is doublestranded DNA. The hydrogen-bonded regions of RNA are much smaller and less stable than those of DNA, the cooperative effects being accordingly weaker. It might be suggested that limited and short-lived unwinding of double helices is much more frequent in RNA than it is in DNA, thus providing more opportunities for base interaction with CH,O. Formaldehyde addition to the double-helical regions of RNA thus becomes possible a t room temperature and a t low concentrations of CH,O. Stabilization of RNA double helices by means of Mg2+ gives them almost the same stability as DNA. At room temperature and in the presence of Mg2+,a high percentage of tRNA bases is completely unavailable to the action of formaldehyde [Fig. 3; see also references (67, S S ) ] . Similar results were reported for tRNAPheat 35°C (66). The influence of formaldehyde treatment on the hyperchromic effect (57, 32, 69) deserves special consideration. Figure 4 shows typical "melting curves" of RNA. With untreated RNA, the sigmoid curve reflects the cooperative process of thermal denaturation. As the ionic strength is decreased, the midpoint of the ascending part of the curve, the T,, is shifted toward lower temperatures. The gradual and comparatively small increase in absorption on heating RNA treated with formaldehyde is independent of the ionic strength. The shape of the curve resembles those of poly (A) and poly(C) (either treated or untreated with formaldehyde) in neutral solutions (50, 2 9 ) . This resemblance, as well as the absence of
24
M. YA. FELDMAN
F---l
0.55
10
30
50
70
90 OC
FIQ.4. Absorbancc as a function of temperature of TMV-RNA bcfore and after reaction with formaldehyde (32).RNA was treated with 1.2 M CH20 for 15 minutes at 85' and rapidly cooled. Measurements were made at 260 nm. At this wavelength, the changes in optical density with rising temperature depend on thermal denaturation only, rather than on the reaction of bases with formaldehyde (heating formaldehyde mixtures with mononucleotides has practically no effect on optical density a t 260 nm). Control (without CH20) in 0.1M phosphate buffer, pH 7.5 ( 0 ) and 0.001M phosphate (0) ; RNA treated with formaldehyde in 0.1 M phosphate (A) and 0.Wl M phosphate ( A ) , Similar curves for thermal denaturation were obtained in experiments with other virus RNA's (32, 70) and with rRNA (71).
the ionic strength effect, shows that hypochromism and, accordingly, the secondary structure of RNA treated with formaldehyde are due to the interaction of stacked bases rather than to hydrogen bonds. I n such an RNA there are few or no double-stranded helical regions. The change in the absorbance of hydroxymethylated RNA on heating is reversible and is eliminated on cooling (32,68-71). A record of the dependence of optical density on temperature, not after RNA treatment with formaldehyde but from the beginning of this treatment, gives the usual melting curves showing a sharp increase in optical density over a limited temperature range. I n this case, cooling reveals two hypochromic fractions. The first, due to base stacking, is rather small and reversible, the second is large and irreversible (70,7 1 ) . Formaldehyde addition to RNA amino groups makes it impossible for
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
25
them to participate in the formation of hydrogen bonds (57) but does not hinder base stacking (68, 69, 32) under suitable temperature. Melting curves similar to those presented in Fig. 4 have been recorded by Hall and Doty [see Fig. 2 in reference ( 5 7 ) ] ,who used urea rather than formaldehyde as ti denaturant. It was later shown that urea fails to give such unequivocal effects as a denaturing agent as does CH,O (72, 7.3, because it appears to weaken rather than to completely abolish both hydrophobic interactions (74) and hydrogen bonding (72). Formaldehyde treatment increases the effective hydrodynamic volume of tRNA molecules. The sedimentation coefficient of tRNA falls by 0.40.7 Svedberg unit (69, 56). Thc intrinsic viscosity rises from 0.06 dl/g to 0 . 0 9 4 1 dl/g (69) and remains so even after free formaldehyde is removed (tRNA precipitation with ethanol and dialysis for 18 hours) (69). A more prolonged dialysis (for 48 hours), to remove not only the free but also the labile bound formaldehyde, results in almost complete restoration of the initial tRNA sedimentation rate. The presence of methylene bonds does not affect the sedimentation characteristics of tRNA ( 5 6 ) . The sedimentation and chromatographic results point to no chain rupture or dimerization (or polymerization) of tRNA on prolonged formaldehyde treatment (15 days, 20°C, pH 4.8). After limited guaniloribonuclease digestion of tRNA containing methylene bridges, large fragments (“halves”) are not separable from each other. Thc methylene cross-links formed both in the presence and the absence of Mg2+ are intramolecular, of the type
TCH7 . . R-
-It.
rather than intermolecular (66). The reversible decrease of Sedimentation coefficients without rupture of the chain on CH,O treatment is also observed in experiments with ribosomal and virus RNA (75-78). The aggregation of RNA a t pH <4.2 and low Mg2+ concentration leads, in the presence of 7.7% CH,O (20 minutes, 60°C), to a quantitative formation of stable specific dimers (78).The 28 S molecules combine with 28 S rRNA only. Similar specific complexes are formed by the 16 S rRNA of E. coli and by the RNA of bacteriophage MS2. Thus formaldehyde appears to fix the dimers by means of interchain cross-links (78, 79):
-RI
CHI
I
-R-
26
M. YA. FELDMAN
3. DEOXYRIBONUCLEIC ACIDS
Native double-stranded DNA fails to react with formaldehyde (6,11). For reaction to occur, it is necessary to destroy the hydrogen bonds of DNA by prolonged dialysis against watcr (11, 80),heating, or alkaline treatment (81). I n some cases, particularly in experiments with heating, the denaturant and formaldehyde are both used, but the mechanism remains the same as whcn the denaturant acts before the formaldehyde. After reaction with formaldehyde, DNA is not capable of renaturation (8, 61). The effect of formaldehyde on the secondary DNA structure is shown by thc melting curves in Fig. 5 (82). I n the absence of formaldehyde and on slow cooling, the DNA is almost completely renatured. On repeated heating, DNA “melts” as usual, the optical density increasing sharply a t about 82°C. The picture is different in the presence of formaldehyde. At first, denaturation proceeds as sharply as when no formaldehyde is present (this part of the curve is not shown in Fig. 5 ) , but a t a lower temperature. At 1% CH,O, the T,,,decreases by about 15°C. A stronger ‘Lhyperchromic” effect (Fig. 5 ) is due to the modification of chromophoric groups. When the temperature is lowered, no renaturation takes place. A small decrease in optical density does not account for even partial renaturation, as evidenced by the form of the curve, the optical density changing gradually both on cooling and repeated heating. However, the presence of some hypochromism points to a secondary structure of hydroxymethylated DNA. On repeated heating, the temperaturedependence curve resembles those for poly(A) and poly(C) in neutral
I
1
1
25”1Oo0 80
I
1
60
40
IIII
I
20”20 40 Temperature ( C ” )
1
I
I
60
80
100
FIG.5. Changes in absorbance at 260 nm on hcnling, slow cooling, and reheating T4 bacteriophage DNA with and without formaldehyde (6’2) (pH 8, 0.37 M CH20). 0,+HCHO; 0 , -HCHO. By permission of Academic Press, Inc., New York.
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
27
medium both in the presence and the absence of CH,O as well as that for hydroxymethylated RNA. This likeness suggests that hydroxymethylated DNA has a secondary structure maintained by base stacking only. Such a structure is not peculiar to native DNA, being due to formaldehyde treatment (this holds only partly for RNA, and the secondary structure of poly(C) and poly(A) at pH 7 is unaffected by formaldehyde; see Sections 111,D, 1 and 2 ) . There is enough evidence to justify the presumption that on partial denaturation caused, e.g., by moderate heating, only unwound sites of deoxyribonucleic acid react with formaldehyde. As formaldehyde prevents renaturation, the cooling of the solution leaves these sites open. It is possible to find by electron microscopy the DNA regions denatured by heating and fixed with formaldehyde (83,84). These are distributed in DNA in a strictly regular fashion rather than randomly. Their number, size and location in the molecules of a particular deoxyribonucleic acid are quite reproducible. Thus, these sites have a specific structure. I n the presence of formaldehyde, DNA undergoes denaturation just as it does in its absence, with the destruction of A - T pairs preceding that of G - C pairs. This fact was proved by two methods, differential spectrophotometry, which allows the melting of A . T and G - C pairs of DNA to be observed separately (85), and by electron microscopy (86). The latter is used to follow the partial denaturation of deoxyribonucleic acids with different base compositions. DNA is heated in 12% CH,O solution a t various temperatures (46"-52") for 10 minutes and then quickly cooled. I n the DNA molecules of papilloma virus with a high content of A - T pairs ( 5 8 % ) , the denatured sites arc evident a t lower temperatures than in those of polyoma virus with fewer A * T pairs (52%).The DNA molecules of Cancer pagurus with very high content of A - T pairs (over 90%) and the synthetic polymer, poly (dA,dT) , melt a t relatively low temperatures following the principle "total or no" change. No melted sites are to bc seen in these polynucleotides. Thus, in the presence of formaldehyde, DNA starts melting in regions enriched with A - T pairs, just as it docs in its absence. Therefore, formaldehyde acts to fix denaturation changes in the DNA structure caused by thermal fluctuations (85). This conclusion is not coiitradictcd by the facts that in the presencc of formaldehyde the melting temperature of DNA is lowered and its denaturation is dependent not only on tcmperaturc, but on CH,O concentration as well. The structure of DNA is dynamic rather than static, being determined by the cquilibrium between two processes: denaturation and renaturation (87, 65, 88). This equilibrium dcpcnds on temperature, with higher temperatures shifting it toward denaturation. I n the presence of formalde-
28
M. YA. FELDMAN
hyde, denaturation becomes irreversible and, therefore, the strand separation takes place a t a lower temperature, This seems to account for the mechanism of the T, lowering of DNA in the presence of formaldehyde (8, 63, 87). DNA denaturation is dependent on the concentration of CH,O. At 45”C, pH 7.2 and an ionic strength of about 0.1, 1% formaldehyde was practically unreactive with phage T4 DNA (no spectral changes observed during 48 hours), but reaction did take place in 15% CH,O solution (81). I n view of the above facts, the effect of high CH,O concentrations can be considered as due to an acceleration of formaldehyde reaction with opening sites produced by thermal fluctuations rather than to an active denaturation of DNA. Thus with respect to DNA, formaldehyde is not an “active,” but a “passive,” denaturing agent that opposes renaturation without causing denaturation. The reaction proceeds only with denatured DNA or with its denatured sites. A pn’ori, it is anticipated that the sites a t the ends of helices (where the chain is ruptured, a t the ends of molecules, or at sites adjacent to the already unwound DNA fragments in which the separation of chains is fixed by formaldehyde) should be less stable on heating than those in the middle of helices (89, 90, 65). Hence, formation of fixed centers of unwinding on moderate heating of DNA in CH,O solutions would induce the accelerated thermal denaturation of adjacent sites (“induction effect” (65)). Such a picture is in accordance with the results of detailed kinetic investigations (81, 89,90,65). However, the number of denatured nucleotide pairs of bacteriophage T 7 DNA containing free (with no CH,O added) amino groups is found to be very small (spectroscopy a t two wavelengths, 3.7% CH,O, pH 9.1, 58°C) ( 6 5 ) .It is doubtful that the induction effect plays an important part in the DNA interaction with formaldehyde. The cooperative character of the helix-coil transition is practically completely retained (the presence of formaldehyde in the solution does not affect the width of the DNA melting range). Electron microscopy (91) does not provide reliable evidence on accelerated melting of the ends of helices.
E. Effect of Formaldehyde on the Functional Activity of Nucleic Acids Some interesting results have been reported on the effects of CH,O modification of RNA’s on their functional properties. It was most surprising to find that under certain conditions modified RNA’s retain a considerable part of the original functional activity, sometimes even in greater degree.
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
29
The amino-acid accepting ability of transfer RNA is completely or almost completely suppressed by omission of Mg2’ from the reaction medium (92-94, 56). However, tRNA that has reacted with CH,O in the presencc of Mg2+ ions retains a considerable amount of its accepting activity. The activity of unfractionated tRNA with respect to four amino acids decreased by 30-50% on treatment with 3% CH,O (pH 7.6, 25°C) during the first 10 hours. Inactivation then stopped completely (92, 93) while the formaldehyde reaction continued. The primary reaction with amino groups is over in 100 hours when 15% of the NH,-groups has been converted to -NH-CH,OH-groups (9). Considerable retention of the acceptor activity in the presence of Mg2’ is also observed with a more intensive modification of tRNA leading to the formation of methylene bonds (1-4 per molecule) (56) whereas with no Mg2+the formation of 4 methylene bonds results in the total loss of acceptor activity (in this study hydroxymethyl groups were all or almost all removed by prolonged dialysis). Denaturation of tRNA in a formaldehyde solution not containing Mgz+(Section 111,D, 2) leads to a complete loss of the amino-acid accepting ability. However, an average of about 50% of the tRNA loses activity w e n with Mg2’ ions present in the solution (92, 93, 56). It is tempting to suggest (56) that intramolecular methylene bonds fix, in the presence of Mg“, not one, but at least two tRNA conformations, the “active” and “nonactive” ones, on the assumption that the two conformations were in equilibrium before formaldehyde fixation. This hypothesis is in accord with the results obtained when studying the acceptor activity of the yeast tRNAV”’ modified by CME-carbodiimide (95).3 Similar ideas are advanced with respect to chymotrypsin cross-linked with formaldehyde (96). The kinetics of CH,O inactivation of the “transfer” function of tRNA (as determined by the incorporation of [“C] phenylalanine into protein in the presence of poly(U) in a cell-free system) is rather similar t o that of the inhibition of acceptor activity. In this study (93), the formaldehyde treatment of the tRNA (an unfractionated preparation from Escherichia coli) was carried out over periods of time in which only methylol, but not methylene, derivatives would be expected to be formed. Some interesting results on the action of formaldehyde on mRNA were obtained for RNA bacteriophage f2 (97), whose messenger activity in the cell-free system is enhanced by mild treatment with 1 M CH,O a t 37°C for 11 minutes (followed by cooling and ethanol precipitation). Such a pretreatment of f2 RNA intensifies the synthesis of four proteins specific to this viral RNA and induces the synthesis of a t least three more CME-carbodiimide is N-cyclohexyl-N’-/3-(4-methylmorpholinium) ethylcarbodiimide p-toluenesulfonate.
30
M, YA. FELDMAN
polypeptides. All syntheses begin with N-formylmethionine, being thus initiated by AUG or GUG codons. By fixing the denaturation of the RNA a t limited sites, formaldehyde seems to make these codons more available for ribosomes thus leading either to increased synthesis of usual proteins or to the appearance of new polypeptides, depending on the localization of these codons. The CH,O modification has thus enabled us to obtain proof for the important functional role of the conformation of tRNA and mRNA. The same modification has also been used to prove the dominant role of the primary rather than secondary structure. Ribosomal RNA (from rabbit reticulocytes) was treated with 3% CHzO a t 63°C for 15 minutes (with subsequent cooling) to destroy completely the secondary structure (98). It was found that the resulting rRNA with disrupted secondary structure is hydrolyzed by ribonuclease T1 (in the same 3% CH,O solution) much more rapidly than is the normal rRNA. The intermediate products of partial ribonuclease (Tl) hydrolysis (10 minutes, 0°C) were discovered, however, to be similar as far as their molecular weight is concerned both for the native and formaldehyde-treated preparation of rRNA. Thus the disruption of the secondary structure does not affect the points of attack of the enzyme. Hence ribonuclease T1 recognizes definite nucleotide sequences. These experiments have excluded an alternative explanation. Formation of relatively stable intermediate products cannot result from the existence of “weak” sites (more available to the enzyme) in the RNA secondary and tertiary structures. This is because these products are also formed when the enzyme acts upon the fully unwound RNA molecules.
IV. Interaction of Formaldehyde with Nucleoproteins
This interaction involves formaldehyde reactions with nucleic acid and protein. It might well be that nucleoproteins undergo specific reactions with formaldehyde to form bridges between the nucleic and protein moieties (93-101). However, no strict chemical proof for this hypothesis has as yet been presented. Before proceeding to review the results available on the action of formaldehyde on nucleoproteins, a brief look a t the present state of the problem of formaldehyde interaction with proteins is pertinent.
A. Formation of Methylene Bridges in the Reaction of Protein with Formaldehyde The main events in the reaction of protein with formaldehyde (under conditions close to physiological ones) can be depicted by the following scheme:
31
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
RNH, RNH-CH2OH
+ CH2O RNH-CH?OH + R'H + RNH-CH2-R' + HzO
At high formaldehyde concentrations, dimethylol derivatives, RN(CH,OH),, are also formed. No labile mono- and dimethylol derivatives, formed in very fast reactions, have been isolated; their identification was made indirectly by physicochemical investigations of amino acids in formaldehydc solutions (102,103). The results of thcsc studies were generalized in the classical revicw by French and Edsall (104) and were subsequently substantiated kinetically (105).Spectral evidence was also provided for the addition of formaldehyde to imidazole protein groups (a-chymotrypsin) (106). Slow secondary reactions result in stable condensation products, methylene derivatives (RNH-CH,-R') . The first to present proof for condensation in reaction of protein with formaldehyde were Nitschmann and Hadorn (107),who showed that when gaseous formaldehyde binds to casein, water is eliminated. However, such a condensation could supposedly take place also on formation of compounds R=CH, and again on formation of methylene bridges . (R-CHZ-R') The first alternative was disproved. Various physical approaches showed that the action of formaldehyde on proteins, under conditions close to physiological ones, gives intermolecular cross-links causing increased molecular weight of proteins and/or intramolecular cross-links hindering denaturation of protein and favoring its renaturation (108112). It was also found that no cross-links are formed when formaldehyde acts on proteins with acetylated amino groups (113,11.6, 108). Methylene cross-links are most likely formed between amino groups and those of amide, guanidyl, phenol, imidazole or indole (114, 115). This conclusion was based on the study of a number of model systems such as alanine CH,O acetamide, proline + CH,O acetamide, threonine + CH,O + $,Cdimethylphenol, threonine CH,O + a-N-acetyl-L-histidine, polyglutamine C H 2 0 alanine, methylene tyrosine polymer CH,O methyl guanidine, etc. The first three reactions yield crystalline products (114, 116) and other products not isolated but. identified by analytical tests, in particular, by color reactions. I n the first stage, formaldehyde is added to the amino group to form the aminomethylol derivative (114) whose secondary reaction with the primary amide or another functional group givcs rise to compounds of the type
+
+
+
+
RNH-CH,-NHCOR',
+
+
RNH-CI&-NHC<
+
+
/m NHR'
As distinct from primary amides, secondary amides do not undergo
32
M. YA. FELDMAN
condensation with formaldehyde and amines under similar conditions (weak acid, room temperature) (114). The claim made a priOri by Nitschmann (107,113)about the formation of methylene bridges between c-amino groups of lysine residues and peptide bonds in adjacent protein chains was actually rejected in model investigations by Fraenkel-Conrat and Olcott. Special investigations were also made of the possible formation of methylene bridges between amide and guanidyl groups as well as between phenolic and amide or phenolic and guanidyl groups (114, 116). These alternatives could not be confirmed. Attempts to obtain methylene bridges between primary and secondary amide groups and between amides and aromatic rings failed even with acid used as catalyst (117). There appears to exist no convincing evidence for the formation of methylene cross-links between the amino groups of protein (114, 108). Direct proof was recently presented for methylene bridge formation by the action of formaldehyde on proteins (118, 119). Formaldehyde reacts with a-N-acetyllysine and a-N-acetyltyrosine to give, a t 37"C, a condensation product that, after deacetylation ( 1 M HC1, 37"C, 48 hours), leads to compound VII ( Lys-CHn-Tyr).
In the same studies, this coinpound was isolated from hydrolyzates of proteins treated with formaldehyde, that is, from serum albumin and toxoids of tetanus and diphtheria. Many authors have determined the amount of formaldehyde bound to proteins (120,121). Of greatest interest appear to be estimations obtained with labeled [ 14C]formaldehyde (122).Under conditions used to prepare toxoids (0.033 M CIZO, or 2200 moles of formaldehyde per mole of diphtheria toxin, a t 37°C) the protein reactions are complete in 15 days. The formaldehyde bound is distributed as follows: part is bound reversibly and can be removed by dialysis; 1 mole of toxin (MW 64,500) binds irreversibly 62 moles of formaldehyde, 14 of which are not liberated even by acid hydrolysis. Lys-CH2-Tyr, amounting to 4 moles per mole of anatoxin, is also stable to acid. Sedimentation constants of the diphtheria and
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
33
tetanus toxoids show little or no difference from those of the starting toxins (about 4.2 S for all cases studied) (123-125). A number of formaldehyde reactions with amino acids and proteins that lie outside the scope of this review have also been reported. Among these are reactions characteristic of free amino acids rather than of proteins, and protein reactions proceeding under conditions that are very far from physiological ones (in the presence of acid or alkali, or heating). Thesc reactions arc reviewed in special works on chemistry of amino acids, proteins and formaldehyde (10.4, 126-128, 1.4).
B. Effect of Formaldehyde on Nucleoproteins 5-Hydroxymethyluracil, obtained from the addition of formaldehyde to uracil (see Section 11, A, l ) , undergoes condensation with some amino acids (26) yielding products in which the residues of uracil and of amino acid are linked by methylenc group. The amino acid residue is connected to the mcthylene group through a sulfur atom (cysteine, homocysteine) or through an amino group (glycine). The reaction proceeds in the presence of acid or alkali and a t elevated temperature, that is, under conditions that are very far from those used with nucleoproteins. More adequate low molecular models do not appear in the literature. The results available on formaldehyde action on nucleoprotein particles such as ribosomes indicate that nucleoprotein fixation is the main result of this effect.
1. RIBONUCLEOPROTEINS There is a resemblance between the changes in ultraviolet spectra of ribosomes and in those of free RNA on formaldehyde treatment (129, 130). These spectral changes serve as proof of formaldehyde addition to the amino groups of rRNA bases in ribosomes. Just as with free rRNA, of ribosomes decreases in the presence of formaldehyde. The dethe T,,, crease is the greater, the stronger the formaldehyde concentration (130). The thermal denaturation of double helices of rRNA, both free and bound in the ribosome, is irreversible in the presence of formaldehyde (the starting double-helical structures are not reestablished on cooling) (130). Such a denaturation of RNA in the ribosome does not, surprisingly, change the hydrodynamic volume of the ribosome particle. Viscosity (130) and sedimentation coefficients of ribosomes (1.29) remain unaffected. It is to be noted that, in these viscosity and sedimentation studies, formaldehyde was not removed from the solutions (lSO),or the removal was effected only partially (129). Under such conditions, the free RNA has an increased effective hydrodynamic volume (Section 111, D, 2). Conversely, thermal denaturation of ribosomes in solution, with no
34
M. YA. FELDMAN
formaldehyde added, causes changes in ribosome conformations that are not fully reversible, judged from the same viscosimetric and sedimentation approaches (131). Ribosome fixation by formaldehyde is apparently due to methylene bonds formed essentially in the protein part of the nucleoprotein (129, 130). Neither high ionic strength (132) nor the presence of dodecyl sulfate (129) or urea (101) induces protein separation from RNA when ribosomes are given a preliminary treatment with formaldehyde. For ribosomes to be fixed, a very mild formaldehyde treatment suffices. Thus, for example, treatment of ribosomes with 0,05% CH,O a t 20°C and p H 7.5 for 75-120 minutes prevents their dissociation to proteins and RNA under the action of 1% dodecyl sulfate. The same treatment a t 0" is insufficient (129). I n other cases short incubation with 24% formaldehyde gives, a t a low temperature (0"4"C,1 hour, p H 6),the necessary fixation and proves useful in electron microscope studies (133, 134) and on ribosome centrifugation in the CsCl density gradient (132). The explanation of the fixing effect of formaldehyde under such mild conditions meets with considerable difficulties. Short treatment periods, low temperatures and neutral rather than weak acidic media do not favor the formation of methylene cross-links, as is known from the results of formaldehyde reactions with proteins and nucleic acids. It may be supposed that stabilization of nucleoproteins necessitates very few crosslinks. It is also likely that the nucleoprotein particle, having a rather rigid structure (e.g., the ribosome), involves functional groups held in a position sterically favorable to their linkage by means of methylene crosslinks in the reaction with CH,O. This steric factor may cause a sharp acceleration of the reaction. 2. DEOXYRIBONUCLEOPROTEINS The first to draw the attention to the interaction of nucleohistone with formaldehyde were Romakov and Bozhko (135). Later, the properties of the product of this reaction were studied in detail (100). Nucleohistone (of chromatin from pea buds) was treated with formaldehyde under extremely mild conditions (24 hours, O'C, p H 7.8), and formaldehyde was then removed by dialysis (100).Under these conditions, 0.5-1% CHIO concentration is enough to fix the nucleoprotein complex. I n contrast to native nucleoprotein, such a complex does not liberate protein in a saline solution of high ionic strength and can be studied in the CsCl gradient. It was found that its buoyant density is 1.411 g/ml, the same as the value calculated for the DNA-protein ratio in nucleohistone. Nucleohistone treated with formaldehyde is more stable to heating than is the native material, and the T, of the treated nucleohistone is
REACTIONS OF FORMALDEHYDE WlTH NUCLEIC ACIDS
35
higher than the T , of the untreated complex. With ribosomes, an opposite relation was observed (see above). Such a divergence in T , might be due to the different experimental conditions used: the T , of ribosomes was determined in the presence of formaldehyde, that of nucleohistone was estimated after CH,O was removed by dialysis. Even after the fifth treatment with Pronase, not all protein is removed from nucleohistone treated with formaldehyde; 4% of the protein remains firmly bound to DNA. I t is suggested (100) that formaldehyde reacts with nucleohistone to form methylene bridges between nucleic acid and protein.
V. Use of Reactions of Nucleic Acids and Nucleoproteins with Formaldehyde
No reaction of nucleic acids seems to have been as useful in experiment and practice as that with formaldehyde. The main fields of its application are the following: (1) study of nucleic acids and nucleoproteins, their structure and biochemical functions; (2) fixation of various biological structures, from ribosomes and bacteriophages to microscopic tissue sections; (3) inactivation of viruses for producing vaccines; and (4) chemical mutagenesis. The first three applications are essentially based on the fixing action of formaldehyde. This effect involves two mechanisms and, respectively, leads to two main results. Hydroxymethyl groups formed in the primary reaction of nucleic acid with formaldehyde fix denaturation by hindering renaturation. Methylene cross-links, formed in the secondary reaction under conditions not causing denaturation, fix the structure of the native RNA or of nucleoprotein. The type of fixation used depends on the particular aim pursued in the work. Of all applications of the reaction not concerned with the fixing action of formaldehyde, the most important is chemical mutagenesis. Aldehyde fixation in morphological studies does not receive special consideration in this review. The fixation of nucleoprotein particles and complexes of RNA’s has been discussed in Sections IV, B and 111, D, 2. The biochemical basis for the application of aldehydes (formaldehyde and acrolein) together with metachromatic dyes for histochemical investigations of RNA and DNA is dealt with in references (136-138).
A. Structural and Functional Studies of Nucleic Acids Formaldehyde is often used when it is desired to destroy double helices and to prevent their regeneration throughout the whole experiment.
36
M. YA. FELDMAN
Denaturation is usually attained by raising the temperature in the presence of formaldehyde followed by rapid cooling of the mixture, heating causing denaturation and formaldehyde preventing renaturation. Formaldehyde possesses a number of advantages over other denaturing agents: the necessary effect is produced by low concentrations of formaldehyde, nucleic acid can be investigated in an essentially aqueous medium, methylene glycol (hydrated formaldehyde) does not absorb ultraviolet light. Some important applications of “fixed” denaturation have already been considered above, namely, the use of formaldehyde reactions in functional studies of nucleic acids [Section 111, E; see also ( 1 3 9 ) ] , denaturation of polynucleotides in the presence of formaldehyde to study base stacking in poly(C), poly(A) and RNA (Section 111, D ) , location by means of electron microscopy of sites of DNA molecules enriched by A.T pairs [Section 111, D, 3; see also (91, 1.40,1 4 1 ) I . The primary formaldehyde reaction is of great value to achieve the separation of polynucleotide chains in order to elucidate their actual size. Thus, for example, heating the giant (>26 S) “DNA-like” RNA of yeasts in the presence of formaldehyde has showed that the preparation consisted actually of aggregates involving RNA molecules with molecular weight close to that of the 17 S component of rRNA (142). The same method has made it possible t o determine (81) that the polynucleotide DNA chain of phage T 4 is continuous and that its molecular weight is half that of the native DNA. This has provided one of the most convincing proofs that the DNA molecule consists of only two uninterrupted polynucleotide chains. Formaldehyde reactions also used for many other purposes, in particular when it is necessary to distinguish single- and double-stranded virus nucleic acids (60, 70, 143), to determine quantitatively the double-helical content of RNA (6, 32) and the number of secondary structure “defects” to eliminate specific features in the conformation of in DNA (89, a), some ribonucleic acids for a more exact estimation of their’ molecular weight (76, 77, 7 2 ) ,to separate the DNA chains in immunological experiments (82, 144), to study nucleic acids in situ in bacteriophages (146147) and in cells (136, 137).
B. Inactivation of Viruses by Formaldehyde in Vaccine Production
Formaldehyde action on virus nucleoproteins is of great practical value for preparation of viral vaccines for human subjects (14.8) and animals (149). Many investigations have dealt with virus “formol” in-
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
37
activation [see, e.g. ( 1 5 0 ) ] , but the chemical mechanism of this process has not been studied directly. The following four features of formaldehyde interaction with proteins, nucleic acids, and nucleoproteins can be considered as the most essential for the CH,O inactivation of viruses in vaccine preparation. 1. Formaldehyde acts both on the protein and nucleic virus component without causing any destruction of polypeptide or polynucleotide chains. 2. Modification of bases, formation of cross-links in nucleic acid and “hardening” of protein ensure that the virus is reliably rendered harmless. 3. Formaldehyde fixes the conformation of nucleoprotein. Recently evidence was produced concerning the special role of antigen conformation in inducing the synthesis of antibodies (151). Most antibodies induced by TMV are likely to be specific for the structure of the surface of the virus particle, for its conformation, rather than for the amino-acid sequence of virus subunits (152). It has also been shown (153) that the nucleoprotein and the free protein of the turnip yellow mosaic virus (crystallizable preparations isolated from the plant sap) are identically precipitated by antiserum to nucleoprotein but, when injected into rabbits, induce the formation of antibodies differently ; the antigenicity of the nucleoprotein is much higher than that of the free protein. Thus, in order for antigenicity to be stabilized it is desirable to fix the nucleoprotein as such, not its protein only. This condition is met by formaldehyde. 4. The small size of the formaldehyde molecule facilitates its passage through the protein shell of the virus. The importance of this fact can be exemplified as follows. Kethoxal (a-keto-P-ethoxybutyraldehyde) inactivates the isolated TMV-RNA much more readily than does formaldehyde. On the other hand, RNA in the virus is inactivated by kethoxal more slowly than by formaldehyde. It might be suggested that the relatively large size of the kethoxal molecule hinders its passage through the protein shell (154). All these peculiarities of formaldehyde action provide a post-facturn explanation of the choice of formaldehyde as an inactivator and fixative for vaccine preparation. The future will tell whether this delayed theoretical explanation will help to improve the preparation of vaccines and to prepare new vaccincs. It is to be noted that soiiie L‘anoinalics”of formaldehyde inactivation are also being explained. This is the ease for the reversible inactivation of TMV (155) and poliovirus (156) on short-term formaldehyde treatment (apparently due to the formation of only methylol derivatives) and the increased stability of the carcinogenic virus SV40 to the inactivating
38
M. T A . FELDMAN
action of formaldehyde [ thc virus contains a double-helical DNA (149)1. The question is now poscd whether all viruses retain their conformation in the formaldehyde reaction. This question, as well as many others cannot be answered a priori. If formaldehyde inactivation fails to give a satisfactory immunological effect, special physicochcmical studirs with purificd virus prcparations will clearly be nccdcd.
C. Effect of Formaldehyde on the Genetic Apparatus of the Cell The mutagenic action of formaldehyde was first described by Rapoport in 1946 ( 3 ) . Of mutagens acting on multicellular organisms, formaldchyde is one of the most interesting and well known (157, 4 ) . Formaldehyde causes mutation in viruses (158, 159), bacteria (1601, Neurospora (161) and Drosophila [on injection into adult flies (162) or introduction into culture medium for larvae (3, 163, 13,10,4) 1. The mechanism of mutagenesis induced by formaldehyde is best known for Drosophila larvae. Formaldehyde causes mutation in male larvae only (163, 4) and solely a t a definite stage of spermatogenesis (immediately preceding meiosis) (164). This shows formaldehyde to be a highly specific mutagen ( 4 ) . Its mutagenic effect has something to do with DNA rcplication, bccause after DNA synthesis is over formaldehyde loses its activity and cxcrts no mutagenic effect on late spermatocytes (165). Formaldehyde can cause mutation (recessive lethal) if the culture medium contains AMP (13). Adenylic acid can be replaced by adenosine or RNA, but not by adenine, cytosine or inosinic acid. Deoxyadenylic acid is less effective than adenylic acid (13, 166, 167, 10, 157). Mutations appear to be induced in Drosophila larvae not by formaldehyde as such, but by its reaction product with adenylic acid. It is suggested (13, 10) that mutation is causcd by the methylene or hydroxymethyl dcrivativcs cntcring one of the DNA (or RNA ( 1 5 7 ) ) chains during synthesis. It should bc noted that participation of a very labile hydroxymethyl product in formaldchydc-induced mutagenesis appears to be unlikely. In any case, the mutagenic action of formaldehyde (on Drosophila larvae) is not a dircct and primary one, but a much more complex phenomenon occurring probably during thc replication of the DNA. I n Drosophila larvac, formaldchydc induccs crossing-over either in the presencc or abscncc of AMP. The second alternative is of considerable interest in principlc as the agents inducing crossing-over act also as mutagens (157, 168). I n this case, formaldehyde is of great value because it allows crossing-over to be induced under conditions (absence of AMP) preventing mutagenesis (157).
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
39
Formaldehyde and number of its addition products, such as methylol derivatives of succinimide, glutarimide, piperidine, pyrrolidine, morpholine, dikctopipcrazine, 2-mercaptoiinidazolc, etc., arrest the growth of the mouse ascitic carcinoma in vivo ( 2 ) and lead to considerable changes in tumor metabolism. Expcrimcnts with mcthylene bis-guanylic acid give some indications as to the mechanism of formaldehyde effect (43). This compound, produced from the reaction of GMP and CH,O (see Section 11, B, 2), suppresses drastically the mitotic activity of human amniotic cells in continuous culture (strain FL). I n the presence of CH,(Gp),, DNA Synthesis is a t first enhanced for 1.5 hours (presumably owing to increased nucleotide pool in the cell) and then hindered. I n contrast, the synthesis of cell RNA is little affected. Reproduction of viruses containing RNA undergoes quite independent changes. With CH, (Gp), in the culture medium, reproduction of poliovirus in FL cells is first suppressed (for 8 hours) and then restored. A hypothesis has been advanced to account for these results ( 4 3 ) . After suitable enzymatic conversions in the ribosephosphate part, the methylene dinucleotide enters the newly synthesized DNA chain with one of its nucleotide residues in place of the appropriate normal nucleotide. During the next replication the free methylene dinucleotide residue can enter the complementary chain. Thus two DNA chains are bonded by a methylene cross-link -Piir1
-Piir-
and mitosis is inhibited. It is supposed that similar cross-links between the complementary chains of the replicative virus RNA inhibit the reproduction of the virus. The methylene bridge links two purine residues, i.e., a purine in one chain is opposed by a purine in the complementary chain, but not by pyrimidine as is usually the case. If the methylene cross-link is removed by hydrolysis or enzymatic reparation, chains will be separated. Purine substitution for pyrimidine thus causes mutation. This hypothesis would be substantially confirmed if methylene dinucleotide could be isolated from DNA. There are, however, as yet no suitable methods available to obtain such compounds from DNA. The highly specific mutagenesis induced by formaldehyde in Drosophila larvae cannot be even hypothetically accounted for (165, 4 ) . The results available (165,4 ) on localization of mutations (X chromosome and the second, but not the Y, chromosome) fail to explain why the formaldehyde reaction product with AMP affects the early spermatocytes
40
M. YA. FELDMAN
and why spermatogonia and all stages of oogenesis are not sensitive to the mutagenic activity of this reaction product. With [ ''C] formaldehyde in the culture medium, the label is discovered autoradiographically in the germ cells a t all stages (169).However, it is extremely doubtful whether this label always belongs to the product of the reaction between AMP and l'CH,O (tentatively CH, (Ap) ?). Just what cells this product permeates and how long it stays in different cells still remains unknown. It is possible that the carly spermatocyte has the most favorable conditions for accumulating methylene dinucleotide up to the concentration needed for its inclusion into the polynucleotide. The cytostatic action and cross-over induction do not necessarily require the intermediate formation of methylene dinucleotide. These effects may also be due to another mechanism such as the direct formaldehydc interaction with cell DNA.
VI. Related Reactions and Their Effects (as Compared to Formaldehyde Reactions) A detailed review of these reactions is not within the scope of this essay, particularly as they have already been dealt with in many reviews (38,170-17s). The purpose of this section is to show the place of formaldehyde as a modifying agent among other aldehydes and bifunctional compounds whose action on nucleic acids has been studied rather thoroughly. A. Miscellaneous Aldehydes A number of aldehydes other than formaldehyde are useful for modification of nucleic acids. These are almost all dicarbonyl compounds. Their interaction with nucleic acid or its component is likely to involve two consecutive reactions with two carbonyl groups. Yet, only the stable end products of these reactions have been well studied; these are discussed below. Particularly well known are the reactions with 1,2-dicarbonyl compounds (154, 174, 176), namely, with glyoxal (OHC-CHO), kethoxal (CH,-CH (OC2H,)-CO-CHO) and pyruvaldehyde (CH,-CO-CHO) . These modifying agents differ from formaldehyde in the following respects. 1. They are more specific than formaldehyde, and stable condensation products are found only in their reactions with guanine, guanosine and deoxyguanosine. At the nucleic acid level, this specificity for guanine rcsiducs of RNA has been unequivocally shown only for kethoxal (176).
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
41
(Vm) 2. l12-l)icarbonyl compounds do not form bridges between two niolccules (or residues) of the base. Two carbonyl groups react with two nitrogen atoms (N-1 and N-2) of guanine, forming a new cycle. I n formula VIII, R = H if guanine interacts with glyoxal and R = CH, or CH,CH (OC,H,) if it reacts with pyruvaldehyde or kethoxal, respectively (174,175).New five-membered rings are also formed in the reactions of guanosine and guanine with ninhydrin (174). 3. With glyoxal (177)and kethoxal (178,l79),the reactions proceed rather rapidly. Thus nonfractionated tRNA reacts with kethoxal a t 37°C and pH 5.0 to give a quantitative modification of guanine residues in about 15 hours with no MgZfand 30 hours in the presence of Mg2+(178). 4. I n principle, l12-dicarbonyl compounds are presumed to affect the secondary structure, just as does formaldehyde, by reacting only with such bases as are localized in single-stranded or unwound double-stranded RNA sites and preventing renaturation in the modified segments (178, 179). However, a very short-lived and limited unwinding, taking place in the fluctuating RNA structure, suffices to cause condensation with 1,2dicarbonyl compounds, which react readily to form a stable product. It appears that even stabilization by M g + ions does not provide for the retention of the secondary structure in the presence of kethoxal (178, 179).Only a t the start of the reaction (30 minutes, pH 7, 37"C, Mg2+) is it possible to locate those tRNAPh' sites that have reacted with [3H]kethoxal without destroying the tRNA conformation (179). 5. l12-Dicarbonyl compounds and formaldehyde are used in different fields. The former are never used for fixation, their mutagenic activity is unknown but kethoxal has been successfully used for labeling and identification of exposed guanine tRNA residues (179,180).On the other hand, the carcinostatic effect and the inactivation of DNA replication are observed under the action of both formaldehyde (or methylene dinucleotides) (2, 43) and l12-dicarbonyl compounds (181,182). Covalent cross-links, hindering the separation of complementary DNA chains on denaturation, are formed on DNA treatment with oxidized spermine [ dialdehyde, OHC (CH,) ,NH (CH,) ,NH (CH,) ,CHO] but are absent when DNA is treated with oxidized spermidinc [monoaldehyde, OHC(CH,),NH (CH,),NH,] (183,184). It follows that both carbonyl
42
M. YA. FELDMAN
groups of oxidized spermine are needed for cross-links. The reaction is nonspecific, for the carbonyl groups of oxidized spermine react with all bases containing amino groups and, though to a considerably smaller extent, with thymine and uracil (186, 184). Another dialdehyde, glutaric aldehyde (OHC (CH2);
B. Difunctional Alkylating Agents4 Formaldehyde is the simplest difunctional reagent. It is of interest to compare the modification of nucleic acids by formaldehyde with the effects produced by other conventional difuctional compounds, such as , aliphatic nitrogen mustard butadiene dioxide (CH,-CH-CH-CH,)
\ /
\/
0 0 HN2 [bis (2-chloroethyl)methylamine, CH,N (CH,CH,Cl) ,] and mustard gas [bis (2-chloroethyl)sulfide, S (CH,CH,Cl) 2]. Reacting with the N-7 of guanine residues in nucleic acids, these compounds give rise to products of monofunctional as well as bifunctional alkylation. Diguanyl derivatives of butadienc dioxide and HN2 are the most chemically studied compounds. The physicochemical and biochemical consequences of bifunctional alkylation of nucleic acids have been most thoroughly investigated in experiments with mustards (188-192). Difunctional alkylation proceeds with intermediate formation of the monoalkyl derivative (170,38, 193). The secondary structure does not Only those rcfercncrs nre given in this srihscction thnt, are not found in the reviews (170, 38).
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
43
prevent the action of alkylating agents. Reacting with the native doublestranded DNA, the difunctional agent forms both interchain and intrachain cross-links (192,194). Modification of nucleic acids by difunctional alkylating agents offers the following advantages over modification by formaldehyde. First, reactions with alkylating agents are very fast, less than 1 hour's treatment with mustard gas (37"C, pH 7) giving the necessary effect in many cases. Second, cross-links are specifically formed only between guanine residues [although the poly(A) reaction with mustard gas gives, together with monofunctional alkylation products, an additional product of difunctional alkylation, presumably bis (adenin-l-ylethyl) sulfide (198)1. Third, it is often possible to compare the difunctional alkylating agent and the corresponding monofunctional agent, for instance, mustard gas, bis (2-chloroethyl) sulfide, and hemisulfur mustard, 2-chloroethyl 2-hydroxyethyl sulfide. Compared to formaldehyde, difunctional alkylating compounds display a number of disadvantages, two of which are of particular importance. First, together with diguaninyl derivatives, a great number of stable by-products of monofunctional alkylation are formed. Thus, 20 minutes' treatment of salmon sperm DNA with mustard gas (37", pH 7.2) gives the following alkylation products (190) : bis (P-guanin-7-ylethyl) sulfide, 2270 of total alkylated bases ; 7- (2-hydroxyethylthioethyl) guanine, 59% ; 1- (2-hydroxyethylthioethyl) adenine, 4% ; 3- (2-hydroxyethylthioethyl) adenine, 15%. Second, alkylation reactions are complicated by hydrolytic release of the alkylated purines. Subsequent chain fission of nucleic acid should also not be ignored, however negligible. Comparison of the biological effects of mono- and difunctional alkylating agents in parallel experiments shows what effects are mainly or partly due to the formation of cross-links. The formation of cross-links in DNA results in the inactivation of bacteriophages containing doublestranded DNA (198, 195, 196),exerts a pronounced cytostatic (carcinostatic) effect, and inhibits DNA replication. The effects of difunctional alkylating agents in vivo are observed in both microorganisms (191, 197) and mammalian cells (198).The compounds exert only a weak action on the synthesis of RNA and protein, just as do corresponding monofunctional agents. The part played by each type of cross-linking, intra- and interstrand, is as yet unknown. There is not yet enough evidence to clarify the role of cross-links in mutagenesis induced by alkylating agents. The mechanism of reparation of defects caused by alkylating agents in vivo also requires further study (191, 198). Although many important problems await elucidation, the information available as to the action of difunctional alkylating agents on nucleic
44
M. YA. FELDMAN
acids in vitro and in vivo is very useful for a general biological interpretation of the nucleic acid modifications caused by difunctional agents.
VII. Conclusion Forrnaldehydc is not only one of thc most useful, but also one of the most extensively studied, agents modifying nucleic acids. It is with formaldehydc that the relationship between the modifying agent and the secondary polynucleotide structure appears to have been most thoroughly invcstigatcd. Thc main field of formaldehyde application is fixation. Formaldehyde fixes two opposite structural states, denatured and native. The denaturation of nucleic acid is fixed by the formation of primary products, methylol derivatives. Thc native macrostructure of the polymer is fixed by methylenc cross-links formed in the secondary reaction. For each fixation, suitable conditions must be carefully chosen. Otherwise, mixed effects arc produccd, which lead to incorrect intcrpretations of results. New and important applications of formaldehyde fixation are to be expected, such as fixation of different tRNA conformations and of oncogenic viruses for vaccine preparation (199). The possible biological effects of a new group of analogs of nueleic componcnts, methylene dinucleotides, are also of great interest.
ACKNOWLEDGMENT The author wishes to thank Dr. E. I. Budowsky for fruitful discussion of some sections of the review.
REFERENCES 1. J. E. Salk and J. 13. Gori, Ann. N . Y . Acnd. Sci. 83, 609 (1960). 2. G. Weitrel, F. Schneider, A.-M. Fretzdorff, K. Seynsche and H. Finger, HoppeSeyler’s Z . Physiol. Chem. 334, 1 (1963). 3. I. A. Rapoport, Dokl.Akad. Nnuk SSSR 54, 65 (1946). 4 . W. Ratnayake, Genet. Res. 12, 65 (1968). 6. H. Fraenkel-Conrat, BBA 15, 307 (1954). G. R. Hnselkorn and P. Doty, JBC 236, 2738 (1961). 7. G. Zuibay and R. Marciello, BBRC 11, 79 (1963). 8. L. Grossman, S. S. Levine and W. S. Allison, JMB 3, 47 (1961). 9. J. T. Penniston and P. Doty, Biopolymers 1, 145 (1963). 10. T. Alderson, Mutalion Res. 1, 77 (1964). 11. M. Staehelin, BBA 29, 410 (1958). 19. M. Ya. Feldmnn, Biokhimiyn 25, 563 (1960). 13. T.Alderson, Nature (London) 187, 485 (1960). 14. J. F. Walker, “Formaldehyde,” 3d ed. Reinhold, New York, 1964. 16. M. Ya. Feldmnn, Biokhimiya 27, 378 (1962). 16. M. Yn. Feldmnn, BBA 149, 20 (1967).
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
45
17. M. Ya. Feldman, Bwkhimiyn 23, 917 (1958). 18. E. J. Eyring and J. Ofengand, Bchem 6,2500 (1967). 19. N. N. Aylward, J. Chem. SOC.B 11. 627 (1966). 20. S. Lewin, Expeiientiu 20, 666 (1964). 21. S. Lewin, J . Chem. SOC. p. 1462 (1962). 22. S. Lewin, J . Chem. Soc. p. 792 (1964). 23. S. Lcwin and M. A. Barncs, J. Chem. Soc. B 13. 478 (1966). 24. D. E. Hoard, BBA 40, 62 (1960). 26. A. M. Michelson and M. Grunhcrg-Manago, BBA 91, 92 (1964). 26. R. E. Cline, R. Fink and K. Fink. J-4CS 81, 2521 (1959). 27. A. H. Alegria, BBA 149, 317 (1967). 2s. K. H. Scheit, I’etrrrhetlroii Lett. 11. 1031 (1965). 29. C. L. Stevens and A. Rosenfeld, Bchem 5, 2714 (1966). 30. M. Ya. Feldman, Biokhimiyn 29, 720 (1964). 31. D. L. Woodhouse, Nature (Loiitlon) 192, 336 (1961). 3.2. H. Boedtker, B c h m 6, 2718 (1967). 33. German Patent 106493 (1897). 34. B. Skowro6skaSerafinowa, Roczn. Chem. 29, 932 (1955). 36. W. Pfleiderer, F. Sigi and L. Grozinger, Chem. Ber. 99, 3530 (1966). 3G. G. W. Kenner and A. Todd, in “Heterocyclic Compounds” (R. C. Elderfield, ed.), Vol. 6, p. 234. Wiley, New York, 1957. 37. R. K. Robins, in “Heterocyclic Compounds” (R. C. Elderfield, ed.), Vol. 8, p. 162. Wiley, New York, 1967. 3s. N. K. Kochetkov, E. I. Budowsky, E. D. Sverdlov, N. A. Simukova, M. F. Turchinsky and V. N. Shibaev, “Organichcskayn khimiya nucleinovikh kislot.” Khimiya, Moskva, 1970. 89. German Patent 667542 (1938). 40. German Patent 669188 (1938). 41. US. Patent 2211710 (1940). 4.2. M. Ya. Feldmnn, unpublished data. 43. M. Ya. Fcldmnn, E. S. Zalmanson and L. N. Mikhailova, Mol. Biol. 5, 847 (1971). 44. C. D. Jardetzky and 0. Jardetzky, JACS 82, 222 (1960). 46. H. A. Szimansky and R. E. Yelin, “ N M R Band Handbook.” IFI/Plenum, New York, 1968. 4G. W. E. Cohn, in “The Nucleic Acids” (E. Chargaff and J. N. Davidson, cds.), Vol. 1, p. 211. Academic Press, New York, 1955. 47. M. Ya. Feldman, unpublished results. 4s. M. Yn. Fcldman and M. R. Shubinn. Dokl. Akud. Nnuk SSSR 174, 236 (1967). 49. R. F. Beers, Jr. and R. F. Steincr, Nature (London) 179, 1076 (1957). 60. G. D. Fasman, C. Lindblow and L. Grossman, Bchem 3, 1015 (1964). 61. German Patent 139907 (1901). 62. H. Fraenkel-Conrat, JACS 78, 882 (1956). 63. A. Gierer and G. Schramm, Nature (London) 177, 702 (1956). 64. M. YR. Feldman, Biokhimiyn 30, 203 (1966). 66. M. Ya. Feldman, Biokhimiyn 25, 937 (1960). 6G. V. D. Axelrod, M. Ya. Feldman, I. I. Chuguev and A. A. Baycv, BBA 186, 33 (1969). 67. B. D. Hall and P. Doty, JMB 1, 111 (1959). 6s. S. Zamenhof. H. E. Alexnnder and G. Leidy, J. Exp. Med. 98, 373 (1953).
46 69. C. GO. R. 61. C.
M. YA. FELDMAN
J. Collins and W. R. Guild, BBA 157, 107 (1968).
L.Sinsheimer, J M B 1, 43 (1959). A. Thomas, Jr. and K. I. Berns, J M B 4, 309 (1962).
62. P. Sheldrick and W. Szybalski, J M B 29, 217 (1967). 63. D.Freifelder and P. F. Davison, Biophys. J. 3, 49 (1963). G4. A. J. van tler Eh, I,. M '. van Kesteren nnd E. F. J. van Rruggm. BBA 182, 530 (1969). 06. H. Utiyama and P. Doty, Bchem 10, 1254 (1971). 66. A. Rosenfeld, C. L. Stevens and M. P. Printz, Bchem 9, 4971 (1970). 67. G.Zubay and R. Marciello. BBRC 11, 79 (1963). 6s. G. D. Fasman, C. Lindblow and E. Seaman, J M B 12, 630 (1965). 69. D. B. Millar and M. MacKrnzir, Bcliem 6, 2520 (1967). 70. R. A. Cox, K. Kanagalingam iind E. S. Sutherland, BJ 120, 549 (1970). T i . M. Edelman, I. M. Verma, D. Saya and U. Z. Littauer, BBRC 42, 208 (1971). 72. H.Boedtker, BBA 240, 448 (1971). 73. V. S. Mayo and S. R. de Kloet, BBA 247, 74 (1971). 74. P. L. Whitney and C. Tanford, JBC 237, 1735 (1962). 76. W. M.Stanley, Jr. and R. M. Bock, Bchem 4, 1302 (1965). 76. M.L.Fenwick, BJ 107, 851 (1968). 77. H.Boedtker, J M B 35, 61 (1968). 78. H. Slegers and W. Fiers, FEBS Lett. 7, 55 (1970). 79. H. Slegers and W. Fiers, Biopolymers 9, 1373 (1970). 80. N.K. Sarkar and A. L. Dounce, BBA 49, 160 (1961). Si. K.I. Berns and C. A. Thomas, Jr., J M B 3, 289 (1961). S9. D. Stollar and L. Grossman, J M B 4, 31 (1962). 83. M. Beer and C. A. Thomas, Jr., J M B 3, 699 (1961). 84. R. B. Inman, JMB 18, 464 (1%). S5. V. V. Simonov, N. I. Ryabchenko and A. M. Povcrenny, Mol. Biol. 1, 297 (1967). 86. E. A. C. Follet and L. V. Crawford, J M B 34, 565 (1968). 87. P. H. von Hippel and K.-Y. Wong, J M B 61, 587 (1971). 88. R.J. Cohen and D. M. Crothers, JMB 61, 525 (1971). 89. E. N. Trifonov, N. N. Shafranovskaya, M. D. Frank-Kamenetskii and Yu. S. Lazurkin, Mol. B i d . 2, 887 (1968). 90. Yu. S. Lazurkin, M. D. Frank-Knmenetskii and E. N. Trifonov, Biopolymers 9, 1253 (1970). 91. R. B. Inman and M. Sch~os,J M B 49, 93 (1970). 92. J. T.Penniston and P. Doty, Biopolymers 1, 209 (1963). 93. J. T. Penniston. M. Steward and M. D. Tucker, BBRC 15, 358 (1964). 94. M. K. Iiuklinnora, I,. I,. Kisrlcv and I,. Tu. Frolova, Biokliimiya 28, 1053 (1963). 96. A. S. Girshovich, M. A. Grachev, N. I. Komnrova and N. I. Mensorova, FEBS Lett. 14, 195 (1971). DG. L. J. Saidel, S. Leitzes and W. H. Elfring, Jr., BBRC 15, 409 (1964). 97. H. F. Lodish, J M B 50, 689 (1970). 98. J. C.Pinder and W. B. Gmtzer, Bchem 9, 4519 (1970). 99. M.Ya. Feldman, Vopr. &fed. Khim. 9, 232 (1963). 100. D.Brutlag, C. Schlehuber and J. Bonner, Bchem 8, 3214 (1969). 101. M.Roberts and I. 0. Walker, BBA 199, 184 (1970). iO2. M.Levy and D. Silberman, JBC 118, 723 (1937).
REACTIONS O F FORMALDEHYDE WITH NUCLEIC ACIDS
47
103. E. H. Frieden, M. S. Dunn and C. D. Coryell, J. Phys. Chem. 47, 10 (1943). 104. D. French and J. T. Edsall, Advan. Protein Chem. 2, 277 (1945). 105. B. P. Zhantalai and Ya. I. Tur’yan, Kinet. Kntal. 3, 325 (1962). 106. Ch. J. Martin and M. A. Marini, JBC 242, 5736 (1967). 107. H. Nitschmann and H. Hndorn, Helv. Chim. Acta 27, 299 (1944). 10s. H. Fraenkel-Conrat and D. Mcrham, JBC 177, 477 (1949). 109. Ii. I. Stracliitskii, iir “Voprosi medicinkoi lihimii” (8. R . Mardnslicv. cd.), Vol. 1, p. 292. Mcdgiz, Moskva, 1949. 110. M. P. Drake and A. Veis, Bchem 3, 135 (1964). 111. D. W. Bannister, BJ 114, 509 (1969). 112. P. V. Hauschka and W. F. Harrington, Bchem 9, 3734 (1970). 113. H. Nitschmnnn and H. Laucncr, Helv. Chim. A d a 29, 184 (1946). 114. H. Fraenkel-Conrat and H. Olcott, JACS 70, 2673 (1948). 115. H. Fraenkel-Conrat and H. Olcott. JBC 174, 827 (1948). llG. J. Blass, BuI1. SOC.Chim. p. 3120 (1966). 117. R. D. Haworth, D . Peacock, W. Smith and R. MacGillivry, J. Chem. SOC. p. 2972 (1952). 11s. J. Blass, B. Bizzini and M. Raynaud, C . R . Acad. Sci. 261, 1448 (1965). 119. J. Blass, B. Bizzini and M. Raynaud, Bull. SOC.Chim. p. 3957 (1967). 120. K. H. Gustavson, Advan. Protein Chem. 5, 353 (1949). 121. N. I. Egorkin, M. A. Mamedov and 0. D. Rokhwarger, “Formaldegidnoye dubleniye.” Gizlegprom, Moskva, 1957. 12.2. J. Blass, B. Bizzini and M. Raynaud, Ann. Znst. Pasteur IlG, 501 (1969). 123. M. L. Petterman and A. M. Pappenheimer, Jr., J. Phys. Chem. 45, 1 (1941). 124. J. F. Largier and F. J. Joubcrt, BBA 20, 407 (1956). 125. J. Blass, Biol. Me‘d. 53, 202 (1964). 126. H. Fraenkel-Conrat, in “Amino Acids and Proteins” (D. M. Greenberg, ed.), p. 532. Thomas, Springfield, Illinois, 1951. 127. P. Desnuclle, in “The Proteins. Chemistry, Biological Activity and Methods” (H. Neurath and K. Bailey, eds.), Vol. 1, Part A, p. 87. Academic Press, New York, 1953. 1%. F. W .Putnam, in “Thc Proteins. Chemistry, Biological Activity and Methods” (H. Neurath and K. Bailey, cds.), Vol. 1, Part B, p. 893. Academic Press, New York, 1953. 129. R. A. Cox, BJ 114, 743 (1969). 130. M.Tal, BBA 224, 470 (1970). 131. M. Tal, Bchem 8, 424 (1969). 132. A. S. Spirin, N. V. Belitsina and M. I. Lerman, J M B 14, 611 (1965). 133. H . E. Huxley and G. Zubay, JMB 2, 10 (1960). 134. S. T . Bayley, JMB 8, 231 (1964). 135. Yu. A. Rornakov and G. V. Bozhko, Biokhimiya 32, 471 (1967). 1SG. M. E. Lamm, L. Childers and M. K. Wolf, J. Cell Bio2. 27, 313 (1965). 137. N. Feder and M. K. Wolf, J . Cell Biol. 27, 327 (1965). 13S. A. V. Furano, D. F. Bradley and L. G. Childers, Bchem 5, 3044 (1966). 139. Yu. N. Kosaganov, M. I. Zarudnaya, Yu. S. Lazurkin, M. D. Frank-Kamenetskii, R. Sh. Beabenlashvili and L. P. Savochkina, Nature (London) New Biol. 231, 212 (1971).
140. W. Doerfler and A. K. Kleinschrnidt, JMB 50, 579 (1970). 141. A. S. Bayev, Yu. L. Lyubchenko, Yu. S. Lazurkin, E. N. Trifonov and M. D. Frank-Kamenetskii, Mo2. Biol. 6, 760 (1972).
M. YA. FELDMAN
48
142. S. R. de H o e t , V. 8. Mayo and B. A. G . Andretin. BBRC 40, 454 (1970). 143. J. M. Bishop and G. Koch, JBC 242, 1736 (1967). 1 4 . A. M. Poverenny, T. L. Aleinikova and A. S. Saenko, Biokhimiya 31, 1150 (1966). 146. R. L. Sinsheimer, JMB 1, 37 (1959). 146. W. Sauerbier, Nature (Loiidon) 188, 327 (1960). 147. T. I. Tikhonenko and E. N. Dobrov, JMB 42, 119 (1969). 148. World Health Organization, “Human Viral and Rickettsia1 Vaccines,” Technical Report Series, No. 325. Geneva, 1966. 149. Ch. Andrewes, “Viruses of Vertebrates.” Bailliere, Tindall and Cox, London,
1964. 160. Chemical Inactivation of Viruses, Ann. N . Y . Acad. Sci. 83, No. 4, Part 11, 564653 (1960). 161. E. Maron, C. Shiozawa, R. Arnon and M. Scla, Bchem 10, 763 (1971). 162. F. A. Anderer, M. A. Koch and S. D. Hirschle, Eur. J . Immunol. 1, 81 (1971). 163. R. Markham, R. E. F. Matthews and K. M. Smith, Nnture (Londoti) 162, 88 (1948). 164. M. Staehelin, BBA 31, 448 (1959). 166. A. Ross and W. Stanley, J . Gen. Physiol. 22, 165 (1938). 166. R. Haas, R. Thomssen, V. Dostal and E. Ruschmann, Arch. Ges. Virusforsch. 9, 470 (1959). 167. T. Alderson, Nature (London) 215, 1281 (1967). 168. G. D. Zasukhina and I. A. Rapoport, Genetika 5, 33 (1965). 169. Yu. Z. Gendon, “Genetika virusov cheloveka i zhivotnikh.” Nauka, Moskva, 1967. 160. E. Englesberg, J. Bactenol. 63, 1 (1952). 161. F. H. Dickey, G. H. Cleland and C. Lotz, PNAS 35, 581 (1949). 162. F. H. Sobels, Radial. Res. SuppZ. 3, 171 (1963). 163. I. H. Herskowitz, Science 112, 302 (1950). 164. C. Auerbach and H. Moser, 2. Vererbungslehre 85, 479 (1953). 166. H. Nafei and C. Auerbach, 2. Vererbungdehre 95, 351 (1964). 16G. T. Alderson, Nature (London) 191, 251 (1961). lG7. A. F. E. Khishin, Mutation Res. 1, 202 (1964). 168. W. E. Ratnayake, Mutation Res. 9, 71 (1970). 169. W. D. Kaplan, Science 108, 43 (1948). 170. P. D. Lawley, This Series 5, 89 (1966). 171. R. Shapiro, This Series 8, 73 (1968). 172. A. Loveless, “Genetic and Allied Effects of Alkylating Agents.’’ Butterworths, London, 1966. 173. R. K. Lyakyavichus, Uspekhi Sour. Genet. 1, 165 (1967). 174. R. Shapiro and J. Hnchmann, Bchem 5,2799 (1966). 176. R. Shnpiro, B. I. Cohen, 8.5.Shiuey and H. Maurer, Bchem 8, 238 (1969). 176. R. Shapiro, B. I. Cohen and D. C. Clagett, JBC 245, 2633 (1970). 177. N. E. Broude, E. I. Budowsky and N. K. Kochetkov, MoZ. BWZ. 1, 214 (1967). 178. M. Litt and V. Hancock, Bchem 6, 1848 (1967). 179. M. Litt, Bchem 8, 3249 (1969). 180. M. Litt, Bchem 10, 2223 (1971). 181. F. A. French and B. L. Freedlander, Cancer Res. 18, 172 (1958). 18.3. 0. L. Klamerth, BBA 155, 271 (1968). 183. U. Bachrach and G. Eilon, BBA 145, 418 (1967).
REACTIONS OF FORMALDEHYDE WITH NUCLEIC ACIDS
49
l S 4 . U. Baclirarh and G. Eilon, BBA 179, 473 (1969). 186. G.Eilon and U. Buclirdi, BBA 179, 464 (1969). 186'. U.Bachrach and S. Pcrsky, BBA 179, 484 (1969). l S 7 . B. W. Kimes and D. It. Morris, BBA 228, 235 (1971). 188. K . W. Kohn, C. I,. Spears cind P. Dots, JMB 19, 266 (1966). 1259. K. W.Kohn and D. M. Green, J M B 19, 289 (1966). 190. P. D.Lawley and P. Brookcs, J M B 25, 143 (1967). 191. P. D.Lawley and P. Brookrs, BJ 109, 433 (1968). 192. P. D. Ltnvley, J. H. Lethbridgc, P. A. Edwards iind K.V. Shootcxr, J M B 39, 181 (1969). 193. R . J. Rutman, E. H. I,. Chun and J. Jones, BBA 174, 6f33 (1969). 104. W.G . Flnmm, N. J. Brrnlieim and I,. Fishbein, BBA 224, 657 (1970). 196. W.G. Verly and I,. Brnkirr, BBA 174, 674 (1969). 1911. L. Brakier and W-.G. Vrrly, BBA 213, 296 (1970). 197. S. Venitt. P. Brookes and P. D. La\vlcy, BBA 155, 521 (1968). 198. B. D.Reid and I. G.Walker, BBA 179, 179 (1969). 199. K.Takizawit and T. Yaniamoto, Gatin 61, 605 (1970).
This Page Intentionally Left Blank
Synthesis and Functions of the -C-C-A Terminus of Transfer RNAl
I
MURRAY P. DEUTSCHER Departmelit of Biochemistry, University of Connecticut Health Center, Farmingtoii, Connecticut
I. Introduction . . . . . . . . . . . 11. Location of the -C-C-A Terminus in the Three-Dimensional
Structure of tRNA . . . . . . . . . . 111. Synthesis and Turnover of the -C-C-A Terminus in Vivo . IV. Enzymatic Synthesis of the -C-C-A Terminus in Vitro . A. Historical . . . . . . . . . . . B. Purified tRNA Nucleotidyltransferases . . . C. tRNA Recognition . . . . . . . . . D. Catalytic Properties . . . . . . . . . E. Misincorporation of Nucleotides . . . . . . V. Role of the -C-C-A Terminus in tRNA Function . . A. Aminoacyl-tRNA Formation . . . . . . . B. Pept,ide Bond Formation . . . . . . . . VI. Possible Control Functions of the -C-C-A Terminus of tRNA References . . . . . . . . . . . .
. .
51
. . . . . .
52 57 60 60 62 67 71 76 78 78 82 86 88
. . . . . .
. .
. . . . . .
. . . . .
.
1. Introduction The central role of tRNA in the biosynthesis of proteins is now well established. Early studies of tRNA demonstrated the presence a t the 3’-terminus of a specific trinucleotide sequence, -C-C-A,’ which is required for its biological activities ( 1 ) . Numerous sequence analyses in the past several years have confirmed the existence of this terminal sequence in all tRNA molecules specific for most amino acids, independent of their biological sources (a). I n fact, the sequence determination of a tRNA involved exclusively in cell wall synthesis revealed
Studies from the author’s laboratory referred to here were supported by grants from the U.S. Public Health Service (GM-16317) and the American Cancer Society (P-523). Abbreviations used : tRNA-C-C-F, tRNA containing a terminal formycin residue ; P-cell, phosphocellulose ; DEAE, diethylaminoethyl cellulose ; tRNA-N, tRNA lacking the entire -C-C-A sequence. 51
52
MURRAY P. DEUTSCHER
that the -C-C-A terminus is present in molecules used for processes other than protein synthesis (S, Sa). Enzymes that incorporate nucleotides into the terminal positions of tRNA have been known since the earliest work describing aminoacyltRNA formation ( 4 ) . During the initial period of investigation (19581963), a substantial amount of information dealing with the function and turnover of the terminal nucleotides was accumulated. However, in the intervening years since those early studies, relatively little work has been devoted to the understanding of the role of this common trinucleotide in tRNA function or to its mode of synthesis. It is only in the past three years that there has been a rcncwed interest in this area, probably due to the increasing number of studies of tRNA biosynthesis ( 5 ) and to the observations that an identical -C-C-A sequence is present a t the 3’-end of many viral RNA molecules (6). It is the purpose of this article to review the studies dealing with the synthesis and function of the -C-C-A terminus of tRNA. A t the present time, other than the anticodon, the only part of the tRNA molecule assigned a specific function (i.e., carrying the amino acid) is the 3’-terminus. This region of tRNA is particularly amenable to study since it is possible to modify its structure without affecting the rest of the nucleic acid chain by use of the enzyme tRNA nucle~tidyltransferase.~ I n addition, this enzyme is itself of interest and is discussed, since its mode of action is particularly pertinent to an understanding of nucleic acid recognition and to thc mechanism of phosphodicster bond synthesis. Other reviews rclatcd to tRNA structure havc appeared recently (6a, 6b).
II. location of the -C-C-A Terminus in the Three-Dimensional Structure of tRNA Although all tRNA molecules sequenced to date can be arranged in a cloverleaf structure with an exposed 3’-terminus, the three-dimensional organization of these molecules is unknown. Nevertheless, some progress has been made and several models for tRNA structure have been proposed [sec article by Cramer in Vol. 11 of this series for a discussion of the problem ( 7 ) l . I n the present article we are particularly interelited in the location of the -C-C-A terminus and its possible interaction with other parts of thc tRNA molecule. Inasmuch as the 3’-terminus must be * The enzyme has also been called -C-C-A pyrophosphorylase or tRNA pyrophosphorylase. However, the trivial name tRNA nucleotidyltransferase (EC 2.7.7.25) is used throughout this article, esprcially since the enzymc undoubtedly works in the direction of synthesis in v i v a
-C-C-A
TERMINUS OF TRANSFER
RNA
53
available for reaction with aminoacyl-tRNA synthetases, peptidyltransferase and tRNA nucleotidyltransferase, it is likely that the -C-C-A sequence is present in an exposed region for a t least a fraction of the time. Several approaches have been employed in order to examine more directly whether the nucleotides in the -C-C-A terminus interact with other parts of thc molecule and are involved in the three-dimensional structure of tRNA, or whether they are completely exposed. These studies have included chemical modification by reagents specific for singlestranded regions of tRNA, degradation by specific enzymes, and physical measuremcnts of tRNA molecules containing fluorescent or spin-labeled moieties at their 3'-termini. The conclusions to be drawn from these various studies are contradictory. Studies involving modification of tRNA by reagents presumably specific for adenine and cytosine residues in exposed regions suggest that the terminal trinucleotide may be exposed under certain conditions. The terminal adenosine in yeast tRNAP'Ie is one of only four residues oxidized to the l-N-oxide by monoperphthalic acid (8). Similarly, 89% of the terminal adenylate moiety of bulk E. coli tRNA can be deaminated to inosinate by an algal adcnylatc deaminase (9). Exposed cytosine residues in tRNA can also be specifically modified by the reagents methoxyamine (o-methylhydroxylamine) or bisulfite. With both yeast tRNAVa' (10)and Escherichia coli SuIIl tRNATYr ( 1 1 ) , under conditions in which only a limited number of cytosine residues are derivatized by methoxyaminc, both cytosines in the -C-C-A terminus are reactive. Likewise, both terminal cytosine residues in yeast tRNATyr (12) are converted to uracil by the action of bisulfite. Only one of the two cytosine residues in E . coli tRNAolU reacts promptly with bisulfite (IS), suggesting that part of the -C-C-A terminus in this tRNA is less accessible under the conditions of the experiment. I n contrast to the chemical modification studies, digestion of tRNA by exonucleases suggests that the terminal trinucleotide is involved in the three-dimensional structure. The early work of Zubay and Takanami (14) indicated that only the terminal -C-A residues of tRNA are removed by snake venom phosphodicsterasc a t 20°C in the presence of Mg2+,whereas more extensive degradation takes place a t 37". These results were interpreted as evidence that only these two residues are exposed a t 20", but that a t higher temperatures the secondary structure of tRNA is sufficiently disrupted to allow further degradation. However, a recent study by Miller and co-workers (15) indicates that all three terminal nuclcotidcs arc, in fact, removed even a t 20°C, but the terminal AMP is rcmovcd about four timcs faster than the first C M P and about
54
MURRAY P. DEUTSCHER
seventy times faster than the second CMP moiety. These same relative rates of nucleotide removal are also found a t 37" indicating that the differences found a t the two temperatures are due only to the general effect of temperature on the rate of reaction, not to the weakening of tRNA structure. What is clear from these studies is that the terminal C M P residues, a t least, must be involved in the three-dimensional structure of tRNA since it is known that all four nucleotides in RNA can be removed a t similar rates if no secondary structure is present (16). The fact that the last four nucleotides of tRNA are not base-paired in the simple cloverleaf configuration suggests that the difference in rates of removal of the terminal residues is due to their interaction with other parts of the tRNA molecule. The action of polynucleotide phosphorylase on tRNA, which has been studied by Grunberg-Manago and her co-workers over the past several years (17-19), suggests that a certain fraction of tRNA molecules can assume a conformation in which they are so totally resistant to phosphorolysis that even the terminal AMP residue is not removed (17).This is true even in solutions containing only a single species of tRNA, although the proportion of resistant structures a t a given temperature varies from one tRNA to another (19).The resistant conformation can be converted to the sensitive one by heating the tRNA a t a temperature above 90°C or by including purine in the reaction mixture (18).Despite the fact that the -C-C-A termini of the resistant forms are inaccessible to polynucleotide phosphorylase, these molecules can be aminoacylated by aminoacyl-tRNA synthetases (It?), indicating that they are not denatured forms of tRNA (20, 2 1 ) . It is difficult to explain these observations unless it is assumed that the binding of tRNA to the synthetase alters its conformation in such a way that the 3-terminus becomes exposed, but that this change in tRNA structure does not occur upon binding to the phosphorylase. These ideas would fit very well with a model for tRNA structure recently proposed by Danchin (22) (see below). Additional evidence for the involvement of the %-terminal nucleotides in the tertiary structure of tRNA comes from physical studies of this nucleic acid. The fluorescent nucleotide, formycin monophosphate can be incorporated into tRNA in place of the terminal AMP residue by the action of tRNA nucleotidyltransferase (23). Examination of both the fluorescence intensity and pK of the formycin residue in tRNA-C-C-F* compared to those of the free nucleoside suggests that the terminal formycin moiety does interact with other parts of the tRNA molecule. I n addition, the T, of tRNA based on fluorescence of the formycin residue is 7" lower and considerably narrower than one based on absorbance (24).These results suggest that the terminal sequence is involved in a
-C-C-A
TERMINUS OF TRANSFER
RNA
55
part of the tertiary structure that melts independently of the whole tRNA molecule. The ordered structure of the -C-C-F terminus is probably identical to that in normal tRNA, since the former molecule also can accept amino acids ( 2 3 ) . Rich and co-workers (25, 26) obtained similar results using a nitroxide spin-label attached to the free amino group of valine in valyl-tRNA. Based on the rate of tumbling of the spin-label, these workers also observed a lower melting temperature for the 3’-terminus relative to the whole molecule, but only under certain conditions. For example, in dilute salt, the transition of spin-label tumbling occurs at the same temperature as the midpoint of the optical density melting curve, although the transition is sharper. Another study (27) in which the polarization of fluorescence of an acriflavin-tRNA conjugate was measured also showed that the nucleoside terminus becomes more mobile about 10°C below the T, based on absorbance when the measurements are performed in 0.02M Mg?’, but not in dilute salt ( 2 7 ) .These results suggest that the -C-C-A terminus may be involved in tertiary structure even when aminoacylated, although the ionic environment obviously plays an important role in the type of structure found. It has also been suggested that the low temperature form may represent a single-stranded stack of bases a t the 3’-terminus rather than an interaction of these residues with other parts of the tRNA molecule ( 2 6 ) . I n view of the suggestions that charged tRNA has a structure different from that of uncharged tRNA (28-29a), it would be of interest to reexamine these spin-label studies with a nitroxide-labeled nucleotide, such as “tempo-AMP” (SO),in the terminal position. It might be possible to incorporate this compound into tRNA with tRNA nucleotidyltransferase. Such studies would allow an investigation of the 3’4erminus without the complication introduced by amino acid loading. Additional, but less direct, evidence for interaction of the -C-C-A terminus with other regions of the tRNA molecule come from the following studies. Millar (31) has shown that cyanoethylation of pseudouridylate residues in bulk E. coli tRNA renders the terminal nucleotides more susceptible to degradation by snake venom phosphodiesterase a t 20°C compared to untreated tRNA, although no differences were found a t 0”. The data suggest that some interactions between 0” and 20” are disrupted, in cyanoethylated tRNA leading to greater exposure of the -C-C-A residues. Sen0 and co-workers demonstrated (32) that the 3’half of E . coli tRNAfMetdoes not interact with the 5’-half if the terminal six nucleotides are missing, even though in this particular tRNA the last five nucleotides are not based-paired in the cloverleaf structure. These workers suggested that the 3’-terminal nucleotides may play an important
56
MURRAY P. DEUTSCHER
role in forming the proper tertiary structure. On the other hand, it has also been shown that yeast tRNAsep and tRNAPhecan assume a denatured conformation in the absence of the last two nucleotides, -C-A (3s). Another piece of information favoring the involvement of the terminal cytosine residues in tRNA structure is that their conversion to uracils by bisulfite treatment renders them more susceptible to nuclease attack ( l a ) , suggesting that they are probably protected by pairing with guanine residues somewhere in the tRNA chain. In the past few years several models for the tertiary structure of tRNA have been proposed (7). I n most of these, the -C-C-A terminus is represented as being completely exposed, an idea not consistent with the available information, Cramer et al. (8) have suggested that the -C-C of the 3‘-terminus is hydrogen-bonded to the invariant -G-G sequence of the dihydrouridine loop and thereby held in a fixed position. Connors et al. (94) suggested that the C-C-A end “threaded through” the dihydrouridine loop, and Melcher (36) hypothesized that the 3‘terminus slipped through a ring made by all three major loops, thus leaving the -C-C-A residues near the anticodon. Upon aminoacylation the terminus would move out of the ring leading to a more exposed position which probably would be required for accepting the growing peptide chain. A main recent model suggested by Danchin (22) is related to the previous ones in that it visualizes the -C-C-A terminus passing through the dihydrouridine loop and pairing with the -G-G sequence in that loop to form a slipknot type of structure. The model further proposes that upon aminoacylation the hydrogen bonding between the terminal cytosine residues and these guanine residues would be disrupted and the loop would slip further down the aminoacyl stem exposing the -C-C-A end for peptide bond formation ( $ 8 ) . It is also suggested that a tRNA minus its -C-C-A would be folded in such a way that the aminoacyl stem would be positioned just under the center of the dihydrouridine loop and that tRNA nucleotidyltransferase could then add the -C-C-A sequence from above and complete the slipknot (29). Although some of the details of this last model might be open to question, the general outlines appear attractive and, furthermore, are consistent with recent data of Danchin and Gunberg-Manago (36, S7). These workers found that modification of the dihydrouridine loop of yeast tRNAPhe by reduction with sodium borohydride does not affect amino-acid charging (S6). However, if the tRNA is first heated to 70” to disrupt structure, the reduced tRNA exhibits greatly decreased aminoacylation compared to heated, unmodified tRNA. Incubating the tRNA a t 25°C leads to a recovery of activity and a conformation change as shown by NMR. The authors postulate that opening the dihydrouri-
-C-C-A
TERMINUS OF TRANSFER
RNA
57
cline residues by reduction decreases the space inside the loop and thereby decreases the rate a t which the -C-C-A terminus can reenter the loop after heat treatment, presumably to reform the slipknot structure ( 3 6 ) . Since yeast tRNAP1’“contains only eight residues in the dihydrouridine loop it would be of interest to repeat this experiment with a tRNA containing a larger loop to determine whether the charging ability of the tRNA returns after a shorter period of incubation. I n another study (37), these workers also found that more oligo (C) can be bound to acylated yeast tRNAP’le and E . coli tRNAVal than to the deacylated species. This would be consistent with the model described above, since, after charging, the -G-G (or -G-G-G) sequences in the dihydrouridine loop would no longer be paired with the -C-C residues of the terminus. Finally, it was observed (19) that tRNA’s with a long dihydrouridine loop are well phosphorolyzed by polynucleotide phosphorylase, possibly because their 3’-termini can move in and out of the loop more readily. It remains to be explained why chemical modification studies suggest a greater degree of exposure of -C-C-A terminus than other types of measurements. Undoubtedly, the conditions under which the modification reactions are performed (pH, temperature, ionic strength) play an important role. For example, all the chemical modifications were performed in high concentrations of salt, which tighten nucleic acid structure (38). In the context of Danchin’s model (ZZ), such conditions might tighten the structure in such a way that the flexible dihydrouridine arm slips down into the position normally found in aminoacylated tRNA, thereby exposing the -C-C-A terminus to chemical attack. The enzymatic and physical studies, in contrast, were carried out a t much lower salt concentrations. It is also possible to imagine that some enzymes, such as the aminoacyl-tRNA synthetases, could bind to the tRNA in a manner that pulls down the dihydrouridine loop, thereby exposing the -C-C-A end, whereas the various degradative enzymes studied might not induce such a change in conformation.
111. Synthesis and Turnover of the -C-C-A Terminus in Vivo Details of the mechanism of tRNA biosynthesis remain to be elucidated. However, it is clear from studies of both microorganisms and mammalian cells that the tRNA is first synthesized as a larger precursor molecule containing extra nucleotides a t both ends and is then specifically cleaved and modified to produce mature tRNA (39).Since all tRNA molecules contain the same terminal -C-C-A sequence, the question arises whether these nucleotides are synthesized during transcription or are added during the subsequent maturation process, especially since there
58
MURRAY P. DEUTSCHER
is an enzyme that can incorporate nucleotides into this terminal grouping. It has been known for some time that the nucleotides in the -C-C-A terminus are preferentially labeled by comparison with nucleotides in the interior of the tRNA chain ( 4 0 ) . This terminal incorporation is particularly pronounced in the presence of actinomycin D since relatively few nucleotides are incorporated into internal positions of the tRNA chain in the presence of the antibiotic while incorporation into terminal either residues is almost unaffected (41-43). I n labeling tRNA with s2Pp,, in the presence or absence of actinomycin, the radioactivity is found to be concentrated in the terminal AMP residue (40, 4.2, 4 4 ) . Such studies led to the postulate that the nucleotides of the -C-C-A terminus, and especially the AMP moiety, turn over independently of the rest of the tRNA molecule (40-43). However, in some of these studies it is not clear that only turnover was being measured. I n fact, the studies of Rosset and Monier (46) with yeast suggest that net synthesis of the -C-C-A terminus on tRNA molecules lacking these residues may also be taking place during the labeling period. These workers found that in a 15-minute pulse-label with 32Pi,the ratio of specific activities of terminal to internal AMP residues is 6.4, and that for CMP residues is 4.3,despite the fact that the C M P residues are not turning over ( 4 5 ) . That turnover of the terminal residues of tRNA also occurs was demonstrated by studies in E. coli (46, 4 7 ) , yeast ( 4 5 ) , rat liver ( 4 4 ) , and rabbit reticulocytes ( 4 8 ) . Cannon labeled tRNA in exponentially grown E. coli with ["Cladenine and showed that the radioactivity is removed from the terminal AMP residue independently of the internal AMP residues (46). This turnover amounts to about 0.5% of the total terminal AMP per minute, or about 20% per generation, and remains constant for four generations ( 4 6 ) .I n a similar study, Rosset and Monier demonstrated that the turnover rate increases from 0.27% to 0.63% of the total terminal AMP residues per minute as the growth rate increases fom 0.57 to 1.09 ( 4 7 ) .The turnover per generation remains constant a t about 20% ( 4 7 ) . Cannon showed further that turnover ceases when chloramphenicol is added to exponentially growing cells, or if cells with stringent control of RNA synthesis are deprived of a required amino acid ( 4 9 ) . I n cells with relaxed control, turnover of the terminal AMP moiety is observed, but only under certain conditions of amino acid starvation ( 4 9 ) . Studies with yeast (45) and rat liver (44) also indicated that turnover of the terminal CMP residues is relatively low compared to that of the AMP, although no quantitative values were assigned to the turnover rates. I n an examination of turnover in rabbit reticulocytes, Holt et al. (48) concluded that the terminal AMP of tRNA turns over com-
-C-C-A
TERMINUS OF TRANSFER
RNA
59
pletely in 4-8 hours, whereas the two CMP residues require an average of about 30 hours. I n addition, it was shown that these values represent actual turnover, not net synthesis. At present, the functional significance of turnover of the terminal nucleotides of tRNA is not known (see Section V I ) . Some of the labeling studies described above suggested that a portion of the radioactivity found in the terminal nucleotides might arise from net synthesis on tRNA molecules lacking the -C-C-A sequence. Such molecules are presumed to he intermediates in tRNA biosynthesis. Since an enzyme exists that can incorporate these nucleotides into tRNA, it has been assumed that the terminal residues are added in a posttranscriptional process, although no direct evidence for this idea has been described. This hypothesis was strengthened by the observations of Daniel et al. ( 5 0 ) , who found that the terminal AMP and penultimate CMP residues of tRNA are sensitive to pancreatic RNase digestion in tRNA. DNA hybrids, whereas these moieties are not removed by T1 RNase. These data suggest that the -C-C-A terminus does not have a complementary sequence on the DNA. However, it is also possible that the last few residues on tRNA do not hind tightly to DNA and, for that reason, are sensitive to the RNase. Despite this earlier evidence, the suggestion that the -C-C-A terminus may be synthesized independently of the rest of the tRNA molecule has been thrown into doubt recently by the results of Altman and Smith (50~1,5 1 ) . These workers sequenced a precursor tRNA molecule isolated from E. coli infected with $80 phage. The phage carried a mutant SuIII gene specifying tyrosine tRNA, which leads to high yields of the precursor. The precursor molecule of about 130 nucleotides contains the complete tRNA primary sequence as well as additional residues a t both the 3’- and 5’-ends (Fig. 1 ) . Since the -C-C-A sequence is already present and is followed by the three additional nucleotides, -U-C-U, it was concluded that the -C-C-A terminus is part of the transcriptional unit of this tRNA. In addition, incubation of the tRNA precursor with an E. coli extract leads to removal not only of the extra -U-C-U sequence, but also of the two terminal residues in the normal -C-C-A terminus ( 5 2 ) . If the C-C-A terminus of tRNA is, in fact, transcribed from every tRNA gene, one wonders what is the function of tRNA nucleotidyltransferase. This point is particularly perplexing since in many cases turnover of the terminal residues is limited to the AMP moiety, whereas the enzyme can accurately synthesize the complete -C-C-A sequence. I n view of the high turnover number and specificity of tRNA nucleotidyltransferase, it seems unlikely that the enzyme’s role would be limited to repairing the small number of tRNA molecules that lose part of their
60
MURRAY P. DEUTSCHER
A U G
A
C
A C-G
0,
C*G U -G U S A C-G pppG
*
C AG G C C AG U A A A AG C AU UA C C CG *C C A
c
U C
U
FIG.1 . Sequence of the SUIIItRNA precursor, adapted from Altman and Smith (61).The arrows indicate where cleavage must occur to generate the mature tRNA.
terminal sequence during turnover. The fact that tRNA nucleotidyltransferase is present in all sources examined, as well as in mitochondria ( 5 S ) , further suggests a significant function for this enzyme. Since incubation of the tRNA precursor leads to loss of part of the terminal sequence, the enzyme may, in fact, play a role during tRNA maturation. Isolation of mutants lacking tRNA nucleotidyltransferase would help to clarify its function in tRNA metabolism. Of course, the possibility also exists that tRNATyr is an exception, and in other tRNA molecules the -C-C-A sequence is not transcribed. It may be that the terminal -C-C-A sequence in this particular tRNA precursor actually is part of the 3’fragment removed during maturation, but fortuitously containing the same nucleotides reincorporated. Such an idea might be valid since tRNATYr contains three consecutive -C-C-A sequences a t its 3‘-end. This suggestion would also explain the unexpected removal of the terminal -C-A residues accompanying hydrolysis of the extra 3’-nucleotides. Otherwise, this process would appear to be quite wasteful.
IV. Enzymatic Synthesis of the -C-C-A Terminus in Vitro A. Historical The investigations into the nature of protein and RNA synthesis during the late 1950’s are an interesting example of how two completely separate lines of inquiry can ultimately lead to the same facts. At that
-C-C-A
TERMINUS OF TRANSFER
RNA
61
time, the importance of the RNA in the “soluble” portion of the cell (tRNA) was discovered and it was shown that a common trinucleotide sequence was present on these RNA molecules. Simultaneously, many investigators examining the incorporation of RNA precursors into RNA, reported that AMP is often incorporated into terminal positions and adjacent to CMP residues. As it turned out, in most cases, the RNA synthesis measured actually represented the limited incorporation of nucleotides into the terminus of tRNA. It was first shown by Heidelberger et al. (54),using [s2P]AMP and a liver fraction free of nuclei, that there is a specific site of nucleotide incorporation since close to 90% of the label was released as 2’- and 3’C M P after alkaline hydrolysis. I n contrast, Goldwasser (55) had demonstrated earlier, with a complete liver homogenate, that label from [3*P] AMP was distributed among all four nucleotides. It is clear now that in the earlier study (55) the incorporation probably represented net RNA synthesis taking place in nuclei, whereas the results of Heidelberger et al. (54) represented terminal addition to tRNA. I n a series of further studies from several laboratories, it became apparent that AMP incorporation is into the terminal position of the soluble RNA fraction, adjacent to a CMP residue (4, 56-60), and that ATP is the precursor (4, 58, 5 9 ) . I n detailed examinations of the terminal addition reaction, Hecht et al. (1, 4 ) showed that ATP, C T P and UTP are precursors for nucleotide incorporation into the RNA of the “pH 5 fraction,” but that G T P is inactive. A prior incubation of the pH 5 fraction decreased AMP incorporation unless CTP was also present. RNA’s from the soluble fraction of mammalian, bacterial or yeast cells were all active nucleotide acceptors, whereas microsoma1 and nuclear RNA had no activity. The reaction required Mg2+,and was inhibited by pyrophosphate, which reversed the reaction. The 2: 1 ratio of C M P and AMP incorporation, as well as the location of the incorporated residues, indicated that the -C-C-A sequence was synthesized by a terminal addition of nucleotides. This sequence of three nucleotides a t the end of tRNA is required for amino-acid charging (1, 6 1 ) , and furthermore, it has been demonstrated that the amino acid is actually esterified to either the 2‘ or 3‘ hydroxyl of the terminal adenosine (1,62, 63, 63a).
By 1960, the terminal addition of nucleotides to tRNA had been observed in extracts from rat liver (4, 58, 59, 64), Ehrlich ascites cells ( 4 ) , chick embryo (65) and E . coli ( 6 6 ) .Although much of the early data has been substantiated, several puzzling observations still remain to be explained. For instance, Harbers and Heidelberger (64) found that GMP was incorporated into a particular fraction of RNA and almost exclusively next to a UMP residue. These workers suggested the possibility that a
62
MURRAY P. DEUTSCHER
-U-U-G sequence might be synthesized. The incorporation of UMP into tRNA in vitro was also demonstrated in these carly studies ( 4 ) and shown to be in the terminal position, although the level of incorporation was relatively low. The significance of these labeling patterns is not clear since -U-U-G termini have not becn found in tRNA. UMP incorporation by tRNA nucleotidyltransferasc will be discussed further below. I n another puzzling observation, Hecht et al. (4) showed that the extent of AMP incorporation into pH 5 RNA is doubled by the presence of GTP, but not by UTP. CTP, as expected, also led to a large increase in AMP incorporation, but the effects of GTP and CTP were not additive. At present, there is no adequate explanation for this effect of GTP. Finally, Hurwitz and Bressler (67) isolated an enzyme from calf thymus glands that utilizes CTP and adds a limited number of CMP residues to the cnd of RNA chains. No other triphosphate was a substrate, and the only active RNA acceptor was a low molecular weight RNA isolated from the thymus. The relation of this CMP incorporating activity to tRNA nucleotidyltransferase is not understood. It may be related to the poly (C) polymerase activity found in thymus extracts (68).I n addition, the low molecular-weight thymus RNA used in these studies was a substrate only for CMP incorporation, even with an enzyme preparation from E . coli (69).The identity of this RNA is not known.
B. Purified tRNA Nucleotidyltransferases The first purification of the enzyme involved in the terminal addition of nucleotides to tRNA was reported by Canellakis and Herbert in 1960 (70, 71) . These workers isolated three presumably distinct ribonucleoproteins from rat liver, which incorporated AMP and CMP into the RNA present in the preparation (70, 7 1 ) .I n the next several years, the enzyme was purified several hundredfold from E . coli (69, 759, rat liver (73) and rabbit muscle (74) to specific activities in the range of 1-6 pmoles of AMP incorporated per hour per milligram of protein (see Table I).Each of these preparations also incorporated CMP, and the ratios of the two activities remained essentially constant throughout the purification, suggesting that a single enl;yme was probably involved. None of these enzymes was characterized with regard to either purity or physical and chemical properties of the protein. Further detailed studies of these interesting enzymes were neglected until the past two or three ycars when highly purified preparations from E . coli (75-78), yeast (79-80) and rabbit liver (81) became available. Some of the properties of these tRNA nucleotidyltransferase preparations are listed in Table I. I n these recent studies, the enzymes have been purified as much as several thousandfold. Although the actual extent of
TABLE I
PROPERTIES O F PURIFIED tRNA
Source
1. Escherichia coli B
Purification (-fold) -100
Specific activit.y (pmoles/mg/ hour) 4.9,37”C
2. E. eoli W 3. E. coli MRE 600 4. E . coli B
-200 -1000 -4000
5.1,37”C 0.2, 37°C 29, 37°C
5. E. coli B 6. E. coli MliE 600
-7000 -
36, 30°C 1.1, 37°C
7. Bakers’ yeast 8. Bakers’ yeast
-8000 -5000
1400, 32°C
-100 -400 -250 -25,000
0.0075, 25°C 6.3, 37°C 0.8, 37°C 2000, 37°C
9. Rat liver 10. Rat liver 11. Rabbit muscle 12. Rabbit liver
a
Sephadex.
c
Equilibrium ultracentrifugation.
-
Molecular weight
37, O W 45, oooa 54, OOob 42, OOOa 70,000’ 71,000” 44,000” 47, 000’ 48, 000”
NUCLEOT1DYLTRANSFE:RASES
Constant ratio Sedimentation CMP/AMP rate incorpora(S) tion?
3td z Comments Two peaks on IIEAEcellulose
-
60% pure Peak fraction, almost pure
Two peaks on IIEAEcellulose Homogeneous 3 Ribonucleoproteins Two peaks on phosphocellulose, homogeneous
Reference 72
2 cl a
u)
*
H
w
P
60 75 77
78 76
4
u)
9
m
s Y
5
70 80 71 73 74 81
* Dodecyl sulfate-acrylamide-gel electrophoresis. 0,
w
64
MURRAY P. DEUTSCHER
purification may be incorrect because of interfering activities in the crude extracts, it is obvious that these enzymes are present in cells in extremely small amounts. Despite the fact that several of these preparations were reported to be pure (80, 8 l ) , or nearly so (75, 7 7 ) ,their specific activities vary over an extremely wide range. Miller and Philipps (77) reported that their preparation from E. coli has a specific activity of about 30, whereas a 60%-pure enzyme from another strain of E. coli described by Carre et al. (75) has a specific activity of only 0.2 when expressed in the same units. Other purified E. coli preparations, which were not characterized for purity, also have specific activities in the same range (76, 7 8 ) . I n contrast, the enzymes purified from yeast by Sternbach et al. (80) and from rabbit liver by Deutscher (81) have specific activities of about 2000 pmoles per milligram of protein per hour. The turnover number calculated for the rabbit liver enzyme amounts to about 1500 molecules of AMP incorporated per molecule of enzyme per minute, which is probably greater than that for any enzyme synthesizing a phosphodiester bond. This high turnover number is even more surprising since the enzyme must dissociate from its tRNA substrate after the addition of every AMP residue, whereas DNA polymerase and RNA polymerase presumably remain attached to DNA during their action. It is curious that the eukaryote enzymes have such high turnover numbers compared to the prokaryote enzymes. Perhaps this may reflect different roles for tRNA nucleotidyltransferase in the two types of cells. On the other hand, the number of tRNA molecules per molecule of enzyme may vary considerably in prokaryotic and eukaryotic cells, but this has not been determined. In all cases in which they have been examined, the highly purified enzymes incorporate both nucleotides, AMP and CMP, into tRNA. It was demonstrated for the rabbit liver enzyme (82) that the two activities have the same relative rates of incorporation over a 7000-fold purification range, and that on the basis of acrylamide gel electrophoresis, isoelectric focusing and heat inactivation, AMP and CMP are incorporated by a single protein. The tRNA nucleotidyltransferases purified from the various sources generally fall into a relatively narrow molecular weight range (Table I). Miller and Philipps reported that the enzyme purified from E. coli B has a molecular weight of 54,000 based on dodecyl sulfate-acrylamide-gel electrophoresis, and 45,000 based on chromatography on Sephadex G-100 ( 7 7 ) .Similarly, enzymes purified from E. coli M R E 600 have a molecular weight determined on Sephadex of either 42,000 (76) or 37,000 ( 7 5 ) .The latter preparation also has a sedimentation coefficient of 2.9 S. Deutscher reported that the rabbit liver enzyme has essentially the same molecular weight of 44,000-48,000 when examined by equilibrium ultracentrifuga-
-C-C-A
TERMINUS OF TRANSFER
RNA
65
tion, dodecyl sulfate-acrylamide-gel electrophoresis or Sephadex G-100 chromatography (81). The sedimentation coefficient ( s ~ ~ of , ~ 3.6-4.0 ) for this protein is in good agreement with the molecular weight value, assuming a globular protein (81).I n contrast to these results, the tRNA nucleotidyltransferase purified from yeast by Sternbach et al. (80) has a molecular weight of about 70,000,both by equilibrium ultracentrifugation and of 4 . 2 s . Another purified yeast enzyme gel electrophoresis, and an szo,w also has a sedimentation coefficient of about 4 5 determined by sucrose gradient centrifugation (79). For the few cases in which it has been studied (77, 80,81),the molecular weight of tRNA nucleotidyltransferase determined by dodecyl sulfate-acrylamide-gel electrophoresis is essentially identical to that measured by nondisruptive methods, suggesting that these enzymes are single polypeptide chains. Furthermore, both the yeast (80) and rabbit liver enzymes (81) are devoid of any nucleic acid as determined by their ultraviolet absorption spectra. These results indicate that the synthesis of a specific -C-C-A sequence is not directed by a protein-bound template. Despite the fact that the yeast and rabbit liver enzymes have considerably different molecular weights, they have almost identical isoelectric points of about 7.5 (80, 82) (the liver enzyme actually has multiple forms with isoelectric points between 6.5 and 8, but the two main peaks are a t 7.2 and 7.5). The homogeneous rabbit liver enzyme contains no unusual amino acids and displays no unusual patterns in its amino acid composition (81).Both the rabbit liver (81) and rabbit muscle enzymes (82a) are relatively insensitive to sulfhydryl reagents and in some cases are actually stimulated. The enzyme from E . coli B, however, is inhibited 50% by 4-8 pM N-ethylmaleimide or p-mercuribenzoate (83).The rabbit liver (81) and some E. coli enzymes (75, 78) are stimulated by p-mercaptoethanol, but the rabbit liver tRNA nucleotidyltransferase is inhibited by dithiothreitol (81). The presence of multiple forms of tRNA nucleotidyltransferase has been reported by several workers. As discussed above, Canellakis and Herbert described the separation on hydroxyapatite of three ribonucleoproteins from rat liver, each of which is active for AMP and C M P incorporation (70). Furthermore, each fraction is eluted a t its original salt concentration when rechromatographed on hydroxyapatite. Multiple peaks for the E . coli enzyme were also reported by Preiss et al. (72) and by Gross et al. (76). I n the latter case, it was also shown that the molecular weight of the two forms are identical, but that one enzyme incorporates more AMP residues for a given tRNA preparation. Deutscher showed that the rabbit liver enzyme can be separated into two major forms and several minor ones by isoelectric focusing (82). Furthermore,
66
MURRAY P. DEUTSCHER
two forms of the enzyme also can be separated on phosphocellulose each of which incorporates AMP, C M P and UMP into tRNA, but a t different relative rates (81). These two proteins have very similar structural and catalytic properties, but some differences can be detected. For example, one protein appears to contain seven cysteine residues and the other four (81).I n addition, the response of the two enzymes to changes in reaction temperature or to the presence of high concentrations of salt in the assay are markedly different ( 8 4 ) .At present, the significance of multiple forms of tRNA nucleotidyltransferase is still not understood. Since, in the case of the liver enzymes, the two forms are so similar, it was suggested (81) that one of the proteins may have been damaged or modified during purification. Alternatively, if one of the proteins were modified specifically, this may indicate a control mechanism or physiological response for altering the enzymatic activity of the protein. Finally, it is possible that, the two forms of the enzyme represent proteins with different subcellular localizations. The last suggestion bears some further consideration. tRNA nucleotidyltransferases have generally been purified from high-speed supernatant fractions and were thought to be localized in the cytoplasmic fraction of cells. Mukerji and Deutscher (63),prompted by the finding of multiple forms of the liver enzyme, examined the subcellular localiza-
SUBCELLULAR DISTRIBUTION
TABLE I1 OF tRNA NUCLEOTIDYLTRANSFERASE IN RAT LIVER
Fraction Homogenate Crude nuclear Purified nuclei Crude mitochondrial Extracted mitochondria (freeze-thawing)* Extracted mitochondria (Triton X-loo)* Crude microsomal Purified microsomes High-speed supernatant
Total activitya (units)
8.8 0.5
Distributionc
(%) 69 4 <1 2
35 27 2 <1
65
0 Total activity is based on 10 g of liver. One unit equals 1 pmole of AMP incorporated per hour. * Recovery of purified mitochondria was only about 40%, so these values must be multiplied by 2.5 for total activity (values in parentheses). A value of 12.8 units was set equal to 100% of total cellular activity. This number was obtained by assuming that all the activity was localized in the high-speed supernatant (8.3units) plus the extracted mitochondria1 (4.5 units after correction) fractions.
-C-C-A
TERMINUS OF TRANSFER
RNA
67
tion of tRNA nucleotidyltransferase in rat liver (Table 11).It was observed that in addition to the cytoplasmic protein, extracted mitochondria also contain activity, amounting to about 35% of that in the whole cell. The other major subcellular fractions, nuclei and microsomes, are devoid of activity. The mitochondrial enzyme is localized in the matrix of the organelle and is not assayable unless the mitochondria are first ruptured by either freezing and thawing or by treatment with Triton X-100. The crude mitochondrial enzyme has similar catalytic properties to the one in the cytoplasm. However, the relation of the mitochondrial and cytoplasmic enzymes to the two forms of the enzyme purified from rabbit liver is still being explored.
C. tRNA Recognition The tRNA nucleotidyltransferases offer an interesting contrast t o the aminoacyl-tRNA synthetases with regard to their specificity for tRNA. Enzymes in the latter group utilize as substrates only a small number of tRNA chains, and, in many cases, even display species specificity such that tRNA molecules specific for the same amino acid may not be recognized in a heterologous system (85). In contrast, tRNA nucleotidyltransferases appear to recognize tRNA molecules specific for all amino acids and isolated from all organisms. Thus, aminoacyl-tRNA synthetases recognize the differences between tRNA molecules and tRNA nucleotidyltransferases recognize the similarities. An understanding of the structural properties required for the interaction of a nucleic acid with tRNA nucleotidyltransferase should give considerable information about the common features of tRNA structure. Although tRNA nucleotidyltransferases can utilize any type of tRNA as a substrate, these enzymes are almost completely inactive with other types of nucleic acid. Daniel and Littauer demonstrated that the enzyme isolated from rat liver cannot incorporate AMP into rRNA, TMV RNA, poly ( A ) , poly (C), poly (A,C) or poly (A,G,U,C) (73), and, in addition, these substrates are pyrophosphorolyzed very poorly, or not a t all. Similar results were also obtained with the enzyme from E . coli M R E 600 (75). The latter enzyme is also inactive with R17 and 5 S RNA, but it can incorporate an AMP residue into turnip yellow mosaic virus RNA (86). Likewise, under the usual conditions of assay, the rabbit liver enzyme is inactive with poly(A), poly(U), poly(C), poly(G), QB RNA and DNA (84, 87). However, a t high levels of enzyme, rabbit liver tRNA nucleotidyltransferase is able to incorporate nucleotides into liver rRNA (87). This anomalous incorporation occurs a t a very slow rate and very high concentrations of enzyme and rRNA are required in order to measure the reaction, So, although tRNA nucleotidyltransferases may have high
TABLE 111 CATALYTIC PROPERTIES OF PURIFIED tRNA NUCLEOTIDYLTRANSFERASES Apparent K , (triphosphates) (mM)
source 2. 3. 4. 5. 6.
7. 10. 11.
Escherichia coli B E . coli W E. coli MRE 600 E . coli B E. coli B E . coli MltE 600 Bakers’ yeast Ratliver Rabbit muscle
12. Rabbit livep
DH optimum 8.5 8.4 9.5 9.0-9.4 9.5
9.5 9.5 9.5 9.5
Apparent K , (tRNAp (pM)
ATP
CTP
UTP
tRNA-C-C
tRNA-C
tRNA-N
Reference
-
-
-
0.023 0.33 0.095 0.16 0.19
0.083 0.017 0.015 0.06
-
-
-
-
0.18 6.5
-
0.072 -
0.21 9 9.6
0.98 3.8
0.18 0.008
-
78 69 76 85 78 76 79 73 82
2
0.037 0.004
4
84
0.40
0.17
-
0.05
-
12
-
-
-
6
0.20
18
26d
a The apparent K, for tRNA-C-C was determined with ATP; the apparent K, for tRNA-C and tRNA-N was determined with CTP except as noted. Numbers of the various enzymes correspond to those in Table I. Constants for the rabbit liver enzyme were determined with phosphocellulose peak 11. Determined with ATP.
z 5 cd
-C-C-A
TERMINUS OF TRANSFER
RNA
69
specificity for tRNA molecules, other types of nucleic acid may act as acceptors if the conditions are forced (see Section IV, E). Relatively little work has been done to examine the binding of tRNA to tRNA nucleotidyltransferases. Kinetic studies of the E. coli (76, 7 8 ) and rabbit liver (84) enzymes have generally given K , values in the range of 5-20 pM for the various tRNA substrates (Table 111). However, Miller and Philipps (83)reported K , values of about 0.2 pM with the enzyme from E . coli B, which is about two orders of magnitude lower than that found by Best and Novelli (78) with an enzyme from the same source. The reason for this discrepancy is not apparent. Direct binding of the enzyme to tRNA has also been studied by the use of either sucrose gradient centrifugation, binding to nitrocellulose filters, or Sephadex chromatography. Honda, working with a relatively impure E . coli tRNA nucleotidyltransferase, showed that the enzyme forms a complex with yeast and E. coli tRNA’s that could be detected on sucrose gradients, but that rRNA and MS2 RNA are not bound ( 8 8 ) . His data also suggested that the enzyme has a lower molecular weight than tRNA, although such results have not been obtained with more highly purified preparations. Deutscher demonstrated that the enzyme isolated from rabbit liver forms a tight 1 : 1 complex with tRNA-C-C that can be isolated on Sephadex G-100 (81). Furthermore, this enzyme appears to be bound to tRNA during the early stages of purification, but the nucleic acid can be removed by chromatography on DEAE-cellulose. Morris and Herbert detected complex formation between the yeast enzyme and tRNA’s with a variety of termini, including those with 3’-phosphoryl groups ( 7 9 ) .However, tRNA with an intact -C-C-A terminus does not bind to nitrocellulose filters in the presence of the enzyme. Poor binding of tRNA-C-C-A to tRNA nucleotidyltransferases is also indicated by its high Ki as an inhibitor of the E . coli (83) and rabbit liver enzymes (891, and by its 10-fold higher K , (89) as a substrate for the poly(C) polymerase activity of the rabbit liver enzyme ( 8 7 ) . Studies of the recognition site on tRNA for tRNA nucleotidyltransferase have generally followed the same path as those for elucidating the aminoacyl-tRNA recognition region. These have included the use of chemically modified or degraded tRNA’s as AMP and C MP acceptors. The results suggest that the structural requirements for nucleotide acceptance are considerably less stringent than those for amino-acid loading. Thus, modification of tRNA by NH,OH, which destroys cytosine residues ( g o ) , or by cyanoethylation, which affects pseudouridine residues ( 9 1 ) , or by sodium borohydride reduction, which destroys dihydrouracil residues (92, 9 3 ) , has relatively little effect on the ability of tRNA to accept AMP. In addition, substitution of 60% of the uracil residues of yeast
70
MURRAY P. DEUTSCHER
tRNA by fluorouracil (94), which converts the common -G-T-$-C sequence to -G-flu-flu-C and also affects secondary structure, likewise does not impair AMP incorporation. On the other hand, treatment of rat liver (90) or E. coli (95) tRNA with nitrous acid or by UV irradiation (96) decreases AMP acceptance. Low levels of bromination or methylation of yeast tRNA actually stimulate AMP addition, but a t high extents of modification the tRNA is no longer an acceptor (97). tRNA can still be recognized by the tRNA nucleotidyltransferase even after removal of a considerable number of nucleotides. Thus, removal of five nucleotides from the anticodon region of yeast tRNA does not affect AMP incorporation (98, 99). Gross et al. (76) have shown that undefined yeast fragments containing 10 or 40 nucleotides are still able to accept AMP. However, Bernardi and Cantoni observed that removal of only 15% of the nucleotides from the 5' end of yeast tRNA with spleen phosphodiesterase decreased AMP incorporation by 50% , and 30% digestion decreased incorporation by 80% (100). Similarly, half-molecules of tRNA do not protect E . coli tRNA nucleotidyltransferase against heat inactivation unless they are first reannealed ( 1 0 a ) . I n the most complete examination to date of the AMP and CMP acceptor activity of tRNA fragments, Overath et al. (101) showed that half and three-quarter molecules and mixtures of fragments from tRNAPhe or tRNAser can accept AMP and CMP. The poorest acceptors are those in which the normally double-stranded aminoacyl stem is disrupted by the absence of the 5'-terminal nucleotides. However, the results from this work are very puzzling. It was claimed that all the fragments used in the study were pure. Yet, many fragments could accept AMP and CMP to only a small fraction of the theoretically expected value. If a homogeneous population of fragments can accept AMP or CMP a t all, it would be expected that these nucleotides should be incorporated completely. One possibility to explain these results is that the rate of incorporation of nucleotides into some of the fragments is so slow that the yeast tRNA nucleotidyltransferase is inactivated before the reaction is completed. A similar phenomenon was observed with the rabbit liver enzyme during studies of the misincorporation of nucleotides since these reactions also occur a t an extremely slow rate (87). From these results it is clear that only a part of the overall tRNA structure is required for recognitidn by tRNA nucleotidyltransferase. Nevertheless, something about the overall conformation may also be recognized, since denatured tRNALeUis not an AMP acceptor ( 1 0 2 ) . Possibly in the denatured conformation, the aminoacyl stem is buried and inaccessible to the enzyme. It appears from these observations that a likely candidate for the recognition site, and one that is common to all
-C-C-A
TERMINUS O F TRANSFER
RNA
71
tRNA’s, is the double-stranded aminoacyl stem with its seven base pairs. Consistent with this idea is the relatively poor activity of single-stranded fragments, and the loss of activity upon removal of only a few nucleotides from the 5‘-end of the molecule. Likewise, removal of nucleotides from the anticodon region would be expected to have no effect. If this hypothesis is correct, then synthetic stems such as oligo(G) *oligo(C) or oligo(A) oligo(U) might be acceptors of C M P and AMP.
D. Catalytic Properties The enzyme tRNA nucleotidyltransferase can incorporate AMP and CMP into tRNA molecules from which all, or part, of the terminal sequence has been removed, thus regenerating intact tRNA-C-C-A with the usual amino acid acceptor activity (1, 72, 7 3 ) . One wonders how the enzyme can limit nucleotide incorporation to two C M P residues and one AMP residue, and in the proper sequence. Since the purified tRNA nucleotidyltransferases contain no nucleotide material that could act as template, the mechanism whereby the specific sequence is synthesized must be determined by the proper relationship of active sites within the protein. At present, generalizations about the mechanism of nucleotide addition and the arrangement of triphosphate binding sites cannot be made since, in many respects, the bacterial and mammalian enzymes appear to be quite different. All the tRNA nucleotidyltransferases studied have alkaline pH optima, in the range of pH 9-10 for nucleotide incorporation (Table 111). Apparently, the enzyme does not work a t its p H optimum in vivo. Alternatively, the reaction in vitro may be quite different from that catalyzed in vivo. Despite the similarity of high pH optima and also that of being able to work on all tRNA’s, the enzymes purified from E. coli appear to differ from the mammalian enzymes, especially with respect to their triphosphate sites. Thus, the apparent K, values for ATP generally vary from about 0.1-0.3 mM for the E . coli enzymes (7578, 83) although one older report indicated a value of 0.02 mM (69) (Table 111).In contrast, the three purified mammalian enzymes have K , values one order of magnitude higher, approximately 1-4 m M ( 7 3 , 8 2 , 8 4 ) . Likewise, the K , values for C T P are also different. Those for the E . coli enzymes are in the range of 0.015-0.08 mM (69, 76-78, 83), whereas the rat liver enzyme has a K , value of 0.18 mM ( 7 3 ) .I n addition, the rabbit muscle (82a) and rabbit liver (84) enzymes give nonlinear double reciprocal plots for CTP, suggesting the presence of multiple C T P binding sites. Anthony et al. extrapolated the two linear portions of the l/v vs 1/S plot for C T P and calculated K , values of 0.008 mM and 0.037 mM ( 8 2 ~ ) . Deutscher, using a wider concentration range for CTP, was able to fit
72
MURRAY P. DEUTBCHER
the curved double reciprocal plot by computer to two K,, values of 0.004 mM and of 0.4 mM (84).The 10-fold difference in the high K,,, value for the two rabbit enzymes is probably due to the fact that the experiments of Anthony et al. (8%) extended only to 0.16 mM C T P and the K,, was calculated by an extrapolation of the three highest C T P concentrations even though theoretical considerations indicate that the line should be curved throughout. Nevertheless, these results suggest that the rabbit enzymes, a t least, probably contain two C T P binding sites. It should be pointed out, however, that all of these K,, values are really only apparent K,’s and may be greatly affected by the concentration of tRNA present. Further differences between the bacterial and mammalian enzymes have been observed in their response to the presence of a second triphosphate. Thus, with the bacterial enzymes, ATP inhibits CMP incorporation and C T P inhibits AMP incorporation (75-78, 83). This inhibition has been reported to be competitive (77, 78) in the case of two enzymes, and noncompetitive (75) with another one. I n the case of the rabbit enzymes, C T P also inhibits AMP incorporation. However, ATP stimulates, rather than inhibits, CMP incorporation (84, 103). The inhibition of AMP incorporation by C T P is competitive with the rabbit muscle enzyme (8%) and noncompetitive with the enzyme from rabbit liver (103). I n addition, AMP incorporation catalyzed by the rabbit muscle enzyme is inhibited (3040%) by equal concentrations of G T P or U T P (8Za), whereas the E. coli enzymes are inhibited only when U T P is present in large excess, and not a t all by G T P (75, 83). With the rabbit liver enzyme, it was shown that AMP incorporation in the presence of 1 mM ATP is 50% inhibited by 3 mM U T P and about 15-20 mM G T P (103). The different catalytic properties of the mammalian and bacterial tRNA nucleotidyltransferases, as well as the different specific activities discussed above, still remain to be explained. Several pieces of evidence suggest that, in the case of purified rabbit liver, tRNA nucleotidyltransferase, ATP and CTP bind a t separate sites (84,103).First of all, the apparent K , value for ATP is about one order of magnitude greater than even the higher K,, for C T P ( 8 4 ) .Second, high concentrations of salt inhibit AMP incorporation completely, whereas CMP incorporation catalyzed by the major form of the enzyme is stimulated as much as 2-fold (84). Third, CTP inhibits AMP incorporation noncompetitively (103), suggesting distinct sites. Finally, ATP stimulates CMP incorporation a t C T P concentrations of 0.05 to 4 mM (103), and it is difficult to explain how ATP could effect stimulation without binding a t a separate site. Anthony et al. (82a) also postulated the existence of separate sites for ATP and C T P based on the additivity of AMP and CMP incorporation in the presence of both substrates and appropriate
tRNA acceptors. Since the enzyme probably binds only a single tRNA acceptor at a time, it is not clear why these workers observed additivity of nucleotide incorporation. Possibly, their observations could be explained by the use of nucleoside triphosphates at concentrations considerably below saturating levels, so that the presence of both ATP and CTP enabled more enzyme molecules to participate in the reaction. Inasmuch as it appears that the rabbit liver enzyme contains two binding sites for CTP, and that ATP and C T P have separate sites, it has been suggested (84) that tRNA nucleotidyltransferase may contain three sites in tandem, two for CTP and one for ATP. The possibility also exists that the ATP site corresponds to one of the two CTP sites, but that model seems less attractive. In the model suggested, tRNA molecules lacking all, or some, of the terminal residues would bind opposite the appropriate triphosphate site and would, thereby, accept the proper nucleotides for generation of the complete -C-C-A sequence. If a tRNA molecule were bound adjacent to the wrong triphosphate site, it might explain the misincorporation of nucleotides observed with this enzyme (see Section IV, E) . However, the strength of tRNA binding a t the wrong site may be weaker; this is borne out by the finding that the K , for tRNA-C as an acceptor of AMP in the misincorporation reaction is 26 pM, whereas it is only 4-6 pM when CMP and UMP are incorporated (Table 111) ( 8 4 ) ,On the other hand, the K , for ATP for incorporation into tRNA-C is unaffected suggesting that the usual ATP binding site is also involved in this reaction. I n addition to incorporation of the expected nucleotides, A M P and CMP, purified tRNA nucleotidyltransferases also incorporate U M P into tRNA. Daniel and Littauer showed that the ratio of UMP to AMP incorporation remains constant during the 400-fold purification of the rat liver enzyme (73). Deutscher demonstrated UMP incorporation by a homogeneous rabbit liver protein (81) that is inactivated by heat a t the same rate as the AMP and CMP activities (81).UMP incorporation was also observed by Best and Novelli with a purified E. coli enzyme (i’O4), although Miller and Philipps reported that this activity is lost upon further purification (77). Under optimal conditions, UMP is incorporated into tRNA-C and tRNA-N by the rat and rabbit liver enzymes at about one-tenth the rate of CMP (73, 84). Since tRNA-C-C is not a substrate for UMP addition (73, 84, 105),it seems that UTP is acting as an analog of CTP. The K , for UTP with the mammalian enzymes was reported to be in the range of 0.05 to 0.26 mM (73, 84, 106),which is lower than that for ATP, but greater than the K , at the tight binding site for C T P (Table 111). Low concentrations of CTP completely abolish UMP incorporation (73, 103, 105, 106) and the inhibition is competitive (103,
74
MURRAY P. DEUTSCHER
106). I n addition, UTP inhibits CMP incorporation (103, 106), but this inhibition reaches a maximum of only 60% (103).It has been suggested (84) that UTP acts as an analog a t the low K , site for CTP, since U M P incorporation is completely abolished by concentrations of C T P that can saturate only the tight binding site, and because U T P can only partially inhibit CMP incorporation. I n addition, low concentrations of ATP stimulate UMP incorporation, in a manner similar to that found for CMP addition (103, 106). UMP is incorporated into tRNA molecules in the positions normally occupied by C M P residues, thereby leading to the synthesis of tRNA-U, tRNA-C-U and tRNA-U-C (73, 87, 105, 106). tRNA molecules containing two UMP residues are generally not made (73, 87, 106) although this reaction can be forced a t high levels of enzyme ( 8 7 ) .tRNA chains containing UMP residues accept AMP relatively poorly (73, 8 7 ) , in contrast to chains containing C M P residues. At high levels of the rabbit liver enzyme it has also been possible to incorporate UMP into the terminal position usually occupied by AMP, generating tRNA-C-C-U and tRNAC-U-U ( 8 7 ) . Other analogs of ATP and C T P can also be used as substrates by tRNA nucleotidyltransferase. Thus, bromo-CMP (107) and iodo-CMP ( 7 ) can be added to tRNA in place of CMP. The AMP base analogs tubercidin, toyocamycin, sangivamycin (108) and formycin monophosphate (23) (Fig. 2 ) , can also be incorporated into the terminal position of tRNA. Another ATP analog, adenosine 5’-0- (1-thiotriphosphate) is also used as a substrate and is incorporated into yeast tRNApheto generate a phosphorothioate linkage between the terminal adenosine and cytidine residues (109).In contrast, other analogs of AMP, such as G M P ( 8 4 ) , 2-aminopurine nucleotide ( d d ) , 2,6-diaminopurine nucleotide (24) and I M P (110), are not incorporated into tRNA. dATP is also not a substrate for either the E. coli (72, 7 5 ) , rabbit muscle (74) or rabbit liver (84) tRNA nucleotidyltransferases. With the rabbit liver enzyme, this is true even in the presence of Mn2+ rather than Mg2+ ( 8 9 ) . If nucleotide analogs such as dAMP, cordycepin phosphate or 2’-O-MeAMP were incorporated, they would generate tRNA molecules lacking the 2 or 3’-hydroxyl group. The amino acid acceptor activity of such tRNA molecules might elucidate the site of attachment of amino acids to tRNA. Nucleotide incorporation catalyzed by tRNA nucleotidyltransferases is accompanied by stoichiometric pyrophosphate release (72-74), and it has been known for some time that these enzymes can also catalyze the reverse reaction, the pyrophosphorolysis of tRNA (4, 69, 71-74). This reaction is dependent on the presence of RNA, and the same nucleotides
-C-C-A TERMINUS
HO
O F TRANSFER
OH
HO
Adenosine
75
RNA
OH
HO
Tubercidin
H
OH
Toyocamycin
HocQHH HO
OH
Sangivamycin
HO
OH
Formycin
FIG.2. Structure of adenosine and the adenosine analogs tubercidin. toyocamycin, sangivamycin. and form\.cin.
arc removed as are incorporated by the enzyme. Incorporation of label from ["PIPP, into G T P and UTP has also been reported (65, 7 1 ) , but not with any of the more purified enzymes (72, 7 3 ) . It has also been observed that greater incorporation of PP, into nucleotide mat,erial occurs if unlabeled triphosphates are present (69),and this finding may indicate that pyrophosphate exchange takes place in addition t o the pyrophosphorolysis of tRNA. Ribosomal RNA is not a substrate for pyrophosphorolysis (72, 7 3 ) , although a slow rate of reaction with poly(C) and poly (A,G,U,C) has been observed ( 7 3 ) .Blockage of the vicinal hydroxyls of tRNA by aminoacyl- or peptidyl-groups prevents pyrophosphorolysis (111). Surprisingly, the optimal p H for pyrophosphorolysis is 7.5 compared to 9.5 for nucleotide incorporation (73) although this may just indicate that the active form of pyrophosphate in the reaction is present in greater amounts a t the lower pH. Despite the more normal p H optimum for the reverse reaction, it is doubtful that pyrophosphorolysis plays a role in vivo since active pyrophosphatases would prevent the
76
MURRAY P. DEUTSCHER
accumulation of any significant amounts of PPi. The pyrophosphorolysis and pyrophosphate exchange reactions of tRNA nucleotidyltransferases have been very poorly examined, although such studies would be very valuable in elucidating any intermediate steps (i.e., an enzyme-nucleotide) that may occur during nucleotide incorporation.
E. Misincorporation of Nucleotides Under the appropriate conditions tRNA nucleotidyltransferases synthesize a perfect -C-C-A sequence on the 3'-terminus of tRNA. Nevertheless, with other conditions these enzymes catalyze the incorporation of incorrect nucleotides and utilize other RNA's as acceptors. It was first shown by Daniel and Littauer (112) that rat liver tRNA nucleotidyltransferase could add AMP to tRNA-C to generate tRNA-C-A. Klemperer and Haynes, using an enzyme from the same source, reported that in the presence of MnZ+,runs of CMP, as many as 10 nucleotides long, could be incorporated into 5 S and rRNA, and that -A-A and -U-U sequences could be made on phosphodiesterase-treated tRNA (113). These workers also observed that a small amount of CMP is incorporated into poly (A) epoly (U) and poly(1) epoly (C) , whereas the single stranded polymers are inactive. Miller and Philipps described the incorporation of three C M P residues into tRNA-N and two CMP residues into tRNA-C, but reported that this anomalous incorporation is lost upon further purification of the E . coli enzyme (77). I n contrast, Best and Novelli reported that a 7000-fold purified E. coli tRNA nucleotidyltransferase catalyzes the incorporation of excess CMP residues into tRNA-C and tRNA-C-C, but is inhibited by ATP (104). These workers also described the synthesis of tRNA-C-A, and the possible formation of tRNA-C-A-A. Deutscher, using a homogeneous rabbit liver tRNA nucleotidyltransferase, examined this problem in more detail (87). It was observed that a t low levels of enzyme the nucleotides incorporated into tRNA-C-C-A, tRNA-C-C, tRNA-C and tRNA-N are those expected for synthesis of the normal -C-C-A sequence except for the formation of tRNA-C-A (see Table IV) . At high levels of enzyme, tRNA molecules with a variety of unusual termini can be made. These include molecules with extra A*MP residues, tRNA-C-A-A, tRNA-A-A and tRNA-A-A-A, as well as molecules containing all lengths of CMP residues. Intact tRNA-C-C-A is not a substrate for AMP incorporation, even at high levels of enzyme, but CMP is incorporated. However, the presence of C T P stimulates AMP incorporation into this substrate. That C M P incorporation is actually into intact tRNA and not into a contaminating nucleic acid was shown by the release of the terminal AMP residue as 2'- and 3'-AMP
-C-C-A
TERMINUS O F TRANSFER
RNA
77
TABLE IV SUMMARY OF PRODUCTS SYNTHESIZED BY tRNA NUCLEOTIDYLTRANSFERASP tRNA substrate
Enzyme level
tRNA-C-C-A
Low
Triphosphate substrate
Product ~~~~
High tRNA-C-C
Low High
tRNA-C
Low High
tItNA-N
Low High
ATP CTP ATP CTP ATP CTP ATP CTP ATP ATP CTP ATP CTP ATP ATP CTP ATP CTP
+ CTP + CTP
None None None tRNA-C-C-A(pC), tRNA-C-C-A None tRNA-C-C-A tRNA(pC), tRNA-C-C-A tRN A-C-A tRNA-C-C tRNA-C-A-A tRNA(PC)n tRNA-C-C-A None tRNA-C-C tRNA-A, tRNA-A-A, tRNA-A-A-A tRNA(pC),
after alkaline hydrolysis. Increasing levels of enzyme and long times of incubation lead to the formation of runs of CMP on every tRNA substrate. When both ATP and CTP are present, the terminal position is usually occupied by AMP, even when many C MP residues have been incorporated. The excess C M P incorporation can be inhibited somewhat by ATP, but can be prevented completely by high concentrations of KC1 (87). These results indicate that purified tRNA nucleotidylfransferase contains poly (C) polymerase activity. Recent data (89) have demonstrated that the poly (C) polymerase activity actually is associated with tRNA nucleotidyltransferase. The activity copurifies during 5t 25,000-fold purification and is heat inactivated at a n essentially identical rate a t several different temperatures. The responsc of poly(C) polymerase to pH, Mg2+ concentration, C T P concentration and incubation temperature is almost identical to that of the normal CNP-incorporating activity. Poly (C) polymerase activity is most pronounced in the presence of Mn2+,although Mg2+ and Co2+are also active. Since the rate of poly(C) polymerase activity is less than 1% of that of normal CMP incorporation, it is not normally detected. The poly(C) polymerase can also utilize rRNA as a substrate, incorporating as many as 40 CMP residues per chain (87). With rRNA
78
MURRAY P. DEUTSCHER
as the substrate, it is also possible to incorporate a single AMP residue on each nucleic acid chain (89). The mechanism whereby tRNA nucleotidyltransferase synthesizes these various anomalous termini is still a matter of conjecture. Nevertheless, it is clear that these reactions occur a t very slow rates and can be detected only a t high levels of enzyme. It is curious that CTP, which appears to have two binding sites, is incorporated into tRNA and rRNA extensively, whereas ATP, which has only a single binding site, is incorporated only to a limited extent. Possibly slippage back and forth between the two CTP sites accounts for the poly (C) polymerase activity. The finding that homogeneous, mammalian tRNA nucleotidyltransferase preparations also contain poly (C) polymerase activity raises questions about the significance of the poly (C) polymerases described previously (68, 114, 116).
V. Role of the -C-C-A Terminus in tRNA Function It has been known since the earliest studies of tRNA function that the activated amino acid is attached to the 2'- or 3'-hydroxyl group of the terminal AMP moiety, and that removal of this nucleotide residue renders the tRNA inactive (1, 62, 63, 6%). Since the 3'-terminal residue carries the amino acid, it is obvious that this portion of the tRNA molecule must interact with the aminoacyl-tRNA synthetases during the charging reaction and also with the peptidyltransferase in the course of peptide bond formation. In trying to assess the role of the -C-C-A terminus in the charging and transfer reaction, it must be borne in mind that the action of tRNA in these processes requires proper recognition of the terminus as well as its ability to accept and transfer the amino acid. Thus, it is possible to imagine circumstances in which the terminal residues might be modified in such a way that tRNA could still interact with the enzymes, but could not accept or transfer amino acids. Generally, the recognition process has been examined by either direct binding studies or by testing modified tRNA as a competitive inhibitor. A. Aminoacyl-tRNA Formation Investigations into the function of the -C-C-A terminus in the aminoacylation reaction have generally employed two types of approach. I n both cases, tRNA is modified in its terminal residues and then tested either for its ability to interact with a synthetase or for its acceptor activity. The conclusion to be drawn from these studies is that modification of the terminal nucleotides has different effects depending on the synthetase under study. A number of workers have examined the effect
-C-C-A
TERMINUS OF TRANSFER
RNA
79
of oxidizing tRNA or of removing residues from the -C-C-A terminus on the interaction of tRNA with a synthetase. Since these modifications lead to tRNA molecules that cannot accept amino acids, interaction with the synthetase cannot be measured by the overall biological reaction, aminoacylation, but only by less direct methods. Converting the 2'- and 3'-hydroxyls of tRNA to a dialdehyde by periodate oxidation destroys acceptor activity ( 6 3 ) . Nevertheless, such modified tRNA molecules appear to bind to synthetases since they act as competitive inhibitors (116'-121). Moreover, since the binding constant of the tRNA does not appear to be greatly affected by the oxidation (116-121) , it appears that, although these oxidized molecules are inactive, they interact normally with the synthetases. Presumably i t is the presence of the aldehyde grouping that prevents the tRNA from being an acceptor. In fact, Cramer et al. have shown that reduction of periodateoxidized yeast tRNAPhe with NaBH, to generate a diol structure leads to an active tRNA with a normal K,, but about one-half the normal V,,, (122). However, in the case of yeast tRNALy8, reduction with borohydride decreases the inhibitory properties of oxidiaed tRNA (118, 123), possibly because the tRNA becomes a substrate. Although periodate-oxidized tRNA does bind to synthetases, i t cannot participate in some of the reactions of intact tRNA. Thus, oxidized tRNA does not stimulate the pyrophosphate exchange reaction observed with glutamyl- (124) or arginyl-tRNA synthetase (126). Similarly, oxidized tRNA does not induce the breakdown of valyl-AMP catalyzed by isoleucyl-tRNA synthetase (126'). However, oxidized tRNA can protect arginyl-tRNA synthetase against heat denaturation (127). tRNA's lacking all or part of the -C-C-A terminus are prepared either by treatment with snake venom phosphodiesterase (14) or by the successive actions of periodate, an amine and alkaline phosphatase (128). Using the latter method, it is possible to remove only the terminal nucleoside residue, leaving the phosphate group intact. I n contrast to oxidation of the terminal ribose moiety, which generally has little effect upon binding of tRNA to its synthetase, actual removal of terminal residues can lead to more drastic changes in tRNA-enzyme interactions, although again this varies with the system studied. Thus, E . coli tRNA-C inhibits valyl- and isoleucyl-tRNA formation (117, 126), and liver tRNA-C-Cp inhibits glutamyl-tRNA formation (124). I n each of these cases, the modified tRNA is a competitive inhibitor, but with a higher Ki than periodate-oxidized tRNA, suggesting that the terminal residues contribute to the binding of tRNA to the synthetase. A more extreme example was found with yeast serine tRNA-C-C in that this molecule, even in excess, does not inhibit serine incorporation (129). I n a more
80
MURRAY P. DEUTSCHER
detailed examination of the inhibitory properties of tRNA molecules lacking all, or part, of the -C-C-A terminus, Roy and Tener observed that the inhibition varied with the synthetase being examined (118). Phenylalanine incorporation is relatively little affected by any modified tRNA, whereas valyl-tRNA formation is sensitive to all the inhibitors. Direct binding studies of modified tRNA’s to synthetases indicate that tRNA-C-C and tRNA-C bind strongly to E . coli isoleucyl-tRNA synthetase (130).Similarly, valine tRNA-C-Cp forms a complex with yeast valyl-tRNA synthetase and inhibits formation of a complex with intact tRNAV*l (131). The affinity of the modified tRNA for the enzyme is within a factor of two of that for intact tRNA (131),although if Sephadex rather than sucrose gradients is used to detect complex formation, tRNA-C-Cp does not inhibit (132). Binding of modified tRNA’s to synthetases can also be studied indirectly by other methods. For example, intact yeast tRNASe’ labilizes the seryladenylate-enzyme complex, and a similar effect is observed with tRNA-C-C (133). However, 10-fold higher concentrations of the modified tRNA are required to effect the same degree of complex breakdown. E. coli arginyl-tRNA synthetase is protected against heat denaturation by tRNA (127).Removal of the terminal AMP and cytidine moieties does not decrease the ability of tRNA to protect, whereas removal of the phosphate between the two cytidine residues leads to a large decrease in protector activity. These studies with modified tRNA’s indicate that for some synthetases the nucleotides of the-C-C-A sequence contribute significantly to tRNA binding, although presumably they only reenforce the binding of the “recognition site.” On the other hand, if the “recognition site” is, in fact, the overall conformation of a particular tRNA molecule, including the location of the -C-C-A terminus, this distinction between conformation and “recognition site” becomes meaningless. Since all synthetases must bind to the terminal residues in order to effect aminoacid attachment, it may only be in those cases in which the -C-C-A terminus also contributes to the “recognition site” that removal of terminal residues abolishes binding of the tRNA. The second approach employed to examine the function of the -C-C-A terminus in aminoacylation is to alter one, or more, of these residues, leaving the terminal ribose intact and then determining whether these modified tRNA’s can still accept amino acids, The terminal residues can be altered either by chemical modification or by using tRNA nucleotidyltransferase to incorporate nucleotide analogs. Several modifications of the terminal adenine have been reported, and, in many cases, these altered tRNA’s still retain acceptor activity.
-C-C-A
TERMINUS O F TRANSFER
RNA
81
Deamination of the AMP moiety of E . coli tRNA to I M P by algal adenylate deaminase leads to a product that accepts glycine and an amino-acid mixture to the same extent as untreated tRNA (9). As discussed above, the terminal adenosine moiety of tRNA can be substituted by tubercidin, toyocamycin, sangivamycin (108) or formycin (23) using tRNA nucleotidyltransferase (Fig. 2). tRNA containing tubercidin a t the 3’4erminus accepts lysine arginine, valine, leucine, tyrosine, proline and serine a t close to normal levels, whereas phenylalanine is poorly incorporated (108). tRNA’s containing either toyocamycin or sangivamycin accept an amino-acid mixture at half normal levels in 15 minutes. However, it is not clear from these observations whether extents of incorporation are being measured (108). tRNA containing a formycin terminus also accepts a variety of amino acids a t close to normal levels (23). I n contrast to the data with nucleotide analogs, chemical modification of yeast tRNAPhe with monoperphthalic acid to yield the N-loxide of adenosine renders the tRNA inactive as an acceptor (8). It has also been possible to modify yeast tRNAPheso that a phosphorothioate linkage is introduced between cytidine 75 and adenosine 76 (109). This modified tRNA has a normal K,, but its V,,, for aminoacylation is reduced to one-half and the extent of charging is only 60% of normal. Several other studies have described modification of the terminal cytosine residues. Incorporation of 5-bromo-CMP into liver tRNA using tRNA nucleotidyltransferase and 5-bromo-CTP leads to a product that accepts several amino acids a t close to the levels found with a tRNA reconstituted with C T P (107). However, it is not apparent in this experiment whether both CMP residues or only the terminal one has been modified. Similarly, yeastPhe containing 5-iodocytidine in the penultimate position is still chargeable (7). I n contrast, modification of the two terminal cytosine residues of E . coli SuIII tRNATrrwith methoxyamine destroys the acceptor activity of this tRNA, whereas modification of only cytosine 84 does not inactivate the molecule (194).Likewise, modification of the two terminal cytosine residues of E . coli tRNAeMet by UV light inactivates this particular molecule (196). In these latter two cases it could be shown that the inactivation of the tRNA’s was due almost entirely to modification of the cytosine residues in the -C-C-A sequence. In contrast, conversion of both terminal cytosine residues in yeast tRNATyr to uracils by the action of bisulfite does not affect the extent of tyrosine charging ( 1 2 ) . The conclusion to be drawn from the foregoing chemical modification studies is that the -C-C-A terminus can tolerate considerable alteration and still remain active. The only change of the terminal adenosine moiety that leads to inactivation is N-1 oxidation, whereas modification of the
82
MURRAY P. DEUTSCHER
6-amino group or the imidazole ring has relatively little effect. Inactivation by N-1 oxidation may be due to steric effects caused by introduction of the oxygen atom or to removal of a potentially hydrogen-bonding nitrogen. On the other hand, a bulky bromine or iodine atom, or a methoxy group, can be introduced into a t least one of the cytosine residues without affecting charging. Modification of both cytosine residues, however, appears to inactivate the molecule, although conversion to uridines, in one case, has no effect. At the present time insufficient data are available to generalize whether certain residues within the -C-C-A terminus or certain functional groups on these residues are more important to tRNA function than others. A final approach to elucidating the function of the -C-C-A terminus in aminoacylation has been to change the length or sequence of residues within the terminus with tRNA nucleotidyltransferase. Thus, Daniel and Littauer synthesized liver tRNA-C-A, which lacks one of the CMP residues, and suggested that this molecule could accept leucine and phenylalanine to the usual extent, but a t considerably lower rates (112). Recent evidence, however, indicates that those results may have been due to some contamination by tRNA containing two CMP residues or to synthesis of intact tRNA during the aminoacylation reaction (136). Using rabbit liver tRNA nucleotidyltransferase, it has been possible to synthesize tRNA’s with a variety of 3’-termini (87) (Table IV). Examination of the amino-acid acceptor activity of these molecules should prove very useful for understanding the function of the terminal -C-C-A sequence in the reaction catalyzed by aminoacyl-tRNA synthetases.
B. Peptide Bond Formation The synthesis of peptide bonds takes place by transfer of the growing peptide chain from the -C-C-A terminus of one tRNA molecule to an amino acid attached to the -C-C-A terminus of a second tRNA. This reaction is catalyzed by the enzyme peptidyl transferase which is part of the larger ribosomal subunit (137). Raacke has recently suggested (138) that two peptidyltransferases may, in fact, be required. Inasmuch as the formation of peptide bonds involves amino acid moieties attached to the termini of tRNA molecules, it is appropriate to inquire how important the actual -C-C-A sequence is for this process. It was shown early, by measurement of the binding of modified tRNA’s to ribosomes, that the -C-C-A terminus plays a role in this interaction. Thus, tRNA molecules lacking the entire -C-C-A terminus do not bind to rat liver ribosomes in the presence of transfer enzymes (139, 140). Similarly, removal of the terminal adenosine moiety prevents the nonenzymatic binding of tRNA to E . co2i ribosomes (141). Cleavage
-C-C-A
TERMINUS OF TRANSFER
RNA
a3
of the C2’-C3’ bond of the terminal adenosine of tRNAPhe likewise prevents binding to ribosomes a t both T-factor-dependent and -independent sites (142). Interaction of modified tRNA’s with E . coli ribosomes has also been examined by measuring the inhibition of the nonenzymatic binding of aminoacyl-tRNA’s in the presence of mRNA (143-146). Since periodate-treated tRNA inhibits phenylalanyl-tRNA binding equally as well as deacylated tRNA (145), an intact terminal ribose is not required for interaction with ribosomes, although there is some question about this result (144). tRNA-C-Cp, tRNA-C-C and tRNA-C also inhibit phenylalanyl-tRNA binding to 70 S ribosomes, but not as well as intact, deacylated tRNA (149, 144). I n contrast, these modified tRNA’s are as effective as intact tRNA in inhibiting aminoacyl-tRNA binding to 3 0 s ribosomal subunits (143, 144). These results suggest that the terminal adenosine moiety plays a role in binding to 70 S, but not 30 S ribosomes. tRNA lacking the entire -C-C-A sequence also inhibits phenylalanyltRNA and lysyl-tRNA binding, but not as well as deacylated tRNA (144, 145). A significant advance in our understanding of the mechanism of peptide bond formation came with the discovery that substrate analogs containing only fragments of the tRNA molecule could act as peptide donors (146) and peptide acceptors (147-149). The use of these various analogs of the peptidyl-tRNA and aminoacyl-tRNA molecules has allowed a detailed examination of the structural requirements for peptide bond formation. From this information it has been possible to establish what features of the -C-C-A terminus are required for binding and reaction at the P-site and A-site on ribosomes (150). Structural requirements for the P-site were determined by measuring the reaction of various N-acylaminoacyl oligonucleotides with puromycin in the presence of ribosomes and methanol (161). Under these conditions, reaction with the hexanucleotide fragment, C-A-A-C-C-A-fMet is 5Q76 completed within 15 minutes a t 0”.The nucleotide fragments A-A-C-CA-fMet, A-C-C-A-fMet and C-C-A-fMet are equally active, whereas C-A-fMet and fMet-adenosine are without activity. The active fragments lead to an initial rate of reaction about one-half that of intact fMettRNA. Similarly, C-C-A-acetylleucine is active for transferring acetylleucine to puromycin. Although these studies do not distinguish between effects of structure on the affinity for peptidyltransferase or on the rates of reaction once bound, it is clear that the -C-C-A terminus by itself is sufficient for binding and reaction at the P-site of ribosomes. However, further removal of one 3’-CMP residue leads to an inactive substrate. Since intact tRNA’s have greater activities than the corresponding terminal fragments, other parts of the tRNA molecule must also interact
84
MURRAY P. DEUTSCHER
with the ribosome to increase the stability of binding. Inasmuch as the effect of concentration was not examined in these experiments, it is not possible to determine whether -C-C-A-fMet could attain the same initial rate as intact fMet-tRNA, given high enough levels of the fragment. Information is also available on the structural requirements for interaction a t the A-site. It has been known for some time that puromycin, an. analog of the aminoacyl-adenosine terminus of tRNA, can act as a peptide acceptor ( 1 4 7 ) , suggesting that only the terminal adenosine residue of tRNA is required for interaction a t the A-site. However, the only active analogs of puromycin are those in which the p-methoxyphenylalanine moiety is replaced by certain other aromatic amino acids (147, 152, 153). This result is surprising since the aminoacyl-tRNA’s that normally act as acceptors must include derivatives of all amino acids. It appears that the peptidyltransferase center on the ribosome may contain a hydrophobic binding site that helps to stabilize the binding of certain puromycin derivatives, but not others. More important for our purposes are the results, with puromycin analogs substituted on the 5‘-hydroxyl group. Addition of a 3’-CMP moiety to the 5’-hydroxyl of the glycyl analog of puromycin made this molecule almost as active as puromycin for inhibiting poly (U) -directed polyphenylalanine synthesis either in an E . coli (152) or a reticulocyte system (153).Thus, an analog of the aminoacyl-terminus of tRNA containing both the terminal cytidine and AMP residues is an inhibitor even if the aminoacyl moiety is the usually inactive residue, glycine. When the glycyl analog of puromycin is substituted a t the 5‘-hydroxyl with AMP, UMP or GMP, the resulting compounds are not inhibitors (152, 153), substantiating the specificity for the terminal C-A residues of tRNA a t the A-site. Further information about the specificity of the A-site comes from an examination of the ability of various aminoacyl-nucleoside or nucleotide derivatives to act as acceptors of the peptide chain. It was first demonstrated by Takanami (154) that the nascent polypeptide could be transferred to tRNA fragments prepared by digestion of aminoacyltRhTA’s with T1 RNase. Using more defined compounds, it was shown that leucyl-, phenylalanyl- and tyrosyladenosine are inhibitors of pro. tein synthesis in a cell-free system from E . coli, whereas adenosine, free amino acids, or other leucyl esters are inactive (148). Inhibitions of about 50% are obtained with 1 pM puromycin, but require about 100 pM leucyladenosine and 10 pM phenylalanyl-and tyrosyladenosine (148). Thus, as with the puromycin derivatives, aromatic amino acids appear to stabilize the interaction with the A site. Glycyladenosine or glycylAMP, even a t 10 mM, are almost totally inactive in releasing polylysine from E. coli ribosomes, whereas C-A-Gly is half as active as puromycin
-C-C-A
TERMINUS OF TRANSFER
RNA
85
(149). In contrast, U-A-Gly has a small effect, and U-U-Gly is inactive (149). In further studies of this phenomenon, Rychlik and co-workers (155157) showed that a variety of other aminoacyl-nucleosides could act as acceptors of the nascent peptide, with both Ac-Phe-tRNA and poly (Lys) tRNA as donors. The activity of the acceptors decreases in the sequence Phe-Ado > Phe-Ino > Phe-Cyd ; whereas Phe-Guo, Phe-Urd and PhedAdo are inactive (155).Furthermore, C-I-Gly releases the nascent polypeptide chain from poly (Lys)-tRNA, but dC-A-Gly has little activity (157). These results demonstrate that molecules containing only the terminal adenosine residue and an amino acid are sufficient for binding and reaction a t the A-site. The presence of a C-A sequence further stabilizes the binding in the case of certain aminoacyl-derivatives (particularly glycine). Since Phe-Cyd can act as an acceptor, base pairing between the terminal adenine of tRNA and rRNA probably does not play a role in the peptidyltransferase reaction. However, the 2’-hydroxyl groups on both the terminal adenosine and penultimate cytidine residues appear to be required. These 2‘-hydroxyl groups may be important for forming hydrogen bonds to the transferase or for forming intramolecular hydrogen bonds required for proper orientation of the tRNA terminus (155). Alternatively, the 2’-hydroxyl group of the terminal adenosine residue may be the initial acceptor of the nascent peptide prior t o reaction with the aminoacyl residue (158). Further evidence for the involvement of the -C-C-A terminus of tRNA in peptide bond formation was suggested by the finding that the trinucleotide, C-C-A stimulates the formation of fMet-OEt catalyzed by peptidyltransferase in the presence of fMet-tRNA and ethanol (159). The trinucleotide is only 10% as active as deacylated tRNA on a molar basis, but can attain the same maximal rate of ester formation. The stimulation of peptidyltransferase is specific for C-C-A, and C-A is inactive. Sequence isomers such as C-A-C and A-C-C as well as a variety of other trinucleotides, are inactive. Furthermore, periodate oxidation of the terminal adenosine of tRNA eliminates the stimulation of fMet-OEt formation. Aminoacylation of the tRNA leads to dipeptide formation rather than ethyl ester synthesis. The data suggest that the trinucleotide sits in the A-site, thereby stimulating peptidylransferase to catalyze a nucleophilic attack by ethanol. From the foregoing discussion it is clear that the -C-C-A terminus of tRNA plays a major role in peptide bond formation. At both the Asite and the P-sites, oligonucleotide fragments containing only a complete, or partial, -C-C-A sequence are sufficient to promote peptide bond formation. However, the structural requirements a t the two sites are different.
MURRAY P. DEUTSCHER
86
The complete C-C-A terminus is required for activity a t the P-site, whereas in some cases an aminoacyl-adenosine is all that is necessary to accept the nascent peptide, although addition of a CMP residue does increase activity. When the aminoacyl group is lacking, such as in the case of ethyl ester formation, a complete C-C-A sequence must be present for activity. If, in fact, the peptidyltransferase activities a t the putative A- and P-sites actually represent two different enzymes, as suggested by Raacke ( I % ) , the different structural requirements are not a t all surprising.
VI. Possible Control Functions of the -C-C-A Terminus of tRNA The turnover rate of the terminal nucleotides of tRNA is too slow to be coupled one-to-one with peptide bond formation. Both in E . coli (49) and rabbit reticulocytes (48) the slow turnover rate and the number of tRNA molecules involved also rules out any direct relationship between turnover and peptide chain release. Studies with in vitro protein synthesizing systems have also indicated that the adenylate moiety of aminoacyl-AMP is not incorporated into tRNA (160) and that there is no turnover of the terminal AMP of tRNA coupled to amino-acid transfer (161). Nevertheless, there does appear to be some relation between turnover and protein synthesis. For example, inhibition of protein synthesis in E. coli by chloramphenicol or amino-acid starvation leads to a cessation of turnover ( 4 9 ) . Similarly, injection of puromycin or cycloheximide into rats decreases the relative specific activity of the terminal adenylate residue of liver tRNA compared to internal residues ( l e g ) , suggesting an inhibition of turnover. It has been suggested (46, 47) that the turnover of the terminal residues corresponds simply to a limited action on tRNA by a nuclease such as the RNase I1 of E . coli. This reaction then would really have no metabolic significance, but would represent only the occasional damage of tRNA molecules that happen to be uncharged a t any given instant. This degradation could occur on the ribosome after the poptide chain has been transferred. On the other hand, the turnover of all, or part, of the terminal -C-C-A sequence in vivo raises the possibility that this process may serve a control function. A simple and rapid method for turning off protein synthesis would be to remove the terminal adenylate moiety from tRNA. It has been assumed by many workers that the enzyme that removes the terminal residues from tRNA is, in fa&, tRNA nucleotidyltransferase, and until recently this eneyme was actually designated “CCA pyrophos-
-C-C-A
TERMINUS O F TRANSFER
RNA
87
phorylase.” However, it is unlikely that this activity is responsible for nucleotide removal in cells since the pure enzyme contains no nuclease activity, even for terminal residues (81). Furthermore, the high levels of pyrophosphatase in cells would preclude the accumulation of pyrophosphate and, therefore, would prevent reversal of the synthetic reaction. These considerations suggested the existence of a nuclease that selectively removes only a limited number of residues from the 3’terminus of tRNA. Such an activity has been detected in rabbit liver and partially purified (163).Control of protein synthesis by removal of the 3’-terminal residue of tRNA, therefore, could be exercised either by tRNA nucleotidyltransferase or by this nuclease. Alternatively, the rate of protein synthesis may be controlled by addition of the -C-C-A sequence to a pool of inactive tRNA molecules lacking these residues. Several observations are consistent with a possible control function for the turnover of the terminal nucleotides of tRNA. Stationary phase and commercial yeast tRNA generally lack the terminal AMP moiety, whereas this residue is largely intact in growing cells (46). However, strain differences have been found (164). Another dormant system, unfertilized sea urchin eggs, may also contain deficient tRNA (165) possibly because of incomplete termini. Furthermore, upon fertilization, there is a dramatic increase in the incorporation of label into the nucleotides of the -C-C-A terminus (166, 167). It should be pointed out, however, that the lack of labeling in unfertilized eggs may be due to the inability of the 32Pilabel to be incorporated into ATP and CTP. In addition, completion of the -C-C-A terminus of tRNA cannot be the only mechanism for triggering the onset of protein synthesis following fertilization since ribosomes from unfertilized eggs seem also to be inactive [see Timourian (166) for references]. Yet another system in which protein synthesis may be controlled a t the level of the terminus of tRNA is the nonlactating bovine mammary gland (168). tRNA isolated from this tissue appears to lack the terminal trinucleotide sequence and thus cannot be charged. The terminal nucleotides can be replaced in the presence of rat liver tRNA nucleotidyltransferase, ATP and CTP to regenerate active molecules (168). It is curious that those systems that contain a defect in the terminal sequence (i.e., stationary phase yeast, unfertilized sea urchin eggs and nonlactating mammary gland) are all relatively dormant. Finally, Stent has suggested a model (169) whereby removal and addition of nucleotides from the -C-C-A termini of specific tRNA molecules could regulate the rate of synthesis of specific proteins. Removal of the terminus from tRNA molecules needed to translate certain codons could effectively shut off or decrease the rate of the synthesis of specific
88
MURRAY P. DEUTSCHER
proteins. Such a mechanism might explain thc slow rate of terminal turnover of tRNA that has been observed.
REFERENCES 1. L. I. Hrcht. M. 1,. Strplienson and P. C. Znniecnik, P N A S 45, 505 (1059). 2. M. Staehelin, Experie,ilin 21, 1 (1971). 3. G. G. Loringer, R. J. Roberts and J. L. Strominger, FP 30, 1217 (1971). Sn. H. A. Sober, ed., “Handbook of Biochemistry and Molecular Biology,” 2nd ed., pp. H-130-133. Chemical Rubber Co. 4 . L. I. Hecht, P. C. Zamecnik, M. L. Stephenson and J. F. Scott, JBC 233, 954 (1958).
5. D. So11, Science 173, 293 (1971). 6. U. Rensing and J. T. August, Nature (Londoii) 224, 853 (1969). 60. D. H. Cause, F. yon der Haw, A. Maelicke and F. Cramer, A R B 40, 1045 (1971).
Gb. S. Arnott, Progr. Biophys. Mol. B i d . 22, 181 (1971). 7. F. Cramer, This Series 11, 391 (1971). S. F. Cramer, H. Doepner, F. yon der Hnar, E. Schlimme and H. Seidel, PNAS 61, 1384 (1968). 9. C. Li and J. Sii, BBRC 28, 1068 (1967). 10. T. I. Jilyaeva and L. L. Kisselev, FEBS Lett. 10, 229 (1970). 11. A. R. Cashmore, D. M. Brown and J. D. Smith, J M B 59, 359 (1971). 12’. Z. K h a n , K. A. Freude, I. Kilrnn and R. W. Chambers, Nature (London) New Biol. 232, 177 (1971). 13. R. P. Singhal, JBC 246, 5848 (1971). 14. G. Zubay and M. Takanami, BBRC 15, 207 (1964). 15. J. P. Miller, M. E. Hirst-Bruns and G. R. Philipps, BBA 217, 176 (1970). 16. T. Nihei and G. L. Cantoni, JBC 238, 3991 (1963). 17. M. N. Thang, W. Gusehlbauer, H. G. Znchau and M. Grunberg-Mnnngo, J M B 26, 403 (1967). 18. M. N. Thang, B. Beltchev and M. Grunberg-Manago, EJB 19, 184 (1971). 19. B. Beltchev, M. N. Thang and C. Portier. EJB 19, 194 (1971). 20. T. Lindahl, A. Adams and J. R. Fresco, PNAS 55, 941 (1966). 21. W. J. Gartland and N. Sueoka, PNAS 55, 948 (1966). 32. A. Danchin, FEBS Lett. 13, 152 (1971). 23. D. C. Ward, A. Cernmi, E. Reich, G. Acs and L. Altwerger, JBC 244, 3243 (1969). 24. D. C. Ward, E. Reieh and L. Stryer, JBC 244, 1228 (1969). 35. B. M. Hoffman, P. Scliofield and A. Rich, P N A S 62, 1195 (1969). 26. P. Schofield, B. M. Hoffman and A. Rich, Bchem 9, 2525 (1970). 87. D. B. Millar and R. F. Steiner, Bchem 5, 2289 (1966). 25. P. S. Sarin and P. C. Zamernik, BBRC 20, 400 (1965). 29. R. Stern, L. E. Zulra and U. Z. Littauer, Bchem 8, 313 (1969). 29n. M. Colin, A. Danchin and M. Grunberg-Mnnago, J M B 39, 199 (1969). 30. T. R. Krugh, Bchem 10, 2594 (1971). 31. D. B. Millar, BBA 174, 32 (1969). 52. T. Seno, M. Kobayashi and S. Nishimura, BBA 190, 285 (1969). 33. R. E. Streeck and H. G . Zachau, FEBS Lett. 13, 329 (1971). 34. P. G. Connors, M. Labanauskas and W. W. Beemnn, Science 166, 1528 (1969).
89 56. G. Melcher, FEBS Lett. 3, 185 (1969).
SO. A. Danchin and M. Grunberg-Manago, BBRC 39, 683 (1970). S7. A. Danchin and M. Grunberg-Manago, FEBS Letl. 9, 327 (1970). 38. J. R. Fresco, in “Informational Macromolecules” (H. J. Vogel, V. Bryson and J. 0. Larnpen, eds.), p. 121. Academic Press, New York, 1963. 3.9. R. H. Burdon. This Scrics 11, 33 (1971). 40. C. Scholtissek, BBA 61, 499 (1962). 41. R. M. Franklin, BBA 72, 555 (1963). 4% I. Merits, BBA 108, 578 (1965). 43. Y. Moulk and R. M. Landin, BBRC 20, 491 (1965). 44. R. M. Landin and Y. Moulk, BBA 129, 249 (1966). 46. R. Rosset and R. Monier, BBA 108, 376 (1965). 4G. M. Cannon, BBA 87, 154 (1964). 47. R. Rosset and R. Monier, BBA 108, 385 (1965). 4s. C. E. Holt, P. B. Joel and E. Herbert, JBC 241, 1819 (1966). 49. M. Cannon, BBA 129, 221 (1966). 60. V. Daniel, S. Sarid and U. Z. Littauer, Science 167, 1682 (1970). 60a. S. Altman, Nature (London) New B i d . 229, 19 (1971). 61. S. Altman and J. D. Smith, Nature (London) N e w B i d . 233, 35 (1971). 62. S. Altman, personal communication. 63. S. K. Mukerji and M. P. Deutschrr, JBC 247, 481 (1972). 64. C. Heidelberger, E. Harbers, K. C. Leibman, Y. Takagi and V. R. Potter, BBA 20, 445 (1956). 66. E. Goldwasser, JACS 77, 6083 (1955). 6G. A. R. P. Paterson and G. A. LePage, Cnncer Res. 17, 409 (1957). 67. M. Edmonds and R. Abrams, BBA 26, 226 (1957). 6s. E. S. Canellakis, BBA 25, 217 (1957). 69. E. Herbert, JBC 231, 975 (1958). GO. C. Coutsogeorgopoulos, BBA 44, 189 (1960). GI. L. I. Hecht, M. 1,. Stephenson and P. C. Zamecnilr, BBA 29, 460 (1958). G2. H. G. Zachau. G. Acs and F. Lipmann, PNAS 44, 885 (1958). 6.9. J. Preiss, P. Berg, E. J. Ofengand, F. H. Bergmann and M. Dieclrmann, PNAS 45, 319 (1959). G3n. H. G. Zachau and H. Feldmann, This Series 4, (1965). G4. E. Harbers and C. Heidelberger, BBA 35, 381 (1959). 06. C. W. Chung, H. R. Mahler and M. Enrionc, JBC 232, 1448 (1960). 66. K. Moldave, BBA 43, 188 (1960). 67. J. Humitz and A. E. Bresler, JBC 236, 542 (1961). 68. M. Edmonds, JBC 240, 4621 (1965). G9. J. J. Furth, J. Hurwitz, R . Krug and M. Alexander. JBC 236, 3317 (1961). 70. E. S. Canellalris and E. Herbert, PNAS 46, 170 (1960). 71. E. S. Canellakis and E. Herbert, BBA 45, 133 (1960). 72. J. Preiss, M. Dieckmann and P. Berg, JBC 236, 1748 (1961). 7s. V. Daniel and U. Z. Littauer, JBC 238, 2102 (1963). 74. J. L. Starr and D. A. Goldthwait, JBC 238, 682 (1963). 76. D. S. Carrk, 8. Litvak and F. Chaperille, BBA 224, 371 (1970). 7 s . H. J. Gross, F. R. Duerinck and W. C. Fiers, EJB 17,116 (1970). 77. J. P. Miller and G. R. Philipps, JBC 246, 1274 (1971). 78. A. N. Best and G. D. Novelli, ABB 142, 527 (1971). 79. R. W. Morris and E. Herbert, Bchem 9, 4828 (1970).
90
MURRAY P. DEUTSCHER
80. H. Sternbach, F. von der Haar, E. Schlimme, E. Gaertner and F. Cramcr, EJB 22, 166 (1971). 81. M. P. Deutscher, JBC 247, 450 (1972). 82. M. P. Deutscher, JBC 245, 4225 (1970). SZa. D. D. Anthony, J. L. Starr, D. S. Kcrr and D. A. Goldthwait, JBC 238, 690 (1963). 83. J. P. Miller and G.
R. Philipps, JBC 246, 1280 (1971). 84. M. P. Deutscher, JBC 247, 459 (1972). 86. K. B. Jacobson, This Series 11, 461 (1971). 86. S. Litvak, D. S. Car& and F. Chapeville, FEBS Lett. 11, 316 (1970). 87. M. P. Deutscher, JBC 247, 469 (1972). 88. H. Honda, BBA 195, 587 (1969). 89. M. P. Deutscher, unpublished results. 90. M. Takanami and K. I. Miura, BBA 72, 237 (1963). 91. A. V. Rake and G. M. Tener, Bchem 5,3992 (1966). 92. P. Cerutti, BBRC 30, 434 (1968). 93. T. Igo-Kemenes and H. G. Zachau, EJB 10, 549 (1969). 94. R. Giege, J. Heinrich, J. H. Weil and J. P. Ebel, BBA 174, 53 (1969). 96. J. A. Carbon, BBA 95, 550 (1965). 96. P. D. Harriman and H. G. Zachau, JMB 16, 387 (1966). 97. B. Rether, J. H. Weil and J. P. Ebel, BUZZ. Sac. Chim. Biol. 47, 1591 (1965). 98. I. I. Chuguev, V. D. Axelrod and A. A. Bayev, BBRC 34, 348 (1969). 98. I. I. Chuguev, V. D. Axelrod and A. A. Bayev, BBRC 41, 1CB (1970). 100. A. Bernardi and G. L. Cantoni, JBC 244, 1468 (1969). 100a. J. P. Miller and G. R. Philipps, Bchem 10, 1001 (1971). 101. H. Overath, F. Fittler, K. Harbers, R. Thiebe and H. G. Zachau, FEBS Lett. 11, 289 (1970). 102. T. Lindahl, A. Adams, M. Geroch and J. R. Fresco, PNAS 57, 178 (1967). 103. S. K. Mukerji and M. P. Deutscher, unpublished results. 104. A. N. Best and G. D. Novelli, ABB 142, 539 (1971). 106. H. G. Klemperer and E. S. Canellakis, BBA 129, 157 (1966). 106. A. FernandezSorensen, D. D. Anthony, and D. A. Goldthwait, JBC 241, 5019
(1966). 107. R. L. Soffer, S. Uretsky, L. Altwerger and G. Acs, BBRC 24, 376 (1966).
105'. S. C. Uretsky, G. Acs, E. Reich, M. Mori and L. Altwerger, JBC 243, 306 (1968). 109. E. Schlimme, F. v. d. Haar, F. Eckstein and F. Cramer, EJB 14, 351 (1970). 110. A. Mehler and Y . Tal, personal communication. 111. P. Pulkrabek and I. Rychlik, BBA 179, 245 (1969). fiZ. V. Daniel and U. Z. Littauer, JMB 11, 692 (1965). 113. H. G. Klemperer and G. R. Haynes, BJ 104, 537 (1967). 114. M. G. Page, G. R. Haynes and H. G. Klemperer, BJ 102, 181 (1967). 116. J. G. Cory, A. W. Benson and A. J. Girgenti, BBRC 42, 778 (1971). 116. H. Hayashi and K. I. Miura, JMB 10, 345 (1964). 117. J. Torres-Gallardo and M. Kern, PNAS 52, 91 (1965). U S . K. L. Roy and G. M. Tener, Bchem 6, 2847 (1967). 119. M. P. Stulberg and K. R. Isham, PNAS 57, 1310 (1967). 120. M. P. Deutscher, ABB 125, 758 (1968). 121. V. A. Korzhov and L. S. Sandakhchiev, Biokhimiga 31, 71 (1966). 122. F. Crumer, F. von dcr Hnnr and Schlimme, FEBS Letl. 2, 136 (1968).
-C-C-A
TERMINUS OF TRANSFER
RNA
91
123. V. A. Korzhov, Mol. B i d . 4, 47 (1970). 124. M. P. Deutscher, JBC 242, 1132 (1967). 126. A. H. Mehler and S. K. Mitra, JBC 242, 5495 (1967). 126. A. N. Baldwin and P. Berg, JBC 241,839 (1966). 127. S. K. Mitra, K. Chakraburtty and A. H. Mehler, J M B 49, 139 (1970). 128. H. C. Neu and L. A. Heppel, JBC 239, 2927 (1964). 129. M. H. Makman and G. L. Cantoni, Bchem 5, 2246 (1966). 130. M. Yarus and P. Berg, J M B 42, 171 (1969). 131. U. Lagerkvist and 1,. Rymo, JBC 245, 435 (1970). i32. U. Lagerkvist, L. Rymo and J. Waldenstrijm, JBC 241, 5391 (1966).
1%. H. G. Bluestein, C. C. Allende, J. E. Allende and G. L. Cantoni, JBC 243, 4693 (1908). 134. A. R. Cashmore, FEBS Lelt. 12, 90 (1970). 136. L. H. Schulman, PNAS 66, 507 (1970). 136. Y. Tal and U. Z. Littauer, personal communication. 187. R. E. Monro, T. Staehelin, M. L. Gelma and D. Vazquez CSHSQB 34, 357 (1969). 13s'. I . R. Raacke, PNAS 68, 2357 (1971). 139, M. Takanami, BBA 55, 132 (1962).
140. W. S. Bont, F. Puizinga, H. Bloemendal, M. F. Van Weenen and L. Bosch, A B B 109, 207 (1965). iq. M. Cannon, R. Krug and W. Gilbert, J M B 7, 360 (1963). 149. C. M. Chen and J . Ofengand, BBRC 41, 190 (1970). 1.43. Y. Kuriki, I. Fukuma and A. Kaji, JBC 244, 1365 (1969). 144. S. Pestka, JBC 2-45, 1497 (1970). 146. N. Shimizu, H. Hayashi rind K. I . Miura, JBC 67, 373 (1970). 146. R. E. Monro and K. A. Marcker, J M B 24, 347 (1967). 147. D. Nathans and A. Neidle, Nature (London) 197, 1076 (1963). 148. 5. P. Waller, T. Erdos, F. Lemoine, S. Guttman and E. Sandrin, BBA 119, 566 (1966). 149. I. Rychlik, S. Cliludek and J . Zcmlicka, BBA 138, 642 (1967).
160. M. S. Bretscher, CSHSQB 31, 289 (1966). 161. R. E. Monro, J. Cernti and K. A. Marcker, PNAS 61, 1042 (1968). 162. R. H. Symons, R. J. Harris, L. P. Clarke, J. F. Wheldrake and W. H. Elliott, BBA 179, 248 (1969). 163. R. J. Harris, J. E. Hanlon and R. H. Symons, BBA 240, 244 (1971). 164. M. Takanami, PNAS 52, 1271 (1964). 166. I. Rychlik, J. Cernh, S. ChlBdek, J. Zemlicka and Z. Haladovk, J M B 43, 13 (1969). 16G. I. Rychlik, J. Cernli, S. ChlBdek, P. Pulkrabek and J. Zemlicka, EJB 16, 136 (1970). 167. J. Zemlicka and S. Chlkdek, Bchem 10, 1521 (1971). 168. H. Neumann, V. E. Shashova, J. C. Sheehan and A. Rich PNAS 68, 1207 (1968). 169. E. Scolnick, G. Milman, M. Rosman and T. Caskey, Nature (London) 225, 152 (1970). 100. K. K. Wong and K. Moldavc, JBC 235, 694 (1960). 161. D. Nathans and F. Lipmann, PNAS 47, 497 (1961). 162. Y. Moulk and R. M. Landin, FEBS Lett. 8, 189 (1970). 163. M. P. Deutscher, FP 29, 871 (1970). 104. R. Giege and J.-P. Ebel, BBA 161, 125 (1968).
92
MURRAY P. DEUTSCHER
f66. H. Timourian, Develop. Biol. 16, 594 (1967). 166. V. R. Glisin and M. V. Glisin, PNAS 52, 1548 (1964). f f l . P. R. Gross, K. Kraemer and L. I. Malkin, BBRC 18, 569 (1965). 168. M. D. Herrington and A. 0. Hawtrey, BJ 116, 405 (1970). 169. G. 5. Stent, Science 144, 816 (1964).
Mammalian RNA Polymerases SAMSON T. JACOB' Physiological Chemistry Laboratories, Department of Nutrition and Food Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts
1. Introduction . . . . . . . . . . . . . 11. Quantitative Extraction of RNA Polymerase from Mammalian Cells . . . . . . . . . . . . . . . A. Methods of Solubiliaation . . . . . . . . . B. Recovery of the Enzyme . . . . . . . . . 111. Multiplicity, Nomenclature and Intranuclear Localization . . A. Separation of Multiple Forms of RNA Polymerase by Column Chromatography . . , . . . . . . . . B. Nomenclature . . . . . . . . . . . . C. Nuclear Localization . . . . . . . . , . D. Relative Concentrations and Specific Activity . . . . IV. Properties of RNA Polymeraees . . . . . . . . A. Stability . . . . . . . . . . . . . B. Metal Ion and Ionic Strength Optima . . . . . . c. Sensitivity to a-Amanitin in vitl.0 . . . . . . . D. Effect of a-Amanitin in Bivo . . . . . . . . E. Template Specificity . . . . . . . . . . F. Factor Requirements . . . . . . . . . . V. Subunit Structure and Molecular Weight . . . . . . VI. Regulation of RNA Polymerases . . . . . . . . VII. Mitochondrial RNA Polymerase . . . . . . . . VIII. Summary and Conclusions . . . . . . . . . . Notes Added in Proof . . . . . . . . . . . References . . . . . . . . . . . . . .
93
95 95 101 101 101 101 103 103 106 106 106 107 108 110 111 112 114 117 119 121 121
1. Introduction Spectacular progress has recently been made in the elucidation of the structure of bacterial DNA-dependent RNA polymerase (EC 2.7.7.6) and of its role in the regulation of transcription [reviewed recently by Burgess ( I ) , Martin ( l a ) , and Sethi ( I b ) ] .The ease with which this enzyme is solubilized and purified from bacterial sources is mainly responsible for Present address : Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey Medical Center, Hershey, Pennsylvania. 93
94
SAMSON T. JACOB
these achievements. Unlike the prokaryotic RNA polymerase, the eukaryotic enzyme is tightly bound to a complex consisting of DNA, histones, acidic proteins and RNA. Consequently, studies on mammalian RNA synthesis have utilized either whole nuclei or an “aggregate enzyme” obtained as a crude, insoluble preparation from nuclei by precipitation with KC1 ( 2 ) . The quality of the RNA synthesized in isolated nuclei (3-10) or nucleoli (11-14) is significantly affected by divalent metal ions and salt concentration. I n the presence of Mg”, the RNA formed in the polymerization reaction is predominantly (G C)-rich rRNA, whereas the RNA synthesized with high salt and Mn2+is mostly (A U)-rich, DNA-like RNA ( 4 ) . These results are compatible with the following possibilities: (a) a single polymerase transcribes selective regions of the chromatin template under different ionic conditions, or (b) there are different species of RNA polymerase with specific cation and salt requirements. Although the first possibility has been widely accepted, there are instances where changes in ionic conditions have no effect on the template activity. For example, salt in bacterial systems stimulates the initiation of RNA synthesis without any significant modifications of the template (16).Moreover, prokaryotic cells with their simple chromosomal structure can exhibit remarkable specificity of transcription, with other factors (16) conferring initiator specificity on the “core” RNA polymerase. The second possibility seems attractive for the following reasons : (a) multiple forms of many enzymes have been described, particularly in eukaryotic cells; (b) the ribosomal genes are apparently regulated independently (17,18) and are usually localized within the nucleolus (19-22). Thus, the RNA polymerase responsible for the synthesis of rRNA probably functions within the nucleolar structure and the enz y m e ( ~ )involved in the synthesis of nonribosomal RNA species is active within the extranucleolar compartment (nucleoplasm) of the nucleus. Furthermore, several physiological factors such as hormones have been shown to stimulate specifically the Mg2+-dependentpolymerization reaction (1); it appears that a t least two polymerases are present in the nucleus. It is evident that the possibility of the existence of multiple forms of RNA polymerase in eukaryotes cannot be tested with crude aggregates of RNA polymerase systems in which the enzyme is associated with the deoxyribonucleoprotein template. Consequently, the role of RNA polymerase in the control of genetic expression in mammalian cells has not been clearly understood. Such a regulatory role of RNA polymerase can be adequately evaluated only by analyzing purified enzyme preparations with exogenous templates. The recent success of several investigators in obtaining RNA polym-
+
+
MAMMALIAN
RNA
POLYMERASES
95
erase in good yields with high degrees of purity from a variety of eukaryotic cells has resolved many such problems and has thus paved the way to a better understanding of the mechanism(s) of RNA synthesis in higher organisms. This article deals with the recent developments in the field of mammalian nuclear RNA polymerases. I have also attempted to speculate and advance my own interpretations of the available information on this subject.
II. Quantitative Extraction of RNA Polymerase from Mammalian Cells
A. Methods of Solubilization Attempts have been made to release RNA polymerase free of DNA from chick embryo (as), bovine lymphosarcoma ( d 4 ) , rat testes (d5), corn seedlings (96), HeLa cells (97)and rat liver (98-32). I n all these instances, the amounts of soluble enzyme recovered were either low or not reported a t all. The instability of the enzyme following solubilization was primarily responsible for failure in further purifications. Consequently, these procedures have not furnished the exact amount or all the types of RNA polymerase present in a tissue. Recently, several groups of investigators have succeeded in extracting the enzyme from a variety of animal tissues in quantities that are sufficient for further purification and analysis. Thus RNA polymerase has been solubilized quantitatively from liver tissue of the rat (33-.@), Xenopus Zuevis (47) and the monkey (@), from calf thymus (39, 49-51), sea urchin embryos (39,52),embryos (47) and ovaries (53) of Xenopus Zaevis, mouse embryo cells ( 5 4 ) ,HeLa cells (55), KB cells (48), bovine lymphoid tissue (56) and rat ventral prostate gland ( 5 7 ) . The various methods employed for the quantitative extraction of RNA polymerase from mammalian tissues are outlined in Table I and are described below with the references to the original procedure. They can be broadly classified into three categories: ( a ) mild treatment, (b) moderately drastic (strong) treatment, and (c) drastic treatment of the tissue or the cell nuclei. The solubilization of RNA polymerase by mild treatment can be achieved by one of the following procedures: (i) suspending the cells in buffer for various lengths of times a t 4' (54); (ii) homogenizing the tissue in a slightly alkaline buffer (41, 5 1 ) ; (iii) grinding the tissue in a Waring Blendor using a suitable buffer (56); and (iv) incubating the nuclei a t 37" in Tris buffer with pH in the range of 7.9-9.1 (33, 43). The moderately drastic treatment consists of brief sonication in a medium of low ionic strength (34, 35). The more drastic treatment in-
TABLE I SOLUBILIZATION AND CHROMATOGRAPHIC SEPARATION OF MAMMALIAN RNA POLYMERASES
Source of enzyme
Outline of the procedure for the extraction of enzyme(s)
Chromatographic elution properties of the enzymes"
Number of enzymes resolved
W
Q,
References
Rat Liver (a) Isolated nuclei
Incubation at 37"for 30 min in alkaline Fractionation on DEAESephadex with buffer (pH 8.9-9.1), followed by cf.; (NH&SO4 IA (0-0.03M) enzyme usually ppted with IB (0.12 M ) (NH4)eSOr and dialyzed.
4 (possibly 5)
SS, 56
2
S5,36
Fractionation on DEAESephadex with I (0.15 M) I1 (0.25 M) I11 (0.30 M)
3
58
Fractionation on DEAESephadex with (NHI)&OI I (0.15 M) Negligible I1 and I11 Fractionation on DEAESephadex with (N&)&O4 I1 (0.25 M) I11 (0.30M)
1
38
2
58
'IA (0.20-0.22 M)
(b) Isolated nucleoli Brief sonimtion, followed by incub% tion in alkaline buffer. Not ppted with salt.
IIB I11 (0.30 M) Fractionation on DEAESephadex or phosphocellulosewith (NH4)&04. Two enzymes were resolved IA (0-0.03M) IB (0.15 M)
Rut LioW (a) Isolated nuclei
Sonication for 1 min in presence of 0.3 M (NH4)&04, PH 7.9, followed by reduction of ionic strength and cf.; enzyme ppted with (NH4)&04 and dialyzed. (b) Isolated nucleoli Same as above
( c ) Isolated nucleoplasm
Same as above
4
P
c)
i?
Rat Liver Isolated nuclei
(a) Incubation a t 37" for 1 hour with Fractionation on DEAE-cellulose with KC1; I (0.23 M)-nucleolar enzyme. buffer containing 0.07 M KCl followed by cf. Enzyme not ppted with Bechromatography of I on phosphosalt. cellulose with KCl: IA (0.4-0.55 M) IB (0.6-0.70 M) (b) Sonication in presence of 0.3 M Fractionation on DEAESephadex with (NH4)&04, pH 7.9, followed by re(NHd804 B (0.35 M) duction of ionic strength and cf. EnRechromatography of B on phosphozyme ppted with (NH4)804and dialyzed. cellulose with (NH~)&OI B (0.25 M)
2
42
1
44
23
5
Total 3
Rut Liver Isolated nuclei
Sonication in presence of 0.75 M NaC1, Fractionation on DEAE-cellulose with stirring in the cold for 1.5 hours, reNH4Cl duction of ionic strength and cf. EnI (0.10M) I1 (0.28 M) zyme not ppted with salt.
2
40
Sonication for 7 min in presence of Fractionated on DEAE-cellulose with 0.48 M (NH,)804 followed by cf. ; (N&)&Ot followed by salt pption, reduction of A (0.12 M) ionic strength and removal of DNA B (0.30 M) with protamine sulfate. The enzyme finally ppted with (NH4)&04 and dialyzed.
2
46
Incubation in 0.32 M sucrose, pH 8.0 Fractionated on DEAE-Sephadex with at 0" for 8-15 hours, followed by cf., (N&)&O4 I (0.15 M) (NH&!% pption and dialysis I1 (0.25 M)
2
48
Rat liver Isolated nuclei
Rut lwer/African green monkeg liver Crude nuclei (700 g pellet)
CD
w
(Continued)
TABLE I (Continued)
Source of enzyme xenopus .?a& liver Whole tissue
Calf thymus Isolated nuclei
Calf thymus Isolated nuclei
Outline of the procedure for the extraction of enzyme(s)
Chromatographic elution properties of the enzymesa
Sonication in presence of 0.3 M (NH&~OI, pH 7.9, reduction of ionic strength and cf.; ppted with salt and dialyzed.
Fractionated on DEAESephadex with (NH~)&OI I (0.15 M) I1 (0.25M)
Fractionation on DEAE-cellulose with Sonication for 5-7 min in presence of 0.48 M (NH,)&o,, followed by d., (NH~)&OI,after the enzyme was initially adsorbed on the column with pption with salt and dialyzed. 0.04 M salt A (0.15 M) A (0.3 M) B (0.30M) Or B (0.25M) with phosphocellulose columns Rechromatography of B on D E A E cellulose, after the enzyme was initially absorbed on the column with 0.08 M salt: IB (0.22M) IIB (0.27 M) Sonication in presence of 0.3 M (NH4)2SO4, (PH 7.9), followed by reduction of ionic strength and cf.; ppted with salt and dialyzed.
Fractionation on DEAESephadex with (NHI)&OI I (0.15 M) I1 (0.27 M)
Number of enzymes resolved
2
References
47
Total 3
2
39 4
8
Calf thymus Whole tissue
Calf thymus Whole tissue
Sea urchin embryos Isolated nuclei
4 (possibly 5 )
Homogenizationof the tissue at pH 7.8, Fractionation on DEAEeellulose with KC1 addition of 0.1 M (NH4)&304 to reI (0.25 M ) move DNA and final pption with I1 (0.35 M) salt, followed by dialysis.
2
51
Sonication for 1 min in presence of Fractionation on DEAE-Sephadex.with 0.3 M (NHi)i?IO4, (PH 7.9),followed (NHi)i?IOd by reduction of ionic strength and I (0.15 M) cf.; ppted with (NH&?~OIand I1 (0.22 M) dialyzed. I11 (0.30M)
3
38
Fractionation on DEAE-Sephdex with (NHd804 I (0.12M) I1 (0.23 M) I11 (0.30M)
3
47
Sonication of crude chromatin prepara- Fractionation on DEAE-cellulose with tion in buffer containing 0.75 M KCl, KCl reduction of ionic strength and cf. I (0.15M) I1 (0.30M)
2
53
Xenopus lawis embryos Whole cells Same as above
z
xenspvs laavis ooytes
(a) Whole cella
56
Tissue ground with buffer in blender, Fractionation on DEAESephadex with cf. and ppted with protamine sulfate (NH4)SOt I (0.05 M) and ammonium sulfate. I1 (0.10M) I11 (0.13 M) IV (0.34 M)
(Continued)
TABLE I (Continued)
Source of enzyme
Outline of the procedure for the extraction of enzyme(s)
(b) Isolated nucleoli Same as above
HeLa cells Crude nuclei
Chromatographic elution properties of the enzymes" Fractionation on DEAE-cellulose with KC1 I (0.15 M)
+
Number of enzymes resolved 1
0 0
References 63
66
Incubation in hypotonic solution con- Fractionation on phosphocellulosewith taining 0.01 M (NH~)&OI and 0.5% (N&)801 Triton-X for 60 min at 4", cf. I (0.20 M), nucleolar enzyme
K B cells Whole cells
L ymphosarcoma Whole tissue
Incubation in 0.32 M sucrose (pH 7.9) Fractionation on DEAE-cellulose with a t 0" for 8-15 hours, followed by cf. KCl and (NH4)&04 pption and dialysis. I (0.25 M) I1 (0.35M)
2
Tissue ground with buffer in blender, cf., the enzyme ppted with (NH,)&O( and dialyzed.
3
Fractionation on DEAESephadex with (NHd80r I1 (0.10M) I11 (0.13 M)
J Y
(0.34
66
M) u,
+-
Rat ventral prostate gland Isolated nuclei
Sonication in presence of 0.3 M Fractionation on DEAE-cellulose with (NH4)&04, (PH 7.9), followed by KC1 reduction of ionic strength and cf.; I (0.3 M) ppted with (NH4)&04 and dialyzed. I1 (0.65 M)
2
67
a Nomenclature'as used by the investigators. The figures in parentheses indicate the molarity of the salt required for the elution of the enzymes.
!
Z
5 4
+-
8
MAMMALIAN
RNA
POLYMERASES
101
volves sonication in a medium of high ionic strength (37, 58, 60). The choice of a procedure depends largely on the type of tissue or cells from which the enzyme is extracted.
B. Recovery of the Enzyme The recovery of the enzyme in the initial extract is of primary importance. It is usually difficult to quantitate the yield of the enzyme after solubilization, since the solubilized enzyme is assayed with exogenous DNA as the template, whereas the aggregate enzyme uses its own chromosomal template in which much of the DNA is not available for transcription. If the polymerase is present in sufficient quantities in intact nuclei with DNA in the chromatin matrix as the limiting factor, addition of exogenous DNA to the solubilized enzyme preparations is likely to produce a dramatic rise in the enzyme activity. In most cases, this factor has been neglected in estimating the recovery of the enzyme after solubilization. Consequently, the yield of the enzyme in the initial extract has frequently been overestimated. This error can be considerably reduced if the difference in the activity of the nuclei before and after extraction of the enzyme is taken as an index of the recovery of the extracted enzyme (33). The recovery of the enzyme solubilized from rat liver nuclei by incubation in an alkaline medium, as measured by the latter procedure, is usually over 80%.
111. Multiplicity, Nomenclature and Intranuclear localization A. Separation of Multiple Forms of RNA Polymerase by Column Chromatography The chromatography of the enzyme solubilized from a variety of animal tissues on DEAE-cellulose or DEAE-Sephadex has revealed multiple forms of RNA polymerase (Table I).The multiplicity of RNA polymerase has also been observed in lower eukaryotes, such as an aquatic fungus (58), yeast (59)and maize (60).The enzymes are usually eluted from the column using a linear gradient of (NH,)*S04or KC1. Four discrete enzymes can be eluted from the column a t 0-0.05 M, 0.10-0.15 M, 0.200.30 M and 0.30 M-0.37 M ammonium sulfate (Table I). The enzymes of rat ventral prostate gland have been eluted from the column with higher than usual salt concentrations (67).
B. Nomenclature The nomenclature of mammalian RNA polymerases has not been uniform because different criteria have been adopted by various investi-
102
SAMSON T. JACOB
gators in classifying the enzymes. The three enzymes separated chromatographically between 0.10 and 0.37M salt concentrations are referred to as I, I1 and I11 in the order of their elution from the column (38, 6 1 ) . The enzymes I and 11,the major species of RNA polymerases detected in most tissues examined, are also designated by A and B, respectively (36, 50). A typical chromatographic profile of RNA polymerase solubilized from rat liver nuclei appears in Fig. 1. The recent suggestion by Chambon and his colleagues (45) to use the differential sensitivity of the RNA polymerases to a-amanitin as the only criterion for naming the different enzymes has neglected the large amount of other information available, such as cell localization and ionic requirements (see the section on the properties of RNA polymerases). On the other hand, a nomenclature based solely on the order of chromatographic elution of the enzymes presents some problems as it is possible to detect additional enzymes under proper conditions. Ideally, the enzymes within a given transcription system, such as nucleus, chloroplast and mitochondrion, should be grouped together: e.g., nuclear RNA polymerase I, 11, etc.; mitochondria1 polymerase I, 11, etc.; and so on. Since the isolation of enzymatically active nucleoli from many cells or tissues is extremely difficult, it is not always feasible to localize the nuclear polymerases further within nucleolar and nucleoplasmic regions, as has been achieved with the enzymes from rat liver. If the enzymes can be subsequently resolved into additional subspecies, the latter can be designated as A, B, m
'P
FRACTIONS (ML)
FIG. 1. Column chromatographic profile of RNA polymerase solubilized from rat liver nuclei (also see 36 and 61).
MAMMALIAN
RNA
POLYMERASES
103
C, etc., preceded by the number of the parent enzyme-for example, IA, IB, IC, etc. The subunits of the mammalian enzymes can be designated as a, p, y, etc. (subunits of I as Ia, IF, Iy, etc.; subunits of I1 as IIa, IIp, I I y , and so on), as in the case of bacterial RNA polymerase. The nucleolar enzyme eluted in the wash (0-0.05M salt) has been called V , (“void volume peak”) ( 3 6 ) .Since the only other enzyme found in the cell nucleolus a t this time was I, V , was redesignated as IA ( 6 1 ) . Recently, the enzyme I has been further resolved on a phosphocellulose column into two peaks of activity, IA and IB, eluted a t 0.48 and 0.65 M KCl, respectively (43). Consequently, two of the enzymes have the same terminology (IA) and hence the enzyme V,, separated from enzyme I as a distinct peak during the first fractionation on a DEAE-cellulose or DEAE-Sephadex column, is reclassified as enzyme IV. Thus the original nucleolar enzyme I is a mixture of enzymes IA and IB, and enzyme IV is an additional nucleolar RNA polymerase. Enzyme I1 has also been further resolved chromatographically into two additional enzymes, IIA and I I B (36, 45, 46).
C. Nuclear localization Enzyme I has been established to be of nucleolar origin (36, 38). Recently, it was demonstrated that enzyme IV is also of nucleolar origin (61). Enzymes IA and IB (43) are probably localized in the nucleolus since they are resolved from enzyme I of the nucleolus. Enzymes I1 (IIA I I B) and I11 (38) are of nucleoplasmic origin. Thus a t least in the case of rat liver, a total of six distinct forms of RNA polymerase have been separated by column chromatography, out of which three are localized in the nucleolus, the remaining three being in the nucleoplasm.
+
D. Relative Concentrations and Specific Activity It is not feasible to make an accurate estimate of the relative concentrations of different polymerases, as different procedures have been employed for the extraction of RNA polymerases from the same tissue. Furthermore, considerable variations in the stability of the enzymes, particularly the nucleolar polymerases, have been reported. Generally speaking, in almost all normal tissues, the amount of enzyme I appears to be less than that of enzyme 11. In rat liver, enzymes I11 and I V are present in equal proportions and are slightly lower than enzyme I ( 3 6 ) .Enzymes I11 and IV have not been reported to exist in tissues other than liver and sea urchin. The ratio of enzyme IIA to enzyme I I B is much higher in rat liver than in calf thymus (4.6). Whether this difference is a characteristic of the organs or results from selective loss of enzymes during the purification is presently unknown. The highest specific activity reported for a
TABLE I1 NUCLEAR LOCALIZATION, NOMENCLATURE AND PROPERTIES OF RNA POLYMERASES
Source of enzyme
Nuclear localization
Properties of the enzymes sugNomen- gested Sensitivity Optimal clature nomento Activity with Mn*+ (NH,)~o, used clature a-amanitin Activity with Mg*+ (M)
Template requirement
Rat liver Isolated nuclei and Nucleolus nucleoli Nucleolus
IA IB
IV
I
2.0
0.03 0.04
IIA IIB I11
8.0
0.06
Nucleoplasm
IIA IIB I11
Isolated nuclei and Nucleolus nucleoli Nucleoplasm Nucleoplasm
I I1 I11
I I1 I11
2
A IB IIB
I IIA IIB
IA IB B
IA
I I1
I I1
Nucleoplasm
-
Native nucleolar DNA most effective Denatured DNA
0.1-0.2
Rut liver
Rut liver Isolated nuclei
Rut liver Isolated nuclei
IB
5
1.1
0. 7
0.07 0.12
Native or denatured DNA Denatured DNA
0.025 0.025
I1
Rat liver Isolated nuclei
Native DNA Denatured DNA
References
Calf thymus Whole t.issue
A IB IIB
Xenopus laevis Liver Xenopus laevis Embryos Whole tissue
Native DNA Native DNA
Nucleolus
I I1 I11
I I1 I11
10 2.5
0-0.2
I
I1
I I1
3 7
0.W
I I1 I11
I I1 I11
I I1
I I1
HeLa cells Isolated nuclei Mouse embryos Whole cells
Rat ventral Nucleolus Prostate gland Isolated nuclei and Nucleoplasm nucleoli a
0.04O
0.10 0.10
46960
Pz
l-z
9
Sea urchin Embryos Isolated nuclei
Xenopus laevis oocytes Whole cells or nucleoli
I IIA IIB
0.016 in presence of M@+.
1
I I1
I I1
I I1
0.01-0. OF
47
c
5 cd 0
5
E
47
E
m
(I)
65
I I1 I I1
58, 76
0.04 0.09
Native DNA
66
54
+
2.4
57
3.3
* Determined in presence of Mnz+;in presence of M@+, the salt optima were 0.01 and 0.06 for enzymes I and 11, respectively.
F
0
cn
106
4
SAMSON T. JACOB
mammalian RNA polymerase is 300-600 units per milligram of protein [ l unit of activity is defined as nanomoles of nucleotide incorporated per 10 minutes a t 30°C (50)1. Recently, Weaver et al. (62)obtained polymerase I1 preparations from calf thymus and rat liver with specific activities ranging from 400 to 1000, which are similar to the specific activity reported by Burgess (63,64) for the E . coli polymerase. The selection of a suitable procedure for the estimation of enzyme protein is crucial in assessing the specific activity of RNA polymerase preparations. It is known that Lowry’s procedure for the estimation of proteins is liable to cause errors in the presence of a wide variety of compounds ( 6 5 ) . Glycerol and sucrose (66), tris (hydroxymethyl)aminomethane (67) and sulfhydryl compounds (for example, dithiothreitol and glutathione) interfere with the color produced in the Lowry reaction (66). I n general, protein precipitapts such as trichloroacetic or perchloric acids do not affect Lowry’s procedure, and consequently Bennett (68) has recommended a modification of Lowry’s procedure in which the interfering materials are first removed by acid precipitation. I n my laboratory, this procedure has been routinely and successfully used for the estimation of enzyme proteins. The large amount of tissue frequently used in the extraction of RNA polymerase yields enzyme in acid-precipitable quantities at the final stage of purification.
IV. Properties of RNA Polymerases The properties of the polymerases are summarized in Table 11.
A. Stability The nucleolar RNA polymerases appear to be less stable than the nucleoplasmic enzymes, particularly in the presence of salt (36, 4 3 ) . For this reason, it has been recommended that salt be avoided in the extraction and purification of the nucleolar enzymes. I n fact, the elimination of salt from the purification process results in higher yield of these enzymes (36, 42-44). Furthermore, salt has also been shown to induce alterations in the sedimentation properties of nucleolar enzyme I (50). The stability of all the enzymes can be considerably enhanced by the presence of large amounts of bovine serum albumin and 35% glycerol, and the nucleolar enzymes can even be stored for several weeks in this medium at -90°C without losing appreciable activity.
B. M e t a l ion a n d Ionic Strength Optima The polymerases exhibit different optima for divalent metal ions and (NH,) ?SO,. The nucleolar enzymes show their optimal activities a t low
MAMMALIAN
RNA
POLYMERASES
107
ionic strength and utilize MnZCand Mg2+equally well. On the other hand, higher Mn2+concentrations and ionic strengths are required for optimal activity of the nucleoplasmic enzymes. The enzyme from rat ventral prostate gland shows unusually large requirements of Mgz+and Mn2+for enzyme 11. Although the crude and purified nuclear enzymes have identical MgZf optima they differ markedly in their salt requirements. Thus, purified enzymes require considerably lower concentration of salt than the 0.4M (NH,),SO, that is usually employed for the analysis of the enzyme activities in isolated nuclei. Studies on the solubilized enzymes (33, 69, 70) indicate that the most significant effect of salt is on the enzyme. An identical observation is that KCl (0.2M) activates bacterial RNA polymcrasc in the presence of native DNA (1). Maitra and Barash (15) have shown that the function of salt in the bacterial RNA polymerase reaction is to detach the newly formed RNA from the enzyme and consequently to allow reinitiation of RNA chains. It is possible that salt can cause similar effects on mammalian polymerase(s) as well. The possibility that high concentrations of salt can, in addition, stimulate the chromntiii activity in isolated nuclei or nucleoli by detaching the proteins that mask the template DNA cannot be ruled out at present.
C. Sensitivity to a-Amanitin in Vifro Stirpe and Fiume (71)first observed that the activity of RNA polymerase in isolated nuclei under high ionic conditions (Mn2+and ammonium sulfate) can be inhibited by a-amanitin, a toxin isolated from the poisonous mushroom, Ainanita phalloides (72, 7 3 ) . Its selective effect on polymerase activity in the presence of Mn2+differs sharply from the effect of inhibitors that act on the DNA template, such as actinomycin ( 4 ) and aflatoxin ( 7 4 ) ,to which the Mg'f-activated enzyme is usually more sensitive. These observations suggested that a-amanitin might act on RNA polymerase itself. Experiments to test this possibility grove that this is indeed the case ( 7 5 ) . Subsequent studies in my laboratory (34) and elsewhere (50, 76, 77) have demonstrated that the toxin selectively inhibits the nucleoplasmic enzymes a t a concentration as low as 0.03 pg/ml (3 X 10-sM) whereas the nucleolar enzymes are not affected even a t inucli higher doses. In addition to the nucleolar RNA polymerases, the minor nucleoplasmic enzyme I11 does not appear to be inhibited by a-amanitin ( 7 6 ) . a-Amanitin is as specific for the eukaryotic enzyme (75) as rifamycin or rifampicin is specific for the prokaryotic enzyme (75, 78-80). Rifamycin has no significant effect on animal nuclear RNA polymerases (33, 39, 50, 7 8 ) . Unlike most inhibitors of RNA synthesis (81-90), a-amanitin inhibits RNA synthesis by binding to RNA polymerase (50, 75) rather
108
SAMSON T. JACOB
than to the DNA template. An analysis of the stoichiometry of the reaction by plotting initial velocity against enzyme concentration in the presence of different concentrations of the inhibitor ( 9 1 ) , shows that one molecule of amanitin inhibits one molecule of enzyme I1 ( 5 0 ) . Direct evidence for binding of the toxin to the enzyme has been obtained by cosedimentation of enzyme and [ methy2-14C]a-amanitin in glycerol gradients ( 9 2 ) . Further investigations on the mode of action of the toxin reveal that it inhibits RNA synthesis after the initiation step, presumably a t the level of chain elongation (75, 77, 9 3 ) . The mechanism of action of n-amanitin thus differs from that of rifampicin, which inhibits bacterial RNA synthesis by preventing chain initiation (80), but resembles that of another bacterial RNA polymerase inhibitor, streptolydigin that appears to inhibit chain elongation ( 9 4 ) . However, streptolydigin, in very high concentrations, also inhibits both the nucleolar and nucleoplasmic enzymes from calf thymus ( 5 0 ) . The overall conclusions from experiments using a-amanitin in vitro are (a) that a-amanitin reacts with the enzyme itself, not with the DNA template, (b) that it does not interfere with initiation of RNA synthesis and (c) that it is specific for eukaryotic RNA polymerase.
D. Effect of a-Amanitin in Vivo Experiments using a-amanitin in vitro strongly indicate that the toxin can inhibit specifically the synthesis of mRNA in vivo without affecting ribosomal RNA synthesis in the nucleolus. If this is indeed the case, a-amanitin will then become a useful tool to study ( a ) the turnover of mRNA in higher organisms and (b) the transcriptional control of biochemical processes. In order to prove the possible differential effects in vivo, the incorporation of [14C]orotic acid into nucleolar and extranucleolar (nucleoplasmic) RNA following injection of a-amanitin to rats has been examined ( 9 5 ) . Contrary to expectations, the synthesis of ribosomal as well as nonribosomal RNA is significantly inhibited within an hour of amanitin treatment (95, 9 6 ) . The inhibition of rRNA synthesis has been further confirmed (95) by (a) the disappearance of the nucleolar 45 S RNA optical density peak from the sucrose density gradient profile of nuclear RNA and (b) a sharp decrease in the methylation of nuclear RNA with [~nethyl-'~C] methionine, which under these conditions methylates mainly rRNA, made in the nucleolus. The effect of amanitin on the rRNA synthesis is only transient and the inhibition disappears completely within 2 or 3 hours. However, the nonribosomal RNA synthesis remains severely depressed over long periods. The finding that rRNA synthesis is transiently inhibited after injection of the toxin into intact animals is interesting, However, it agrees
MAMMALIAN
RNA
POLYMERASES
109
with the early results obtained by electron microscopy (97), that. treatment of mice with amanitin in vivo causes rapid fragmentation of the nucleolus, implying that the nucleolus is susceptible to amanitin toxicity. Since rRNA synthesis is inhibited in vivo, it is important to know whether active nucleolar polymerase is lost from the nucleus after administration of the inhibitor. Treatment with a-amanitin in vivo usually results in extensive loss of activity of the nucleolar polymerases, and the recovery of the nucleolar enzyme activity is not as fast as that of the labeling of nucleolar RNA in vivo. One complicating factor involved in studies on the purified RNA polymerase obtained after amanitin treatment in vivo, is that the procedures for the solubilization and purification by chromatography may remove amanitin or an inhibitory metabolite from the enzyme and thus occasionally result in a higher activity than that in the intact cell ( 3 6 ) . Several explanations can be given for the inhibition of rRNA synthesis by amanitin in vivo. (a) It is possible that amanitin is converted to a toxic metabolite(s) that in turn inhibits the activity of nucleolar as well as extranucleolar polymerase. (b) It could be that the function of the nucleolar RNA polymerase is regulated by some extranucleolar factor sensitive to amanitin. (c) mRNA synthesized in the extranucleolar compartment may be needed for the synthesis of a rapidly renewed protein factor involved in the nucleolar polymerase function. Although all classes of RNA in rat liver are inhibited by treatment with amanitin in vivo there are reports that in some species, such as mouse (71) and Xenopus Eaevis embryos ( 5 3 ) , the ribosomal RNA-synthesizing machinery in the nucleolar compartment is unaffected by amanitin in vivo. The reason(s) for the difference in the response of the latter species is not very clear. It is possible that amanitin can be converted into a functional metabolitc (as suggested in the above paragraphs) by the active drug-metabolizing enzymes present in rat liver microsomes and that this derivative of a-amanitin affects the nucleolar RNA polymerase as well. Experiments to test this hypothesis have not been performed. It is known that actinomycin D, at doses commonly used for inhibition of mRNA synthesis in animal cells, not only produces cytotoxic effects in the liver, but also degrades newly synthesized RNA (98-100). It is thus evident that actinomycin D cannot be employed satisfactorily as a specific inhibitor of RNA synthesis, especially of mRNA synthesis. Unlike actinomycin D, a-amanitin can inhibit all RNA synthesis in vivo, when used a t very low doses. Consequently it should be possible to examine the requirement of de novo synthesis of RNA and specifically of mRNA for a biochemical process (if a proper time period such as 3 hours
110
SAMSON T. JACOB
after amanitin treatment is selected, when only extranucleolar RNA synthesis remains inhibited). Thus it has been demonstrated that the induction of tyrosine transaminase in rat liver by cortisol (101) or by cyclic AMP (109)is dependent on the de novo synthesis of RNA.
E. Template Specificity Most investigators have used calf-thymus DNA as template for purified enzymes. However, a t least for rat liver enzymes, purified liver nuclear DNA has been shown to be a better template than calf thymus DNA (35). Generally speaking, nucleolar polymerases act preferentially on native DNA whereas the nucleoplasmic enzymes utilize denatured DNA more efficiently. However, since neither polymerase I nor polymerase I1 of Xenopus laevis shows any striking preference for native DNA as opposed to denatured DNA, the specificity of transcription may require some other factor(s) that interacts with the enzyme or the DNA or both ( 4 7 ) .The nucleolar RNA polymerase of rat liver transcribes native nucleolar DNA fifteen times more efficiently than whole nuclear DNA. The activity of the nucleoplasmic enzymes is increased only slightly by substituting nuclear DNA with native or denatured nucleolar DNA. The higher activity of nucleolar DNA with the nucleolar enzyme is not due to fragmentation or single-strand breaks in the DNA (S. T. Jacob, unpublished observations). The nucleolar enzyme from Xenopus laevis embryos also acts preferentially on ribosomal DNA rather than on the bulk nuclear DNA ( 4 7 ) ,provided the salt concentration is above 0.05 M. However, no significant difference in the rates of transcription of the two templates has been observed at low salt concentrations. The only means to study the template specificity of purified RNA polymerase is to use DNA of defined structure in vitro. In studies performed so far, either polynucleotides or viral DNA have been used. Studies with synthetic polynucleotides have shown that templates composed of pyrimidine nucleotides are read far more readily by both nucleolar and nucleoplasmic enzymes than those made of purine nucleotides. This is true for both single and double-stranded templates (39). Polymerase I1 reads the dC, strand of dI,.dC, over thirteen times more rapidly than it does calf thymus DNA (39). These enzymes, however, differ in the rate of reading dT, which is transcribed by nucleolar enzyme I but not by nucleoplasmic enzyme I1 (39). Double-stranded DNA of adenovirus 2 with a mass of 23 X los daltons (103) and the circular, superhelical double-stranded DNA of SV40 virus (104) with a mass of 3 X lo6 daltons, have been used (48). It has been concluded that similar base sequences of these DNA’s are transcribed asymmetrically by both nucleolar and nucleoplasmic enzymes.
MAMMALIAN
RNA
POLYMERASES
111
The T 4 DNA is a poor template for all the enzyme fractions (39, 60) even in the presence of sigma factor, which dramatically stimulates the activity of the core E . coli polymerase (63). The enzymes from calf thymus transcribe twisted circular DNA (Py I) and open circular DNA (Py 11) from polyoma virus very poorly, whereas mouse DNA (Py 111) from the pseudovirions, at least a t nonsaturating levels, appears to be a better template than calf thymus DNA for the mammalian enzymes ( 5 0 ) . One possible explanation for the latter observation is that the relatively small Py I11 DNA offers more ends where initiation could occur than native calf-thymus DNA. However, the specificity of transcription, as evaluated by studies with synthetic or viral templates, may not be similar to that expressed in the cell. It should be pointed out that the RNA formed by “naked” DNA does not resemble qualitatively or quantitatively the natural RNA in the cell (106).The histones, specific chromosomal RNA, and acidic proteins of the chromatin possess some role in the regulation of transcription (105109). The experiments of Gilmour and Paul (106) clearly demonstrate that only the RNA transcribed from nucleoprotein that is reconstituted from the components of the chromatin is similar to natural RNA. It is thus clear that the specificity of RNA polymerase in the transcriptional process can be evaluated only by analyzing the product of the enzymes formed with native chromatin preparations as the template.
F. Factor Requirements Factors influencing the RNA polymerase of bacterial (63, 110, 111) and other microbial sources (112) play an important role in the positive control of gene transcription. It is tempting to assume that such a control mechanism exists also in higher organisms. Since bacterial sigma factor has no demonstrable stimulatory effect on the mammalian enzymes (50, 55) when added in vitro, it was deemed desirable to look for mammalianspecific factors that could regulate the transcript‘onel process. Two groups of investigators (40, 51, 113) have recently identified a factor that can stimulate the activity of nucleoplasmic enzymes obtained from rat liver and calf thymus. The factor in the enzyme preparations from liver appears to be present in the cytoplasm. Both the factors have been partially purified and a 100-fold purification of the one from liver has been achieved. The factor is a protein with a sedimentation coefficient of 3 3 . 5 s and a molecular weight of approximately 70,000. The specific stimulation of the nucleoplasmic enzyme I1 can be observed only in the presence of native double-stranded DNA. The preferential transcription of denatured DNA by the nucleoplasmic polymerase in the absence of the factor, implies that this enzyme is complete only with its associated
112
SAMSON T. JACOB
factor. The observed stimulation is not due to the action of a nuclease that can cause single-strand breaks in native DNA and consequently expose more initiation sites on the DNA. There seems to be a specific recognition between the enzyme and the factor as is suggested by the fact that the factor binds to the cnzyme. Since there is no simple stoichiometric relationship between factor bound to polymerase and its stimulatory effect on the enzyme, a catalytic action of the factor is suggested. These results are thus consistent with the effects of sigma factor on bacterial RNA polymerase. However, the question, whether or not the factor can promote initiation of RNA synthesis a t specific sites of DNA cannot be answered a t present. The possibility that the factor interacts with the enzyme or enzyme-template complex, changing its transcriptional properties, cannot be ruled out. The mechanism of action of the factor thus remains unanswered. It is interesting to note that no such factor for the nucleolar enzyme has yet been isolated. It should, however, be pointed out that microinjection of E . coli factor into Xenopus laevis oocytes results in a significant stimulation of both nucleolar and nucleoplasmic polymerases ( 5 3 ) . The absence of a stimulating effect when sigma is added in vitro may suggest that it interacts with endogenous “phosphocellulose-like” components (63) to initiate RNA synthesis.
V. Subunit Structure and Molecular Weight The most reliable information on the molecular structure of RNA polymerases has been obtained with the two a-amanitin-sensitive nucleoplasmic enzymes, arbitrarily named IIA and I I B (4446” 5 0 ) . Success in the elucidation of the structure of these enzymes came from their stability during the purification process, as compared to the relative instability of the nucleolar enzymes. I n the initial studies, polyacrylamide gel electrophoresis (114) of the polymerases suggested the presence of three major subunits with molecular weights of 215,000, 185,000 and 150,000 for calf thymus enzymes (50) and 200,000, 180,000 and 160,000 for the enzymes of rat liver (44).The molecular weights of the components present in the bands were determined by comparison of their mobilities with those of marker proteins by the procedure of Shapiro et al. (115). Recently Weaver et al. (66) succeeded in analyzing the minor components of the nucleoplasmic enzymes. These studies have revealed that the nucleoplasmic enzymes consist of four distinct subunits each, and thus the two forms of enzyme I1 of rat liver possess molecular structures of [ (190,OOO) (150,000) (35,000) (25,000) and [ (170,000) (150,OOO) (35,000) The corresponding enzymes from calf thymus have similar (25,000) subunit compositions; the enzyme with the subunit structure (190,000)
MAMMALIAN
RNA
113
POLYMERASES
(150,000) (35,000) (25,OOO) is the most predominant nucleoplasmic enzyme in this tissue. However, since the proportion of the enzyme containing the 170,000 subunit can be increased by addition of a proteolytic inhibitor during the isolation of the enzyme or “aging” the enzyme a t 4°C in the crude state, the 170,000 subunit may be derived from the 190,000 subunit (6.2). Whether both enzymes are present in rat liver nuclei or one is formed by degradation of the 190,000 subunit to the 170,000 subunit during the isolation is not yet clear. However, the production of two distinct polymerase species by specific proteolysis is a possibility ( 6 2 ) . It is interesting to point out that Leighton et al. (116) have recently observed a specific proteolytic modification of RNA polymerase during sporulation of Bacillus subtilk However, these studies do not rule out the possibility that the two subunits may be products of separate genes. Using highly purified preparations of enzymes IIA and IIB, Kedinger and Chhmbon (6%) established their subunit compositions as (214,000) (140,000)1 (34,000)1ol’ (25,000)~(16,500)a and (180,000)1 (140,000)1 (34,000) or (25,000), (165,000) 4, respectively. The subunit with molecular weight 16,500 has not been detected by Weaver et al. (62). There is also some discrepancy in the molar ratios of the smaller subunits. However, there is a general agreement on the size and molar proportion of the larger subunits. Kedinger and Chambon (62a) could not demonstrate any significant conversion of form IIA to form IIB by “aging” a t room temperature for a t least two hours. Whether such a conversion by a specific in vivo proteolysis is possible remains to be clarified. Sedimentation rates of 14.5-15.5 S have been obtained for calf thymus and rat liver enzyme 11. Minimum molecular weights estimated from these values, on the assumption of a globular shape, are about 350,000400,OOO (6.2), which compares well with the 495,000 reported for E . coli RNA polymerase (1).On the basis of densitometry analysis and sedimentation characteristics, a molecular weight of 500,000-700,OOO has been suggested by previous investigators (&, 5 0 ) . It is interesting to note that the large subunits of a t least one of the nucleoplasmic enzymes resemble the p and p‘ subunits of the E . coli polymerase in their electrophoretic mobility and molecular weight. Whether the functions of the large subunits of animal enzymes are identical to those ascribed to the p and p’ subunits of the E. coli enzyme is not known. I n view of the differential sensitivity of thc E . coli enzyme and the nucleoplasmic enzymes to inhibitors such as rifampicin and a-amanitin, it seems unlikely that the structures of their subunits are identical. This is further supported by the observation that rifampicin binds to the p subunit of the E. coli enzyme (117).Similarly, the smaller subunits of O1.
114
SAMSON T. JACOB
enzyme I1 do not exhibit any resemblance to either the subunits or the factors isolated from the E . coli enzyme. It is tempting to assume a structural relationship between nucleolar enzyme and bacterial RNA polymerase on the basis of their insensitivity to a-amanitin. However, the insensitivity of the nucleolar enzyme to rifampicin as well tends to rule out such a possibility. None of these observations indicate any structural similarity between the eukaryotic RNA polymerases and the prokaryotic “core” RNA polymerase. Since the large subunits of enzyme I differ from those of enzyme 11, an interconversion between these enzymes as proposed by Chesterton and Butterworth (@) is also highly improbable (&).
VI. Regulation af RNA Polymeruses The RNA-synthesizing ability can be regulated either by modifications in the chromatin template or by changes in the activity or levels of RNA polymerases. Qualitative changes in RNA synthesis are induced by hormones (118-1i?8), by partial hepatectomy (169-136) and by nutritional or dietary factors (153-159). I n certain cases, changes in RNA polymerase activity have also been measured. The most significant early changes are observed in the stimulation of ribosomal RNA synthesis in vivo and of the RNA polymerase activity assayed in a medium of low ionic strength. However, these investigations have been carried out with aggregate enzymes in which the polymerase is tightly bound to its chromatin template, Consequently, the actual mechanism (s) by which RNA synthesis is altered has not been elucidated. I n attempts to resolve this problem, animal chromatin preparations have been used with bacterial RNA polymerase to distinguish the effects on the template activity from those on the polymerase. The administration of appropriate hormones in vivo results in a stimulation of chromatin activity in rat liver (140,141), uterine tissue (I@), prostate gland (143) and skeletal muscle (144). Similar results, although less well established, have been reported after in vitro incubation of rat liver nuclei ( 1 4 ) and chromatin (146) with cortisol and uterine chromatin with estradiol (147).The reported in vivo or in vitro stimulation in the activity of isolated chromatin is usually far less significant than that of the whole nuclear preparations. However, it has been widely accepted that the activation of RNA synthesis induced by hormones and other factors is mostly due to the effect on the chromatin. No alternative suggestions have been given to explain the difference in the magnitude of response in the chromatin and in the whole nuclear preparations. Thc discovery of the multiple forms of RNA polymerase in
MAMMALIAN
RNA
POLYMERASES
115
higher organisms that are structurally diffcrciit from prokaryotic enzyme has cast serious doubt on the validity of the experiments involving bacterial polymerase and animal chromatin. Furthermore, since recent experiments (S. T. Jacob, unpublished observations) reveal that the mammalian chromatin is read much more efficiently by the nuclear enzymes than by the bacterial polymerase, a specificity in the recognition of the animal genome by the mammalian enzymes is indicated. Another factor that further complicates the interpretations of the results is the reported diurnal rhythmicity of rat liver chromatin in template activity ( I @ ) . To differentiate the alterations in the template from those in the polymerase, Yu and Fiegelson (149) used actinomycin D to inhibit the template function of endogenous nucleolar DNA and a synthetic template, poly(dC) (which is insensitive to actinomycin D ) , to assess RNA polymerase activity. Although these studies have suggested that the increased RNA synthesis is largely due to a stimulation of the activity of nucleolar RNA polymerase rather than an activation of chromatin, it is not possible to distinguish, under these conditions, the activity of homopolymer-forming enzymes from that of authentic RNA polymerase. From measurements of the number of RNA chains initiated by estradiol as an estimate of the RNA polymerase molecules, Barry and Gorski (150) concluded that this hormonc increases RNA polymerase activity in uterine nuclei by specifically enhancing the activity rather than the absolute amount of the polymerase. Blatti and co-workers (39) and Stirpe (151) have estimated (a) nucleolar polymerase activity by incubating the nuclei in presence of a-amanitin and media of low ionic strength, and (b) the nucleoplasmic enzyme I1 by subtracting the activity in the presence of Mn’+, high salt and amanitin from the activity under the same conditions in the absence of amanitin. Using this procedure, the former group of investigators showed that estradiol and glucocorticoids generally increase the activity of nucleolar enzyme I, whereas partial hepatectomy results in a stimulation of the activity of nucleoplasmic enzyme I1 as well. Experiments with inhibitors of protein synthesis such as cycloheximide and/or puromycin show that either de novo synthesis of a protein factor(s) or of RNA polymerase itself accounts for the enhanced synthesis of ribosomal RNA (a) in uteri after treatment of female rats with estradiol (152-154) ; (b) in liver following partial hepatectomy (155); (c) in liver after refeeding of starved rats with Stock diet (156) or with a meal of tryptophan-containing amino acid mixture (135, 138) ; and (d) in Ehrlich ascites tumor cells upon exposure to a medium enriched in amino acids (139). Since inhibitors such as cycloheximide can almost completely inhibit the RNA polymerase activity in control animals (157)
116
SAMSON T. JACOB
as well, the interpretation of the results obtained with these inhibitors may not be significant. Furthermore, cycloheximide has been shown to have a selective effect on ribosomal RNA synthesis in vivo (157-159) and on nucleolar RNA polymerase activity in vitro (157). All these investigations suggest a role for RNA polymerase(s) in the regulation of RNA synthesis. However, since these studies were performed using aggregate enzyme preparations, the results, although suggestive, are not conclusive. The use of purified RNA polymerases with exogenous templates has simplified this problem considerably. I n one such investigation (61), the effect of a single injection of hydrocortisone into adrenalectomized male animals has been to stimulate selectively the activities of purified nucleolar polymerases. The degree of stimulation of the purified enzymes accounts for the stimulation of the enzyme activity observed in the isolated nucleolar preparations where the enzyme is analyzed with its associated deoxynucleoprotein template. These observations thus clearly indicate a new type of cellular regulation, namely the regulation of RNA polymerase by hormones independently of the template activity. Similar results have been obtained with growth hormone and triiodothyronine (160) and with androgenic hormones ( 5 7 ) . Further studies (Sajdel and Jacob, unpublished observations) indicate that the increased secretion of corticosterone in response to stress can result in a stimulation of the activity of purified nucleolar RNA polymerases. These findings suggest that the enhanced hepatic RNA polymerase activity following in vivo administration of corticosteroids is due to a physiological rather than a pharmacological effect of the hormones. Recent studies ( 1 6 0 ~ show ) that RNA polymerase activities of forms IA, I B and I1 are approximately ninefold, twofold and twofold higher, respectively, in a minimal-deviation rat hepatoma cell line (Reuber H-35) in the liver, again suggesting the possible role of multiple RNA polymerases in the cellular regulation. At least two explanations can be given for the augmentation of the activities of purified RNA polymerases in response to various factors: (a) modification of the enzyme structure (allosteric changes) ; (b) increased de novo synthesis of the enzyme. Recently some attempts have been made to distinguish between these two effects. It has been demonstrated (61) that in order to saturate a fixed excess quantity of exogenous DNA, smaller amounts of RNA polymerase are required from adrenalectomized animals than from cortisol-treated animals and that a t the saturation point, the higher enzyme activity of the cortisol-treated animals still persists. These observations suggest that corticosteroids induce an activation of preexisting enzyme molecules rather than an increased synthesis of RNA polymerase. Using a different technique, Barry
MAMMALIAN
RNA
POLYMERASES
117
and Gorski (150) arrived a t similar conclusions on the action of estradiol. Recent findings (70), that histones can interact directly with the RNA polymerase, suggest that a stimulation of the RNA polymerase activity can be brought about by a dissociation of the polymerase from argininerich histones. It is possible that the complex containing histones and RNA polymerase can be disrupted by chemical modifications of histones such as acetylation (161) or phosphorylation (162). Following the treatment with hormones, the polymerase activity may also be modified by interaction with a hormone-receptor complex or a chemically modified hormone. The properties of the altered RNA polymerase have not yet been examined. The effects of other physiological and nutritional factors on purified polymerases have also not been explored. A de novo synthesis of RNA polymerase may be involved under certain conditions where an increased RNA synthesis has been observed. As mentioned earlier, the interpretations of experiments using inhibitors of protein synthesis are often misleading. The most satisfactory means to assess the synthesis of RNA polymerase is to measure the actual amount of the enzyme by immunoprecipitation, but this technique requires highly purified and homogeneous enzyme for the preparation of an authentic antiserum. Finally, the synthesis of the enzymes could be followed by labeling with a suitable amino acid.
VII. Mitochondria1 RNA Polymerase Only a concise summary of some relevant findings on mitochondrial RNA polymerase are presented in this section. Compared with nuclear RNA polymerase, relatively little is known about the properties and function of mitochondrial polymerase. Earlier studies on mitochondrial RNA polymerase have been conducted with intact organelles. Mitochondria isolated from fungi (163, 164), plants (165-168) and higher organisms (169-174) exhibit RNA polymerase activity; it is also much more active in embryonic rat tissue (176), germinating seeds (176) and in yeast cells in which glucose repression has been released (177).Recently, soluble enzyme has been obtained from Neurospora crassa (178), Blastocladiella emersonii (179), yeast (180, 181) and rat liver (182-184). The enzymes from N . crassa and yeast have been extensively purified. The requirement of sodium dodecyl sulfate for the extraction of rat liver mitochondrial polymerase (183) suggests a close association of the enzyme with the membrane. The partially purified rat liver enzyme has associated with i t almost saturating levels of DNA; consequently, it does not require additional exogenous DNA for its activity (182-184). The yeast mitochondria1 enzyme appears to occur
118
SAMSON T. JACOB
in at least two forms (180,181).Like the prokaryotic RNA polymerase, the enzymes from rat liver (182, 184) or heart (173)and N.crassa (178) are sensitive to rifampicin. However, there have been conflicting reports on the sensitivity of yeast mitochondrial enzyme to this drug. Scragg (181) has detected rifampicin-sensitive polymerase ( 8 ) in yeast, whereas Tsai et al. (180)have claimed that this enzyme is resistant to inhibition by the drug. The reason for this discrepancy is not clear. It is possible that a factor or factors needed for conferring sensitivity to rifampicin were lost from some enzyme preparations. I n contrast to rifampicin, a-amanitin does not inhibit the mitochondrial enzymes (178,180, 183, 184) although there are preliminary reports (184a, 184b) that show the inhibition of one form of yeast mitochondrial enzyme by a-amanitin. Each of the yeast mitochondrial enzyme differs from the corresponding nuclear polymerase with respect to response to divalent metal ions, ionic strength and templates ( 1 8 4 ~ )Compared . to thc mitochondrial enzymes of mammalian tissues, the yeast enzymes appear to have very high molecular weights ( 1 8 4 ~ )We . have recently observed that rat liver mitochondria contain very active homopolymer-synthesizing enzymes that are insensitive to pancreatic RNase, rifampicin and actinomycin D (Jacob and Schindler, unpublished observations). The varying degrees of response of some liver mitochondrial RNA polymerase preparations to actinomycin D (170,184), RNase (170), and rifampicin (184) may be the result of contamination of the polymerase with homopolymer-synthesizing enzymes. The enzyme from N . crassa transcribes poly (dA-dT) more efficiently than the mitochondrial DNA itself (178), which might reflect the presence of (A + T)-rich regions in mitochondrial DNA (186).Indeed, normal and mutant strains of yeast have usually a high content of A T(8&83%) (186). It is possible that the concentration of A T regions constitute a constraint on the coding capacity of mitochondrial DNA. Although the mitochondrial RNA polymerase is usually inhibited by rifampicin but not by a-amanitin, this enzyme resembles more the bacteriophage T7 specific enzyme (187)than the corresponding E. coli enzyme. The bacterial enzyme is composed of several subunits with other factors conferring specificity in the transcriptional process (1). Both phage and mitochondrial enzymes consist of a single subunit of relatively low molecular weight (T7 enzyme, MW 100,000; N . crassa enzyme, MW 64,000; rat liver enzyme, MW 64,000-68,000). This remarkable similarity between the phage and mitochondrial polymerases might' reflect the fact that both these enzymes transcribe a relatively small genome with only few cistrons or operons (188).The fact that rifampicin inhibits RNA synthesis by binding to the p subunit of E . coli polymerase
+
+
MAMMALIAN
RNA
POLYMERASES
119
(117)suggests the possibility that the mitochondria1 enzyme is similar to the
p subunit of prokaryotic enzyme. VIII. Summary and Conclusions
The objective of this rcview is to document the present status of RNA polymerases involvcd in RNA synthesis in mammalian cells, with emphasis on some recent developments in the field of nuclear RNA polymerase. The recent findings on this subject can be summarized as follows. (a) The RNA polymerases of eukaryotic nuclei exist in multiple forms. (b) These enzymes are compartmentalized within the nucleus. (c) They have different requirements for cations and salt. (d) The nucleolar enzymes are insensitive to a-amanitin in vitro whereas the nucleoplasmic enzymes arc generally inhibited by thc toxin, which binds to the enzyme and prevents RNA chain elongation. (e) The nucleolar enzymes are more activc with native DNA as the template, whereas the nucleoplasmic enzymes are more efficient with a denatured template; however, addition of a cytoplasmic protein factor can restore the ability of the latter enzyme to transcribe preferentially native DNA. ( f ) The subunit composition of nucleolar polymerase I appears to be different from that of the nucleoplasmic enzyme I1 ; both are structurally different from the bacterial RNA polymerase. (g) The RNA-synthesizing capacity of RNA polymerase can be modified by alterations in the activity and/or level of RNA polymerase, suggesting an independent role for RNA polymerase in the regulation of genetic expression in higher organisms. (h) The mitochondrial RNA polymerase of higher organisms has been partially solubilized and purified ; it is usually inhibited by rifampicin but is insensitive to a-amanitin. I n spite of the advances that have bcen made in our understanding of the transcriptional process in eukaryotic cells, there are several aspects of the problem that are not yet understood. For example, the role of the different mammalian RNA polymerascs in RNA synthesis remains to bc clarified. Since the subunit structures of the predominant nucleolar and nucleoplasmic polymerases appear to differ from one another, it is uiilikcly that these enzymes are derived from a common “corc.” Consequcntly, it is possible that thc nuclcolar enzymcs are involved in the synthcsis of ribosomal RNA precursor (45 S RNA) and of uridine-rich low-molecular-weight RNA of the nucleolus (189-191), whereas the nucleoplasmic enzymes make mRNA, tRNA, 5 S RNA, and possibly poly(A) involved in the transport of functional mRNA to the cytoplasm in some eukaryotes (192-196).A recent report (196~)shows that the
120
SAMSON T. JACOB
amanitin-sensitive enzyme from young maize seedlings can, under proper conditions, indeed make poly ( A ) . Only an analysis of the composition of RNA transcribed from native or reconstituted chromatin preparations will ultimately throw some light on these possibilities. Some attempts have recently been made in this direction (196%). A possible regulation of RNA polymerase activity by shifts in the intranuclear distribution of cations such as Mgz+ and Mn2+ and salts merits serious consideration. Since the polymerases show specific requirements for these ions, it is important (a) to examine the intranuclear levels of these metals and (b) to investigate changes in the polymerase activity in response to changes in their distribution. It may be pointed out here that polyanions such as spermine and spermidine, the concentrations of which are dramatically altered during growth and development (197203), stimulate RNA synthesis. The effect of these compounds on the activity of purified RNA polymerase should also be examined with a view to understanding their role in the transcriptional process and their specific function in the cellular regulation of RNA synthesis. The regulation of the activity of purified nucleolar RNA polymerase by hormones independent of any significant modification in the chromatin template is very interesting, considering the emphasis in the past on template modification as the most prominent means of gene regulation. Only the early effect of hormones on the purified RNA polymerase activity has been examined with purified RNA polymerases. A later and more permanent effect on chromatin activity exerted by hormones or by other physiological factors is a possibility that should be investigated. Qualitative changes in RNA synthesis are not always paralleled by changes in RNA polymerases. There are reports (47)showing no dramatic changes in the relative activities or amounts of polymerases I and I1 during the development of Xenopus laevis, while there are striking changes in the quantity and quality of nuclear RNA synthesis. The most surprising finding was the presence of normal amounts of polymerase I in the anucleolate mutant of Xenopus laevis, which is evidently not producing any ribosomal RNA (204).These observations tend to rule out any regulatory mechanism in which the amount of RNA polymerase is limiting within the cell. It is possible that, under certain conditions, RNA polymerases are present in excess, with other regulatory factors (needed for specific initiation) limiting. Future work to characterize any such factors in eukaryotic cells, such as u factor in prokaryotic cells, should be promising. Finally, the factors that are involved in initiation, termination and release of RNA chains in eukaryotic cells should be explored.
MAMMALIAN
RNA
POLYMERASES
121
NOTES ADDED IN PROOF 1. Recently, highly purified enzyme I has been obtained from calf thymus nuclei with a subunit composition of (20,000)1 (126,000)1 (51,000)1 (44,0W)1 (25,000)2 (16,!500), ( 1 ) . This subunit pattern accounts for the molecular weight of the native enzyme which is about 550,000 5 10%. 2. The inhibitory effect of various semi-synthetic derivatives of rifamycin SV on calf thymus DNAdependent RNA polymerases I and I1 has been examined ( 2 ) . Some of these derivatives having highly hydrophobic side-chains, like AF/013, completely inhibit both types of activities a t concentrations of 20 to 40 pglml. Unlike a-amanitin, initiation and not elongation is inhibited by these derivatives. 1. F. Gissinger and P. Chambon, EJB 28, 277 (1972). 2. M. Meilhac, Z. Tysper and P. Chambon, EJB 28, 291 (1972).
ACKNOWLEDGMENTS I wish to thank Dr. Elizabeth M. Sajdel for many useful discussions and for help in the preparation of the tables. The experimental work performed in the author’s laboratory was supported by a U.S. Public Health Service grant (GM 18534) and by the Damon Runyon Memorial Fund for Cancer Research (DRG 1062).
REFERENCES 1. R. R. Burgess, ARB 40, 711 (1971). l a . R. G. Martin, Annu. Rev. Genet. 3, 181 (1969). l b . V. S. Sethi, in “Progress in Biophysics and Molecular Biology” (J. A. V. Butler and D. Noble, eds.), p. 67. Pergamon, Oxford, 1971. 2. S. B. Weiss, PNAS 46, 1020 (1960). 3. C. C. Widnell and J. R. Tata, BBA 87, 531 (1964). 4 . C. C. Widnell and J. R. Tata, BBA 123, 478 (1966). 6. C. C. Widnell, T. H. Hamilton and J. R. Tata, JCB 32, 766 (1967). 6. X. J. Blackburn and H. G. Klemperer, BJ 102, 168 (1967). 7. P. Chambon, M. Ramue, P. Mandel and J. Doly, BBA 157, 504 (1968). 8. A. E. Pegg and A. Korner, ABB 118, 362 (1967). 9 . A. 0. Pogo, V. C. Littau, V. G. Allfrey and A. E. Mirsky, PNAS 57, 743 (1967). 10. J. D. Johnson, B. A. Jant, L. Sokoloff and S. Kaufman, BBA 179,526 (1969). 11. S. T. Jacob, E. M. Sajdel and H. N. Munro, BBA 157, 421 (1968). 12. T. 5. Ro and H. Busch, BBA 134, 184 (1967). 13. G . Siebert, J. Villalobos, Jr., T. S. Ro, W. J. Steele, G. Lindenmayer, H. Adxms and H. Busch, JBC 241, 71 (1966). 14. J. D. Johnson, B. A. Jant, S.Kaufman and L. Sokoloff, ABB 142, 489 (1971). 16. U. Maitra and F. Barash, PNAS 64, 779 (1969). 16. R. R. Burgess, JBC 244, 6168 (1969). 17. D. D. Brown and E. Littna, JMB 8, 669 (1964). 18. G. Guidice and V. Mutolo, BBA 138, 276 (1967). 19. F. M. Ritossa and S. Spiegelman, PNAS 53, 737 (1965). 20. H. Wallace and M. L. Birnstiel, BBA 114, 296 (1966). $1. D. D. Brown and I. B. Dawid, Science 160, 272 (1968). 2lu. M. L. Birnstiel, M. Chipchase and J. Spiers, This series 11, 351 (1971).
122
SAMSON T. JACOB
22. H. Busch and K. Smetana, in “The Nucleolus” (H. Busch and K. Smetana. eds.), p. 160. Academic Press, New York, 1970. 23. J. J. Furth and P. Loh, BBRC 13, 100 (1963). 24. J. J. Furth and P. Ho, JBC 240, 2602 (1965). 26. P. Ballard and H. G. Williams-Ashman, JBC 241, 1602 (1966). 26. E. R. Stout and R. J. Mans, BBA 134, 327 (1967). 27. A. Ishihama, BBA 145, 272 (1967). R8. M. Ramue, J. Doly, P. Mandel and P. Chambon, BBRC 19, 114 (1965). 29. D. D. Cunningham and D. F. Steiner, BBA 145, 834 (1967). SO. K. Seifart and C. E. Sekeris, Hoppe-Seyler’s 2.Physiol. Chem. 348, 1555 (1967). 31. M. L. Goldberg, H. D. Moon and W. Rosenau, BBA 171, 192 (1969). 32. S. Liao, D. Sagher and S. Fang, Nature (London) 220, 1336 (1968). 33. S. T. Jacob, E. M. Sajdel and H. N. Munro, BBRC 32, 831 (1968). 34. S. T. Jacob, E. M. Sajdel and H. N. Munro, BBRC 38, 765 (1970). 36. S. T. Jacob, E. M. Sajdel, W. Muecke and H. N. Munro, CSHSQB 35, 681 (1970). 36. S. T. Jacob, E. M. Sajdel and H. N. Munro, Advan. Enzyme Regul. 9, 169 (1971). 37. R. G . Roeder and W. J. Rutter, Nature (London) 224, 234 (1969). 38. R. G. Roeder and W. J. Rutter, PNAS 65, 675 (1970). 39. S . P. Blatti, C. J. Ingles, T. J. Lindell, P. W. Morris, R. F. Weaver, F. Weinbcrg and W. J. Rutter, CSHSQB 35, 649 (1970). 40. K. H. Seifart and C. E. Sekeris, EJB 7 , 408 (1969). 41. I<. H. Seifart, in “Lepetit Colloqium on RNA Polymerase and Transcription” (L. Silvestri, ed.), p. 233. Amer. Elsevier, New York, 1970. 42. C. J. Chesterton and P. H. W. Butterworth, FEBS Lett. 12, 301 (1971). 43. C. J. Chesterton and P. H. W. Butterworth, EJB 19, 232 (1971). 44. C. J. Chesterton and P. H. W. Butterworth, FEBS Lett. 15, 181 (1971). 46. C. Kedinger, P. Nuret and P. Chambon, FEBS Lett. 15, 169 (1971). 46. J. L. Mandel and P. Chambon, FEBS Lett. 15, 175 (1971). 47. R. G. Roeder, R. H. Reeder and D. D. Brown, CSHSQB 35, 727 (1970). 48. W. Keller and R. Goor, CSHEQB 35, 671 (1971). 49. M. Gniazdowski, J. L. Mandel, Jr., F. Gissinger, C. Kedinger and P. Chambon, BBRC 38, 1033 (1970). 60. P. Chambon, F. Gissinger, J. L. Mandel, Jr., C. Kedinger, M. Gniazdowski and M. Meihlac, CSHSQB 35, 693 (1970). 61. H. Stein and P. Hausen, CSHSQB 35, 709 (1971). 62. R. G. Roeder and W. J. Rutter, Bchem. 9, 2543 (1970). 63. G. P. Tocchini-Valentini and M. Crippa, CSHSQB 35, 737 (1970). 64. J. P. Monjardino and L. V. Crawford, CSHSQB 35, 659 (1970). 66. B. Sugden and J. Sambrook, CSHSQB 35,663 (1970). 66. J. J. Furth and G. E. Austin, CSHSQB 35,641 (1970). 67. W. I. P. Mainwaring, F. R. Mangan and B. M. Peterken, BJ 123, 619 (1971). 68. P. A. Horgen and D. H. Grifiin, PNAS 88,338 (1971). 69. H. Ponta, U.Ponta and E. M’intersberger, FEBS Lett. 18, 204 (1971). 60. E. C. Strain, K. P. Mullinix and L. Bogorad, €“AS 68, 2647 (1971). 61. E. M. Sajdel and S. T. Jacob, BBRC 45, 707 (1971). 62. R. F. Weaver, 5. P. Blatti and W. J. Rutter, PNAS 88, 2994 (1971). 6%. A. Kedinger and P. Chambon, EJB 28, 283 (1972).
MAMMALIAN
RNA
POLYMERASES
123
63. R. R. Burgess, A. A. Travers, J. J. Dunn and E. K. F. Bauta, Nature (London) 221, 43 (1969). 64. R. R. Burgess, JBC 244, 6160 (1969). 66. H. N. Munro and A. Fleck, in “Mammalian Protein Metabolism” (H. N. Munro, ed.), Vol. 3, p. 423. Academic Press, New York, 1969. 66. B. Gerhardt and H. Beavers, Anal. Biochem. 24, 337 (1968). 6’7.E . Layne, in “Methods in Enzymology” (S. P. Colowick and X. 0. Kaplan, eds.), Vol. 3, p. 447. Academic Press, New York, 1957. 65. T. P. Bennett, Nature (London) 213, 1131 (1967). 69. F. Stirpe and F. Novello, EJB 15, 505 (1970). 70. T. C. Spelsberg and L. S. Hnilica, BBA 195, 55 (1969). 71. F. Stirpe and L. Fiume, BJ 105, 779 (1967). 72. T. H. Wieland, Science 159, 946 (1968). 73. L. Fiume and T. H. Wieland, FEBS Lett. 8, 1 (1970). 74. H. V. Gelboin, J. S. Wortham, R. G. Wilson, M. Friedman and G. N. Wogan, Science 154, 1205 (1966). 76. S. T. Jacob, E. M, Sajdel and H. N. Munro, Nature (London) 225, 60 (1970). 76. T. J. Lindell, F. Weinberg, P. W. Morris, R. G. Roeder and W. J. Rutter, Scieiice 170, 447 (1970). 17. C. Kedinger, M. Gniaadowski, J. I,. Mandel, F. Gissinger and P. Chambon, BBRC 38, 165 (1970). ?S. W. Wehrli, J. Nuesch, F. Knusel and M. Staehelin, BBA 157, 215 (1968). 79. W. Wehrli, F. Knusel, K. Schmid and M. Staehelin, PNAS 61, 667 (1968). 50. A. Travers and R. R. Burgess, Nature (London) 222, 537 (1969). 81. E. Reich and I. H. Goldberg, This series 3, 183 (1964). 52. I. B. Weinstein, R. Carchman, E. Marner and E. Hirschberg, BBA 142, 440 (1965). 83. B. I(. Bhuyan and C. G. Smith, PNAS 54,566 (1965).
$4.
C;. Hartmann, H. Goller. K. Koschel, W. Kersten and H. Kersten, Biochem. Z . 341, 126 (1964). 56. A. M. DeRecondo, A. M. Frayssinet, C. Lafarge and E. LeBreton, BBA 119, 322 (1966). 86. C. D. Ward, E. Reich and I. H . Goldberg, Science 149, 1259 (1964). 57. M. J. Waring, J M B 13, 269 (1965). 55. B. Nicholson and A. Peacocke, BJ 100, 50 (1966). 59. R. W. Ruddon and J. M. Johnson, Mol. Pharmacol. 4, 258 (1968). 90. W. Troll, S. Belman, E. Berkowitz, Z. F. Chiemlewicz, J. L. Ambrus and T. J . Bardos, BBA 157, 16 (1968). 91. J. F. Morrison, BBA 185, 269 (1969). $9. M. Meihlac, C. Kedinger, P. Chambon, V. Govindan, H. Faulstich and T. Wieland, FEBS Lett. 9, 258 (1970). 93. F. Novello, L. Fiume and F. Stirpe, BJ 116, 177 (1970). 94. R. Schlief, Nature (London) 223, 1068 (1969). 06. S. T. Jacob, W. Muecke, E. M. Sajdel and H. N. Munro, BBRC 40, 334 (1970). 96. J. Niessing, B. Schnieders, W. Kuna, K . H. Seifart and C. E. Sekcris, X. Naturforsch. B 25, 119 (1970). 97. L. Fiume and L. Laschi, Sperimenlale 115, 228 (1965). 9s. H. S. Schwarta. J. E. Sodergren, M. Garofalo and S. S. Stenberg, Cancer nee. 25, 307 (1965).
124
SAMSON T. JACOB
H. S. Schwartz, S. S. Stcrnhrrg and F. S. Philips. Canner Ren. 26, 1873 (1966). H. S. Scliwarta and M. Garofalo. Mol. Phromncol. 3, 1 (1967). 101. C. E. Sekeris, J. Nirssing and K. H. S. Seifart, FEBS Lett. 9, 103 (1970). 102. P. Jolicoeur and F. Labric, FEBS Lett. 17, 141 (1971). 103. M. Green, M. Pina, R. Kimrs, P. Wcnsink, 1,. Maclinttic and C. A. Thomas, Jr.. PNAS 57, 1302 (1967). 104. L. V. Crawford and P. H. Black, Virology 24, 388 (1964). 106. J. Paul and R. S. Gilmour, JMB 34, 305 (1968). 106‘. R. S. Gilmour and J. Paul, JMB 40, 137 (1969). 107. I. Bekhor, G. Kung and J. Bonner, JMB 39, 351 (1969). 105. R. C. Hiiang and P. C. Hunng, JMB 39, 365 (1969). 109. J. E. Mayfield and J. Bonncr, PNAS 68,2652 (1971). 110. E. I(. F. Bnutz, F. A. Btiuta and J. J. Dunn, N n f w s (Lotdoti) 223, 1022 (1969). 111. W. C. Summers and 11. l3. Sirgel, Nature (Londoii) 223, 111 (1969). 112. R. Losick nnd A. L. Sonensheim, Nature (London) 204, 35 (1969). 113. I<. H. Seifart, CSHSQB 35, 719 (1970). 114. J. V. Maizcl, Jr., it& “Fiindamental Trcliniqucs in Virology” (K. Hahel and N. P. Salaman, eds.), 1). 334. Acadrmic Press, New York, 1969. 116. A. 1,. Shapiro, E. Vinuela and J. V. Maiael, Jr., BBRC 28, 815 (1967). 116. T. J. Leighton, R. K. Freese and R. H. Dol, FP 30, 1969 (1971). 117. W. Zillig, P. Palm, V. S. Sethi and D. Rabusstty, Ann. N . Y . Acad. Sci. 171, 910
99. 100.
(1970). 115. W. D. Wicks and F. T. Kenncy, Science 114, 1346 (1964). 11.9. J. Gorski, JBC 239, 889 (1964). 120. D. J. Begg and H. N. Munro, Nrrtnie (Lowdoit) 207, 483 (1965). 121. P. A. Dukes nnd C. E. Sekcris, Z. Physiol. Chem. 341, 149 (1965). 12.3. S. Liao, R. W. Barton and A. M. Lin, PNAS 55, 1593 (1966). 1.33. S. Liao and A. H. Lin, PNAS 57, 379 (1967). 124. 0. Barnabei and F. Scrcni, BBA 91, 230 (1967). 1%. F. L. Yu and P. Fcigelson, BBRC 35, 499 (1969). 126. S. T. Jacob, E. M. Sajdel and H. N. Munro, EJB 7, 449 (1969). 127. J. Hanoune and P. Feigelson, BBA 199, 214 (1970). 125. J. R. Tata, in “Biochemical Actions of Hormones” (G. Litwack, ed.), Vol. 1, p. 89. Academic Press, New York, 1970. 129. K. Tsukada and I. Lieberman, JBC 239, 2952 (1964). 130. M. Muramatsu and H. Busch, JBC 240, 3980 (1965). 131. S. T. Jacob, W. J. Stecle and H. Busch, Cancer Res. 27, 52 (1967). 132. A. 0. Pogo, V. C. Littau, V. G. Allfrey and A. E. Mirsky, PNAS 57, 743 (1967). 133. J. R. Warner, M. Girard, H. Latham and J. E. Darnell, JMB 19, 373 (1966). 134. J. R. Warner, JMB 19, 383 (1966). 136. J. Vesley and A. Cihak, BBA 904, 614 (1970). 136. M. E. Smulson and J. Thomas, JBC 244, 5309 (1969). 137. M. E. Smulson, BBA 199, 537 (1970). 13s. A. R. Henderson, BJ 120, 205 (1970). 139. M. T. Franze-Fernandez and A. 0. Pogo, PNAS 68, 3040 (1971). 140. M. E. Dahmus and J. Bonner, PNAS 54, 1370 (1965). 1.41. M. Beato, K. H. Seifart and C. F. Sekeris, ABB 138, 272 (1970). 148. K. Barker and L. Warren, PNAS 56, 1298 (1966). 143. F. R. Mangan, G. E. Nenl and D. C. Williams, ABB 124, 27 (1968). 1.44. C. B. Breuer and J. R. Florini, Bchem 5, 3857 (1966).
MAMMALIAN
RNA
POLYMERASES
125
146. M. Beato, J. Homoki, J. Lukiics and C. E. Sekcris, Hoppe-Seyler‘s 2. Physiol. Chem. 349, 1099 (1968). 140. H. L. Stackhousc and C. J. Chcstsanga, BBA 155, 159 (1968). 147. K. Barker and J. Warren, Endocrinology 80, 536 (1967). 14s. W. L. Steinhart, BBA 228, 301 (1971). 149. F. L. Yu and P. Feigelson. PNAS 68, 2177 (1971). 160. J. Barry and J. Gorski, Bchem 10, 2384 (1971). 161. F. Novello and F. Stirpe, FEBS Lett. 8, 57 (1970). 162. W. D. Noteboom and J. Gorski, PNAS 50, 250 (1963). 163. J. Gorski, JBC 239, 889 (1964). 164. J. A. Nicolette, M. A. Lemaliieu and G. C. Mueller, BBA 166, 403 (1968). 166. K. Tsukada and I. Lieberman, JBC 240, 1731 (1965). 166. T. Onishi, BBA 217, 384 (1970). 167. M. Maramatsu, N. Shimada and T. Higashinukagawa, J M B 53, 91 (1970). 168. M. Willems, M. Penman and S. Penman, JCB 41, 177 (1969). 169. F. Wanka and P. J. A. Schrauwen, BBA 254,237 (1971). 160. E. A. Smuckler and J. R. Tata, Nature (London) 234, 37 (1971). 1000. C. J. Cliesterton, S. M. Humphrey and P. H. W. Butterworth, BJ 126, 675 ( 1972). 1Gl. V. G. Allfrey, in “Regulatory Mechanisms for Protein Synthesis in Mammalian
Cells” (A. S. Pietro, M. R. Lamborg and F. T. Kenney, eds.), p. 65. Academic Press, New York, 1968. 1G2. T. A. Langan, in “Regulatory Mechanisms for Protein Synthesis in Mammalian Cells” (A. S. Pietro, M. R. Lsmborg and F. T. Kenney, eds.), p. 101. Academic Press, New York, 1968. 103. F. Herzfeld, Hoppe-Seyler’s Z. Physiol. Chem. 351, 658 (1970). lG4. D. J. K. Luck and E. Reich, PNAS 52, 931 (1964). 1/37. E. Wintersberger and U. Wintersberger, FEBS Lett. 6, 58 (1970). 1GG. E. Wintersberger, BBRC 40, 1179 (1970). 1G7. Y. Suyamn and J. Eyer, JBC 243,320 (1968). 168. S . Yang and R. S. Criddle, Bchem 9, 3063 (1970). 1GO. G. F. Kalf, Bchem 3, 1702 (1964). 170. D. Neubert and H. Helge, BBRC 18, 600 (1965). 171. G. Saccone, N. N. Cadaleta and E. Quagliariello, BBA 138, 474 (1967). 172. Z. G. Slimerling, BBRC 37, 965 (1969). 173. J. G. Gamble and R. H. McCluer, JMB 53, 557 (1970). 174. M. Ash!%-elland T. S. Work, A R B 39, 251 (1970). 176. D. Neubert, H. Helga and H. J. Merker, in “Biochemical Aspects of the Biogenesis of Mitochondria” (E. C. Slater, J. M. Papa and S. Quagliariello, eds.), p. 251. Adriatica Editrica. Bnri, 1968. 170. P. Lado and M. Schwendimann, Life Sci. 6, 16881 (1967). 177. D. J. South and H. R. Mahler, Nature ( L o d o n ) 218, 1226 (1968). 178. H. Kuntzel and K. P. Schafer, Nature (London) 231, 265 (1971). 179. P. A. Horgen and D. H. Griffi, Nature (London) 234, 18 (1971). 180. M. J. Tsai, G. Michaelis and R. S. Criddle, PNAS 68, 473 (1971). 181. A. H. Scragg, BBRC 45, 701 (1971). 182. M. N. Gadnleta, M. Greco and C. Saccone, FEBS Lett. 10, 54 (1970). 183. C. Saccone, R. Gallerani, M. N. Gadaieta and M. Greco, FEBS Lett. 18, 339 (1971). 184. B. D. Reid and P. Parsons, PNAS 68,2830 (1971).
126
SAMSON T. JACOB
184a. R. W . Benson, FASEB Abstr. 31, No. 1450 (1972). 184b. R. Eccleshall and R. S. Criddle, FASEB Abstr. 31, No. 1447 (1972). 186. G. Bernardi, F. Carnevali, A. Nicolaieff, G. Piperno and G. Tecce, J M B 37, 493 (1968). 186. L. I. Grossman, D. R. Cryer, E. S. Goldring and J. Murmur, JMB 62, 566 (1971).
187. M. Chamberlain, J. McGrath and L. Waskell, Nature (London) 228, 227 (1970). 188. M. M. K. Nass, Science 185, 25 (1969). 189. M. Muramatsu, J. L. Hodnett and H. Busch, JBC 241, 1544 (1966). 190. T. Nakamura, A. W. Prestayko and H. Busch, JBC 243, 1368 (1968). 191. H. Busch, in “The Nucleolus” (H. Busch and K. Smetana, eds.), p. 285. Academic Press, New York, 1970. 192. J. E. Darnell, R. Wall and R. J. Tushinski, PNAS 68, 1321 (1971). 193. S. Y. Lee, J. Mendecki and G. Brawerman, PNAS 68, 1331 (1971). 194. M. Edmonds, M. H. Vaughan, Jr. and H. Nakazato, PNAS 68, 1336 (1971). 196. L. Philipson, R. Wall, G. Glickman and J. E. Darnell, PNAS 68, 1336 (1971). 196. J. E. Darnell, L. Philipson, R. Wall and M. Adesnik, Science 174, 507 (1971). 196a. R. H. Benson and R. J. Mans, FASEB Abstr. 31, No. 1179 (1972). 196b. P. H. W. Butterworth, R. F. Cox and C. J. Chesterton, EJB 23, 229 (1971). 194. J. Janne, Acta Physiol. Scand. Suppl. 300, 1 (1967). 198. G. Moruzzi, B. Barbiroli and C. M. Caldarera, BJ 107, 609 (1968). 199. C. M. Caldarera, M. S. Moruzai, B. Barbiroli and G. Moruzri, BBRC 33, 266 (1968). 800. B. C. Monlton and S. L. Leonard, Endocrinology 84, 1461 (1969).
201. A. E. Pegg, D. H. Loekwood and H. G. Williams-Ashman, BJ 117, 17 (1970). 202. B. Barbiroli, A. Corti and C. M. Caldarera, FEBS Lett. 13, 169 (1971). 203. D. H. Russell, PNAS 68, 523 (1971). 204. D. D. Brown and J. B. Gurdon, PNAS 51, 139 (1964).
Poly(ad enosine diphosphate ribose) TARASHI SUGIMURA Biochemistry Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, arid Department of Molecular Oncology, The Institute of Medical Science, Tokyo University, Minato-ku, Tokyo, Japan
I. Introduction . . . . . . . . . . . . . 11. Chemical and Physical Properties of Poly(ADP-Rib) . . . A. Characteristics of Poly(ADP-Rib) . . . . . . . B. Characteristics of Ado(P)-Rib-P . . . . . . . C. Derivatives of Ado(P)-Rib-P . . . . . . . . 111. Purification of Poly(ADP-Rib) . . . . . . . . . A. Incubation of Precursor with Enzyme Preparation . . . B. Separation of Poly(ADP-Rib) . . . . . . . . IV. Biosynthesis of Poly(ADP-Rib) . . . . . . . . A. General Character . . . . . . . . . . . B. Association of Polymerase with Chromatin . . . . . C. Association of Poly(ADP-Rib) with Nuclear Proteins . . D. Inhibitors . . . . . . . . . . . . . E. Relation between Enzyme Forming Poly (ADP-Rib) and . . . . . . . . . . . . . NADase F. Purification of Enzyme . . . . . . . . . . V. Biodegradation of Poly(ADP-Rib) . . . . . . . . A. Snake Venom Phosphodiesterase . . , . . . . B. Rat Liver Phosphodiesterase . . . . . . . . C. Enzymatic Cleavage of the Ribose-Ribose Bond . . . . VI. Natural Occurrence . . . . . . . . . . . VII. Possible Biological Significance . , . . . . . . . VIII. Related Phenomena . . . . . . . . . . IX. Future Problems . . . . . . . . . . References . . . . . . . , . . .
.
.
.
.
.
127 129 129 130 131 132 132 132 134 134 135 137 138 139 141 142 142 143 144 145 146 147 148 149
1. Introduction I n 1963, Chambon, Weill and Mandel made the observation that C ] into the acidincorporation of radioactivity of [~ d e n i n e - ~ATP insoluble material in a nuclear preparation from hen liver is enhanced a t least 1000-fold by the presence of NMN ( 1 ) . I n 1965, we confirmed this stimulation: using a nuclear preparation from rat liver (2).We found 127
128
TAKASHI SUGIMURA
that the acid-insolublc reaction product was not converted to an acidsoluble form by treatment in 0.5N NaOH a t 37" for 18 hours, and concluded that it was not poly (A) (2, 3). The reaction product was hydrolyzed by snake venom phosphodiesterase, and an unknown, radioactive substance was isolated from the hydrolyzate, which accounted for most of the initial reaction product and differed from 5'-AMP (3).The behaviors of this peak on paper and column chromatographies were very similar to those of adenosine 3',5'-bisphosphate and adenosine 2',5'-bisphosphate. This substance was later found to be 2'[5"-phosphoribosyl] -5'AMP, Ado (P)-Rib-P' (4-7,9, 11). I n Strasbourg, intensive studies were made on thc reaction product and the correct structure of Ado(P)-Rib-P was reported by Chambon et a2. (4) and Doly and Petek (5).The structure of Ado(P)-Rib-P was also elucidated by groups in the National Cancer Center, Tokyo (6-9) and Kyoto University (10,11). Knowing the structure of Ado(P)-Rib-P, the whole structure of the product was proved to be that shown in Fig. 1. The observations made in all three laboratories support this structure. The nuclear preparations contain NAD pyrophosphorylase, which produces [ adenine-"C] NAD from [adenine-W] ATP and NMN. These preparations also catalyze the polymerization of the ADP-Rib moiety of NAD. Thus, the reaction product found was [adenine-l'C]poly(ADP-Rib) (4,6,7,9,11). 12'-(5"-Phosphoribosyl)-5'-AMP (I) has been variously abbreviated as phosphoribosyl-AMP, PR-AMP, $-ADPR or Ado(P)-Rib-P. Ado(P)-Rib-P is recommended as the abbreviation. 2'-(Ribosyl)b'-AMP (11) has been abbreviated as ribosyl-AMP, R-AMP and Ado (P)-Rib ; 2'-(5"-phosphoribosyl) adenosine (111) as phosphoribosyladenosine, PR-AR and Ado-Rib-P ; fl'-ribosyladenosine (IV), as ribosyl adenosine, R-AR or Ado-Rib. Poly ADPR, poly(ADP-Rib), poly (ADPribose) and polymer of ADP-ribose have been used for the polymer; (ADP-Rib). is recommended as a short, unambiguous term. I Me I Rib-Rib I 1 P P Ado(P)-Rib-P P-L'-Ad0(2'-1')Rib-5"-P
m Me I Rib-Rib I P Ado-Rib-P Ad0(2'-l")Rib-5~-P
n Me I Rib-Rib I P Ado(P)-Rib P-5'-M0(2'-1")Rib
rv fde Rib-Rib Ado-Rib Mo(Z'-l")Rib
129
POLY (ADENOSINE DIPHOSPHATE RIBOSE)
Ade -Rib
I
P-P
kib-Rib
I
/Me
Ade
I
P-P
I
/Me
{ I :I Rib-Rib! Rib-Rib! RibI I l l I l l P+P
P+P
FIG.1. Structure of poly(ADP-Rib). Ade: adenine; Rib: n-ribose; P : phosphate. For the structure of the repeating unit (between broken lines), see Fig. 2.
This article surveys the information available on poly (ADP-Rib) and related subjects through December, 1971. The only previous reviews of studies on this unique biopolymer are two reviews in Japanese (12, IS) and a corcprehensivc rcvicw of the research in Strasbourg in a thesis (14).
II. Chemical and Physical Properties of Poly(ADP-Rib)
A. Characteristics of Poly(ADP-Rib) Incubation of nuclear preparations from hen or rat liver with N M N and ATP variously labeled showed that the 5'-phosphoribose moiety of NMN and the 5'-AMP moiety of ATP became incorporated into a n acidinsoluble product (4, 7, 8, 10).Studies with variously labeled NAD also revealed that all of the NAD except the nicotinamide moiety was incorporated into the product (4, 6-11). No incorporation of the nicotinamide moiety of NMN or NAD into the acid-insoluble material was detected even when NAD very highly labeled a t the nicotinamide moiety was used. The acid-insoluble product was highly purified, as described later, and completely freed from RNA and DNA (15,16),and was found to consist of polymerized ADP-Rib. Poly (ADP-Rib) shows the general characters of a polynucleotide. It is readily soluble in water in neutral and alkaline conditions. It precipitates in 5% trichloroacetic acid, 5% trichloroacetic acid 0.25% sodium tungstate (pH 2.0) or 66% ethanol 0.2M acetate buffer (pH 4.8). Poly(ADP-Rib) also precipitates in the presence of excess Mgz+ (14). (ADP-Rib),, has an s value of 2 4 s (4, 9, 11). Purified poly(ADP-Rib) has a buoyant density of about 1.57 on cesium sulfate equilibrium density gradient centrifugation ( 9 ) , being less dense than Fz virus RNA but heavier than T 4 DNA (17). On methylated albumin kieselguhr, the polymer moves as a broad band (11). On hydroxyapatite, poly(ADP-Rib) elutes after RNA and DNA and with a much higher concentration of buffer. This characteristic behavior was utilized in its purification (16). Purified poly(ADP-Rib) has an absorption maximum a t 258 nm a t pH 7.0, indicating no substitution in the adenine ring. It is deaminated by HNO,. Acid hydrolysis in 1M HCl a t 100°C for 10 minutes yields
+
+
130
TAKASHI SUGIMURA
hypoxanthine (11), Analysis indicates adenine, ribose and phosphate in the molar ratio of 1:2:2 (4,9, 11).The phosphate groups are all resistant to alkaline or acid monophosphatase (4, 9, 11). Poly(ADP-Rib) is relatively stable in alkali; little of the acidinsoluble material becomes acid-soluble on treatment with 0.5 M NaOH a t 37°C for 18 hours. However, boiling in 1M HC1 for 7 minutes results in total conversion to acid-soluble material (9). Acid treatment splits the ribose-ribose bond, yielding adenine and ribose 5-phosphate (11). Poly(ADP-Rib) is not hydrolyzed by DNase I, DNase 11, pancreatic RNase, RNase T1, micrococcal nuclease, spleen phosphodiesterase, potato phosphodiesterase, potato nucleotide pyrophosphatase, spleen NAD nucleosidase or trypsin (4, 9-11). It is readily hydrolyzed by phosphodiesterase from the venom of Crotalus adamanteus (4, 9-11). Snake venom phosphodiesterase, freed from 5‘-nucleotidase by the method of Keller (18) or of Sulkowski and Laskowski (19), also hydrolyEes poly (ADPRib) ( 2 0 ) . The main product of the hydrolyzate, separated by Dowex 1-formate column chromatography (6, 9-11) , is Ado(P)-Rib-P (4, 9-11, 13), a minor product is 5’-AMP (6,11, 15). The chain length of poly(ADP-Rib) can be determined from the molar ratio of Ado(P)-Rib-P to 5’-AMP plus 1, after complete hydrolysis of poly (ADP-Rib) by snake venom phosphodiesterase, since 5’-AMP should only be derived from a terminus (4, 9, 11). The A280:A2B0ratio of absorption of purified poly (ADP-Ribose) is 0.26. When poly (ADP-Rib) was prepared from an adenine-labeled precursor, either ATP or NAD, the specific radioactivity (counts per minute per OD?,,,) of polymer was about 1.27 times that of the precursor, indicating the presence of a tertiary structure due to interaction of adenine bases (15).Digestion of poly(ADP-Rib) with snake venom phosphodiesterase or heat treatment of poly (ADP-Rib) resulted in 20-25% increase in the optical density a t 260 nm (IS). Recently, a component of poly(ADP-Rib) was found with a much larger s value but with a chain length of 20-25 repetitions of ADP-Rib units. The heavier component could be completely separated from the lighter component (s values of 2-4 S) by sucrose-density gradient centrifugation or Sephadex G-200 gel filtration. The true molecular features of the heavier component are not yet known (91).
B. Characteristics of Ado(P)-Rib-P A major product isolated from a digest of poly(ADP-Rib) with snake venom phosphodiesterase is Ado (P)-Rib-P, 2’ [5”-phosphoribosyl] -5’AMP (4,9,11). Chambon e t al. (4) first designated this as p-ADPR. Ado(P)-Rib-P has absorption maxima a t 261, 259 and 258 nm under
131
POLY ( ADENOSINE DIPHOSPHATE RIBOSE)
HO
OH
FIG.2. Structure of Ado(P)-Rib-P.
alkaline, neutral and acidic conditions, respectively, showing that positions 1 and 3 of the adenine ring and the amino group of adenine are not substituted (4, 9, 11).Ado(P)-Rib-P contains 1 mole of adenine, 2 moles of ribose and 2 moles of phosphate (4, 9, 1 1 ) . The phosphate groups are all susceptible to Escherichiu coli alkaline phosphatase (4, 22), potato acid phosphatase (9) or prostate acid phosphatase ( 1 1 ) . Only 1 mole of periodate is consumed per mole of adenine of Ado(P)Rib-P, indicating that only one of the 2 moles of ribose in Ado(P)-Rib-P has free adjacent hydroxyl groups a t the 2' and 3' carbons (9). Doly and Pctek isolated N6-mcthyladeninc, 2,3,5-trimethylribose and 3,5-dimethylribose by two-dimensional paper chromatography from an acid hydrolyzate of the methylated Ado-Rib obtained from Ado (P)-Rib-P, confirming the presence of a 1' to 2' bond between two riboses ( 5 ) . Nonspecific adenosine deaminasc from Aspergillus oryzae deaminates adenosine but not adenosine substituted a t the 2' OH group (17).Ado(P)-Rib-P is not susceptible to this enzyme, providing additional support for the presence of a 1' to 2' bond between two ribose molecules ( 1 3 ) . Hydrolysis of Ado (P)-Rib-P by dilute mineral acid liberates ribosyl 5-phosphate and 5'-AMP ( 4 ) . All the above data are consistent with the structure of the main product, Ado (P)-Rib-P, shown in Fig. 2.
C. Derivatives of Ado(P)-Rib-P The two phosphates of Ado(P)-Rib-P are susceptible to alkaline phosphomonocstcrase. Partial digestion of Ado (P)-Rib-P with this enzyme yields 2'- (ribosyl)-5'-AMP, Ado (P)-Rib, and 2'- (5"-phosphoribosyl) adenosine, Ado-Rib-P. These two derivatives may be separated
132
TAKASHI SUGIMURA
from each other and from related compounds, including Ado-3‘,5‘-P2, Ado-2’,5’-Pz and ADP-Rib by column, paper and thin-layer chromatographies (22, 23). The separation of these dephosphorylated derivat.ives of Ado(P)-Rib-P was essential for determination of the terminal structure of poly(ADP-Rib) (24, 25). The phosphate group at the 5‘ position of the AMP moiety of Ado(P)-Rib-P is much more susceptible to alkaline phosphomonoesterase than the phosphate group at the 5“ position of the phosphoribose moiety of Ado(P) -Rib-P ( 2 2 ) . Complete hydrolysis of Ado (P)-Rib-P with phosphomonoesterase yields Ado-Rib. Ribosyladenosine has been reported to be present in a crude preparation of tRNA from Saccharomyces cerevisiae, although it is uncertain in this case whether the linkage between the two ribose molecules is 1’ to 2‘ or 1’to 3‘ (26).
111. Purification of Poly(ADP-Rib) A. Incubation of Precursor with Enzyme Preparation The nuclei of the livers of rats or hens contain very active NAD pyrophosphorylase for the polymerization of ATP and NMN. With NAD as a precursor, calf thymus is better because the nuclear preparation is easily separated. The following preparations are all suitable as enzyme sources: a crude preparation of nuclei obtained by means of 0.25M sucrose; a purified preparation of nuclei obtained by Chauveau’s method using 2.2 M sucrose (27) ; an aggregated enzyme preparation from nuclei ( 4 ); and chromatin prepared by Marushige and Bonner’s method (28,29).Addition of M ADP-Rib or M 3’:5’cyclic AMP effectively inhibits the enzyme degrading poly (ADP-Rib) and enhances the yield (dl). Incubation times of 10 minutes and 30 minutes are suitable with NAD and ATP + NMN, respectively, as substrates, under normal incubation conditions (8, 15, 16). With ATP plus NMN as substrates, addition of Mg2+is essential, since NAD pyrophosphorylase requires this ion.
B. Separation of PolytADP-Rib) 1.
GELFILTRATION
The procedure (15)involved (a) Pronase digestion and phenol extraction, (b) digestion with pancreatic RNase and DNase, (c) gel filtration through a Sephadex G-50 column, (d) digestion with micrococcal nuclease and spleen phosphodiesterase, and (e) a second gel filtration on Sephadex. With this procedure, the overall recovery of acid-insoluble radioactivity
POLY (ADENOSINE DIPHOSPHATE RIBOSE)
133
was more than 50% (15). Increase of the specific radioactivity (counts per minute per OD,,,) and decrease of the ratio of absorption a t 280 nm to that at 260 nm were used as criteria of purity of poly (ADP-Rib) . The ratio of the specific radioactivity per OD,,, unit of purified poly(ADPRib) to that of the [ C ~ - ~ ~ P ] A used T P as a precursor was 1.27:l. The A2Ra:A200 ratio of purified poly(ADP-Rib) a t the final step was 0.26. After the second gel filtration, poly(ADP-Rib) was free of RNA and DNA. The average chain length of the resulting poly (ADP-Rib) was 2030 ADP-Rib units. 2. HYDROXYAPATITE COLUMNCHROMATOGRAPHY
Hydroxyapatite column chromatography proved effective to separate poly(ADP-Rib) from DNA and RNA (16).Chromatin was incubated with NAD or ATP plus NMN and the product was precipitated. The acid-insoluble precipitate was digested with Pronase and the fraction containing DNA, RNA and poly (ADP-Rib) was prepared by phenol treatment. On chromatography of this fraction on hydroxyapatite, RNA, DNA and poly(ADP-Rib) with a chain length of 25 ADP-Rib units were eluted with 0.15 M, 0.25 M and 0.35 M phosphate buffer (pH 6.8), respectively. When the DNA, RNA and poly(ADP-Rib) fractions had previously been digested by pancreatic DNase and RNase, the separation of poly(ADP-Rib) from DNA was much better, and poly(ADP-Rib) of shorter chain length could be obtained in a highly purified state, the oligo ribo- and deoxyribonucleotides being eluted with more dilute phosphate buffer. A linear relationship was obtained between the chain length of the material eluted and the phosphate concentration of the elution buffer. Miwa et al. (21) recently developed a rapid method to prepare poly(ADP-Rib) in bulk. By incubating a crude nuclear preparation of calf thymus with NAD and subjecting the mixture of RNA, DNA and poly (ADP-Rib) to hydroxyapatite column chromatography, about 10 mg of poly(ADP-Rib) were obtained from 100 mg of NAD ( 2 1 ) . Separation of oligo (ADP-Rib) was also achieved on hydroxyapatite columns by elution with dilute phosphate buffer. 3. MAGNESIUM PRECIPITATION
Doly (14) purified poly (ADP-Rib) with magnesium precipitation from the aqueous solution after digestion with DNase and RNase, followed by Pronase and phenol extraction. Poly (ADP-Rib) was precipitated with 0.1 M MgCl, and precipitated poly (ADP-Rib) was dissolved in 50 mM EDTA. Ethanol precipitation was repeated several times, and
134
TAKASHI SUGIMURA
finally the poly (ADP-Rib) was dissolved in water and lyophilized. The chain length of the poly (ADP-Rib) thus obtained was 20 ADP-Rib units.
IV. Biosynthesis of Poly(ADP-Rib) A. General Character As described above, NMN-dependent incorporation of the radioactivity of [ ~ d e n i n e - ~ ~ C ] Awas T P first observed with chicken liver nuclei. Later the same reaction was observed with rat liver nuclei, and the reaction conditions wcrc reported in detail (4, 8, 10, 23, 29). Thc preparations of chicken and rat liver both contained NAD pyrophosphorylase, so NMN and ATP served as precursors of poly (ADP-Rib) . Incorporation of radioactivity from I adenine-14C]ATP in the presence of NMN was drastically decreased by addition of unlabeled NAD (4, 6, 10), suggesting that NAD was an obligatory intermediate. When NAD labeled in either part of its ADP-Rib moiety was used as a precursor, nuclei from various rat tissues all showed some activity to produce poly (ADP-Rib). Chambon et al. reported that incorporation of [32P]NADwas not inhibited by addition of unlabeled ADP-Rib ( 4 ) . Addition of NADasc from beef spleen abolished the incorporation ( 4 ) . NADH, NADP and ADP-Rib could not serve as substrates of poly (ADP-Rib) (8). Nuclei prepared from rat brain (SO), rat kidney (SO), regenerating rat liver (SO), fast-growing rat ascites hepatoma cells (30), slow-growing rat Morris hepatomas (SI), rat Novikoff hepatoma (S2), mouse liver ( S I ) , mousc Ehrlich ascites tumor ( 3 3 ) , hen erythrocytes (SO) and calf thymus (21) all form poly (ADP-Rib) from NAD. Nuclear preparations from trout and carp livers and a nuclear preparation from the protozoon Tetmhymenu pyrijormG, also have this ability (31).It seems quite probable that nuclear preparations from all species of animals may have an enzyme forming poly (ADP-Rib) from NAD. Nuclei from tissues with many mitotic cells, such as ascites hepatoma cells, or with few mitotic cells, such as normal hepatocytes, show similar abilities to form poly(ADP-Rib) from NAD, although the former showed slightly higher activity, indicating that the growth rate of cells is not directly related to the activity of poly(ADP-Rib) formation in the nuclei (34). Nuclei of Novikoff hepatoma cells show much higher activity. On the contrary, hepatoma cells do not form poly(ADP-Rib) from labeled ATP and NMN, because their nuclei have a very low NAD pyrophosphorylase activity ( 3 5 ) . Hilz and Kittler found no correlation between poly(ADP-Rib) polymerase activity and the rate of synthesis of DNA in neonatal and adult liver and hepatomas. Howevcr, they found a close
POLY ( ADENOSINE DIPHOSPHATE RIBOSE)
135
correlation between the activity and the DNA content of normal and malignant tissues that differed widely in proliferation rates (36‘).R a t liver nuclei were separated into various fractions by zonal centrifugation by Johnston et al. (37, 38). Nuclei of stromal cells (2nS) synthesized little RNA or DNA. The nuclei of both diploid and tetraploid parenchymal cells (2nP, 4nP) actively synthesized RNA, whereas the synthesis of DNA was concentrated in a fourth class of nuclei, intermediate in size between 2n and 4n. Haines et al. (39) found the highest activities of the enzyme catalyzing formation of poly (ADP-Rib) in nuclei involved in synthesis of RNA. Therc arc no obscrvations on thc ~ ~ r r s e n cofc this enzyiuc activity in the nuclear fraction of higher plants. However there is evidence that it is present in the nuclear fraction of the yeast Saccharomyces cerevisiae ( 4 0 ) . The enzymc was not found in a whole cell extract of Xeurospora crassa (30).No activity has yet been found in prokaryotic organisms, such as Escherichiu coli, Pseudo~nonasnerziyinosn and Lactobacillus casei (30). The formation of poly(ADP-Rib) seems to be restricted to eukaryocytic nuclei, having the chromatin structure. The most frequently used enzyme source has been the nuclear preparation obtained by Chauveau’s method using 2.2 M sucrose solution (23, 29). Nuclei may be disrupted mechanically or supersonically and a sediincntable fraction, called the aggregated enzyme preparation, was also used as an enzyme source (1, 4 ) . The apparent optimum pH for poly(ADP-Rib) formation was 8.6 (4) with glycine-NaOH buffer and p H 8.0 with Tris buffer (8, 41). The enzyme forming poly(ADP-Rib) from NAD was quite heat labile (4, 8). Nishizuka et al. (10) found that treatment of the crude enzyme preparation with DNase diminished formation of poly (ADP-Rib) from NAD, and Chamhon et al. ( 4 ) found that the reaction of A T P and N M N was inhibited by DNase digestion. DNase treatment was used by Shimizu et al. (4.2) and later Yamada et al. (43) to solubilize the polymerase activity from an aggregated enzyme preparation. Partially purified enzyme required DNA for the formation of poly(ADP-Rib) ( 4 3 ) and DNA seemed to be required for its elongation (50, 44).
B.
Association of Polymerase with Chromatin
On fractionation of nuclei, most of the enzyme activity is found in the chromatin fraction obtained by the method of Marushige and Bonner (28) while the soluble fraction, ribosomal fraction and nucleonemata from the nuclei have no activity (50). Thus the purified chromatin fraction is a good enzyme source (44,45). The chromatin contains 80-90% of the total
136
TAKASHI SCGIMTJRA
poly (ADP-Rib) polymerase activity in the rat liver nuclei, and about 20% of the protein. Ueda et al. (44, 46) treated chromatin with a high concentration of ammonium sulfate to dissociate DNA from protein and subjected the resulting preparation to gel filtration on Sephadex G-200. The activity to synthesize poly (ADP-Rib) was recovered exclusively in the void volume, which consisted mainly of DNA, while the bulk of protein was eluted later. Polymerase activity seemed to be bound relatively firmly to the DNA. They observed that low concentrations (0.1-0.5M ) of ammonium sulfate markedly depressed poly (ADP-Rib) formation with marked incrc'ase in RNA synthrsis. On increasing the concentration of ammonium sulfate, poly (ADP-Rib 1 synthesis increased again and reached a maximum a t a concentration of 1.7 M. The initial velocity in 1.7 M ammonium sulfate was 40% of that without salt. Only sulfate and phosphate ions a t high concentration increased poly (ADP-Rib) polymerase activity. Furthermore, it was noticed that there was no disappearance of poly(ADPRib) at high salt concentrations, which might inhibit degradation of the polymer by rat liver phosphodiesterase or by an enzyme splitting its ribose-ribose bonds. On centrifugation of the chromatin-enzyme complex in cesium sulfate solution, the activity to form poly (ADP-Rib) was found in the DNA peak at a density of 1.34, which carried less-dissociable protein. Gel filtration of this complex on Sephadex G-200 in the presence of 1.6 M ammonium sulfate yielded DNA in the void volume with a minute amount of protein and most of the polymer-forming activity (44, 4.5). Nishizuka et al. (44) reported that the average chain length of a polymer made by an intact chromatin fraction was 6.37. This chromatin was partially digested with increasing concentrations of DNase, resulting in a decrease in the average chain length and total acid-insoluble radioactivity. It was also found that a purified preparation of nucleoli from rat liver nuclei (46') contained no activity to synthesize poly (ADP-Rib) . Ueda et al. (46) also reported the association of the product, poly (ADP-Rib) , with DNA on gel filtration in the presence of salt as in the enzymatic reaction. However, the product dissociated from DNA on cesium sulfate density gradient equilibrium centrifugation, implying that the binding was not covalent (4.5). Proof that the bonds were not covalent was that treatment with sodium lauryl sulfate or proteinase resulted in release of the polymer from DNA (4.5). Hilz and Kittler incubated isolated nuclei of Ehrlich ascites tumor cells with [3H]adenine-labeled NAD, washed them with isotonic sucrose and subjected them to radioautographic analysis. Silver grains were evenly distributed over the whole nucleus, the nucleolus possibly being free (33).Oikawa et al. incubated cultured cells from dissected tissues of
POLY (ADENOSINE DIPHOSPHATE RIBOSE)
137
FIQ.3. Radioautographs of rat embryo cells. Cultured on a cover slip and incubated with I'HINAD. (A) X400; (B) X1000.
whole rat embryos with [~denine-~
C. Association of Poly(ADP-Rib) with Nuclear Proteins Poly (ADP-Rib) precipitates with aggregated enzyme or chromatin, and the addition of sodium dodecyl sulfate or proteinase promotes the release of poly (ADP-Rib) , hence poly (ADP-Rib) may be linked with protein (46). Nishizuka et al. (44) reported that the acid-insoluble radioactivity in the nuclei after incubation with [~denine-~'C]NAD is in various protein fractions. Tris-extractable proteins, phenol-soluble proteins, acidic proteins, residual proteins and especially histone (HC1-soluble) , all possessed
138
TAKASHI SUGIMURA
radioactivity. These histones were separated by CM-cellulose column chromatography (53),and all fractions contained radioactivity (53). The bond between ADP-Rib and histone was quite labile with a half-life of 5 minutes on incubation in 0.1N NaOH a t 0". The bond was broken on treatment with 2 M hydroxylamine a t pH 7.0 as rapidly as that of phenylalanine esterified to tRNA. These results are compatible with the supposition that the ADP-Rib moiety may be transferred to the carboxyl group in the protein molecule (4.4). Otake et a,?.(64) reported the binding of poly (ADP-Rib) with histone on CsCl equilibrium density gradient centrifugation in the presence of 1M guanidinium chloride, using the method of Huang and Bonner (55), providing additional support to the claim that the ADP-ribose polymer is covalently bound to histone. They incubated rat liver nuclei with [s2P]NADand extracted histone by the method of Steele and Busch (56). This crude histone preparation was separated into three distinct peaks of radioactive protein by CM-cellulose column chromatography. These fractions were then subjected to CsCl equilibrium density gradient centrifugation by the method described above. Miwa et a,?. (57) incubated rat liver nuclei with labeled NAD, disrupted the nuclei and extracted the histone fraction. They purified it by CM-cellulose and Amberlite IRC-50 column chromatographies. The purified histone fraction was then digested with Pronase, and the ADPribosylated histone fragment was isolated by Dowex 1 column chromatography. Meilhac (58) performed a similar experiment and isolated ADP-ribosylated peptides. These were digested with phosphodiesterase without and with alkaline phosphatasc, and phosphoribosyl peptides and ribosyl peptides were isolated. Their constituent amino acids have not yet been determined. Incidentally it was found that poly(ADP-Rib) bound to histone is not completely converted to an acid-soluble form by snake venom phosphodiesterase, possibly owing to steric hindrance to the action of phosphodiesterase on poly (ADP-Rib) combined with protein. This ADP-ribosylation or oligo ADP-ribosylation or poly ADPribosylation of nuclear proteins, including histones, might represent a new type of biochemical modification of histones in addition to the already known reactions such as methylation (59), pliosphorylation (60) and acetylation (61) of histones.
D.
Inhibitors This reaction is strongly inhibited by nicotinamide and less strongly by isonicotinic acid hydraside. The possible involvement of a certain type of NADase in this polymerization reaction has been suggested (8, 10, 40,
POLY(ADENOSINE DIPHOSPHATE RIBOSE)
139
62). Clark et al. reported that rat liver nuclear NADase and poly (ADPRib) polymerase are strongly inhibited both by nicotinamide and 5methylnicotinamide (63). The formation of poly(ADP-Rib) decreased 86% on addition of 2 mM parachloromercuribenzoate (4, 8). The incorporation was also inhibited by DNase, and this inhibition was reversed by DNA, heparin or dextran sulfate, but not by RNA, poly(A) or poly(U) ( 4 ) . Preiss et al. found that poly(ADP-Rib) polymerase from HeLa S3 cells is strongly inhibited by thymidine a t the concentration used to arrest cell cultures in the S-phase ( 3 2 ) . This inhibition is very specific and thymidine analogs like BrdIird and IdUrd have effects comparable to that of thymidine. However, FdUrd and other natural nucleosides do not inhibit poly (ADP-Rib) polymerase. They also found that nicotinainidc and 5-methyl nicotinamide inhibit poly (ADP-Rib) polymerasc from HeLa S3 cells (32). Many antibiotics, including actinomycin D, mitomycin C, chloramphcnicol, cycloheximide and chromomycin A, do not inhibit the rcaction (8).
E. Relation between Enzyme Forming Poly(ADP-Rib) and NADase Nakazawa et al. (SO,41) noted the reseiiiblance of the nuclear enzyme forming poly (ADP-Rib) to nuclear NAD glycohydrolase (NADase) . The nuclear NADase is known to carry out an exchange reaction between the nicotinamidc of NAD and certain pyridine derivatives (30,41). However, inicrosomal NADase, which can also catalyze the exchange reaction, failed to form poly(ADP-Rib). This might be related t o the fact that polymerization starts with ADY-ribosylation of nuclear proteins. Nishizuka et al. suggested the presence of threc different NADases: cytoplasmic NADase, nuclear NADase tightly bound to chromatin, and a third enzyme that is also bound to chromatin but that can catalyze poly(ADP-Rib) formation. The second and third enzyme might be a single enzyme (30). Furthermore the K,, values of cytoplasmic and nuclear NADases and the enzyme for poly (ADP-Rib) synthesis were 1.7 X 2.5 X lo-' and 2.5 X lO-"M, respectively. Shimizu et al. (42) digested chromatin with DNasc and obtained NADase activity specific for poly (ADP-Rib) formation in the supernatant. The insoluble fraction after DNase digestion still contained NADase and the properties of the latter were more closely related to those of a NAD hydrolase. Bock et al. also described the presence of NADase in Ehrlich ascites tumor cell nuclci ( 6 5 ) .They found somc differencc between thc NADases in nuclci and microsomes. The nuclear NADase was highly specific for
140
TAKASHI SUGIMURA
NAD, and was inhibited 50% by 0.2 mM nicotinamide, while the microsoma1 NADase could split NAD, NADP and NMN in an activity ratio of 1:0.5:0.2.They suspected that the former enzyme might be identical with an enzyme that polymerizes the ADP-Rib moiety of NAD. Romer et al. (62) also found two NADases in Ehrlich ascites tumor cells, one in the cytoplasm and the other in the nuclei. The nuclear NADase was inactive against NADP. Moreover it was not inhibited a t all by l e 3 M isonicotinic hydrazide, whereas the cytoplasmic NADase was inhibited 60%. The optimum pH values of the microsomal and nuclear NADases were pH 6.2 and 8.2, respectively ( 6 2 ) .The microsomal enzyme formed the acetylpyridine analog of NAD on incubation with NAD and acctylpyridine whereas the nuclear NADase did not ( 6 2 ) .Romer et al. found an almost stoichiometric relation between NAD disappearance, determined with cyanide, and [ a d e n i n e - W ]NAD incorporation into the acidinsoluble material, and suggested that all NADase activity measured by the cyanide method represented polymerizing activity in nuclei of Ehrlich ascites tumor cells. This was in contrast to the nuclear preparation of rat liver where degradation of NAD was usually greater than formation of poly (ADP-Rib) (41, 42). Nakazawa et al. (41) summarized comparative results on microsomal NADase, chromatin NADase and the poly (ADP-Rib) -forming enzyme as shown in Table I. NADase, which can catalyze the exchange reaction of the nicotinamide moiety of NAD with free nicotinamide, histamine or 4-aminoimidazole carboxamide, may be related to poly (ADP-Rib) polymerasc (63, 64) , since formation of poly (ADP-Rib 1 involves transglycosidation of thc nicotinamide of NAD with ribose of the AMP moiety of another molecule of NAD. Nishizuka et al. (SO) emphasized that the nicotinamide ribose linkage is a high-energy bond (8 kcal) as previously recognized by Kaplan and OF NAD.w: P~~OPEHTIIZS
Inhibitor Exchange reaction K , for NAD Optimum pH Heat stability Specificity DNase treatment
TABLE I POLY(ADP-RIH)-FORMING ENZYME(S)
AND
Microsomal NADase
Chromatin NADase
Pyridine derivative Positive 0.17mM 6.4 Heat stable NAD, NADP Resistaiit
Pyridine derivative Positive 0.25mM 7.6-8.0 Labile NAD Sensitive
Poly (ADP-Rib) formation Pyridine derivative 0.25mM 8.0 Labile NAD Semitivc
POLY ( ADENOSINE DIPHOSPHATE RIBOSE)
141
his co-workers (66). Zatman et al. reported that a single protein of mammalian NADase showed two different activities, NAD transglycosidase and NAD hydrolase activity. The common intermediate, ADPribosylated enzyme, might be formed with the concomitant release of nicotinamide. The ADP-ribose group of the intermediate would then be transferred to some other pyridine derivative in the NAD transglycosidase reaction or to water in the NAD hydrolase reaction (66).
F. Purification of Enzyme The cnzyme activity to form poly(ADP-Rib) is firmly bound to chromatin. The aggregated enzyme preparation from nuclei also has the activities of NAD pyrophosphatasc, NADase and phosphodiesterase. Attempts to purify the enzyme to form poly (ADP-Rib) by solubilization with DNase were partially successful (4%’).About one-third of the poly (ADP-Rib) polymerase activity was recovered in the soluble form, while only one-twentieth of the NAD hydrolase activity was recovered in the soluble fraction. The activity to hydrolyze poly(ADP-Rib) in the soluble fraction was also one-thirtieth of that in the aggregated fraction. It should be noticed that solubilized poly (ADP-Rib) polymerase activity represents the NADase activity determined using cyanide. The solubilized poly (ADP-Rib) polymerase was inhibited by nicotinamide, but not by isonicotinic acid hydrazide. Yamada et al. (43) partially purified the enzyme forming poly (ADPRib) from rat liver nuclei, by isolation of disrupted nuclei, solubilization of thc enzyme by DNase digestion and two fractionations with ammonium sulfate. The yield was about 15% with 10-fold purification. The enzyme required DNA, histone, MgCl,, and dithiothreitol for activity. DNA could not be replaced by polyanions, such as poly(U), poly(A), poly(C), RNA, polyvinyl sulfate, methyldextran sulfate or heparin. The enzyme was as active on native DNA as on heat-denatured DNA and on poly[d (A-T)], but less active on poly(dG) -poly(dC) and on acid-soluble oligodeoxyribonucleotide. Histones, lysine-rich histone and arginine-rich histone were equally effective in stimulating the reaction. The molecular weight of the enzyme was determined to be 78,000 by sucrose density gradient centrifugation. The product of the reaction was poly (ADP-Rib) with an average of 8 ADP-Rib units. Purification involving butanol treatment, acetone precipitation, DEAE-cellulose column chromatography and adsorption on and elution from calcium phosphate gel was also attempted, giving 20% recovery and 80-fold purification. The requirement of this preparation for DNA for activity was not very strict (67). Doly purified the enzyme to form poly(ADP-Rib) from the super-
142
TAKASHI SUGIMURA
natant fraction after disrupting chicken liver nuclei with homogenization in 0.2M NazHPOa (pH 8.5)-0.1 mM EDTA. Acetone precipitation and hydroxyapatite column chromatography were applied. Enzyme thus obtained with 20-fold purification contained histone in the preparation itself, but required the DNA for the reaction (14).
V. Biodegradation of Poly(ADP-Rib) A. Snake Venom Phosphodiesterase As described previously, the breakdown of poly (ADP-Rib) by snake venom (Crotalus adamanteus) phosphodiesterase was observed a t an It proved to be a early stage in studies on poly (ADP-Rib) (4,6,7,9,11). very useful tool in determining the structure of poly(ADP-Rib). Commercial snake venom phosphodiesterase was freed of 5’-nucleotidase by the method of Keller (18) or Sulkowski and Laskowski (19). This purified snake venom phosphodiesterase hydrolyzed poly (ADP-Rib) a t the pyrophosphate bond endonucleolytically, as illustrated in Fig. 4. An intermediate was obtained by gel filtration of a partial hydrolyzate of poly (ADP-Rib) with this enzyme (94). This intermediate, an oligomer of Ado (P)-Rib-P, was incubated with alkaline phosphomonoesterase, the phosphomonoesterase was removed and the product was completely hydrolyzed by snake venom phosphodiesterasc. Ado-Rib-P, Ado (P)-RibP, and Ado(P)-Rib were found in the hydrolyzate, supporting the conAde -Rib
I
P-P
t
-Rib
I
Ade
Ade
I I I Rib-Rib Rib-Rib Rib-Rib I P-P I I P--P I I I
Ade
Ade
kib-Rib
kib-Rib
kb-Rib
I
I
I
P-P
I
t
Ade
-Rib
l
P
I Rib-Rib l
P
l
P
Ade
I Rib-Rib l 1 P P
I
P
Ade
I I Rib-Rib Rib I P-P I I
partial hydrolysis
PTp!
Ade
I
Ade
Ade
Ade
kib-Rib
Rib
I
P
I
1
P--P
1 I
complete hydrolysis
Ade
I Rib-Rib I I P
P
Ade
I EBb-Rib I I P
P
Ade
I I P
Rib
FIQ.4. Hydrolysis of poly (ADP-Rib) by snake venom phosphodiesterase.
POLY (ADENOSINE DIPHOSPHATE RIBOSE)
Ade
Ade
I Rib-Rib +I I P
P-P
Ade
143 Ade
I I I Rib-Rib Rib-Rib Rib-Rib I I I I 1 IP-P P--P P
1
phosphomonoesterase
Ade
Ade
I Rib-Rib
I Rib-Rib I
P--P
I
t
Ade
I Rib-Rib I
P
Ade
I
P-P
I Rib-Rib I I
t
Ade
Ade
I Rib-Rib
I Rib-Rib
P
P
I
I
P
I
I
P
I I
Rib-Rib
P--P
t
Ade
complete hydrolysis by snake venom phosphodiesterase
1
Ade
I I
Rib-Rib
P
FIG.5. Studies of tcrminnl structure of oligo(ADP-Rib).
clusion that snake venom phosphodiesterase digested the polymer endonucleolytically, as illustrated in Fig. 5.
B. Rat liver Phosphodiesterase Futai and Mizuno found a new phosphodiesterase forming 5’-mOnOphosphate (68), and soon this enzyme was reported to be the first enzyme from animal tissues to hydrolyze poly (ADP-Rib) (49, 69). The enzyme was purified 200-fold from a rat liver homogenate by n-butanol treatment, streptomycin sulfate precipitation, ammonium sulfate fractionation, batchwise treatment with DEAE-cellulose and finally DEAE-Sephadex column chromatography. The optimal pH for hydrolysis of the polymer is around pH 10 (69). The products of the complete hydrolysis of poly (ADP-Rib) are Ado (P) Rib-P and 5’-AMP. This phosphodiesterase rapidly hydrolyzes p-nitrophenyl esters of nucleoside 5’-monophosphate and various oligonucleotides, while it hydrolyzes DNA and RNA slowly. The degradation product is 5’-monophosphate and the initial site of attack is the 3‘hydroxy end of the oligonucleotide. This enzyme hydrolyzes NAD, M NADH and ADP-Rib. Hydrolysis is completely inhibited by EDTA or HgCl,. For hydrolysis of p-nitrophenyl uridine 5’-monophosphate, NAD or A-U, the octimal pH is also 10. I n contrast to snake venom phosphodiesterase, this phosphodiesterase hydrolyzes poly (ADP-Rib) ezonucleolytically from a terminus from
-
TAKASHI SUGIMURA
144 Ade -Rib
I
P-P
Ade
Ade
Ade -Rib
I
P-P
Ade
Ade
Ade
I I I I I Rib-Rib Rib-Rib Rib-Rib Rib-Rib Wb I P-P I I P-P I I P-P I I P-P I I
Lb-Rib
I
I
P-P
I
4I
Ade
4
Ade
Ade
I I P
Rib
I
I t Ade
Ade
I I I Rib-Rib Rib-Rib Rib-Rib I P-P I I P-P I I PI
Ade
Ade
I I I I -Rib Rib-Rib Rib-Rib Rib-Rib Rib-Rib 1 1 P-P 1 l P-P 1 l P l Pl PI P-P
Ade
I I P
Rib
FIQ.6. Hydrolysis of poly(ADP-Rib) by rat liver phosphodiesterase.
which 5’-AMP should be released, as illustrated in Fig. 6. The actions of this enzyme on poly (ADP-Rib) and p-nitrophenyl uridine 5’-mOnOphosphate are inhibited by 5’-AMP. The direction of exonucleolytic hydrolysis was determined (26) by preparing separately poly (ADP-Rib) labeled with a t the ribose from the AMP phosphate derived from the NMN moiety or with moiety of NAD. It was concluded that this phosphodiesterase attacked poly (ADP-Rib) at the pyrophosphate bond a t the terminus, which should yield 5’-AMP. Kinetic studies suggest that both p-nitrophenyl uridine 5’-monophosphate and poly (ADP-Rib) are hydrolyzed by the same site or by overlapping active sites (49).
C. Enzymatic Cleavage of the Ribose-Ribose Bond Recently Miwa and Sugimura discovered a new enzyme in a calf thymus nuclear preparation that splits the ribose-ribose linkage of poly(ADP-Rib) as shown in Fig. 7 (60).This is a novel mechanism for degradation of poly (ADP-Rib) . This enzyme was mainly concentrated in the nuclear fraction and was easily extracted with 0.1 M sodium phosphate buffer (pH 7.0) and 1 mM 2-mercaptoethanol. The enzyme was purified about 100 times by streptomycin treatment, ammonium sulfate fractionation, DNase digestion, and phosphocellulose and hydroxyapatite column chromatographies. The optimum pH is around 7 and
145
POLY (ADENOSINE DIPHOSPHATE RIBOSE)
Ade -Rib
I
P-P
I Rib-Rib I I +
P-P
Ade -Rib
I
P-P
Ade
Ade
I
Rib-Rib
I
I
P-P
1
Ade
I I Rib Rib Rib-Rib I I I I P-P
P-P
I Rib-Rib I I +
P-P
Ade
Ade
Rib-Rib
Rib
I
I
I
+
P-P
I
I
Ade
Ade
Ade
Rib
Rib Rib
Rib Rib
P-P
P-P
I
I
I
I
I
I
I I
FIG.7. Hydrolysis of poly(ADP-Rib) at ribose-ribose bond by an enzyme from calf thymus.
activity is almost completely inhibited by M p-chloromercuribenzene sulfonate or M M HgCl,. Activity is also strongly inhibited by ADP-Rib. Partial hydrolysis of poly (ADP-Rib) with this enzyme yields the acid-soluble reaction products, ADP-Rib and oligo (ADP-Rib) . Ueda et al. found a similar enzyme in rat liver nuclei ( 5 1 ) .They found that the ribose-ribose linkage of Ado (P)-Rib-P and the linkage between protein and ADP-Rib are resistant to this enzyme. The activity to degrade poly (ADP-Rib) is inhibited by adenosine-3’: 5’-cyclic monophosphate, the apparent Ki being around 1.5 mM. The name poly(ADPRih) glycohyrlrolase was proposed for this cnzymc.
VI. Natural Occurrence Doly and Mandel (70) reported the natural occurrence of poly(ADPRib). They injected chickens with a dose of 300 pg of nicotinamide per 1OOg body weight and 4 hours later, 10 mCi of 32Piper 1OOg. The chickens were killed 6 hours later, and liver nuclei were separated. 3zPlabeled poly(ADP-Rib) was obtained by the method of Chambon et al. (4) in the presence of unlabeled poly (ADP-Rib) synthesized separately in vitro. They also showed that a hydrolyzate of this radioactive polymer contained radioactive Ado (P)-Rib-P. Hall reported the presence of 9- [2’ (3’)-O-ribosyl-~-~-ribofuranosyl] adenine in a crude preparation of tRNA of yeast ( 2 6 ) . Heated at 100” in 0.1 N HCl for 2 hours, this compound gave a single spot UV-absorbing corresponding to adenine. Only 1 mole of periodate was consumed per mole of ribosyladenosine, when determined a t pH 5.5. This indicated that one pair of vicinal hydroxyl groups in the molecule was blocked. Hall suggested that ribosyladenosine might arise from a fraction isolated fortuitously with tRNA (26).It is worth noting that the activity to
-
146
TAKASHI SUGIMURA
form poly(ADP-Rib) from NAD was found in a nuclear preparation isolated from yeast (40).
VII. Possible Biological Significance Since the discovery of the covalent bond between poly(ADP-Rib) or oligo(ADP-Rib) and nuclear proteins (&,64), it has been suspected that poly(ADP-Rib) may play a role in regulation of the function of chromatin. Burzio and Koide reported that a prior incubation of rat liver chrodTTP incorporation into acidmatin with NAD greatly reduces [ SH] insoluble material in the presence of three other kinds of dNTP. During this incubation, poly (ADP-Rib) is formed in chromatin. Incubation without NAD or with NAD plus nicotinamide did not produce this great decrease in the template capacity of chromatin for DNA synthesis ( W ) , as shown in Table 11. When chromatin was incubated with NAD and then with externally added DNA polymerase of Micrococcus luteus, its template activity was lost. Burzio and Koide concluded that the suppression of endogenous DNA polymerase activity in adult liver nuclei by a prior incubation with NAD is due to poly (ADP-Rib) , This observation was confirmed by Ueda et al. (72) and also be Hilz and Kittler ( 3 6 ) . Bureio and Koide (73) found that DNA obtained after complete removal of the protein from NAD-treated rat liver chromatin possesses template activity similar to that from untreated chromatin. Furthcrmorc stepwise removal of proteins from chromatin resulted in gradual release of the radioactivity of ADP-Rib and reduction of the inhibition. These results support the idea that the decrease in the template activity for DNA synthesis following incubation of chromatin with NAD is due to ADP-ribosylation of associated chromatin. Incubation of chromatin with NAD does not affect its capacity for RNA synthesis (73). TABLE I1 OF DNA SYNTHESIS INDUCED R Y PoLY(ADP-RIB) THEINHIBITION AND THE EFFECT OF NICOTINAMIDE
Prior incubation in the presence of -
NAD (4mM) NAD (4 mM) NAD (4 mM)
+ nicotinamide (10 mM) + nicotinamide (20 mM)
[JHIdTTP incorporation (cpm/100 mg protein) 2460 250 1500 2060
Inhibition
(%I 90 39 16
POLY (ADENOSINE DIPHOSPHATE RIBOSE)
147
Burzio and Koide (36)extended their work to other rapidly replicating tissues, regenerating liver and Novikoff hepatoma. They found again that DNA synthesis was greatly inhibited by incubation of nuclei from normal and regenerating liver with 4 mM NAD. On the contrary, treatment of nuclei from Novikoff hepatoma with 4 mM NAD did not alter thc template activity for DNA synthesis. They found that Novikoff hepatoma contained less of the total acid-insoluble radioactivity from labeled NAD in the histone fraction than other tissues. This suggests that ADPribosylation may be involved in regulation of DNA synthesis in normal and regenerating liver, but not in Novikoff hepatoma. Hilz and Kittler found that the endogeneous polymerase activity of the nuclei of Ehrlich carcinoma cells and HeLa 53 cells is suppressed by incubation with NAD ( 3 6 ) . This clear-cut difference between the effects of NAD on the nuclei of normal and malignant cells requires further studies. Smulson et al., using synchronized HeLa cells, reported that poly(ADP-Rib) polymerase showed maximal specific activity during the G1 phase and significantly lower specific activity during various periods of the S phase. This suggests that transfer of the ADP-Rib moiety from NAD to nuclear proteins is an important nuclear event at some time immediately before DNA replication ( 7 4 ) .Acetylation of histone showed a maximum in the late S phase in Chinese hamster cells (75) although Pogo et al. indicated that acetylation of histone occurs much earlier than the phytohemagglutinin-induced S phase (76). Poly(ADP-Rib) polymerase may be important in vivo in the control of the tissue concentration of the nicotinamide nucleotide (29). It was once thought that poly(ADP-Rib) might be a reservoir of NAD, but the reverse reaction, which should yield NAD from poly (ADP-Rib) and nicotinamide, was never observed (10). It is still possible that nicotinate can push the reverse reaction to produce deamido-NAD from poly(ADP-Rib) . Deamido-NAD could not be a substrate for polymerization ( l o ) , so that deamido-NAD could be reutilized to form NAD, if the reverse reaction with nicotinic acid was possible (39).The reversibility of formation of ADP-ribosylated nuclear proteins has not been studied extensively.
VIII. Related Phenomena A novel type of pyridine nucleotide, ADP-ribosyl NAD, was found in Azotobacter vinelandii by Imai et al. (77). ADP-ribose is linked glycosidically to NAD a t position 2' or position 3' of the nicotinamide mononucleotide moiety of NAD, giving a mixture of the a- and p-forms in
148
TAKASHI SUGIMURA
the configuration of the nicotinamide N-ribosyl linkage in the molar ratio of about 1 :1. However, ADP-ribosyl NAD did not serve as a coenzyme for yeast alcohol dehydrogenase and was not cleaved by Neurospora crmsa NAD glycohydrolase. Imai and Suzuki (78) also presented evidence of the occurrence of ATP-ribosyl NADP in the extract of Azoto-
bacter vinelandii. 5'-Phosphoribosyl pyrophosphate (P-Rib-PP) and ATP yielded phosphoribosyl-ATP, N-1- (5'-phosphoribosyl) adenosine triphosphate, with phosphoribosyl-adenosine triphosphate:pyrophosphate phosphoribosyltransferase, the enzyme involved in the first step of histidine biosynthesis. It was suggested that this enzymatic reaction proceeds through the formation of a covalent bond between the phosphoribosyl moiety and the enzyme (79). Ames described the spectra of N-1-ribosyladenosine 5'-triphosphate (80), which differ from those of adenosine-ribose. Honjo et al. (81) found that diphtheria toxin transferred the ADPRib portion of NAD to transferase 11,resulting in the inactivation of this enzyme and simultaneous release of a stoichiometric amount of nicotinamide. The covalent bond between ADP-Rib and transferase I1 is rather stable in alkaline conditions, unlike the bond formed on ADP-ribosylation of histone. A further difference of ADP-ribosylation of transferase I1 was that diphtheria toxin can catalyze the reverse reaction to form NAD from ADP-ribosylated transferase I1 and nicotinamide (82, 83). The ADP-ribosylation and the reverse reaction are most active a t p H 8.5 and 5.2, respectively. Diphtheria toxin does not catalyze either hydrolysis of NAD or the exchange reaction between NAD and nicotinamide (83). ADP-ribosylation of transferase I1 was also observed by Collier and Cole (841, Goor and Maxwell (85), Everse et al. (86) and Montanaro et al. (87).
IX. Future Problems Poly (ADP-Rib) was discovered in experiments in vitro on incubation of nuclear preparations of animal cells with NAD by groups of Mandel in Strasbourg ( 4 ) , of Sugimura in Tokyo (6-9) and of Nishizuka in Kyoto (10, 11).The natural occurrence of poly(ADP-Rib) was reported by Doly and Mandel (70).The most important outstanding problems at present are the demonstration of the existence of poly ADP-ribosylated, oligo ADP-ribosylated or ADP-ribosylated nuclear proteins in vivo. The chemical structure of the covalent bond between ADP-Rib and nuclear proteins should also be determined. Studies on phenomena related to chromatin function should also bc uscful. Thesc phcnomena include de-
POLY (ADENOSINE DIPHOSPHATE RIBOSE)
149
pression of template activity for DNA synthesis by poly (ADP-Rib) , inhibition of poly (ADP-Rib) synthesis by thyinidine and changes in the synthesis of poly (ADP-Rib) associated with the cell cycle. The physicochemical and biological properties of the highly purified polymer should also be investigated now that poly (ADP-Rib) can bc obtained in quantity. ACKNOWLEDGMENTS The author is grateful to Drs. S. Fujiniura, S. Haseyawa, Y. Shimizu, H. Okuyama, H. Matsubara, T. Shima, A. Oikawa, M. Yamada, M. Mina, N. Yosliimura, M. Nagao, H. Kagai and T. Matsusliima of this laboratory for their participation in experiments which made it possible to write this article. The work in the author’s laboratory was supported by grants from the Japanese Ministry of Education, the Japanese Ministry of Health and the Waksman Foundation.
REFERENCES 1. P . Chambon, J. D. Weill and P. Mandel, BBRC 11, 39 (1963). 2. S. Fujimura, T. Sugimura, K. Okabe and T. Yoshida, Seikngnki~( J . J a p . Biochem. Soc.) 37, 554 (1965). 3. S. Fujimura and T. Sugimura, SeikagaLzi ( J . Jap. Biochem. Soc.) 38, 691 (1966). Q. P. Cliambon, J. D. Weill, J. Doly, M. T. Strosser and P. Mandel, BBRC 25, 63s (1966). 5. J. Doly and F. Petek, C. R . Acntl. Sci. 263, 1341 (1966). 6 . S. Fujiniura, S. Hasegawa and T. Sugimura, BBA 134, 496 (1967). 7. T. Sugimura, S. Fujimura, S. Hasegawa and Y. Kawamura, BBA 138, 438 (1967). 8. S. Fujimura, S. Hasegawa, Y. Shimizu and T. Sugimura, BBA 145, 247 (1967). 9. S. Hasegawa, S. Fujimura, Y. Shimizu and T. Sugimura, BBA 149, 369 (1967). 10. Y. Nisliizuka, K. Ueda, K. Nakaznwn and 0. Hnyaishi, JBC 242, 3164 (1967). 11. R. H. Reeder, K. Ueda, T. Honjo, Y. Nishizuka and 0. Hayaishi, JBC 242, 3172 (1967). 12. T. Sugimura and S. Fujimura, Proteiir, Nucleic Acid and Enzyme 12, 1059 (1967). 13. T. Sugimura and Y. Shimizu, Seikagakii ( J . Jap. Biochem. Soc.) 40, 137 (1968). 14. J. Doly, P1i.D. Thesis, University of Strasbourg (1968). 16. T. Shima, S. Fujimura, S. Hasegawa, Y. Shimizu and T. Sugimura, JBC 245, 1327 (1970). 16. T. Sugimura, N. Yoshimura, M. Miwa, H. Nagai and M. Nagao, ABB 147, 660 (1971). 17. S. Hasegawa, S. Fujimura, Y. Shimizu, H. Okuyama and T. Suginiura, Seikagnku ( J . Jap. Biochem. Soc.) 39, 702 (1967). 18. E. B. Kellrr, BBlIC 17, 412 (1964). 19. E. Sulkonski and M. Laskowski, BBA 240, 443 (1971). 20. M. Yamada, unpublished. 91. M. Miwa, H. Nagni, T. Sugimura, M. Yamnda and N. Yoshimura, Seikagaku ( J . Jnp. Biochem. Soc.) 43, 685 (19771). 2.2. T. Shima. S. Hasegawa, S. Fujimura, H. Matsubara and T. Sugimura, JBC 244, 6632 (1969). 23. S. Fujimurn and T. Suyimura, in “Mctliods in Enzynioloyy,” Vol. 18U (D. B.
150
TAKASHI SUGIMURA
McCormick and L. D. Wright, vol. eds.), p. 223. Academic Press, New York, 1971. 34. H. Matsubara, S. Hasegan-a, S. Fujimura, T. Shima, T. Sugimuia and M. Futai, JBC 245, 3606 (1970). 26. H. Matsubara, S. Hascgtiwa, S. Fujimura, T. Shima, T. Sugimuia and M. Futai, JBC 245, 4317 (1970). 2G. R. H. Hall, Bchem 4, 661 (1965). ST. J. Chauveau, Y. MoulB and C. Rouiller, Exp. CeZl Res. 11, 317 (1956). 98. K.Marushige and J. Bonner, JMB 15, 160 (1966). 29. Y. Nishizuka, K . Ueda and 0. Hayaishi, in “Methods in Enzymology,” Vol. 18B (D. B. McCormick and L. D. Wright, vol. eds.), p. 230. Academic Press, New York, 1971. SO. Y. Nishizuka, K. Ueda, K. Nakazawa, R. H. Rccdcr, T. Honjo and 0. Hayaishi, J . Vitaminol. 14, Suppl. 1, 143 (1967). 31. T. Sugimura, unpublished. 32. J. Preiss, R. Schlaeger and H. Hilz, FEBS Lett. 19, 244 (1971). 33. H. Hilz and M. Kittler, Hoppe-Seyler’s Z.Physiol. Chem. 349, 1793 (1968). 34. S. Fujimura, Y. Shimizu, S. Hasegawa and T. Sugimura, Proc. Jap Cancer Ass. 26th Annu. Meeling 105 (1967). 36. L. Burzio and S. S. Koidr, FEBS Lett. 20, 29 (1972). 36. H. Hilz and M. Kittler, Hoppe-Seyler’s 2. Physiol. Chem. 352, 1693 (1971). 37. I. R. Johnston, A. P. Mathias, F. Prnnington and D. Ridge, Nature (London) 220, 668 (1968). 3s. I. R. Johnston, A . P. Mathias, F. Pennington and D. Ridge, BJ 109, 127 (1968). 39. M. E. Haines, I. R. Johnston, A. P. Mathias and D. Ridge, BJ 115, 881 (1969). 40. T. Sugimura, S. Fujimura, S. Hasegawa, Y. Shimizu and H. Okuyama, J . Vitamind. 14, 135 (1968). 41. K. Nakazawa, K. Ueda, T. Honjo, K. Yoshihara, Y. Nishizuka and 0. Hayaishi, BBRC 32, 143 (1968). 42. Y. Shimizu, S. Hasegawa, S. Fujimura and T. Sugimura, BBRC 29, 80 (1967). 43. M. Yamada, M. Miwa and T. Sugimura, ABB 146,579 (1971). 4.4. Y. Nishizuka, K. Ueda, K. Yoshihara, H. Yamamura, M. Takeda and 0. Hayaishi, CSHSQB 34, 781 (1969). 46. K. Ueda, R. H. Reeder, T. Honjo, Y. Nishizuka and 0. Hayaishi, BBRC 31, 379 (1968). 46. S. Hasegawa and T. Sugimura, unpublished. 47. A. Oikawa, Y. Itai, H. Okuyama, S. Hasegawa and T. Sugimura, Exp. Cell Res. 57, 154 (1969). 48. A. Oikawa and T. Sugimura, unpublished. 49. M. Futai, D. Mizuno and T. Sugimura, JBC 243, 6325 (1968). 60. M.Miwa and T. SugimurB, JBC 246, 6362 (1971). 61. K. Ueda, J. Oka, S. Narumiya, N. Miyakawa and 0. Hayaishi, BBRC 46, 516 (1972). 62. E. W. Johns, D. M. P. Phillips, P. Simson and J. A. V. Butler, BJ 77, 631 (1960). 63. Y.Nishizuka, K. Ueda, T. Honjo and 0. Hayaishi, JBC 243, 3765 (1968). 64. H. Otake, M. Miwa, S. Fujimura and T. Sugimura, J . Biochem. 65, 145 (1969). 66. R. C. Huang and J. Bonner, PNAS 54, 960 (1965). 66. W.J. Steele and H. Busch, Cancer Res. 23, 1153 (1963). 67. M.Miwa and T. Sugimura, unpublished. 68. M. Meilhnc, P1i.D. Thesis, Univewity of Strasbourg (1970).
POLY (ADENOSINE DIPHOSPHATE RIBOSE)
151
87, 258 (1963). GO. K. Murray, Bchem 3, 10 (1964). 61. M. G. Ord and L. A. Stocken, BJ 102, 631 (1967). G2. V. Riimer, J. Lambrecht, M. Kittler and H. Hilz, Hoppe-Seyler’s 2. Physiol. Chem. 349, 109 (1968). 03. J. B. Clark, G. M. Ferris and S. Pinder, BBA 238, 82 (1971). G4. S. G.A. Alivisatos, Federation Proc. 24, 769 (1965). G6. K. W.Bock, V. Gang, H. P. Beer, R. Kronau and H . Grunicke, EJB 4, 357 ( 1968). GO. L. J. Zatman, N. 0. Kaplan and S. P. Colowick, JBC 200, 197 (1953). G7. M. Yamada, M. Miwa and T. Sugimura, Seikagaku ( J . Jap. Biochem. Soc.) 42, 477 (1970). GS. M. Futai and D. Mizuno, JBC 242, 5301 (1967). GO. M. Futai, D. Miauno and T. Sugimura, BBRC 28, 395 (1967). 70. J. Doly and P. Mandel, C. R . Acad. Sci. 264, 2687 (1967). 71. L.Burzio and S. S. Koide, BBRC 40, 1013 (1970). 72. K. Ueda, Seikagaku ( J . Jap. Biochem. Soc.) 43, 438 (1971). 73. L.Burzio and S. S. Koide, BBRC 42, 1185 (1971). 74. M.Smulson, 0 . Henrilrsen and C. Rideau, BBRC 43, 1266 (1971). 76. G. R. Shephard, B. J. Norlond and J. M. Hardin, BBA 228, 544 (1971). 76. B. G. T. Pogo, V. G. Allfrey and A. E. Mirsky, PNAS 55, 805 (1966). 77. T.Imai, S . Okuda and S. Suzuki, JBC 244, 4547 (1969). 7s. T.Imai and S. Suauki, Protein, Nucleic Acid and Enzyme 15, 162 (1970). 78. R.M. Bell and D. E. Koshland, Jr., BBRC 38, 539 (1970). SO. B.N. Ames, R. G. Martin and B. J. Garry, JBC 236, 2019 (1961). 81. T.Honjo, Y. Nishizulca and 0. Hayaishi, CSHSQB 34, 603 (1969). 82. T.Honjo, Y. Nishiauka, 0. Hayaishi and I. Kato, JBC 243, 3553 (1968). 83. T. Honjo, Y. Nishizuka, I. Kato and 0. Hayaishi, JBC 246, 4251 (1971). 84. R. J. Collier and H. A. Cole, Science 164, 1179 (1969). 86. R.S. Goor and E. S. Maxwell, JBC 245, 616 (1970). 86. J. Eversc, D. A. Gardner, N. 0. Kaplan, W. Galasinski and K . Moldave, JBC 245, 899 (1970). 8Y. L. Montanaro, S. Sperti and A. Mattioli, BBA 238, 493 (1971). 69. D. M. P. Phillips, BJ
This Page Intentionally Left Blank
The Stereochemistry of Actinomycin Binding to DNA , and Its Implications in Molecular Biology HENRYM. SOBELL*
'
1
Department of Chemistry, The University of Rochester, Rochester, New York, and Department of Radiation Biology and Biophysics, The University of Rochester, School of Medicine and Dentistry, Rochester, New York
I. 1ntroduct.ion . . . . . . . . . . . . . 11. Solution Studies of the Actinomycin-DNA Interaction . . . A. Evidence Concerning the Polynucleotide Conformation . . B. Evidence Favoring Hydrogen-Bonded Recognition . . . C. Evidence Favoring Intercalation . . . . . . . . D. The Actinomycin-Deoxyguanosine Model Reaction . . . 111. The Actinomycin-DeoxyguanosineCrystalline Complex . . . A. Actinomycin Has 2-fold Symmetry . . . . . . . B. The Complex Has 2-fold Symmetry . . . . . . . C. The Water Structure . . . . . . . . . . IV. The Aetinomycin.DNA Complex . . . . . . . . A. Intercalation and Hydrogen Bonding to Base-Paired d G d C Sequences . . . . . . . . . . . . . B. Detailed Stereochemical Model . . . . . . . . C. Supporting Evidence . . . . . . . . . . D. Other Intercalating Agents . . . . . . . . . V. A General Principle Governing Protein-Nucleic Acid Recognition . A. Nuclease Specificity . . . . . . . . . . . B. Do Operators and Repressors Have 2-fold (or 4-fold) . . Symmetry? . . . . . . . . . . . C. A Model for Genetic Recombination . . . . . . . D. DNA Replication and Chromosome Structurc . . . . . VI. Possible Medical Implications . . . . . . . . . VII.Summary . . . . . . . . . . . . . . References . . . . . . . . . . . . . .
153 155 155 155 156 157 158 158 159 163 165 165 168 171 175 178 178 180 182 185 187 188 189
1. Introduction Actinomycin C1(D) is a cyclic-polypeptide-containing antibiotic widely used in the study of molecular and cell biology (Fig. 1). It is
* Present address : Department of Pharmncology, Stanford Universit.y School of Medicine, Pnlo Alto, California. 153
154
HENRY M. SOBELL
0
0
L-MeVal
Sar
o-Val
L - T ~ H,C/
MI
HN
L o I
I
CH,
o=c
/
CH,
I
I CHS
FIG. 1. Structure of actinomycin C,(D). Abbreviations: MeVal, methylvaline; Sar, sarcosine ; Pro, proline ; Val, valine ; Thr, threonine.
one of the most potent antitumor agents known, although, because of its extreme toxicity, has found only limited clinical use. The activity of the antibiotic stems from its ability to bind double-helical DNA and to inhibit specifically RNA synthesis (1-6).Deoxyguanosine residues are essential for the binding reaction as shown by extensive studies with naturally occurring and synthetic DNA duplexes (4, 6, 7 ) . The spectral perturbations that accompany actinomycin binding to DNA can be mimicked by the addition of deoxyguanosine to solutions of actinomycin (8),although similar spectral changes can be induced with a variety of other purines and organic aryl sulfonates (6, 9). Two models have been proposed to explain the binding of actinomycin to DNA. Thc first of these involves direct hydrogen-bonding recogniti’on between the guanine ring and the chromophore residue and is based on studies with a series of synthetic polymers possessing or lacking 2-amino functional groups on purine residues, as well as careful characterization of chcrnical groups on actinomycin essential for binding (10-12).The second model, based on detailed spectroscopic, hydrodynamic and kinetic measurements, and supported by observations that actinomycin promotes the unwinding of supercoilccl covalently circular DNA, involves inter-
STEREOCHEMISTRY OF ACTINOMYCIN BINDING TO
DNA
155
calation of the phenoxazone ring system between base pairs in the DNA helix, analogous to the binding of aminoacridines to DNA (9, 13, 14). This model, however, leaves unexplained the origin of guanine specificity in the binding reaction. We have already described a detailed molecular model for actinomycin-DNA binding which uses the geometry determined by X-ray crystallography of a n actinomycin. deoxyguanosine crystalline complex (15-19). Thc model is of broad interest for several reasons. I n the first place, it provides a structural explanation for a large mass of physical and biochemical data concerning the interaction of actinomycin with DNA and this, for the first time, correlates the three-dimensional structure of an antibiotic with its biological action. Second, the binding of actinomycin to DNA demonstrates two important structural features utilized by DNA in binding other types of molecules. The first of these, intercalation, is used in binding a large variety of drugs and antibiotics to the DNA helix (14), and the model provides detailed stereochemical information concerning this. The second feature concerns the demonstration of a general principle that several classes of proteins may utilize in recognizing symmetrically arranged nucleotide sequences on the DNA helix (,%-2S). The actinomycin-DNA stereochemical model presented here provides detailed information concerning this important principle, a principle central in our understanding of protein-nucleic acid recognition.
II. Solution Studies of the Actinornycin-DNA Interaction A large body of evidence is available concerning the interaction of actinomycin with DNA. This can be summarized as follows:
A. Evidence Concerning the Polynucleotide Conformation Actinomycin binds tightly to double helical DNA, but poorly, if a t all to double-helical RNA, an RNA-DNA hybrid helix, or single-stranded forms of DNA or RNA (24-26).
B. Evidence Favoring Hydrogen-Bonded Recognition The binding of actinomycin to DNA requires the presence of deoxyguanosine residues, the 2-amino group on guanine being essential for the binding reaction ( 4 ) . Thus, synthetic DNA-like polymers of the type, d(A-T),,, dA,,-dT,, d(1-C), and dI,.dC,, do not bind actinomycin, whereas polymcrs of the type, d (G-C) ,,, dG, dC,,, d (a2R-T)n1 and a?R = 2,6diaminopuriue nucleoside ; azR = 2-aminopurine nucleoside.
156
HENRY M. SOBELL
FIG.2. Unit structures of the synthetic polymers used in actinomycin binding studies. a2R = diaminopurine (nucleoside) . The associated homopolyrners, poly(dG* dC), poly (dI*dC), and poly(dA.dT) have also been synthesized and their binding properties studied. The 2-amino group on the purine residue appears to be essential for thc actinomycin binding reaction.
d(a2R-T),,l bind actinomycin tightly (7, 11, 24) (Fig. 2). The 2-amino group on the purine residue appears to be essential for the binding reaction. Substitution of the 2-amino group on the phenoxazone ring system with a hydroxyl-, chloro-, or a dimethylene amino group inhibits the actinomycin-DNA binding reaction (9,19).
C. Evidence Favoring Intercalation Addition of actinomycin to solutions containing low molecular weight (lo5) DNA causes an increase in the intrinsic viscosity and a decrease in the sedimentation constant for the complex ( 9 ) . Thc spectral changes observcd when actinomycin binds to DNA can be mimicked by the addition of a large number of different aryl sulfonates to solutions of actinomycin (9). The kinetics of association and of dissociation of actinomycin from DNA are sensitive to chemical substituents introduced on the 7-position of the phenoxazone ring system (9).
STEREOCHEMISTRY OF ACTINOMYCIN BINDIXC TO
DNA
157
The binding of actinomycin to covalently circular supercoiled DNA causes unwinding of the DNA, as evidenced by its sedimentation behavior a t increasing concentrations of actinomycin (IS).
D. The Actinomycin Deoxyguanosine Model Reaction It has been known for many years that a variety of purine nucleosides form complexes with actinomycin resulting in spectral changes similar to those observed in the actinomycin-DNA interaction (8). Of all the purine nucleosides tested, deoxyguanosine complexes most tightly with actinomycin, the association constant being 1.7 X lo3 M-l (26, 27). If ethanol-water solutions of actinomycin and deoxyguanosine are prepared
FIG.3. Single crystals of the actinomycin*deoxyguanosinecrystalline complex. Approximately X20.
158
HENRY M. SOBELL
and allowed to evaporate slowly at room temperature over several days, large single crystals develop containing actinomycin and deoxyguanosine cocrystallized as a 1:2 stoichiometric complex (Fig. 3 ) . The stoichiometry of the solid-state complex appears to be characteristic of the crystalline complex itself and does not reflect thc solution stoichiomctry from which the crystals arise.
111. The Actinomycin Deoxyguanosine Crystalline Complex Details of the X-ray analysis are not presented here, as they have already appeared (18). The crystalline complex consists of one actinomycin, two deoxyguanosine, and twelve water molecules, a total of 140 atoms (excluding hydrogens) in the asymmetric unit. The structure is observed a t atomic resolution.
A. Actinomycin Has 2-fold Symmetry The 2-fold symmetry is shown in Fig. 4, which shows a computerdrawn illustration of the actinomycin molecule as viewed down its approximate dyad axis (lying roughly along a vector connecting the 0-N bridging atoms in the phenoxazone ring). Although the symmetry is not exact (exact symmetry would require the amino group and the quinoid oxygen to be on both sides of the chromophore residue), both polypeptide chains closely obey this noncrystallographic 2-fold symmetry. The conformations of the peptide linkages are as follows: L-threonine-Dvaline, trans; D-valine-L-proline, cis; L-proline-sarcosine, cis; sarcosineL-methylvaline, trans; L-threonine-carboxamide carbonyl oxygen and carbon of chromophore, trans. A strong hydrogen bond exists between neighboring cyclic pentapeptide chains connecting the N-H of one Dvaline residue with the carbonyl oxygen of the other D-valine residue [2.94, 2.96 A]. No other hydrogen bonds stabilize the actinomycin structure either between chains or within chains. These findings are consistent with nuclear magnetic resonance data implicating the D-valine N-H groups as hydrogen bond donors, and also serve to confirm several of the assignments made regarding the conformation of the polypeptide chains (2830). It is evident from Fig. 4 that the quinoidal portion of the phenoxazone ring system is slightly twisted in a propeller-like fashion with respect to the aromatic portion of the chromophore. A marked deviation from planarity is observed for the amino group nitrogen atom, which lies 0.5 A from the least-squares plane of the phenoxazone ring system.
STEREOCHEMISTRY OF ACTINOMYCIN BINDING TO
DNA
159
FIG.4. Computcrdrnwn illustrniion of the nctinomycin molecule viewed down its approximate dyad axis. The phenoxazone ring is in the center of the figure and projects out toward the viewer. Hydrogen bonds connecting D-valine residues on neighboring chains are indicated by dashed lines. Note the twist of the quinoidal portion of t.he phenoxaaone ring system and the nonplanarity of the 2-amino group.
B. The Complex Has 2-fold Symmetry This symmetry is shown in Fig. 5. The two deoxyguanosine molecules interact with the two cyclic pentapeptide residues and stack on alternate sides of the phenoxazone ring system. A strong hydrogen bond [2.80, 2.82 A] connects the guanine %-amino group with the carbonyl oxygen of the L-threonine residue. A weaker hydrogen bond connects the guanine N-3 with the N-H group on this same L-threonine residue [3.15,3.25 A]. The conformation of both deoxyguanosine molecules is anti, this describing the relative orientation of the deoxyribose residues with the guanine
HENRY M. GOBELL
160
P
Q
F I ~5. . Same view as in Fig. 4, but with the two deoxyguanosine molecules in place. The approximate 2-fold symmetry of the complex is apparent. Notice a slight altcrat,ion in thc stacking of tlic deoxyguanosinc molecule immediately abovc the quinoidnl portion of the plienoxasone ring system, resulting from the nonplanarity of the chromophore in this region. Dotted lines indicate hydrogen bonds connecting thc actinomycin pcntnpeptidc chains with thc deoxygunnosine molccules.
rings ( 3 1 ) .One deoxyribose residue is puckered C3’endo-C2’exo, while the other is C2’endo-C3’em (32).The sugar residues of both deoxyguanosine molecules arc in closc stcric juxtaposition with the isopropyl groups of the L-methylvaline residues (see Fig. 6 ) , and hydrophobic contacts such as these, as well as the stacking of guanine and phenoxazone rings, imparts stabilization to thc complex. Hydrogen bonding, however, plays a key role in the association, and this explains the specificity that actinomycin dcmonstratcs for guanine residues in the modcl reaction ancl in the binding reaction with DNA. Related studies of associations bctwecn monomer
STEREOCHEMISTRY O F ACTINOMYCIN BINDING TO
DNA
161
FIG.6. Coniputcr-drawn illuxtration of tlic actinoni~cin.deoxyguanosine coinplcx viewed at an 80" angle to the phenoxazone ring system showing the sandwichlke stacked arrangement of guanine and phenoxazone rings. Dotted lines indicate hydrogen bonds connecting the nctinomycin pcntapeptide chains with the deoxyguanosine molecules.
purines and pyrimidines in solution and in thc crystalline state have demonstrated the importance of hydrogen bonding in base-pairing recognition (33-35), and, although the details of the stereochemistry differ, the same is truc in this examplc of protein-nucleic acid recognition. The 1 :Z stoichiotnetry of the complex is a direct consequence of the ,%fold symmetry of actinoinylcin and reflects the two chemically equivalent binding sites available to deoxyyuanosine for coinplex formation. It will bc scen that this has clccpcr mcaiiing with regard to actinomycin DNA binding, and, perhaps, to repressor-operator binding generally.
-
162
-...
HENRY M. SOBELL
-R
STEREOCHEMISTRY O F ACTINOMYCIN BINDING TO
DNA
163
C. The Water Structure The complete crystal structure is shown in Fig. 7. The structure contains 140 atoms in the asymmetric unit, of which 12 atoms are water oxygens (these and several symmetry-related water oxygens are shown as black balls). The water structure surrounding the complex is of particular interest in view of the large positive entropy change accompanying actinomycin -DNA binding, which probably reflects the rearrangement of water structure during the binding reaction ( 2 6 ) .Similar, but smaller, entropic changes accompany the actinomycin-deoxyguanosine solution association. The structure is stabilized by a total of 152 hydrogen bonds in each unit cell. Approximately 80% of these involve interactions with water structure. I n contrast with the symmetry observed in the complex, there appears to be little or no symmetry in the immediate water structure surrounding the complex. This reflects, in part, the amino and quinoid oxygen groups on the phenoxazone ring system, which are involved in water hydrogen bonding contacts, as well as a large amount of intermolecular hydrogen bonding between symmetry-related complexes that involve water bridges between various functional groups on the nucleosides and peptide chains. A significant number of water-water hydrogen bonding contacts are observcd, some of these resulting in “icelike” tetrahedrally coordinated structures. However, the majority act to bridge various functional groups on actinomycin and deoxyguanosine molecules, both within and between symmetry-related asymmetric units. The water structure appears to be well ordered and rigidly held in this structure (in contrast with thc situation in protein crystals), and this probably accounts for the hardness and excellent diffraction these crystals demonstrate. Almost all donor and acceptor groups are involved in hydrogen bonding. Exceptions are the nitrogen-7 on one deoxyguanosine and the methylFIG.7. The actinomycin*deoxyguanosine crystal structure as viewed down the axis. Black circles with highlights indicate water molecules. Deoxyguanosine molecules have been shaded with striped lines and are seen stacked above and below the plane of the cliromophore residue. The actinomycin molecule is indicated with dark open lincs and circlcs. Tlic surrounding crystal structurc is shown with lighter lines. Black dots indicate hydrogen bonds bctwecn atoms at neighboring levels. Daslicd lines indicate hydrogen bonds between atoms located at different levels in adjoining unit cells. Additional hydrogen bonding in tlic surrounding structure is indicated by small opcn circlcs. From Jain and Sobcll (IS). c
164
HENRY M. SOBELL
FIQ.8. Stepwise assembly of actinomycin.DNA complex using the space-filling Corey-Pauling-Koltun (CPK) molecular models. Top, left and right : actinomycin viewed down its dyad axis and perpendicular to the plane of thc chromophore, respectively. Middle, left and right: same views of act,inomycin.deoxygunnosine complex. Lower, left and right: same views of actinomycin. (dGdC) complex.
STEREOCHEMISTRY OF ACTINOMTCIK BINDING TO
DNA
165
valine carbonyl oxygen atom on one of the two pentapeptide chains. Although stacking of guanine and phenoxazone rings imparts energy of stabilization to the complex, it is clear that hydrogen bonding accounts for a far larger contribution to the total free energy of the lattice.
IV. The Actinomycin DNA Complex A. Intercalation and Hydrogen Bonding to BasePaired dG-dC Sequences This section provides a model for actinomycin- DNA binding that uses the geometry determined in the actinomycin. deoxyguanosine crystalline complex (Fig. 8 ) . Deoxycytidine 5'-phosphate is placed opposite deoxyguanosine to form a hydrogen-bonded guanine cytosine base pair. Adjacent deoxyguanosine and deoxycytidine residues immediately above and below the chromophore can then be connected by a phosphodiester bridge, giving rise to the sequence dG-dC. An immediate consequence of this is the close steric juxtaposition of the 2-amino group on the chromophore residue and a phosphate oxygen. A close steric contact is also noted between this amino group and the deoxycytidine furanose ring oxygen. These contacts suggest possible hydrogen bonding between these groups, although, in the case of the phosphate oxygen, hydrogen bonding may utilize a water bridge. It is of interest that, whereas this amino group appears to be important for actinomycin-DNA binding, it is not essential for the actinomycin .deoxyguanosine solution association (S6).This had previously suggested a geometric difference between these associations, but this must now be reexamined, Figures 9 and 10 show the complex with two base pairs added above and below the central intercalated base-paired dG-dC sequence. The 2-fold symmetry of the entire complex is apparent, this reflecting the 2-fold symmetry of the hexanucleotide duplex (both the sugar-phosphate chains as well as, in this case, the polynucleotide base sequence) coinciding with the 2-fold symmetry relating subunits on the actinomycin molecule. This important principle, first recognized by Bernardi in his studies of the nuclease enzyme, spleen acid deoxyribonuclease ( 2 0 ) , may be a general one used in protein-nucleic acid recognition and is discussed in detail below. The model predicts, therefore, that the chromophore on actinomycin intercalatcs between the base-paired dinucleotide sequence, dG-dC, while the peptide subunits lie in the narrow groove of the DNA helix and interact with deoxyguanosine residues on opposite chains through specific hydrogen bonds.
-
166
HENRY M. SOBELL
FIG.9. CPK space-filling model of actinomycin complexed with six base pairs, as viewed from the deep groove of the DNA helix. This model is obtained by adding two base pairs above, and two below, thc central intercalated d G d C sequence, shown in the lower portion of Fig. 8. The 2-fold symmetry of this complex is apparent.
STEREOCHEMISTRY OF ACTINOMYCIN BINDIX’G TO
DNA
167
FIG.10. CPK space-filling model of actinomycin complexed with six base pairs as viewed from the narrow groove of the DNA helix. The peptide subunits of actinomycin form numerous van der Waals contacts with atoms in both sugar-phosphate chains. The 2-fold symmetry of this complex is apparent,.
168
HENRY M. SOBELL
8. Detailed Stereochemical Model It is informative to review in detail the steps in assembly of the actinomycin- DNA hodel, beginning with the actinomycin molecule and the configuration obsetved in the actinomycin. deoxyguanosine crystalline complex. This is shown in Fig, 11 (A-D), and in Figs. 12 and 13 [these figures have been obtained from coordinates of the actinomycin. DNA model after careful model building studies using the Kendrew skeletal models ( i ' g ) ] . Figure 11A shows the actinomycin molecule viewed down its dyad axis. The two cyclic pentapeptide chains have been idealized to be related by exact 2-fold symmetry. The 7-carbon of the proline ring is puckered approximately 0.5A from the plane of the other four ring atoms and projects forward toward the viewer. This 2-fold symmetry means that the chemical environment above the plane of the chromophore is reproduced below the plane of the chromophore, neglecting the asymmetry of the phenoxazone ring system. It is not surprising, therefore, that the two deoxyguanosine molecules interact on opposite sides of the phenoxazone ring with the pentapeptide chains and that the complex has 2-fold symmetry (shown in Fig. 11B). The slight asymmetry in the complex reflects the twisting of one side of the phenoxazone ring system, which causes a small but significant stacking orientation change for the deoxyguanosine molecule located immediately above. Next, deoxycytidine is placed opposite deoxyguanosine using the Watson-Crick hydrogenbonded geometry. A phosphodiester bridge can then be formed connecting deoxyguanosine and deoxycytidine residues on either side of the phenoxazone ring, generating the unique dinucleotide sequence, dG-dC (Fig. 11C). Two base pairs are next added above and two below the central intercalated dG-dC sequence (Fig. 11D). The complete hexanucleotide sequence shown is $(A-T-G-C-A-T) . This DNA fragment (six base F i r s , or twelve nucleotides) interacts with. four hydrogen bonds and numerous van der Waals interactions with the actinomycin molecule. Figures 12 and 13 demonstrate steps in assembly of the actinomycin-DNA model as viewed from different angles in stereo pairs. Major structural features of the actinomycin * DNA stereochemical model therefore include: 1. Intercalation of the phenoxazone ring system between the baseFIG.11. Steps in assembly of detailed actinomycinaDNA stereochemical model. (A) Actinomycin, viewed down its approximate dyad axis. (B) the actinomycin. deoxyguanosine complex viewed down its dyad axis (compare with Fig. 5 ) . ( C ) The actinomycin. (dG-dC) complex. ( D ) The actinomycin- ( d A d T d G d C d A d T ) complex. Dotted lines indicate hydrogen bonds. Helix axis is shown by vertical dnsheddotted line. Arrows indicate 5' + 3' direction of DNA chains.
This Page Intentionally Left Blank
STEREOCHEMISTRY OF ACTINOMYCIN BINDING TO
DNA
169
FIGS.12 ( l o p ) and 13 (bottom). Coinl)utrr-l$~~nerat~d stereo pairs showing the steps in assembly of the actinomycin DNA model. These were kindly supplied by Dr. Louis Katz, Graphic Facility for Interactive Displays, Department of Biological Sciences, Columbia University, New Yo&, New York.
170
HENRY &I. SOBELL
paired dinucleotide sequence, dG-dC. This results in movement of both guanine residues approximately 1.25 A toward the helix axis and unwinding the helix - 18”.Both the chromophore and the guanine-cytosine base pairs are tilted 10” to a plane normal to the helix axis. The nonplanarity of the quinoidal portion of the phenoxazone ring system alters the stacking of guanine and cytosine residues immediately above and below, and this results in a twist of 8” between guanine-cytosine rings. Local asymmctry therefore exists in the DNA structure a t the site of intercalation. 2. Conformational changes in the sugar-phosphate backbone. The sugar puckering for both deoxyguanosine residues can be described by C3‘endo-C2’ezo. The puckering for all other sugar residues is C2’endoC3‘exo. The sugar pucker in the I3 form of DNA is also C2’endo-C3’ezo, whereas in the A form i t is C3’endo-C2’exo (37). Deoxyribonucleotides have considerable flexibility in this regard ( 3 8 ) , and it is not entirely unexpected that both sugar conformations appear in the intercalation site. The stereochemistry of the polynucleotide chain in the immediate vicinity of intercalation is best described by the conformation about the C4’-C5’ bond for deoxycytidine residues, this being gauche-&. All other residues are gauche-gauche in this respect, with the exception of deoxyguanosine residues, which are cis-gauche. The gauche-cis and cis-gauche conformations are stereochemically acceptable conformations, although they would be expected to have somewhat higher energies than gauchegauche or gauche-trans conformations. We feel that these are not unreasonable, however, in view of the large number of van der Waals contacts in the actinomycin. DNA complex that stabilize this structure. 3. The pcptide portion of the actinomycin molecule lying in the narrow groove of the DNA helix, connected through hydrogen bonds to guanine residues. A strong hydrogen bond [2.90, 2.93 A] connects the guanine 2-amino group with the carbonyl oxygen of the L-threonine residue, while a weaker hydrogen bond connects the guanine N-3 with the N-H group on this same L-threonine residue [2.97,3.08 A]. The hydrogenbonded configuration closely resembles that found in the actinomycin deoxyguanosine crystalline complex (compare Figs. 5 and 11B).I n addition to these hydrogen bonds, numerous van der Waals contacts occur between hydrophobic groups on the actinomycin molecule and the DNA structure and these provide additional stabilization to the interaction. The two cyclic pentapeptide chains are related by 2-fold symmetry. The axis of symmetry relating subunits on actinomycin coincides with the axis of symmetry relating the sugar-phosphatc backbone and base sequence on the DNA helix. 4. Thymine-adenine base pairs immediately proximal to the intercalated dG-dC dinucleotide sequence undergo unwinding. The twist angle
-
STEREOCHEMISTRY OF ACTINOMTCIN BINDING TO
DNA
171
is reduced from 36" in the B form of DNA to 28". This partly reflects the C3'endo-C2'ezo sugar pucker for deoxyguanosine residues and the base tilt of 10" that the thymine-adenine base pairs make with a plane normal axis of symmetry relating subunits on actinomycin coincides with the proline residues on the actinomycin pentapeptide chains. The adeninethymine base pairs farthest from the intercalation site are also tilted 10" .to the plane normal to the helix axis; however, they are related by a twist of 36" from the preceding thymine-adenine base pairs. The total unwinding angle generated when actinomycin binds to DNA is, therefore, -18" (-lSo), or -34". 5. An additional hydrogen bond (not shown) possibly connecting the 2-amino group on actinomycin with a phosphate oxygen on the neighboring sugar-phosphate chain through a water bridge. Another possible hydrogen bond may involve this amino group and the furanose ring oxygen on the deoxycytidine residue [3.20 A].
+
C.
Supporting Evidence The stereochemical model we propose reconciles the data suggesting intercalation as well as hydrogen-bonded recognition, and, in a sense, is a synthesis of the two previous models advanced for actinomycin DNA binding. The specificity actinomycin demonstrates in binding doublehelical DNA, but not double-helical RNA or an RNA-DNA hybrid helix, most probably reflects the steric requirement imposed by the cyclic pentapeptides to recognize the B rather than the A form of a polynucleotide duplex. The rigidity that double-helical RNA and the RNA-DNA hybrid helix demonstrate with regard to their A conformation may be equally important in excluding actinomycin binding (39-41). The large number of favorable van der Waals contacts made between the cyclic peptides and atoms in the narrow groove of the DNA helix undoubtedly provide added stabilization to the complex and act to exclude water during complex formation. Amino-acid substitutions that interfere with this favorable fit would reduce the biological potency of the antibiotic, and this is the case, as seen in Table I. When proline is replaced by hydroxyproline (or hydroxyproline acetate) in one cyclic pentapeptide, the biological activity of the antibiotic is diminished some 20-fold. When, however, proline is replaced by L-allohydroxyproline (or L-allohydroxyproline acetate) , there is only a small change in biological activity. This position effect is readily interpretable from the actinomycin DNA stereochemical model presented hcre. An immediate prediction that this model makes is that poly[d(G-C)] should bind actinomycin most firmly and with highest efficiency (every twelve nucleotides, or every six base pairs) of all the synthetic DNA
-
172
HENRY M. SOBELL
TABLE I EFFECT OF SELECTED SINGLEAMINO-ACID SUBSTITUTIONS ON ANTIBACTERIAL ACTIVITYOF ACTINOMYCINO Amino-acid residue in position 3 of chain Actinomycin
c1
100
Xa
215
X08
57
Xo8 AC
xos
2.5
XoB Ac
0
200 50 25 5 1.5
100
x1.
A
B
L-Pro L-7-oxoPro L-aHYP L-aHypOAc L-HYP bHypOAc L-7-oxoPro
L-Pro LPro >Pro GPro L-Pro L-Pro Sar
Relative activity
From Reich and Goldberg (6).
duplexes, and this is verified in Table 11. Other sequences containing guanine can bind actinomycin, but with lower affinity and with less efficiency. This can be explained by assuming a complex with similar geometry, but forming fewer (less than four) hydrogen bonds between the cyclic pentapeptides and the dinucleotide base-paired sequence. There may be steric strain accompanying this altered interaction, and this could explain the diminished efficiency of binding observed with these polymers. Related data on the interaction between actinomycin and a large number of deoxyribo-dinucleotide monophosphates are now available (42). The dinucleotide, pdG-dC, interacts strongly with actinomycin and in a coTABLE I1 EQUILIBRIUM CONSTANTS AND NUMBER OF BINDING SITESFOR DNA-ACTINOMYCIN INTERACTIONS" DNA
%G+C
72 42 100 100 P~ly[d(T-G)]*p~ly[d(C-A)] 50 Poly[d(T-C)].poly[d(G-A)] 50 POI~[~(T-T-G)].~O~~[~(C-A-A)] 33 Po~~[~(T-T-C)I*~O~~[~(G-A-A)] 33 Poly[d(T-A-C)].poly[d(G-T-A)] 33 Poly(d1) Micrococcus luteus DNA Salmon sperm DNA Poly[d(G-C)] Poly(dG)*poly(dC)
a
From Wells and Lanon (7).
KaPp(M+) x 10-6
Nucleotides per site
2.5
9 20 12 91 25 37 45 67 50 111
2.0
3.2 2.0 1.3 0.6 1.2 0.7 0.8 1.3
STEREOCHEMISTRY OF ACTINOMYCIN BINDING TO
DNA
173
pdG-dA
d pdA-dT
/ 0.W
0.87
1.31
1.75
(NUCLEOT I DEI m M
FIG. 14. (A) Actinomycin.deoxyribodinuc1eotide binding studies, as monitored by difference spectra at 425 nm. N corresponds to thymidine, cytidine, adenosine or guanosine. Actinomycin concentration, 20 p M . (B) Actinomycin.pdG-dC and *pdCdG binding curves. Actinomycin conrentration, 36 p M . Redrawn from Krugh (U).
operative fashion (see Fig. 14A and B ) . Other sequences (either individually, or as complementary pairs) bind actinomycin less tightly and do not demonstrate cooperativity. It is of interest that the four dinucleotides, pdC-dG, pdT-dG, pdA-dG and pdG-dG (in the presence or the absence of the complementary sequence), resemble deoxyguanosine in
174
HENRY M. SOBELL
their binding properties, the reaction being distinctly first order in character. Dinucleotides of the type pdG-dT and pdG-dA bind actinomycin less tightly, the former, however, binding actinomycin more tightly than the latter. The reaction, again, appears to be first order in character. These observations can be explained in stereochemical terms as follows (@): in thc case of dinuclcotides with the general sequence pdN-dG (wherc N represents eitlicr T, C, A or G), binding occurs using the same hydrogen-bonded geometry found in the actinomycin.deoxyguanosine crystalline complex, this involving interaction with both cyclic peptide chains independently, without steric interference. These complexes would not involve intercalation. On the other hand, dinucleotides of the type pdG-dA and pdG-dT can use the same hydrogen-bonded configuration as in the crystalline complex ; however, these complexes would involve intercalation. (These observations follow immediately from an examination of CPK models of these complexes.) Here, complex formation between one dinucleotide and actinomycin would interfere with further complex formation with the second dinucleotide. This reflects the altered stereochemistry imposed by a noncomplementary d G - d T or dG-dA base pair. In the first case, (guaninesthymine base-pairing), the fit is more closely of the Watson-Crick type than in the second case (guanine-adeninebasepairing), and this interference effect almost certainly reflects stereochemical considerations such as these. Detailed kinetic studies on the binding of actinomycin with DNA demonstrate that several fast steps occur initially in the binding reaction, followed by a slow step extending over several minutes (9). This slow step in binding has also been observed in actinomycin binding studies with pdG-dC (46).Although it is not possible to relate these kinetic steps directly with specific stereochemical events accompanying binding, it has been suggested that the prolonged last step may reflect a conformational change affecting the peptide subunits in the actinomycin molecule (9). An alternative explanation, however,-is that an additional conformational change occurs in the polynucleotide backbone during the final stages of complex formation, this involving a change in the deoxyribose sugar puckering from C2’enndo-CS’ezo (as found in the B form of DNA) to C3’endo-CfL’ezo (as observed in the final model). The detailed actinomycin *DNA stereochemical model proposed involves no significant conformational change of the actinomycin pentapeptides (other than, perhaps, a change in puckering of one of two proline rings); for this reason, we favor the latter explanation at this time. Further information is necessary to establish this point. One can therefore envisage the stepwise association of actinomycin with DNA as follows: actinomycin first intercalates between a base-
STEREOCHEMISTRY OF ACTINOMTCIN BINDING TO
DNA
175
paired dG-dC sequence, recognition initially provided by the specific water structure surrounding actinomycin and the polynucleotide backbone and base sequence. As intercalation continues, this ordered water structure is “squeezed out” and specific hydrogen bonding with guanine residues takes place. The polynucleotide conformation a t this stage may cxist with all deoxyribose sugars C2‘endo-C3’ezo, helix unwinding reflecting thc altered stereochemistry in the immediate intercalation site (-18”). The final slow step is an alteration of the deoxyguanosine sugar puckering to C3’endo-C2’ezo, this providing better steric fit between the actinomycin cyclic peptides and the sugar-phosphate chain. This last step provides additional stabilization and specificity to the binding reaction and is accompanied by additional helix unwinding of base pairs immediately above and below the intercalated base-paired dG-dC sequence (-16’).
D. Other Intercalating Agents A decade has now passed since Lerman proposed his intercalation model to explain the strong binding of aminoacridines with DNA (14). It has now become increasingly clear that a large number of additional drugs and antibiotics utilize intercalation to bind DNA (Fig. 15). In addition to the aminoacridines, proflavin and acridine yellow, which act as frameshift mutagens, the list of intercalating agents includes the trypanocides, ethidium and propidium bromides, antitumor antibiotics such as daunomycin, nogalomycin and actinomycin, the antimalarial drug chloroquine, and hycanthone, a possible hydroxylated metabolite of the antischistosomite Miracil D. Important as diagnostic features of an intercalative process are two related effects on the hydrodynamic behavior of DNA: an increase in viscosity and a decrease in sedimentation coefficient (14, 9, 43). An additional sensitive indication concerning this is the alteration of the sedimentation behavior of covalently circular supercoiled DNA in the presence of increasing concentrations of the intercalating drug or antibiotic ( I S , 44) (Fig. 16). At low relative levels of drug bound per nucleotide, a decrease in the sedimentation coefficient is observed for supercoiled closed-circular DNA, but not for “nicked” circular DNA. This can be explained by assuming that right-handed supercoiled DNA exists as a compact structure (therefore having a large sedimentation coefficient) whose superhclix density depends on the duplex unwinding deficiency at the time of closure. Each intercalation event acts to unwind the helix approximately - 18” (this number arrived a t through the stereochemistry of intercalation provided through the actinomycin * DNA binding model). This means that the binding of twenty dye molecules results in the removal of one superhelical turn in the circular DNA duplex.
H
n
Acridtne yellow
Proflavtn
Hycanthone
OC% OH
CHsO
0
0 OH
HO
Meh
w+
OMe
Nogahmycin
Daunomycin
7%
HN-CH-(CH,),-N-H
gy3
c1
CH
+/'
k,H8
I
H Chloroqutne
IreMtamine A
I
DNA
STEREOCHEMISTRY OF ACTINOMYCIN BINDING TO
24
177
24
22
w
22
20 18
20
16
18 16
o
a05
0.10
Ethidium molecules bound/nucleotide
a15
o ao2004~06a08 F’ruflovin decules bound/nucleotide
o
a02 0.04 006 Actinomycin molecules bound/nucleotide
FIG.16. (A) Effect of ethidium bromide on the s9 of +X174 replicative form. The D N A preparation contained 72% closed circles. (B) Effect of proflavin on the 520 of +X174 replicative form. The D N A preparation contained 67% closed circles. ( C ) Effect of actinomycin on the s2,, of +X174 replicative form. The D N A preparaand ( A ) show results from tion contained 75% closed circles. The symbols (0) resolved boundaries of closed circles and nicked circles, respectively. From Waring (13).
Unwinding this tightly coiled, covalently circular DNA would decrease its sedimentation coefficient, a minimum obtained when all superhelical turns are lost. Continued binding after this results in formation of superhelical turns of opposite handedness, and, because of the coiled nature of this structure, the sedimentation coefficient increases. A detailed analytical theory for this process has been described (45, 46). It is of interest that the steroidal diamine, irehdiamine A, produces a clear rise and fall in the sedimentation coefficient of covalently circular supercoiled DNA; these findings are consistent with intercalation (13) (Fig. 17). This compound is, of course, a puckered ring structure and intercalation in the normal sense is not possible. The interaction with DNA appears to be biphasic as judged by optical thermal denaturation studies. At lower concentrations, irehdiamine A stabilizes DNA from thermal denaturation, whereas a t higher concentrations, the opposite is true (47). It has been suggested that these findings reflect two types of complexes, one involving electrostatic interactions between the protonated amino groups on irehdiamine A and the phosphate groups on opposite DNA chains, the other involving some nonspecific ordered micelle formation outside the helix ( 4 7 ) .It is possible that the first type of complex acts to unwind the helix by a nonintercalative mechanism, stabilizing the A FIG.15. Structural formulas for compounds thought to intercalate into the D N A helix. The steroidal diamine, irehdiamine A, has been included among these compounds, although its mode of binding is uncertain.
178
HENRY M. SOBELL
24
22
8 20
b
18
16 I
0 0.01
I
I
0.1 0.3 IDA/nucleotide ratio
0.03
I
1.0
3.0
FIG.17. Effect of irehdinminc A on the sill of +X174 re1)licwtivc form. Thc DNA preparntion contained 74% closed circles. The symbols (0) and ( A ) shorn results from resolved boundnries of closed circles and “nicked” cirrles. rrspcctirrly. From Waring ( I S ) .
form of the DNA duplex. An alternative explanation, however, is that the steroid nucleus fits between base pairs in the DNA helix, this accompanied by local denaturation of base pairs immediately above and below the intercalation site. Such an interaction is sterically feasible, and is immediately consistent with the sedimentation behavior of covalently circular supercoiled DNA in the presence of the steroid. Further data are necessary to elucidate the precise manner in which irehdiamine A binds to DNA.
V. A General Principle Governing ProteinNucleic Acid Recognition
A. Nuclease Specificity The binding of actinomycin to DNA demonstrates a general principle that several classes of proteins may utilize in recognizing symmetrically arranged nucleotide sequences on the DNA helix. This is shown schematically in Fig. 18A and B. Two nucleases that form double-strand scissions in DNA have been described (20, 2 2 ) . The first of these, a spleen acid deoxyribonuclease, is a dimer containing identical subunits. The enzyme is strongly inhibited by actinomycin, and was therefore thought to attack guanine-rich sequences. Bernardi (20) postulated that if the subunits of this enzyme were related by 2-fold symmetry, this would allow the enzyme to recognize the dyad axis on DNA, and, if each subunit had an active site, permit simultaneous double-strand scissions of the sugar-phosphate
STEREOCHEMISTRY OF ACTINOMYCIN BINDING TO
A
8
DNA
179
NUCLEASE SPECIFICITY ACTINOMYCIN SPECIFICITY
. P".
P"
GC
..
3' 5'
3' 5'
poly[d(G-C]]
M./uteus DNA
. .
BERNARD1 ( 2 0 )
KELLY 8 SMITH (22)
A
C
5' 3'
..
G C A T A T
... ...
DlMER RECOGNITION BERNARD1 (20) MONOD (21) KELLY (L SMITH ( 2 2 )
A T A T T A
3' 5'
..
TETRAMER RECOGNITION GIERER (23)
_ *_ _. _ * .
3' 5'
C
C
FIG.18. A schematic diagram illustrating the general principle governing proteinnucleic acid recognition, as exemplified by actinomycin. DNA binding specificity and endonuclease specificity (A and B). If a protein molecule has identical subunits related by 2-fold symmetry when it binds to DNA-the 2-fold axis coinciding with the dyad axis on DNA-then a necessary consequence is that the base sequence in the recognition site have 2-fold symmetry. (C) Extension of this general principle for dimer recognition to include tetramer recognition. One postulates a tandem genetic duplication of the DNA sequence involved in dimer recognition, followed by a hydrogen-bonding rearrangement. This nucleic acid structure can then be recognized by a tetrameric protein having identical subunits related by 4-fold symmetry. Patterns of recognition such as these may exist between operators and repressors.
180
HENRY M. SOBELL
backbone. A necessary consequence of this type of recognition would involve symmetrically arranged sequences, such as dC-dG or dG-dC, the latter being the sequence that actinomycin binds preferentially. The second nuclease is a restriction enzyme isolated from Hemophilus influenme that recognizes the symmetrically arranged hexanucleotide sequence shown in Fig. 18B and introduces a double-strand scission a t its central singularity. Although the subunit character of this enzyme is not yet established, Kelly and Smith (22) postulated a similar protein-nucleic acid recognition pattern for this restriction enzyme. It is of interest in this connection that Meselson and Yuan (48) have demonstrated that two classes of heteroduplex X ( 0 : K ) DNA produced by annealing isolated strands, one modified, the other not modified, are resistant to attack by E . co2i endonuclease. Thus, modification (presumably by methylation) of one strand imparts immunity from the restriction enzyme to the other strand, suggesting some type of 2-fold symmetry a t the recognition site. It remains to be seen whether these findings generally apply for restriction and modification systems in other bacteria [for recent reviews, see Arber and Linn (49) and Boyer (&I)].
B. Do Operators and Repressors Have 2-fold (or 4-fold) Symmetry? The binding of actinomycin to DNA (in particular, to dG-dC sequences) and its specificity in inhibiting the RNA polymerase reaction suggest a primitive repressor-operator character for this complex, which may prove to have more general meaning with regard to the recognition of naturally occurring operators by repressors. If a repressor molecule has identical subunits related by 2-fold symmetry when it binds to DNAthe 2-fold axis coinciding with the dyad axis on DNA-a necessary consequence is that the base sequence in the operator have 2-fold symmetry. This would be true regardless of precisely which groove (or grooves) the repressor binds. This geReral principle for dimer recognition can be extended to include tetramer recognition in the following way (see Fig. 18C).One postulates a tandem genetic duplication of the DNA sequence involved in dimer recognition, followed by a hydrogen-bonding rearrangement (23). This generates a cloverleaf-like structure that can be recognized by a tetrameric protein having identical subunits arranged in one of two ways. If the subunits of the protein are related by 4-fold symmetry, the operator must be a structure that itself possesses 4-fold symmetry, as indicated in Fig. 18C. Alternatively, if the subunits of the protein are related by only 2-fold symmetry (in particular, by one 2fold axis of symmetry), then the operator structure must also have this symmetry. Such a structure can be obtained from the cloverleaf structure
STEREOCHEMISTRY OF ACTINOMYCIN BINDING TO
DNA
181
A FIG.19. Alternative arrangements for a tetrameric protein containing identical subunits interacting with a Gierer-like operator site. (A) One 2-fold axis of symmetry replaces the 4-fold axis of symmetry. This figure is obtained from the right-hand figure shown in Fig. 18C by bending the horizontal leaves forward and the vertical leaves backward, giving rise to a roughly tetrahedral arrangement. It is noticed that the operation that takes the front dimer into the back dimer is a twist of go", a translation away from the viewer, and a change in the protein-protein subunit interaction necessary to sense the same nucleic acid chemical environment. One must thereforc postulate either different protein-protein subunit contacts to achieve identical environments for protein-nucleic recognition, or the same proteinprotein subunit contacts giving rise to different environments for protein-nucleic recognition. Both alternatives are unlikely. (B) 222 symmetry relating protein subunits to nucleic acid cloverleaf structure. Exact 222 symmetry is not possible without interrupting the continuity of the polynucleotide chain. However, pseudo-222 symmetry remains an nlternnte, although. for steric and energetic reasons, a less likely, possibility.
by bending the horizontal leaves forward and the vertical leaves backward, in a roughly tetrahedral arrangement (Fig. 19A). This gives rise to two distinct chemical environments involved in protein-nucleic acid recognition, however, and for this reason seems less likely. Higher symmetry, i.e., 222 symmetry, although possible for a tetrameric protein, is not (strictly speaking) possible for the operator structure shown without breaking the continuity of the polynucleotide backbone (Fig. 19B). While no structural evidence is yet available concerning the arrangement of subunits in the lac or the A repressors, the lac repressor is known to bind DNA as a tetramer (51, 5 2 ) , while the repressor may bind DNA in dimeric form (53, 54). The precise symmetry relating subunits of the 2ac repressor will eventually be revealed by X-ray crystallography; however, strong genetic evidence (55, 56) already points to the existence of %-fold symmetry in the lac operator genetic map (operator-constitutive mutants possessing similar levels of constitutive p-galactosidase activity) , with higher order subdivision possible. These findings, along
182
HENRY M. SOBELL
with the observations that lac repressor binds d (A-T) , selectively with high affinity (57), directly support the Gierer-like operator structure shown in Fig. 18C. However, the most definitive evidence regarding this will be provided by nucleotide sequence data of the lac operator and the X operator (s), and such studies are in progress (58,59).
C. A Model for Genetic Recombination The concept that regions of DNA possessing symmetrically arranged polynucleotide base sequences can exist either as Watson-Crick structures or Gierer-like structures (the latter being induced by a specific structural protein or proteins), leads to a simple but powerful molecular model to explain genetic recombination. This is shown schematically in Figs. 20 and 21. Any model for genetic recombination must explain: (i) the pairing of homologous chromosomes and events leading to reciprocal recombination ; (ii) gene conversion and polarity effects observed with gene conversion resulting in nonreciprocal genetic exchange [see Emerson (60) for an excellent recent review on linkage and recombination a t the chromosome level] ; (iii) genetic and physical chemical evidence regarding singlestrand exchange (the formation of insertion heteroduplexes, as, for example, in transformation), and double-strand exchange (with central heteroduplex formation, as occurs in breakage and reunion with flanking marker exchange) [see Bodmer and Darlington (61) for a review in linkage and recombination a t the molecular level] ; (iv) branched T 4 DNA molecules, which are observed in T 4 pol-lig- phage infection and interpreted as intermediates in T 4 recombination (62). The model presented explains these observations and involves the following features: (i) chromosomes pair due to the formation of Giererlike structures induced by a specific recombination structural protein (8) ; (ii) a Holliday (63) heteroduplex structure is formed, and this can migrate in either direction along the parental DNA molecules; (iii) reciprocal recombination results from the action of a nuclease or nucleases possessing 2-fold symmetry. Details of the model are as follows (see Figs. 20 and 21). Symmetrically arranged polynucleotide base sequences on homologous chromosomes (spaced every operon length or so along the chromosome) are fist converted to their Gierer structures in the presence of a specific structural protein(s), which, for simplicity, we shall call a recombination protein. Typically, a symmetrically arranged sequence contains central sequences [E,G] and [H,F] that do not possess symmetry. Therefore, the Gierer structure contains loops of single-stranded DNA susceptible (either randomly or with specificity) to nuclease attack. When complementary loops
STEREOCHEMISTRY OF ACTINOMTCIN BINDING TO
A
r’? _A.._ _.1._
A I‘
y
DNA
183
B
B
5’ 3,
.... ____
..
..
?’
A I 1 G C C A T G G
1A T A GC CG CG
tO Ei
C G A T A 1
AT A T
_; $-
I A --__ C G
GC
Ei E Z:G 2: -1g TA T A GC CG CG A T T A GC GC CG A T A T T I
_ _.._ _ j.5
1 A A C G G 1 A C C
A T A 1
H;:F GC A T 1 A
_ A_T _TA_ I T G C
A A C G
1 G G C A A T
A C C G T T A
:F
_ ._ _._
.. ..
.. .. I’ 5’
D
C
A T
FIG.20. A model for genetic recombination. Homologous chromosomes A-C and B-D possess specific regions (prrhaps placed every operon length or so along the chromosome) capable of forming Gierer-like structures in the presence of a specific recombination structural protein. Regions such as E-G and H-F form single-stranded denatured loops outside the immediate environment of the protein (which senses only the symmetry-related nucleic arid structure shown) and are therefore suscrptible to nuclease attack (shown by the arrows). When complementary loops G, H are “nicked” and opened, Watson-Crick base-pairing occurs, this followed by extensive propagation of the heteroduplex (shown in the lower two figures), The final structural intermediate is shown in the center of Fig. 21.
184 A
f. ?
..
..
HENRY M. SOBELL
B
I' I' ....
Ji
.... Y
C
D
5'
?
HOLLIDAY (1964)
BROKER & LEHMAN (1971)
FIG.21. A model for genetic recombination (continued). The central structural intermediate can give rise to the Broker-Lehman heteroduplex structure (62)in the absence of polynucleotide ligase, or to the Holliday heteroduplex (63) in the presence of polynucleotide ligase. The Holliday heteroduplex possesses 2-fold symmetry. It can therefore be recognized by a nuclease possessing 2-fold symmetry, which would be able to simultaneously nick strands of the same polarity at homologous sites. This could give rise to reciprocal recombination involving either single- or doublestrand exchange, depending on which strands were cut and joined. Another feature of this heteroduplex structure that results from its 2-fold symmetry is its ability to migrate (by rotary diffusion) in either direction along parental DNA molecules without unwinding difficulties. This would allow recombination to occur randomly throughout the genome and could give rise to polarity effects observed in gene conversion.
are "nicked," i.e., [G,H] , homologous Gierer structures can then come together through base pairing, this followed by propagation of the heteroduplex (the details of which are shown in the lower figures in Fig. 20). One then arrives a t the central intermediate shown in Fig. 21. I n the absence of ligase, this intermediate can become the BrokerLehman structure ( 6 2 ) . I n the presence of ligase, one can form the Holliday heteroduplex. This results from base pairing of "sticky ends" [H,G], followed by sealing of "nicks" in the polynucleotide chain by ligase. The Holliday heteroduplex is a particularly interesting structure
STEREOCHEMISTRY OF ACTINOMYCIN BINDING TO
DNA
185
in that it possesses 2-fold symmetry. It can therefore be recognized by n nuclease possessing 2-fold symmetry, which would simultaneously act to nick strands of the same polarity a t homologous sites. This would give rise to reciprocal recombination involving either single- or doublestrand exchange, depending on which strands were cut and joined. Another feature of the heteroduplex structure (which results from its 2fold symmetry) is its ability to migrate in either direction along parental DNA molecules without unwinding difficulties. This would allow genetic recombination to occur randomly throught the genome and, in addition, could explain polarity effects observed in gene conversion (64). For further details of the model and its genetic implications, see Sobell (65, 77). The model is attractive in its simplicity and logical design. It leads, furthermore, to models of DNA replication and of chromosome structure as well, and these are outlined below.
D. DNA Replication and Chromosome Structure The existence of Gierer-like loops induced by specific structural proteins and spaced every operon length I r so along the chromosome would provide single-stranded regions capablt of base-pairing with small (DNA or RNA) oligonucleotides, these possibly acting as primers for DNA polymerase activity. If these primers consisted of symmetrically arranged base sequences (for example, dA-dT or dA-dT-dA-dT) , DNA synthesis could proceed bidirectionally, resulting in newly synthesized DNA fragments of roughly operon size (see Fig. 22). These fragments could then be joined by polynucleotide ligase to form a continuous polynucleotide chain. The model is attractive in that it utilizes the known chemical properties of the DNA polymerase enzymes and their requirement for primer and template DNA (66-68). It also provides an explanation for the uniforrnity in size of newly replicated DNA fragments in alkaline sucrose gradients (69, 70). Finally, it is consistent with the replicon model for chromosomal replication (71), and these, as well as other aspects of the model will be discussed in further detail elsewhere (77). The ability of a specific protein to bind DNA a t specific sites leads to a model for DNA folding that may be relevant in understanding chromosome structure. One can imagine two states possible for a long DNA molecule, an extended linear state and a folded state (see Fig. 23A and B) , the latter reflecting protein-protein polymerization (either involving covalent or noncovalent bonding). Such a model can be used to explain the morphology of the lampbrush chromosomes [see, for example, a recent review by Taylor (%)I and the Drosophila and Chironomus giant chromosomes (73, 7 4 ) . A folded polymer state may
HENRY M. SOBELL
186
..
5' 3'
3' 5'
FIG.22. A model for DNA replication. Gierer-like loops induced by specific structural proteins and spaced every operon length or so along the chromosome could provide single-stranded regions capable of base-pairing with small (DNA or RNA) oligonucleotides (in this example, dAdT), these acting as primers for DNA polymerase activity. Synthesis could proceed bidirectionally and could simultaneously involve scveral continguoris Gierer-loop regions, this resulting in newly synthesized DNA fragments of roughly operon size. These fragments could then be joined by polynuclcotidc ligase to form a continuous polynucleotide chain.
explain the viscoelastic gel formation observed by Dounce and others for salt-extracted chromatin (75, 7 6 ) .The stability of this DNA-residual protein gel complex is very sensitive to disulfide reducing agents, such as mercaptoethanol, as well as to deoxyribonuclease and various pro-
STEREOCHEMISTRY OF ACTINOMTCIN BINDING TO
DNA
187
FIG.23. A model of DNA folding. If a protein binds to DNA at specific sites, it is possible for the polymer to exist in two states, an extended linear state (A) and n folded state (B). This simple model can be used to explain (in part) the morphology of the lampbrush chromosome and the Drosophila and Chironomus giant polytene chromosomes ( C ).
teinases. Observations such as these are consistent with a folded polymer state model forming the skeletal framework for mammalian chromosomes, and this as well as other aspects of chromosome structure will be discussed more completely elsewhere (77).
VI. Possible Medical Implications The detailed stereochemistry of actinornycin binding to DNA suggests a ratiorialc for thc synthesis of iicw variants of the actinomycin molecule that may find clinical use iii chemotherapy or neoplastic disease and viral infection. One of the major problems in using actinomycin
188
HENRY M. SOBELL
clinically is its extreme toxicity, since it passes through the cellular membrane of both normal and malignant cells without specificity. If it were possible to alter the peptide portion of the actinomycin molecule so as to change its permeability properties with respect to normal and malignant cells, the antibiotic could become a clinically useful drug. Thus, for example, D-valine could be replaced by a derivative of D-valine possessing a long alkyl chain, giving the actinomycin molecule a “tail.” A substitution such as this probably would not affect the ability of the molecule to bind to DNA, but may selectively prevent entrance of the antibiotic into a given cell type. One would hope that a proper tail could be devised that would prevent the antibiotic from passing through the normal cellular membrane while having little effect on transport across the malignant cellular membrane. Along the same lines, one might covalently attach the actinornycin molecule (through its “tail”) to serum albumin and hope that malignant cells that demonstrate pronounced pinocytosis will phagocytize these molecules and poison themselves with actinomycin. Other possible modifications may involve stereospecific peptide subunits designed to recognize other types of base sequences in DNA. These would serve as useful probes in the study of nucleic acid function, and may find chemotherapeutic use in the treatment of certain viral (DNA) infections. Finally, one wonders whether it may be possible to create an actinomycin-like antibiotic able to bind to doublehelical RNA. This would perhaps have use in the treatment of viral (RNA) infections as well as in the area of oncogenic research.
VII. Summary We have successfully cocrystallized actinomycin with its DNA substrate, deoxyguanosine, and have solved the three-dimensional structure of the complex by X-ray crystallography. The configuration observed in the crystalline complex explains in a natural way the stereochemistry of actinomycin binding to DNA. The phenoxazone ring system on actinomycin intercalates between the base-paired dinucleotide sequence, dGdC, while the peptide subunits lie in the narrow groove of the DNA helix and interact with deoxyguanosine residues on opposite chains through specific hydrogen bonds. The binding of actinomycin to DNA demonstrates a general symmetry principle that several classes of proteins may utilize in recognizing symmetrically arranged nucleotide sequences on the DNA helix. ACKNOWLEDGMENTS This work has been supported in part by grants from the National Institutes of Health, the National Science Foundation, the American Cancer Society, and the
STEREOCHEMISTRY OF ACTINOMYCIN BINDING TO
DNA
189
Atomic Energy Commission. H. M. S. was a recipient of a research career development award from the National Institutes of Health during part of the course of this work. This paper has been assigned report No. TTR-34!NK)-179nt, the Atomic Energy Project, the University of Rochester.
REFERENCES 1. J. Kirk, BBA 42, 167 (1960). 2. W. Kersten, H. Kersten, and H. M. Rauen, Nature (London) 187, 60 (1960). 3. E. Reich, R. M. Franklin, A. J. Shatkin, and E. L. Tatum, Science 134, 556 (1961). 4. I. H. Goldberg, M. Rabinowite. and E. Reich, PNAS 48, 2094 (1962). 6 . J. Hurwitz, J. J. Furth, M. Malamy, and M. Alexander, PNAS 48, 1222 (1962). 6. E. Reich and I. H. Goldberg, This series, 3, 183 (1964). 7. R. D. Wells and J. Larson, J M B 49, 319 (1970). S. W. Kersten, BBA 47, 610 (1961). 9. W. Miiller and D. M. Crothers, JiMB 35, 251 (1968). 10. L. Hamilton, W. Fuller, and E. Reich, Nature (Lotidon) 198, 538 (1963). 11. A. Cerami, E. Reich, D. C. Ward, and I. H. Goldberg, P N A S 57, 1036 (1967). 12. E. Reich, I. H. Goldberg, and M. Rabinowitz, Nature (London) 196, 743 (1962). 13. M. Waring, JMB 54, 247 (1970). 14. L. S. Lermm, J M B 3, 18 (1961). 16. H. M. Sobell, S. C. Jain, T. D. Sakore, and C. E. Nordman, Nature (Londoit) 231, 200 (1971). 16. H. M. Sobell, S. C. Jain, T. D. Sakore, G . Ponticello, and C. E. Nordman, CSHSQB 36, 263 (1971). 17. H. M. Sobell, Jerusalem Symp. Quaiit. Chem. Biochem. 4, 149 (1972). 1s. S. C. Jain and H. M. Sobell, J M B 68, 1 (1972). 19. H. M. Sobell and S. C. Jain, J M B 68, 21 (1972). 20. G. Bernardi, Aduan. Enzymol. 31, 1 (1968). 21. J. Monod, in “Symmetry and Function of Biological Systems a t the Macromolecular Level,” Nobel Symp. 11, p. 15. Wiley, New York, 1969. $2. T. J. Kelly and H. 0. Smith, J M B 51, 393 (1970). 23. A. Gierer, Nature (London) 212, 1480 (1966). 94. E. Reich, in “The Role of Chromosomes in Development” (M. Locke, ed.), pp. 73-81. Academic Press, New York, 1964. 26. R. Haselkorn, Science 143, 682 (1964). 26. M. Gellert, C. E. Smith, D. Neville, and G. Felsenfeld, J M B 11, 445 (1965). %’. M. Behme and E. H . Cordes, BBA 108, 313 (1965). 25. S. S. Danyluk and T. A. Victor, Jerusnlem Symp. Qunnt. Chem. Biochem. 2, 394 (1970). 29. F. Conti and P. De Santis, Nature (London) 227, 1239 (1970). 30. B. H. Arison and K. Hoogsteen, Bchem 9, 3976 (1970). 31. J. Donohue and K. N. Trueblood, J M B 2, 363 (1960). 32. M. Sundaralingam, JACS 87, 599 (1965). S3. H. M. Sobell, in “Genetic Organization” (E. Caspari and A. W. Rarin. eds.), Vol. 1, 11. 91. Academic Press, New York, 1969. 3g. H. M. Sobell, Jerusalem Symp. Qttnnt. Chem. Biochem. 4, 124 (1972). 36. D. Voet and A. Rich, This series, 10, 183 (1970). 36. E. Reich, Science 143, 684 (1964).
190
HENRY M. SOBELL
37. S. Arnott, P r o p . Bwphys. Mol. Biol. 21, 205 (1970). 38. M. Sundaralingam, Biopolymeis 7 , 821 (1969). 39. S. Arnott, M. H. F. Wilkins, W. Fuller, and R. Langridge, JMB 27, 525 (1967). 40. S. Arnott, M. H. F. Wilkins, W. Fuller, and R. Langridge, JMB 27, 535 (1967). 41. G. Milman, R. Langridge, and M. J. Chamberlin, PNAS 57, 1805 (1967). 42. T. R. Krugh, PNAS 69, 1911 (1972). 43. W. Kersten, H. Kersten, and W. Szybalski, Bchem 5, 236 (1966). 44. W. Bauer and J. Vinograd, JMB 33, 141 (1968). 46. W. Bauer and J. Vinograd, JMB 47, 419 (1970). 46. W. Bauer and J. Vinograd, JMB 54, 281 (1970). 47. H. R. Mahler, G. Green, R. Goutarel, and Q. Khuong-Huu, Bchem 7, 1568 (1968). 48. M. Meselson and R. Yuan, Nature (London) 217, 1110 (1968). 4.9. W. Arber and S. Linn, ARB 38, 467 (1969). 60. H. W. Boyer, Annu. Rev. Microbiol. 25, 153 (1971). 61. W. Gilbert and B. Muller-Hill, PNAS 58,2415 (1967). 62. A. D. Riggs, H. Suzuki, and S. Bourgeois, JMB 48, 67 (1970). 63. V. Pirrotta, P. Chadwick, and M. Ptashne. Nnture (London) 227, 41 (1970). 64. P. Chadwick, V. Pirrotta, R. Steinberg, X. Hopkins, and M. Ptashne, CSHSQB 35, 283 (1970). 66. T. F. Smith and J. R. Sadler, JMB 59, 273 (1971). 66. J. R. Sadler and T. F. Smith, JMB 82, 139 (1971). 67. S. Y. Lin and A. D. Riggs, Nature (London) 228, 1184 (1970). 68.
M. Ptashne, personal communication.
69. W. Gilbert, personal communication. 60. S. Emerson, in “Genetic Organization,” (E. Caspari and A. W. Ravin. eds.), Vol. 1, p. 267. Academic Press, New York, 1969. 61. W. F. Bodmer and A. J. Darlington, in “Genetic Organization” (E. Caspari and A. W. Ravin, eds.), Vol. 1, p. 223. Academic Press, New York, 1969. 62. T. R. Broker and I. R. Lehman, JMB 80, 131 (1971). 63. R. Holliday, Genet. Res. 5, 282 (1964). 64. S. Fogel, D. D. Hurst, and R. K. Mortimer, Stadler Sump. 1 and 2, 89 (1971). 66. H. M. Sobell, PNAS, 69, 2483 (1972). 66. M. J. Bessman, in “Molecular Genetics” (J. H. Taylor, ed.), Vol. 1, p. 1. Academic Press, New York, 1963. 67. M. Goulian, CSHSQB 23, (1968). 68. T. Kornberg and M. Gefter, PNAS 68, 761 (1971). 69. R. Okazaki, T. Okazaki, K. Sakabe, and K. Sugimoto. Jnp. J . Med. Sci. Biol. 20, 255 (1967). 70. E. K. Schandl and J. H. Taylor, BBRC 34,291 (1969). 71. F. Jacob, S. Brenner, and F. Cuzin, CSHSQB 28, 329 (1963). 72. J. H. Taylor, in “Genetic Organization” (E. Caspari and A. W. Ravin, eds.), Vol. 1, p. 163. Academic Press, New York, 1969. 73. C. B. Bridges, J . Hered. 28, Bo U935). 74. W. Beermann and G. F. Bahr, Exp. Cell Res. 8, 195 (1954). 76. A. L. Dounce, Amer. Scientist 59, 74 (1971). 76. A. E. Mirsky and H. Ris, J . Gen. Physiol. 34, 475 (1951). 77. H. M. Sobell, Advan. Genet. 17, in press.
Resistance Factors and Their Ecological Importance to Bacteria and to Man
I
I
M . H . RICHMOND Department of Bacteriology. Pniversity of Bristol. Bristol. England
I . Introduction . . . . . . . . . . . I1. Resistance Factors and the Genes They Carry . . . A . The Resistance Transfer Factor . . . . . . B . Plasmid Replication . . . . . . . . . C . The Maintennnce and Segregation of Plasmids . . . D. “Curing” . . . . . . . . . . . E . Practical Aspects of Maintenance . . . . . . F. The Gene Products Needed for Conjugation . . . G . DNA Transfer During Mating . . . . . . 111. Resistance Determinants . . . . . . . . A . Penicillin and Cephalosporin Resistance . . . . B. Chloramphenicol Resistance . . . . . . . C . Resistance to Aminoglycoside Antibiotics . . . . D . Tetracycline Resistance . . . . . . . . E . Sulfonamide Resistance . . . . . . . . F. Other Resistance Factor-Mediated Determinants . . I V . Other Plasmids Related to Resistance Factors . . . V . The Mating Process . . . . . . . . . . A . The Pilus Bridge and Its Formation . . . . . B. Gene Transfer . . . . . . . . . . C . The Properties of Newly Infected Recipients . . . D . The Transfer Process: A Summary . . . . . VI . Resistance Factor Transfer in Nature . . . . . A . The Early Observations . . . . . . . . B . Resistance Factors and Pseudomonas aeruginosa in Burns C . Resistance Factors and Resistance Transfer . . . References . . . . . . . . . . . .
. . . .
. . . .
. . . . . . . . . .
. . . . . . . . . .
. .
. .
. . . .
. . . . . .
. . . . . .
. . . . . .
191 193 194 195 203 206 208 209
212 213 213 215 216 219 219 220 220 221 221 223 230 231 233 233 235 238 244
.
1 Introduction The study of transferable drug resistance is a project very much in tune with the times: it has both a fundamental interest a t the molecular level and also the greatest relevance to the everyday life of all of US . At the molecular level. it throws light on how hereditary material introduced freshly into a bacterial cell may survive and become part. for a time a t least. of the informational content of that cell and of the bacterial popula191
192
M. H. RICHMOND
tion of which the cell forms part. I n practical tcrmns, it shows how bacterial cells may respond to a changing environment. Man has made the production of antibacterial substances into a multimillion dollar concern ; and the selection pressure that this cffort exerts on the bacterial population is immense-particularly in certain niches important to man. Everywhere one reads of the appearance and the spread of new or different patterns of bacterial resistance in the environment. Transferable antibiotic resistance is merely one example of a general phenomenon, but its study may show the nature of the steps involved in this process and thereby how to mitigate it. Spread certainly occurs: and it frequently goes a great way to undermine the value of new therapeutic agents. Too often, in the past, the study of gene transfer has interested two groups of people who had too little to say to one another. On the one hand, there were those who were concerned with elucidating the detailed steps of how transfer is effected, what form the transferred information takes, what steps are involved in the survival of the transferred piece in the recipient, and the like. The second group has compiled statistics about the incidence of resistance, charted the emergence of new resistant strains in thc bacterial population and tried to devise ways of reducing both the selection pressure of antibacterial therapy and the chance that resistant organisms would pass from one host to another. Too often these last people were busy hospital bacteriologists with a heavy routine professional commitment who often could not spare the time, and who frequently did not have the training to appreciate the molecular intricacies of the subject. Although the situation is rapidly improving with the worldwide increase in the number of groups making a concerted epidemiological and molecular attack on this problem, there are still only very few written accounts that attempt to deal with both aspects a t the same time [see, however, Anderson ( I ) ] : this article, therefore, tries to fill this gap and bring the story up-to-date. First we examine those aspects of bacterial genetics and biochemistry that are relevant to the survival and transmission of antibiotic resistance genes between bacterial cells. This involves a fairly detailed discussion of the nature and processes associated with the survival and transfer of R-factors' and other plasmids in bacteria. In the second part we examine certain examples claiming to show the importance of R-factor-mediated transfer of antibiotic resistance genes during the course of a clinical infection, and try to assess how widespread this
'Abbreviations: R, resistance (factor) ; RP, R-factors originally isolated in Pseudomonns aeruginosa; RTF, resistance transfer factor: F, fertilitv factor ,: I.. fertility factor specifying syntliesis of colicin I ; CCC, covklently closed circle (of DNA).
RESISTANCE FACTORS
193
process is and how serious in a clinical context. Since the discovery of transferable antibiotic resistance in Japan in the late 1950’s [see Watanabe ( 8 ) , for a review], bacterial mating has been held up as being of the greatest importance in the development of resistant bacterial populations. But there is real doubt as to whether the process is really important in giving rise to antibiotic resistant variants during the coursc of treatment or whether it has a more strategic role to play in building up a reservoir in thc so-called normal, healthy population. I n this review, we try to assess this situation-at least as it exists a t the time of writing. Before starting, it is important to stress that this review is in no way an attempt a t an exhaustive treatment of the molecular biology of R-factors, let alone bacterial plasmids. Throughout, emphasis is on those aspects of R-factor behavior that have most importance from the ecological point of view ; nevertheless, somc emphasis on thc molecular basis of thc process is important.
II. Resistance Factors and the Genes They Carry R-factors first emerged as elements that can promote transfer of genes conferring resistance to antibiotics from strains that carried the R-factors to strains that lacked them [see (1-3) for reviews]. Superficially, Rfactor transfer is analogous to transmission of the fertility factor; the act confers the ability to transfer in its turn on the recipient. There has been some doubt as to whether the donor loses the ability in the process ( 4 ) . Current evidence suggests that it does not [see ( 5 ) and Section V, B, 11. As studies on R-factors multiplied, it emerged that it is useful to divide the genes carried on the elements into two functional groups: The resistance transfer factor and the rcsistance determinants. The first group of genes is responsible for the replication and distribution of the plasmid on cell division and for the promotion of plasmid transfer to recipient cells. Nontransmissible R-factors (or a t least those that rely on methods other than conjugation for their transfer) seem to have the first two of these regions but not the third, and if transfer of this type of element is to take place, these genes must be provided by another plasmid ( I 1. The resistance determinants on an R-factor are thc genes that specify the molecules that confer the resistance. These are frequently biochemical products that destroy or inactivate the antibiotics (6-8), but sometimes they prevent the antibacterial agent from reaching its target within the cell (9). Certain R-factors also carry a number of genes apparently unrelated-or a t least only remotely related-to antibiotic resistance. These are discussed later (see Section 111,F.)
194
M. H. RICHMOND
A. The Resistance Transfer Factor Although it is easy enough to give a catalog of the overall functions of RTF,' the detailed genetic structure of the region, the exact nature of the biochemical products specified and the way in which they are COordinated to achieve plasmid survival and transfer are still largely unknown. It is not even certain how large the region is. Indirect estirhates obtained by coinparing the sizes of transmissible and nontransmissiblc variants of the same R-factor suggest a molecular weight in the region of 50 X 10" for R T F ; and this amount of DNA corresponds to about 70 genes (10-16).However, plasmids that are nontransmissible must still retain some genetic material characteristic of the RTF, and a transmissible fragment that has lost all its resistance determinants may yet carry information not properly part of RTF. Any indirect estimates of size must, therefore, be treated with extreme caution. Nevertheless, it does seem likely that a major part of the DNA of any plasmid is likely to be concerned with the survival and transfer of that plasmid, and this, in turn, stresses how important transmissible genes must be to bacterial populations, since there must be a considerable selection pressure tending to delete such large pieces of genetic information. Even when the genes and their products have no functional role, there must be a pressure tending to delete the genetic information from the cell. I n the last analysis, the energy required to synthesize the useless genes themselves will apply pressure toward their ultimate loss. Any cell that has lost the genes will be energetically more favorably placed than those that have not. The major functions specified by the RTF can be classified as follows: (1) initiation and regulation of plasmid DNA replication; (2) maintenance of plasmids in the cell and their segregation to daughter cells a t division ;
(3) specification of the gene products needed for conjugation; (4) transfer of DNA during conjugation.
Although such a list describes accurately enough the functions that depend primarily on the nature and the behavior of RTF, they are unlikely to reflect clearly the biochemical organization involved. For example, the DNA replication that seems to be an essential part of gene transfer during conjugation (IS) is unlikely to be rigidly independent, a t a biochemical level, from the DNA replication needed for plasmid duplication in growing cells. Furthermore, since each of the functions detailed above itself probably requires many gene products, it seems likely that some genes from the RTF have a relatively wide role to play in plasmid rnaintenancc and transfer, whereas others may be highly
RESISTANCE FACTORS
195
specific. Therefore, it is still premature to expect to get any clear, overall picture of how the genes comprising the RTF act. From the point of view of this article, we concentrate on those aspects of R T F structure and function that must play an important part in the practical aspects of gene transfer discussed later. Of course, all parts of the R T F are relevant to this topic, but some, such as the genes that decide on the number of plasmid copies per cell, those that specify the nature of the conjugation apparatus made by plasmid-carrying cells and those that allow autonomous replication of an incoming plasmid in a new host, must be of central importance. A number of recent detailed accounts of this subject are available (e.g., 14, 15).
B. Plasmid Replication With a number of important exceptions, the total amount of plasmid DNA forms a relatively constant proportion of the total DNA in plasmidcarrying bacterial strains. Between 0.5% and 5% of the DNA is extrachromosomal when a plasmid is present (16, 17).I n general, the carriage of bacterial plasmids seems much more widespread than originally anticipated, and plasmid DNA is often detected without any concomitant biochemical characters bcing evident (18). One can, therefore, think of “orphan” plasmids, much as one thinks of “orphan” viruses. The fact that plasmid DNA comprises a relatively fixed proportion of the cell’s DNA over relatively long periods implies that its rate of replication must be adjusted to be closely in step with that of the chromosome. Analysis often shows one plasmid copy pcr chromosome in the cell [e.g., RlOO in Escherichia coli (19-22)] ; but sometimes a number of plasmid copies exist for each set of chromosomal markers [e.g., the same plasmid in Proteus inirabilis (23, 2 4 ) l . Whichever is the case, a careful regulation of plasmid replication is necessary, since even a small difference between the two rates of DNA synthesis would lead rapidly either t o loss of the plasmid or to conversion of all the cell’s DNA to the plasmid state; this regulation of replication seems to be one important role played by the RTF. I n practice, plasmid replication must be considered in two part